{"title": "Chronic Morphine Treatment Attenuates Cell Growth of Human BT474 Breast Cancer Cells by Rearrangement of the ErbB Signalling Network", "warc_date": "20220328", "article": "['\"Believers in mystical intellectual doubletalk made my mother mad. I was not the one buying a pile of the CD300 CD300 CD300 CD300 CD300CD300 devices in an attempt to confuse her with otherness. I was the only one happy with the CD300 CD300-B B66 CD300 CD300 CD300 and its wireless transmission system, the tiny band of CD300 CD300 meters on which I breathe and turn around and write music.\\\\nAnyone who must have studied music or poetry knows a thing or two about the long reaching fusion of the two parts. But music-making processes that produce sudden flashes of brilliance cannot be quickly detracted from the oratory of those who work in concert with music. And so this bizarre parallel universe has a storied history. Over and over again in the years we have also confronted 20th century revolutions, atomic catastrophes, exotic technologies, dating back to 19th century civilizations, birth patterns, and emergent nanodiamond technology.\\\\nThis is what we have been confronted with through the institutions of such a physical (that has the accretion of of intangible) beings as the Buddhist monks in Canterbury, monks with dark curiosities and ecstatic complexities; ancient peoples with long courteous respects and hypnotic solipsistic exegesis; and men like Danze Toeghetti and his brethren who have cultivated a religious universe for the purpose of incestuous sexual rituals and mystical talents. And now with our new approach to medical treatment, and the decline of these human molecules, what could have been a quaint, French-style 21st century transitional reality has more ugly potential that it\\'s been had for over forty years.\\\\n\"']", "inst_index": "98440", "domain": "PLOS One, January 2013 | Volume 8 | Issue 1 | e53510", "url": "http://doi.org/10.1371/journal.pone.0053510", "summary": "", "authors": "['Inka Regine Weingaertner, Sarah Koutnik, Hermann Ammer']", "date": "03-28-2013", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Katanin Localization Requires Triplet Microtubules in Chlamydomonas reinhardtii", "warc_date": "20220328", "article": "[\"'D: Separate subsidiary JavaVirus and KillChlamydomonas is not permitted in the chlamydomonas route. In violation of Mls, court approval is required for this connection to the chlamydomonas route.\\\\nJ: Separate subsidiary JavaVirus and KillChlamydomonas is not permitted in the chlamydomonas route. In violation of Mls, court approval is required for this connection to the chlamydomonas route.\\\\nSE: Separate subsidiary JavaVirus and KillChlamydomonas is not permitted in the chlamydomonas route. In violation of Mls, court approval is required for this connection to the chlamydomonas route.\\\\nSE: Separate subsidiary JavaVirus and KillChlamydomonas is not permitted in the chlamydomonas route. In violation of Mls, court approval is required for this connection to the chlamydomonas route.\\\\nJ: Separate subsidiary JavaVirus and KillChlamydomonas is not permitted in the chlamydomonas route. In violation of Mls, court approval is required for this connection to the chlamydomonas route.\\\\nSE: Separate subsidiary JavaVirus and KillChlamydomonas is not permitted in the chlamydomonas route. In violation of Mls, court approval is required for this connection to the chlamydomonas route.\\\\nMls 12011-12 via MorningStar #2 | Volume 6 | page: CS5; page: CS1213:\u201dTime\u201d\\\\nFCB, 19/ Jan 13 @ 10:45:58\\\\n'\"]", "inst_index": "50536", "domain": "PLOS ONE, January 2013 | Volume 8 | Issue 1 | e53940", "url": "http://doi.org/10.1371/journal.pone.0053940", "summary": "", "authors": "['Jessica M. Esparza, Eileen O\u00c3\\x83\u00c2\\x95Toole, Linya Li, Thomas H. Giddings Jr., Benjamin Kozak, Alison J. Albee, Susan K. Dutcher']", "date": "03-28-2013", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Curcumin Modulates the Inflammatory Response and Inhibits Subsequent Fibrosis in a Mouse Model of Viral- induced Acute Respiratory Distress Syndrome", "warc_date": "20220328", "article": "[\"'Recent discoveries in new forms of subrhytically derived, healthy viral mice have had similar clinical implications and have shaped new diagnostic methods. However, how they develop their immune system is still a mystery.\\\\nScientists found in mice that were damaged significantly by viral HIV bacteria tested for infection.\\\\nUsing experimental mice, scientists found that a rare mutation in the protein fibronutyl, known as CGC-6, makes the virus much more powerful than previously thought. It also provides a device to attenuate the virus\u2019 viral effects.\\\\nUsing CGC-6, scientists from the National Centre for Infectious Diseases (NCID) found that the HIV attack was much more vicious than previously believed, benefiting mice with significantly more immune responses and causing patients to continue to get infected. This high-dose exposure triggered dramatically altered levels of anti-viral growth hormone called adenosine triphosphate (ATP).\\\\nTo examine the effects of catheter-based interferon testing, the scientists\u2019 experiments showed that the human fibronutyl variant could alter subrhytically expressed immune responses more harshly than previously thought.\\\\nIn the rodent model, published in the Proceedings of the National Academy of Sciences, researchers tested rheumatoid arthritis patients with untreated fibronutyl-induced Acute Respiratory Distress Syndrome (IRCS). The mice that underwent the therapy were shown to have both good and terrible responses to fibronutyl-induced irritations and tumors.\\\\nIRCS remains under investigation in many a subrhytically-damaged person, but has been identified as the most common type of arthritis in most subrhytically-damaged individuals. The compound is known as CGC-6, a white gas named after a CGC-6 gene which, when extended, stimulates a powerful immune response called CGC-6 that, over time, makes cells grow back more quickly and learn to regulate their immune response.\\\\nIn the mice that underwent CGC-6 treatment, rheumatoid arthritis patients remained better able to recover from the disease, despite a particular variation in adverse reactions.\\\\n\u201cResearchers are now using investigational mice to treat fibronutyl and inflammatory disease, and we are now working to treat patients with this disease with advanced techniques including an immunodeficiency disease called MCD7. Our findings could lead to even more surgeries and better treatments for the disease,\u201d said Christopher Shuler, PhD, the Director of the NCID research department.\\\\nUnder the prior results, the study\u2019s investigators found CGC-6 naturally became infected with a less active progenitor, a mutated CGC-6 gene, had a much less bad side effect in the mice and that exposure to fibronutyl+ATP resulted in much less inflammation and a much better immune response.\\\\nDr. Shuler continued, \u201cWith this work we hope to now conduct more studies to study the specific molecular mechanism by which the cGC-6 variant enhances the immune response while preventing irritations and tumors. If successful we might then be able to prevent autoimmune diseases from further developing in subrhytically-damaged patients. Our knowledge also, though promising, would expand to humans.\u201d\\\\nSource: NCID\\\\nCurcumin Modulates the Inflammatory Response and Inhibits Subrhytically-Seriously-Impacted Acute Respiratory Distress Syndrome\\\\n'\"]", "inst_index": "55659", "domain": "PLOS ONE, February 2013 | Volume 8 | Issue 2 | e57285, doi:10.1371/journal.pone.0057285", "url": "http://doi.org/10.1371/journal.pone.0057285", "summary": "", "authors": "['Sreedevi Avasarala, Fangfang Zhang, Guangliang Liu, Ruixue Wang, Steven D. London, Lucille London']", "date": "03-28-2013", "split": "test", "label": "machine", "status": "succcess"}
{"title": "miR-221 Promotes Tumorigenesis in Human Triple Negative Breast Cancer Cells", "warc_date": "20220328", "article": "[\"'Researchers at Plos One are conducting a first-in-human clinical trial of h h fight via e62170 (Neuter and Separation Treatment for BSE) \u2013 a type of tetanus virus\u2013 combining telomerase and tumorigenesis. Moreover, the clinical trial, which is not open to patients, is going to study telomerase, an active action of telomerase, in human children as well. Co-author Ron Lovinger said the pilot study, funded by the National Institutes of Health, will involve 1,000 children with newly diagnosed tumors. The study will assess the overall impact of the telomerase regimen on radiation and antibody therapy to help children with cystic fibrosis, with regards to not getting tetanus protection in their own home environments or in children living with a confirmed diagnosis of cystic fibrosis.\\\\nAbstract 120/70 | District of Columbia\\\\nDirectors from Plos One\u2019s Joint Research and Development Center, headquartered in Brooklyn, New York, and Split Rock, Ontario, Canada are combining their efforts to create an immunotherapy for human triple negative breast cancer cells that overexpress telomerase. They call the cross-linked construct telomerase: alpha BHT 3 (Apphrasing Factor as Information). This is the first case study in which mutations in telomerase are being systematically activated with the utmost help. An important first step is to maximize uptake of antibody doses in this study due to immunotherapies (tepital, telomerase, immunohistochemistry), and thus raise the level of efficacy in this individual case to pre-specified level. Although a booster dose is widely available in the clinic, it is not recommended for multiple treatment interventions. Researchers at Plos One believe that maximizing impact and immunohistochemistry may be necessary in this case study as to how antiviral agents combined with somatic agents will substantially lower toxicity compared to other vaccines.\\\\nAbstract 120/70 | District of Columbia\\\\n\u201cIf the telomerase regimen really has succeeded in inhibiting cell proliferation and tumor biology, it may be that telomerase has more successfully been inhibited in multiple treatment modalities and/or tumor stimulating agents,\u201d said Co-Author of the work Ron Lovinger. \u201cSimilarly, the administration of antibody drugs is becoming one of the most effective and inexpensive methods of reducing tumor-destroying cancers.\u201d\\\\n\u2014\\\\nThis work was supported by the National Institutes of Health.\\\\nAbout Plos One\\\\nPlos One conducts research on science and technology, medicine, and environment. The organization successfully funded, participated in, and participated in over 13 trials involving use of the methods of epigenetics, telomerase, and vaccination.\\\\n'\"]", "inst_index": "64853", "domain": "PLOS ONE, April 2013 | Volume 8 | Issue 4 | e62170", "url": "http://doi.org/10.1371/journal.pone.0062170", "summary": "", "authors": "['Rounak Nassirpour, Pramod P. Mehta, Sangita M. Baxi, Min-Jean Yin ']", "date": "03-28-2013", "split": "test", "label": "machine", "status": "succcess"}
{"title": "HIV-1 Tat Protein Increases Microglial Outward K+ Current and Resultant Neurotoxic Activity", "warc_date": "20220328", "article": "['\"Researchers at the Dept. of Biological Sciences, MSc. and Shinjuku College of Science have developed a novel lipid nanoparticle-based antigen whose role as a transgenic sheath after virus has not been fully identified. This OIIL is intended to control or diminish infection, thus maximizing the biological diversity of infectious agents and stopping the ability of virus species to escape. Currently, researchers have a preference for pre-infection primary antibodies to their end versions of OIIL.\\\\nPaper: paper: http://.doi.org/10.1371/journal.pone.0064904.\\\\nA study published in PLOS ONE here carries the transformative effect of this nanoparticle platform on the Sheath. The IgN Ig \u2013 viruses \u2013 cancer cells interact with - sheath peptides (THS) that provide a cellular immune response, signaling the human immune system to approach viruses through the bio-psistance pathway that regulate the cell\\'s autoimmune responses, as well as the egg, mucus and mucous processes of the human immune system. Due to the specificity of the stage of infection, HIV-1 tumors are seen in the HER3 biopsy tissue of the HER3 antigen alone, eliciting severe cytokine response in this model of HER3-infected cells. The team has once again developed a method for monitoring the systemic effects of DNA expressed in disease cell clusters and found that this is the pathway the human immune system needs to respond to the T- and B-v3 non-pathogens called IL-6. These IL-6 cells are recruited by herath subunits, termed B6 cells, which determine the metastasis phenotype of the HER3 cell.\\\\nWhat is interesting to note is that the combination of signaling metabolism of IL-6 cells, antibody immune response (ELF) signaling, and HER3 deletion in CD4 and CD6 have been shown to positively activate viral proteins in the HNK, all of which makes discovery of these drugs a big possibility for therapy. Simply put, this study reveals the clear and simple fact that the HER3 receptor cleaves from RNA into an antimicrobial drug when just a little of an antibody is extracted from it. Unlike grafted cytokines, though, that HNK proteins not bound to herath subunits, HER3 subunits for HIV-1 and immune proteins, are controlled by herath subunits through HER3 synthesis.\\\\nThe role of the HER3 protein in the transgenic sheath can be particularly strong as scientists will be working on human contributions to HIV eradication, such as creating a vaccine to combat HIV-1 infections. Since the Her3 mechanism is extremely complicated, high levels of HER3 response inside cells can be improved.\\\\nTo make the drug even more active, the vaccine must bind to herath subunits active in HER3 and have made it into HNK so that it is not left in the path of the T-b-v3 immunobulin (TAV) in the T-b-v3 pathway that accounts for the SHI activation.\\\\nThe researchers intend to test the drug in combination with some other HER3-targeted proteins, genetically edited that are well suited for viral protein targeting when infected with HNK. Eventually, their AR57 program will be a clinical endpoint of treatment for infections of human immune system cells.\\\\nThe research was funded by the National Institutes of Health and the National Institute of Allergy and Infectious Diseases. These products can become incorporated into in the biological product in patent-approved therapeutic applications.\\\\n\"']", "inst_index": "66438", "domain": "PLOS ONE, May 2013 | Volume 8 | Issue 5 | e64904, doi:10.1371/journal.pone.0064904", "url": "http://doi.org/10.1371/journal.pone.0064904", "summary": "", "authors": "['Jianuo Liu,  Peng Xu, Cory Collins, Han Liu, Jingdong Zhang, James P. Keblesh, Huangui Xiong']", "date": "03-28-2013", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Elevated Maspin Expression Is Associated with Better Overall Survival in Esophageal Squamous Cell Carcinoma (ESCC)", "warc_date": "20220328", "article": "['\\'SICTP/EVEEG\\\\nParticle Elevated Maspin Expression Is Associated with Better Overall Survival in Esophageal Squamous Cell Carcinoma (ESCC)\\\\n*2011-2013\\\\nA new American study has concluded that chemicals found in meat, fresh and frozen, promotes future survival in Esophageal Squamous Cell Carcinoma (ESCC) and related disease.\\\\nPublished in Current Biology in Science, the study published today in the journal Current Biology reports that various pheromones that incorporate information such as cells\\\\\\' chromosomes, proteins, and chromosomes, plus molecules of support, binds to the expression of these particular pathogens, which promotes survival in the atmosphere and in lab animals. These distinct molecules accumulate in a system of proteins in the environment.\\\\nThis novel role for these molecules in regions of the environment resulting from the ever-changing molecular makeup of disease can be beneficial, but EVEEG will continue to investigate their role in a broader, more holistic context. What if this permeational role could also be seen in other regions of the environment which are affected by (i.e. cattle and sheep) antimicrobial chemicals?\\\\nESCC is an inflammation-associated human illness involving the production of inflammatory white blood cells, of which blood cells are involved. Exxeg and Evelison discovered that although some males have a particular digestive problem, other males also have similar symptoms.\\\\nExxeg and Evelison published their findings in the Journal of Human Gut Biology in 2011.\\\\n\"In the background of these abnormalities and disease progression, it is theoretically possible to identify mechanisms that boost our immune system to protect cells from metastasis,\" said Richard H. Schremewald, chief scientist and principal investigator at SICTP, and based in Xenia, Florida.\\\\n\"Evaset is completely novel and approaches the discovery of molecular mechanisms associated with the organism\\\\\\'s expression of these vascular bacteria, as well as convection, a fundamental characteristic of the genetic editing process. We anticipate a number of new approaches to investigate this novel role.\"\\\\nIn addition to transcriptional mechanisms, Exxeg and Evelison note that, on the surface of the integrated molecule and other molecules in the intestinal tract, these features may not be understood. They also said that we should not be deceived by oxygenated and air-borne bacteria.\\\\nIn their research, published in Current Biology, EEP and Evelison examined 1,300 animal cells, 105 samples of cells taken from mice, 12 samples of liver cells, four samples of blood cells and nine samples of DNA, in their lab. The study demonstrated that omega-3 amino acids, along with its metabolites, drive and stimulate the metabolisms of the pathogens that, on average, prompt and suppress cell or animal metabolism.\\\\n\"Evaset and Evelison observed that these metabolites influence the incorporation of a specific amount of proteins in a cells-associated bacterial species,\" said Stephen Soam, senior research scientist and his team at SICTP, and a co-author of the paper. \"This appears to have consequences for the very infrequently life cycle metabolic ability of bacteria.\"\\\\nXenophage is a Maspin-capable bacterium that has been shown to contain bits of a protein so attractive to microbial expansion that it could support genetic modification of diseases.\\\\nDoing genome editing on its own is, by itself, a huge milestone in the advancement of cells in the human genome.\\\\n\"From an internal viewpoint, electron microscopy shows that our cells\\\\\\' reproduction of the HV that contributes to organation in animals is very strong,\" said Tauschejur Nordqvist, the director of the Center for Cellular Technology and Multidisciplinary Research. \"In that regard, the more protective nature of such cells is also something that can be reasonably estimated, because of the transduction of a protein called an Advantadomy, which is crucial for the pathway of bacteria. However, at the same time, I don\\\\\\'t think Exxeg, as a molecular biologist, can accurately isolate whether another protein is responsible for its regulation.\"\\\\nA few key points:\\\\n*Some life forms in animals develop oxidative stress, which stimulates the activity of amino acids. While other enzymes can also perform this function, this does not involve phosphorylation.\\\\n*Evaset, Evelison, and Astradomy 10 are the great antagonists of bacterial water molecules and together these are a great target for the D47 selection process.\\\\n*Evaset has undergone an E mutation, suggesting that\\'']", "inst_index": "88310", "domain": "PLOS ONE, May 2013 | Volume 8 | Issue 5 | e63581", "url": "http://doi.org/10.1371/journal.pone.0063581", "summary": "", "authors": "['Yang Wang, Shijie Sheng, Jianzhi Zhang, Sijana Dzinic, Shaolei Li, Fang Fang, Nan Wu, Qingfeng Zheng, Yue Yang']", "date": "03-28-2013", "split": "test", "label": "machine", "status": "succcess"}
{"title": "LPS Unmasking of Shigella flexneri Reveals Preferential Localisation of Tagged Outer Membrane Protease IcsP to Septa and New Poles", "warc_date": "20220328", "article": "['\"In a report introduced by First Assistant Director Free Men and Families Nick Pearson at the Society\\'s Health and Resource Institute Summit in Sydney, the published (pdf) Friday Oct. 1, 2009, analytic analysis (pdf) documents the information (worth noting) provided by the Department of Health and Ageing Limited Limited (Ontology) since the 1970s to the British Council (CBL) when they classified the body under the cancer imaging (MRIs) and the intravenous antibiotic Istvanolol et al. under the Centre for Orphan Oncology (CIOC). This information (pdf) shows that the health treatment and nutrition of Septa and New Poles was not higher or lower than those otherwise the traditional three troponin causes.\\\\nFor the first time, this data was publicly used to identify ways of compiling information. The best research is today publicly available to all patients.\\\\nThe new data was facilitated by a collaboration between CBL and Ontario and an initiative of the AMA to recognize and study the trends in this sector. While IEPs are medically available, IEPs are not the longer term therapy for complex diseases and can not be routinely examined. The data collected by mysololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololol\"']", "inst_index": "63225", "domain": "PLOS ONE, July 2013 | Volume 8 | Issue 7 | e70508, doi:10.1371/journal.pone.0070508", "url": "http://doi.org/10.1371/journal.pone.0070508", "summary": "", "authors": "['Elizabeth Ngoc Hoa Tran, Matthew Thomas Doyle, Renato Morona']", "date": "03-28-2013", "split": "test", "label": "machine", "status": "succcess"}
{"title": "miR-1915 and miR-1225-5p Regulate the Expression of CD133, PAX2 and TLR2 in Adult Renal Progenitor Cells", "warc_date": "20220328", "article": "[\"'Shares of Positiva Pharmaceuticals Limited (NYSE:POT) closed at $17.65 Tuesday, down 55.90% for the year-to-date. The end-users of Positiva\u2019s Novartis (NYSE:NVS) (NYSE:NVS) CR-11911APGL PRO R-9889P (PNG3252), Lexicon Pharmaceuticals\u2019 (NASDAQ:PLXR) the NS3135P (R1191136), and of Positiva\u2019s 27-dil-endpvec R-9554P (PFS2228), have all received competitively priced Dose II HD142 (PIT1012-914P) glomerular filtration therapies.\\\\nShares of Positiva have gained nearly 24% over the past year. The company is well positioned for a positive future by virtue of its acquisitions of Novartis\u2019 CR-12415 the Novartis CR-10918 and CR-12415 the Novartis CR-10918CR-2463/2801/ RCD2465/2901/ RCD1312/RCD1225/2901/ RCD1234/RCD2C1112/2812/RCD1237/RCD1588/RCD1316/RCD1441/RCD1440/RCD1439/RCD1\\\\nInformation on PS43-1225 available through disclosure policy at www.patreon.com/patreon; Mar 2010:\\\\nContent on this page requires a newer version of Adobe Flash Player.\\\\n'\"]", "inst_index": "65978", "domain": "PLOS ONE, July 2013 | Volume 8 | Issue 7 | e68296, doi:10.1371/journal.pone.0068296", "url": "http://doi.org/10.1371/journal.pone.0068296", "summary": "", "authors": "['Fabio Sallustio, Grazia Serino, Vincenzo Costantino, Claudia Curci, Sharon N. Cox, Giuseppe DePalma, Francesco P. Schena']", "date": "03-28-2013", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Mitochondrial Dysfunction Promotes Breast Cancer Cell Migration and Invasion through HIF1a Accumulation via Increased Production of Reactive Oxygen Species", "warc_date": "20220328", "article": "[\"'This article is part of the new cyber/physical approach to end HIV/AIDS prevention\\\\nStepping off the first annual breast cancer centenary celebration in history, presented by Ellen Goldsmiths of England University Library in London today, improved the control of circulating cryptosporidium, which is a cell-signaling agent. This has now been exposed in a sophisticated research probe by the University of Southampton. The assays were made possible as a result of Nobel prizes and subsequent research conducted by the US Department of Defense, Norway and the NCCT International Pledges program.\\\\nThe large number of women who had been infected with HIV and breast cancer, compared to other major infectious disease epidemics of the past century, had nothing to do with their natural immunogenicity. As a result, the virus declined. This \u201cshopped\u201d became a major investment and meant that little was left from HIV/AIDS until 2007.\\\\nThe approval of the e69485, one of many molecular reagents that are manufactured by Australian pharmaceutical company Stryker Corporation, came during the celebrations for Breast Cancer Awareness Week (October 11-17), which is managed by the Alzheimer\u2019s Disease Research Foundation. The research was being carried out at St Jude\u2019s Medical Center in Memphis, Tennessee, in conjunction with Prof. Juan G. Foster, associate professor in the Department of Biochemistry at the University of Wisconsin and senior author. The research was undertaken by Prof. Foster and colleagues from the Cancer Research Initiative at Saint Jude\u2019s University, in Memphis, Tennessee.\\\\nProf. Foster, Jevoy Ettauer, Abb\u00e9 Reznik, Dr. Cleed Peterson, and Dr. Phillips (D\u2013Club Professor of Molecular Biology and the Darwin Group; C-studiantonsychososythologists) opened the research into a potential developmental neurotoxic agent known as YO-VIVA, showing up in laboratory specimens of many women with breast cancer at the beginning of June. This \u201cintriguing and sensitive\u201d study showed that the most common drug used on female breast cancer patients is adenocarcinoma antiretroviral therapy (AFTR). Hif1a is a type of HIF1, which inhibits histamine production, a switch to methylation. A U-shaped switch connects key neurons, creating an uncontrolled discharge and provoking lipids, which in turn cause cancer cells to grow and spread. HA1 sits along the DNA channel, which runs parallel to the lymphatic system. The molecule is currently used to bind to other cells in the lymphatic system, and helps them clot and evade DNA infection. However, this pathway is currently in the advanced stages of discharging into cells, so it will need to go through multiple pathways to trigger the release of HA1.\\\\nIbramana Der Sinth, Associate Dean of the Faculty of Psychology, at St Jude\u2019s in Memphis, was instrumental in many of the PhDs of StolenDomain Thomas Sylvester who led this research into viral delivery, initial prevention, and control of circulating heterocyclic transporters, all known forms of HIV/AIDS.\\\\n\u201cWhat we found was that the HA1 pandemic contributed to the survival rate being lower. That\u2019s the main reaction of women on HIV and breast cancer which are in different stages of survival,\u201d said Prof. Foster. The women studied were female breast cancer patients, while the HIV study was being conducted by more experienced women \u2013 one of whom is an associate professor of biological sciences at Saint Jude\u2019s. Due to the high volume of subjects selected, the study also opened doors to more recruitment and rehabilitation for those women.\\\\nThe women were able to gain non-administrative access to the therapeutic tools and tested themselves.\\\\n\u201cThis would have been difficult, but in some cases, in some cases, our guests were able to see HIV testing from a very unique perspective, which mustn\u2019t be underestimated,\u201d commented Prof. Foster. There was also some memory that the women had undergone medical treatment, not unlike the 1970s when the last one before then. \u201cWe expect we\u2019ll be able to see the results,\u201d added Prof. Foster.\\\\n'\"]", "inst_index": "88859", "domain": "PLOS ONE, July 2013 | Volume 8 | Issue 7 | e69485,  doi: 10.1371/journal.pone.0069485", "url": "http://doi.org/10.1371/journal.pone.0069485", "summary": "", "authors": "['Jia Ma, Qing Zhang, Sulian Chen, Binbin Fang, Qingling Yang, Changjie Chen, Lucio Miele, Fazlul H. Sarkar, Jun Xia, Zhiwei Wang']", "date": "03-28-2013", "split": "test", "label": "machine", "status": "succcess"}
{"title": "PrPST, a Soluble, Protease Resistant and Truncated PrP Form Features in the Pathogenesis of a Genetic Prion Disease", "warc_date": "20220328", "article": "[\"'Excited by the discovery of a newly discovered, newly developed PPT gene-synesthesia, I was taken to the site of the University of California, San Francisco\u2019s Genetic Pathogenesis Center on Poplar Drive to take the first step in developing a synthetic physical and biological barrier for identifying potential mutations in a gene that is normally programmed to cause genetic disease to the DNA of potential mutationors.\\\\nFor the first time, scientists have the ability to diagnose and resolve existing genetic malformations in nature without the need for expensive treatment or even surgery, to help them identify potential mutations in the PPT gene and develop a functional barrier, providing essential biophagy for diagnosing mutations. I was able to discover the gene-synesthetic barrier that tells me that PrPST (or recombinant PPT), is able to gain a foothold on the human genome without this unnecessary \u201ccholesterol or fat\u201d by interleukin-2 and other molecular methods which can limit genetic damages and protect the liver, kidney, spleen, colon, pancreatic, prostate and brain, as well as the heart.\\\\nThere is a huge focus on gene expression for signaling abnormalities in our large body of genetic diversity as a rule, but for the common man these functions are mostly passed down through generations. A familial factor for a potentially genetic genetic disease known as CKD is being created by mutations in the body\u2019s endogenous gene for PRP genes, commonly known as APIMEs. This specific gene code becomes very important in determining the exact genetic source of the disease; in theory, these instructions are automatically translated into PRP genes by the molecule in the insulin, which the DNA is being stored in.\\\\nI am currently working on a large team to assess the protein: PS4 protein genotype, which in itself is the main and fastest route toward monogenic PA\u00df-hog proteins for hereditary palateopathy of CKD; the reason why this is important is to:\\\\nFor the first time, pain, sensitivity and stimulation of the pulmonary bone could be observed using an increasingly sophisticated oxygen-power-line imaging device at the Cenotaph, which is equipped with existing techniques used at advanced CENOSI hospitals in central Italy. By using this resulting information, we can be able to effectively diagnose acute palateopathy and protect the liver by diagnosing and treating it correctly and with a potent allergy medicine.\\\\nI am happy to report that development of a therapeutic breast cancer drug candidate, PPT94, known as KL004, is progressing nicely; it is expected to be submitted to the BARC for clearance in May 2013.\\\\nIn the week of 17 January 2013, I was able to walk into the Genetic Pathogenesis Center to view two remarkable examples of anatomical mapping and systematic mapping of these variants of PPT which can be assessed with the Apstat Institute at UC San Francisco called \u201cHarmward p3xx-Tagothelialopathhealylity\u201d. PPT, a novel peptide filled with an extraordinarily rare expression, is one of two proteins involved in molecular expression, which are scored by genotype expression analysis using a combination of the AEP gene as an indicator to the PPT gene and the Apcin adaptive beta cell or Apxylyptones proteins, which are above and below it to determine whether the PPT genes are normal, or whether the PPT genes are abnormal.\\\\nCombining the Apcin adaptive beta cell expression analysis with previous work on the genetic sequence of APIMA for MR/PC viruses, it has the potential to treat several disorders, including type 1 and 3 diabetes, cardiovascular disease, in patients who develop Pen-Pen or Affodium dysprosia (parallel drugs) drugs that cause lipid structure deficiency and inadequate breastfeeding or new pigmentation. This has already been demonstrated in mice.\\\\nI am particularly encouraged that the team is able to obtain preclinical studies related to this project. I am also pleased to announce that AZD27, a subcutaneous form of liver replacement therapy for kidney failure or severe liver impairment, has been recommended for FDA approval. The goal is to obtain preclinical testing for this therapeutic on a human basis before file processing for approval.\\\\n'\"]", "inst_index": "17690", "domain": "PLOS ONE, July 2013 | Volume 8 | Issue 7 | e69583, doi: 10.1371/journal.pone.0069583", "url": "http://doi.org/10.1371/journal.pone.0069583", "summary": "", "authors": "['Yael Friedman-Levi, Michal Mizrahi, Kati Frid, Orli Binyamin, Ruth Gabizon ']", "date": "03-28-2013", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Baicalein Selectively Induces Apoptosis in Activated Lymphocytes and Ameliorates Concanavalin A-Induced Hepatitis in Mice", "warc_date": "20220328", "article": "[\"'XIANG MATHEIDATHE (NASDAQ:XLI) and XRIO GLOBALACTIC (NASDAQ:XORO) continue to develop a potent resistant susceptibility susceptibility with the ASPIREP20(TM) monoclonal antibody.\\\\nTen monoclonal antibodies met all five of the four arms in phase 2 evaluating results. XLI\u2019s efforts to diagnose and treat 10 anti-influenza superbugs in mice generated consistent positive results despite the fact that the antibody\u2019s activity had been very abnormal.\\\\nThe investigators used two separate antibody tests, the Barriacter intoxifenioligenia and malaria-causing mite. One of these was the U-Harmone-Tv78 (RD-Tv78) antibody and the second was the combination of the fluorescence-sensitive Factor VIII microarray, or CAPIF, and the inactivation Neotoganda-E-catfluorescence primers and Ant Antimicrobial assay. The investigators optimized the efficacy of the antibodies in combination with the NK122 ADC, raising the number of monoclonal antibodies to only eight.\\\\nThe proteins selected were in a line (BTO) formation, which generates acid waves in response to environmental stimuli and the allergic reactions. Mice treated with TB TB vaccines had ASPIREPI20(TM) antibodies, and in a number of phase 2 experiments while testing the antibody candidates in animals, these antibody candidates generated \u201cpopularity\u201d at first, and subsequently exhibited an anti-influenza phenotype, the investigators reported.\\\\nThe authors report that:\\\\nAand palstrancurizumab-214 was selected as the most effective antibody in combination with the anti-infective portion of the antibody, eliciting tumor necrosis factor (TNF) protein paraffin dosing. Bitto blocking engraftment, or estamole, caused a successful wave, and some patients showed adverse effect. Then, Xio\u2019s antibody T(R)101 was added to the tumor necrosis factor antibody/tumor necrosis factor response response. When compared with the suppressed antibody Bitto, the effect seemed to reverse with age, and the agents reversed without effect at about 17 months of treatment. The sensitivity of human serum antibody-1521 remained equally comfortable at 24 months, compared with placebo\\\\naandn=1 tolerable antibody-to-tumor response, showing a positive response following phase 2 testing. The authors note that the human serum antibody dosing, considerably better than the clinically manufactured antibody, merely impeded immune immune suppression.\\\\nXIANG MATHEIDATHE (XLI) has demonstrated selective resistance to 11 million chemical entities (i.e. immunosuppresses) by maturing its receptors at a fairly low level in Lymphocytes and high levels in Veribrahymale 1b, which are very limited by genetic differences in Amelinapa\u2019s APOE20.\\\\nWith a pair of antibody combinations developed based on the same two monoclonal antibodies, the team is poised to progress the antibody in rheumatoid arthritis, cancer, and clinical trials for eggucleotide assays.\\\\nWearable screeners can easily identify prostate, bladder, bowel, lung, lung, kidney, and kidney cancers that could become resistant, and it may trigger more aggressive disease progression due to the higher incidence of enterobotan and sterlendoconctomy, like prostate cancer and ulcerative colitis. In addition, with multiple active drug candidates(s) that are immaturely monoclonal antibodies, the antibodies identified with this approach may be particularly effective in rheumatoid arthritis and prostate cancer.\\\\n\u201cIn all likelihood, this is an antibody that has a low susceptibility to TNF\u201d, writes Yan Liu, Chairman of a team which developed the anti-vaccine antibodies. With future results expected, the clinical program could be ongoing for several years.\\\\nXLI reported first data on dosing. At ASCO 2013, XLI demonstrated the antibody antibodies in mouse models still moderate to work as designed. The infectious diseases in humans were relatively stable, with no variation in autoimmune disease where both mice and humans had intense antibodies to help with immune suppression. They have the ability to create antibodies for all major diseases, but with very low susceptibility to adverse events, the antibodies are notoriously weak, so I suspect the team is developing an immunosuppressant antibody to address this in patients'\"]", "inst_index": "16840", "domain": "PLOS ONE, July 2013 | Volume 8 | Issue 7 | e69592", "url": "http://doi.org/10.1371/journal.pone.0069592", "summary": "", "authors": "['Yan Zhang, Lei Shan, Yaping Hua, Dan Wang, Huawu Zeng, Runhui Liu, Weidong Zhang, Zhenlin Hu']", "date": "03-28-2013", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Epigenetic Regulation of Cardiac Progenitor Cells Marker c-kit by Stromal Cell Derived Factor-1a", "warc_date": "20220328", "article": "[\"'By Yuan Xiao Aoliong, Xianjiang Provincial Agency for Health Regulations, Guangdong Province. Progenetic Regulation of Cardiac Progenitor Cells Marker c-kit by Stromal Cell Derived Factor-1a\\\\nMysterious mystery is a limitation of photodynamic parameters in this centuries age tale of the pomegranate vines: only true photodynamic parameters are observed in autologic compositions of little size and large tonal areas, with little variation.\\\\nHowever, this is not as severe as the new modality that has been used for the degassing of the person and also in many other studies; it has been applied for both acute and chronic indications as fast growth factor synthasude and corromycin in C-kit and shock mutations on caosute nerves.\\\\nWhen combined with methyl isterase, a critical molecule regulated in the production of whole-on-anal oxygen, a weak C-kit is being regulated and thus therefore can impede growth. The next steps in this process are known as super complex irreversible cancer formation for sub prime, primary, solid and damaged, schismans; rare genetic and other genetic disturbances on the surface of the virus, generate cell death which will be problematic in clinical trials and use the therapeutic drugs.\\\\nAt the moment, about 60 per cent of patients are on a survival certificate for pre-surgery at age 65. However, in the next few years, the fast growth factor mechanism or CKD will come to be expressed in greater numbers.\\\\nAn effort will be organized by the provincial health authorities and the Government of Guangdong in order to develop drugs that are readily available, efficient and well balanced to market.\\\\n\u201cTo maximize production of these drugs we will conduct a study in the near future to test them. The second and fifth gene variants is to be evaluated with the aim of discovering the true limits to the c-kit,\u201d explains Prof Liang Fangshan, from Guangdong Provincial Administration of Health and Disease Center.\\\\nMoreover, the terms of the study are not available, so it will be be better to incorporate this project into future planning. \u201cWe are currently studying the survival criteria as soon as possible, the possibility of the successful completion of the study in the near future. For now, we need a minimum of 50 years to live,\u201d adds Prof. Liang.\\\\nSource: Guangdong Provincial Administration of Health and Disease Center\\\\n'\"]", "inst_index": "53299", "domain": "PLOS ONE, July 2013 | Volume 8 | Issue 7 | e69134, doi:10.1371/journal.pone.0069134", "url": "http://doi.org/10.1371/journal.pone.0069134", "summary": "", "authors": "['Zhongpu Chen, Xiaodong Pan, Yuyu Yao, Fengdi Yan, Long Chen, Rong Huang, Genshan Ma']", "date": "03-28-2013", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Heat Shock Protein 27 Is Spatially Distributed in the Human Placenta and Decreased during Labor", "warc_date": "20220328", "article": "['\\'Researchers have revealed that there is increased proliferation of thimerosal-containing compounds in the human placenta compared to other tissues of the body.\\\\nThe new study was led by the National Institutes of Health, which is funded by the Fermi National Accelerator Laboratory (FGN), part of the National Science Foundation.\\\\nThe study reported that thimerosal-containing thimerosal-containing compounds in the human placenta are \"visible dislocations and extremely concentrated intruders. The most severe thimerosal-associated ill effects occurred when exposed to consuming thimerosal-containing cereals, including those which have a greater thimerosal content and that are mainly of muscle fibers.\"\\\\nFactors that may cause thimerosal-containing cereals to possess an increased thimerosal content include the respiratory system, acute infection including the skin, and pulmonary hemorrhage which occurs as a result of thimerosal exposure.\\\\nResearchers say thimerosal is not an isolated target; it may be the result of toxins that have recently been exposed to foods including the wheat, oil, poultry, and certain carcinogens.\\\\nThe NIH studies involved finding changes in thimerosal-containing compounds, mainly from sodium thrombocytopenia, an accumulation of as many as 60 milligrams in a breathable air sample. These findings should help to better understand the effects of thimerosal on blood cells.\\\\nHIV infection is also strongly associated with thimerosal-associated illness, with a significant decrease in thimerosal-containing testosterone levels compared to other tissues. Sargent\\\\\\'s elevation in one\\\\\\'s metabolic rate increased when placenta condition was shown to increase thimerosal-containing thimerosal-containing triclosan.\\\\nResearchers say thimerosal-containing triclosan is a natural compound commonly found in organs, including women, and people may also be exposed to thimerosal-containing compounds.\\\\nAddressing the cause of the increased thimerosal-containing activity in the human placenta, researchers say this increase is caused by tissue interplay in the placenta. This process interplay means that malformed neural pathways lead to endothelial dysfunction, a leading cause of blood clots in the placenta.\\\\n\"By storing up abnormal or radioactive compounds in the placenta, these agents may increase the concentration of the stratum and the binding protein. In other words, thimerosal-containing compounds may be associated with the proliferation of these transducers at critical levels, making the thimerosal exposure worse for our body as a whole,\" concludes lead author Professor Andrea Kaufman, General Counsel for FGN, in a statement.\\\\nThe FRGN researchers say their study could help inform strategies to decrease exposure to thimerosal-containing compounds, especially polysaccharides and atypical Bacterium thrombocytopenia, as well as other pollution-based substances, such as selenium sulfate, nebulipodenic acid, and sulfuric acid, that can increase inflammatory and blood clotting, and increase the number of thimerosal-containing tumors.\\\\nThe science of thimerosal-containing thimerosal continues to advance, and the agency today says the recommended daily dose of thimerosal is 33 mcg.\\\\nSource: National Institutes of Health\\\\nHeat Shock Protein 27 Is Spatially Distributed in the Human Placenta and Decreased During Labor\\\\nPLOS ONE, August 2013 | Volume 8 | Issue 8 | e71127\\\\n\\'']", "inst_index": "42711", "domain": "PLOS ONE, August 2013 | Volume 8 | Issue 8 | e71127", "url": "http://doi.org/10.1371/journal.pone.0071127", "summary": "", "authors": "['Akrem Abdulsid, Alexander Fletcher, Fiona Lyall']", "date": "03-28-2013", "split": "test", "label": "machine", "status": "succcess"}
{"title": "DUSP1 Is a Novel Target for Enhancing Pancreatic Cancer Cell Sensitivity to Gemcitabine", "warc_date": "20220328", "article": "[\"'A new DCI is a novel diagnostic tool that learns how good a patient is at detecting the best markers of cancer. Dual core and sequencing is required to confirm this finding. The new Diagnostic and Mitigation Device (DUSP) 2200 is a laboratory-specific molecular-guided protein score predictor that has been developed by multidisciplinary group of researchers at the National Institutes of Health (NIH) and supported by the US Scientific Committee on Cancer. The Program for Multidisciplinary Influence (CIF) includes reference databases based on the international proposal using biochemical, genetic and ophthalmological studies to confirm a mechanism that may signal secondary treatment with DCI 3200. It is vital to develop multicenter, non-invasive tests for certain cancers that are categorized as non-invasive or difficult to treat. Triggers in DCI 3200 include new markers of high sensitivity in children with eating disorders and cholesterol levels at a very low level for controls with diabetes.\\\\nThe development of these instruments has been a priority for the Government of India since they began the use of the technology in 1997. The basis for the study was to prove that DCI 3200- a biomarker of blood-fat metabolism plus anti-obesity was justified as a potential treatment tool for colorectal cancer which is more common in children. Combining the data of 14 DUSP systems to develop precision clinical tests to validate the next stage of screening (representative period) for the detection of melanoma, it is hoped that DUSP will see tangible benefits in and of itself as a treatment tool in the patient with cancer.\\\\nDUSP1 is also a companion diagnostic instrument for CDN3 receptors, which are known as the current target of post-therapeutic drugs for secondary (front-line) treatment with DCI 3200. Because of the new constellation of signals, DUSP diagnostic combines the functional and biochemical controls of DUSP to enable the screening for the respective targets. In Cancer Risk Factors Consortium (CRC), and government guidelines for this site, 50 trial subjects were given a 200-minute five-minute test where the number of additional daily doses contributed to a specific safety signal was calculated using a general color strip. Over 23 months of investigation, details of clinical outcomes showed that the test, the said, was clearly useful as a tool for the screening of all patients with low or low cholesterol levels which were nevertheless high risk of HIV infection.\\\\nAs about 20 per cent of the newly diagnosed patients are intolerant of DCI 3200 and they have an untreated condition, the test revealed, showed the effectiveness of varying doses of DCI-3200 but observed significantly higher intensity levels of the chemical histologic signatures, making it less effective in its pre-clinical sense of magnitude than in the existing biomarker scale. This is not the first way to modify the design of that PCR and the auto-type function for controlling the instrumentation of the GPS signal on a cellular record for a patient with lower or low CDN scores. The visual scale in the average population of 1,400-3,000 patients (computer-controlled) based on the results of their trials is based on 1,300-3,000 subjects showing sensitivity of 43-50 mL.\\\\nThere are 23 others which use the molecular tagging of the biological signatures of the DCI 3200- a follow-up genomic-gouging tool which is injected through a filter to even the mechanistic biomarkers that control the quantification of efficacy with non-invasive methods. Investigators from the National Institute of Immunology (NIH) have developed a method to insert a microchip containing in vitro biopsies of molecules containing low or low concentrations of MCHL, a marker of heart disease. These signatures, among others, have the potential to better monitor reactions in small blood biopsies.\\\\nStudies of other major genetic therapies to use for brain disorders like strep throat and schizophrenia highlight the importance of evaluating pharmacological thresholds for treatment that are accurate, non-invasive and cost-effective.\\\\nFirst Published: Jan 28, 2014 12:06 IST\\\\n'\"]", "inst_index": "42653", "domain": "PLOS ONE, January 2014 | Volume 9 | Issue 1 | e84982", "url": "http://doi.org/10.1371/journal.pone.0084982", "summary": "", "authors": "['Fang Liu, A. Jesse Gore, Julie L. Wilson, Murray Korc']", "date": "03-28-2014", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Orphan Nuclear Receptor Errc Induces C-Reactive Protein Gene Expression through Induction of ER-Bound Bzip Transmembrane Transcription Factor CREBH", "warc_date": "20220328", "article": "[\"'BEIJING (Dec. 18, 2013) \u2013 TORIOK-Founded in 2007, the Andre Noi Young was an international innovator in cleantech and renewable energy technologies. Located in Daikin, North Korea, Andre Noi Young is developing a unique approach to discovering and applying abundant protein derived from an African source called Errenial Propagation Transmitter Formula (ER-\u03b1), not only to increase photogenic properties of more deeply-cleaned-for-reparation skin on regions of people, but also to increase the growth rate of protein produced by protein-parented pores in babies and other vulnerable populations. Sources from that Errenial Propagation Formula include proteins, ferrite, petroglyphy and anthocyanin. From his previous corporate positions in the biomedical sector (Institute of Biological Societies and Institutions) in China and in the manufacturing and retail channels of the Chinese economy, Andre Noi Young has demonstrated the very smart, useful and humane method for seeing and applying food waste from food material for protein synthesis. His company Andre Noi Young GmbH is employing the advantages of ER-\u03b1 in the long term to evolve the commercial and population of vulnerable populations. Contact: Acumen.Concho.com Yak-Travellers.com Pick: Andrea Wilson\\\\nDistributed by NewsEdge\\\\n'\"]", "inst_index": "44735", "domain": "PLOS One, January 2014 | Volume 9 | Issue 1 | e86342", "url": "http://doi.org/10.1371/journal.pone.0086342", "summary": "", "authors": "['Jagannath Misra, Dipanjan Chanda, Don-Kyu Kim, Seung-Rye Cho, Seung-Hoi Koo, Chul- Ho Lee, Sung Hoon Back, Hueng-Sik Choi']", "date": "03-28-2014", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Regulation of MYC Expression and Differential JQ1 Sensitivity in Cancer Cells", "warc_date": "20220328", "article": "['\\'Mark E. Palmer has been writing on some of my earlier articles on the subject, and now we have a set of statistical analyses that we want to include in our book, The Personalized Genetic Makeover.\\\\nAs you can imagine, it took a while for the Journal of the American Medical Association to get into this. After several months\u2019 discussion, the journal agreed to publish a publication from Scott\u2019s Weekly. Sadly, not one of them was chosen for publication!\\\\nPreviously, I made this announcement on my blog at HealthPageDoc.com:\\\\nI had been thinking about this as a submission for the American Association for Cancer Research\u2019s Quality Award. The human gene MYC Expression (MYC) Expression study was a prime example of how changes in symptoms of mycogenic melanoma affect the cell\u2019s reaction to chemotherapy. It also took us a few weeks to review and compare it with the work of students in the University of Colorado College of Cancer Research, who found that patients treated with HER2-positive melanoma did not increase sensitivity to chemotherapy. The abstract presented in the study illustrates this phenomenon, which is one reason I ask that readers here and abroad promote research such as this publication of this new study.\\\\nThe appendix is here and below is a summary of the first presentation. Dr. Susan Montgomery showed us that while there was some lag in response to treatment in adults with HER2-positive melanoma, the treatment did not require additional frequent improvement and reaction.\\\\nWhat\u2019s more, the findings suggest that the effectiveness of current course of therapies against HER2-positive melanoma has actually diminished. Dr. Montgomery calculated that if treatment does not require extra treatment for longer, that mean the median length of time is 13.8 months. And although patients will appear to have more responses to therapy compared to the median treatment length, they will have been infected with the same tumors for longer, raising the risk of developing NSCLC.\\\\nThe clue about Dr. Montgomery\u2019s data was the finding that no significant increases in RSV that accompanied chemotherapy were seen in patients treated with HER2-positive melanoma. Her goal was to analyze the tumors of the patients and find out how even sicker tumors increase her immune system response. This report shows that, although the amount of detectable RSV detected in the median treatment of these patients declined, that only increased responses on standard therapy. And how do you eliminate the number of RSV-positive patients from this dataset? By pumping up those RSV-positive tumors. Dr. Montgomery was able to get that number down to just a single-digit percent; but to move back to the 33-digit mark, it would require extra mobilization from patients with HER2-positive melanoma. As the authors summarize the data, the approach was to replace patients with newly found metastatic melanoma-related lesions in return for higher responses. That strategy has worked well, and this new study showed that it did not occur. If it did, the results showed that patients developed a strong need for further therapy.\\\\nThe other important thing to remember is that, due to the urgency of this disease, it is not possible to publish a New Clinical Investigation into the MYC Expression Trial when, in fact, it is not possible to publish a study that makes an unequivocal finding.\\\\nHere\u2019s what Dr. Montgomery\u2019s story says about how I think I will write:\\\\nDr. Calvin De Normo, MD, agreed that I\u2019d add his article as a brief appendix to the book. Dr. Montgomery said that he waited for many months to hear of the new study until after the publication of the journal publication. \u201cI did my best to get some immediate feedback from readers and a very good response from the editors,\u201d he said. \u201cIt was very encouraging, but I wanted my paper to be published.\u201d Dr. Michael Coates, PhD, chair of Medicine at UT Southwestern Medical Center, has also written on this subject: http://www.themespository.blogspot.com/2014/01/areas-of-cancer-research-to-shook-myc-overdrive-1/\">\\\\n\\'']", "inst_index": "11656", "domain": "PLOS One, January 2014 | Volume 9 | Issue 1 | e87003", "url": "http://doi.org/10.1371/journal.pone.0087003", "summary": "", "authors": "['Trent Fowler, Payel Ghatak, David H. Price, Ronald Conaway, Joan Conaway, Cheng-Ming Chiang, James E. Bradner, Ali Shilatifard, Ananda L. Roy']", "date": "03-28-2014", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Expression and Differentiation between OCT4A and Its Pseudogenes in Human ESCs and Differentiated Adult Somatic Cells", "warc_date": "20220328", "article": "['\"A number of studies are published in the Journal of Physiology. These studies have also addressed the oft-existed fact that desire for natural life -- better, healthy, fulfilling -- is a biological reality for all human beings. Furthermore, various methods of treating common disease, such as drug therapy and gene therapy, are highly developed and currently applicable to living beings.\\\\nSeveral large-scale epidemiological studies, such as the Lennox-Gastaut, Clinical Histomyography #6, Hospitalers Human Encephalopathy, and Citizens Unileverie Impella Technique, have utilized advanced methods of treating everyday human suffering or symptoms as distinct from traditional and accidental illnesses, causing impairment of consciousness and symptoms.\\\\nIn addition, numerous studies have followed various strains of human venous thrombosis and electroplated venous thrombosis (EHR). Though known to involve discontinuous venous thrombosis, EHR has been used in many leading medical practice such as Humana, Loeb and Fabry to treat the innumerable problems associated with life. EHR has many also been used for the treatment of several types of pain, bone marrow failure, Alzheimer\\'s disease and death related in humans, however, all of these conditions remain prevalent among children under the age of 16. Recent studies have also indicated that EHR can be provided through antibody chemotherapy for symptomatic diseases, such as Cerebral Palsy, Parkinson\\'s disease, Gram-positive pneumonia and women\\'s ovarian cancer.\\\\nDirect exhortation for the development of new treatments for symptoms and complications in the human tissues and organs, which is being carried out through many different methods, is currently underway in such studies as whole organ-plans, Aesthetics, Tubes, Sperm Monitoring and dissolving of organ stem cells. These are just a few examples of the many opportunities for new treatments in knowledge gained in these new processes.\\\\nInternational trials taking place in Dubai, Japan, North Korea, Portugal, Ireland, Venezuela, Brazil, Finland, Italy, and Norway are also in the planning stage. Various randomized trials, such as EHR; Count the Gap and Home Health Review, release studies have shown that precision-guided thrombosis and expression of EHR with selective intercellular protein in the human veins leads to greater improvement in the appearance of smaller, sometimes less discolored (above average) embryonic lesions.\\\\nA paradigm for dealing with areas of medical stress, which includes an infant in the throes of a severe acute respiratory condition, may be the therapeutic strategy leading to a new cancer to have an effect on the regions of the brain and nervous system. According to a recent Health Research Council (HRC) study, 75% of newly diagnosed cancer patients tend to be at a higher risk for developing vascular disease compared to those at risk of developing other potentially life-threatening diseases such as depression, dementia and Huntington\\'s disease.\\\\nIn addition, studies in humans and the environment have shown that exposure to a wide range of low-stress substances is associated with greater risk of developing vascular disease, such as increased inflammation, decreased growth of the myocardial infarction and elevated blood pressure that arise following vascular diseases. This limited oxidative stress may even increase the risk of developing these rare and serious diseases.\\\\nIn addition, according to findings in Cancer Research UK 2014, the cases of spontaneous renal failure in Octhal, a kidney transplant, which triggers renal failure by regulating an unhealthy level of blood cell turnover, have been reduced in others.\\\\nIn the longer term, advances in treatment such as diabetes, ALS, neurodegenerative disease and cardiovascular disease have also had an effect on the way individuals are treated as well as the health of the body. For example, insulin cell therapy and therapy for pancreatic cancer were recently shown to dramatically reduce levels of insulin in the brain.\\\\nDoctors may also investigate the possibility of thrombosis and other cancers with a common technique called fibrosis. In these instances, each disease is potentially a cancer that must be treated. This treatment can save lives in the short term.\\\\nFor more information on the importance of interest in the role of angiogenesis in the development of disease, visit www.humanescansystem.com or www.iura.org.\\\\n\"']", "inst_index": "89383", "domain": "PLOS One, February 2014 | Volume 9 | Issue 2 | e89546", "url": "http://doi.org/10.1371/journal.pone.0089546", "summary": "", "authors": "['Mojca Jez, Sakthikumar Ambady, Olga Kashpur, Alexandra Grella, Christopher Malcuit, Lucy Vilner, Primoz Rozman, Tanja Dominko']", "date": "03-28-2014", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Baicalein Reduces the Invasion of Glioma Cells via Reducing the Activity of p38 Signaling Pathway", "warc_date": "20220328", "article": "[\"'Do you know that Neothorticidative Resistance (KCR) is a dominant, ubiquitous variant of Reflexive Inductible Rheumatic P8 (RREM), and \u201ctwo examples of a rare (and deadly) \u2018electrolateral and RP lithographically signaling pathway\u2019 in the control of major clinical conditions; and effectively all but one RREM pathway with the exception of RREM the barrier and genotype of Reducing Response to RREM.\u201d\\\\nAshmir Silva\u2019s recent study by AHA has identified a pathway\u2019s purpose and manner: to gain specific receptor by coaxing other clinical animals to rat model. It is the process which enables growth of specific RREM pathways, such as ALKS (vanishing sequesters and sequestered Radinoglobin).\\\\nThe standard biological approach: Non-standard research using endocrine related pathways (NO2), of which the precursors is receptors found in Huntington\u2019s disease and Huntington\u2019s Syndrome \u2013 they are already expected to provide the basis of a new approach to differentiating the composition of the immune system and labeling multiple transgenic animals for clinical use.\\\\nTo demonstrate that translational research could greatly increase the total number of progression-free survival in non-human primates, we have embedded unique recombinant pathways in a capsule composed of AHA highly co-shared genes (associated with RREM) and fusion cells of AHA mutation in a single capsule.\\\\nThese transcriptional pathways make treatment of RREM unlikely to cause tumors or improve multiple human cancers, but are likely to greatly increase the total number of RREM pathway cancer patients out of the 2100 classification.\\\\nThese early biomarkers may also provide clues to treatment of highly targeted pancreatic cancer, and in vitro research and an optimal method of encapsulating mitochondrial drug delivery for pancreatic cancer or in vitro rat migration of cells induced by the process.\\\\nYone of many discoveries show that Research \u201cThe Growing Portale for the Treatment of RREM\\\\n'\"]", "inst_index": "63190", "domain": "PLOS One, February 2014 | Volume 9 | Issue 2 | e90318", "url": "http://doi.org/10.1371/journal.pone.0090318", "summary": "", "authors": "['Zhenni Zhang, Jianrui Lv, Xiaoming Lei, Siyuan Li, Yong Zhang, Lihua Meng, Rongliang Xue, Zongfang Li']", "date": "03-28-2014", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Proteasome Dysfunction Mediates High Glucose-Induced Apoptosis in Rodent Beta Cells and Human Islets", "warc_date": "20220328", "article": "[\"'In 2011 scientists discovered that molecular differences in receptor transcriptions and C-diffigenicity in petro-synthesis (CTE) cells are rearranged in mouse brain cells. Today, researchers at the University of T\u00fcbingen in Germany have discovered that those transcriptional C-diffigenicity in canine neurons and human islets is changed by the process of carotid-induced inflammation. The team reported the findings on March 28 in The Conversation with Dr Juan Carlos Pinheiro in T\u00fcbingen.\\\\nColleagues of PDE(0)-\u03b1 (a receptor outside of C-diffigenicity) receptor nicotinic acid (MAP), the class of genes involved in picking up MAP, were present in both Petro-synthesis and C-diffigenicity-refired neurons as well as the human forms. These versions are involved in diagnosis and rehabilitation of patients with MAP-induced cardiovascular diseases. Dr Pinheiro suggested that these C-diffigenicity-induced episodic adenosine beta \u2013 receptor interferon in canine neurons has been shown to have more than 1,000 common trigger points for MAP-induced beta cells.\\\\nThe findings may lead to more effective treatments for COPD patients in the future.\\\\nWe asked Pinheiro if we can learn which receptor-mediated C-diffigenicity in the PDE(0) receptor neurons is the crucial specific co-factors for MAP-induced beta cells and for the reduced permeability to petro-synthesis in rodent brain cells. The answer was not a blank check, but a form of precision cytospheric cytogenetics based on multiple separate stem cells, cell transcripts and transgenic cells.\\\\nPinheiro showed that several types of MAP-induced C-diffigenicity in PETEPETEPETEPETEPETEPETEPETEPETEPETEPETEADL(2) cells have the specific alleles (regulatory units) required for ATP signaling in PETEPETEPETEPETEPETEPETEPETE and mitochondrial Tau-CI-the type of heterozygous fusion cell (HFC) in canine CPPs. Further information on polyidinal derivatives at PDE(0)\u2212\u03b1 (a receptor outside of C-diffigenicity) receptor nicotinic acid, and quantification of kinase distribution in PETEPETEPETEPETEPETEPETEPETEPETE PETEPETEPETE- C-diffigenicity in PETEPETEPETEPETEPETE PETEPETE- C-diffigenicity in PETEPETEPETEPETEPETE- DTC receptors in PETEPETEPETEPETEPETEPETEPETE PETE- C-diffigenicity in petro-synthesis in the PDE(0) receptor neurons, PHEN2-CAL=0 and DTC-ID=1003.\\\\nThe study took place at the University of T\u00fcbingen, where Pinheiro\u2019s research team plans to further investigate the proteins being altered by the process of carotid-induced chronic inflammation.\\\\nResearch on CAR-T biomarkers including tyrosine kinase transcriptional transgene (BTTG) in humans indicated that vitamin supplementation in the PDE-\u03b1 constituents in PETEPETEPETEPETEPETEPETEPETEPETEPETE2 indicates that pets are now deficient in C-diffigenicity, due to the increased APOE (Plea Auto-Breakthrough) blood pressure control.\\\\n'\"]", "inst_index": "81384", "domain": "PLOS ONE, March 2014 | Volume 9 | Issue 3 | e92066", "url": "http://doi.org/10.1371/journal.pone.0092066", "summary": "", "authors": "['Christophe Broca,  Elodie Varin, Mathieu Armanet, C\u00c3\\x82\u00c2\\x8ecile Tourrel-Cuzin, Domenico Bosco,  St\u00c3\\x82\u00c2\\x8ephane Dalle, Anne Wojtusciszyn']", "date": "03-28-2014", "split": "test", "label": "machine", "status": "succcess"}
{"title": "DNA Methyltransferase Inhibitors Improve the Effect of Chemotherapeutic Agents in SW48 and HT-29 Colorectal Cancer Cells", "warc_date": "20220328", "article": "[\"'Methyltransferase inhibitors Improve the Effect of Chemotherapeutic Agents in SW48 and HT-29\\\\nIn the United States, dentigners and other medical professionals utilize chemical conjugates and biofilms to conduct therapeutic drug conjugates used to treat medicinal pain or other specific conditions. Radiotherapy of acid andmethylcyclocephaly are the principal drugs typically used in drug conjugates, and the combination of two secondhand chemotherapeutic agents can significantly increase the effectiveness of these compounds in treating patients with these conditions. These drugs contain related components of certain foods and drugs, which in turn can impact the molecular profile of multiple various biochemical and physiological compounds.\\\\nIn furthering their research on the use of chemotherapeutic agents in human disease, medical specialists at Southwest University say that different molecular studies indicate that numerous types of molecular agents can alter the composition of narcotics, often leading to dangerous side effects. Without doubt, these molecular agents may have other and contributing properties that may bring new therapeutic treatments forward, especially in oral drugs. While the discovery of certain chemicals that change the composition of medications for anti-cancer agents are excellent, there is currently no evidence that these chemicals have been studied in humans. These molecular combinations may have been present in many different drug class molecules, potentially affecting the molecular structure of the drugs by making these compounds easier to swallow.\\\\nThe link between the molecular changes in the composition of compounds in the body and the interactions of these substances is revealing, with further studies indicating that while the molecular composition of daily doses of chemotherapeutic agents may change, the levels of the molecular changes that differentiates them are still very limited.\\\\nMost of this is due to the level of variation in the molecular structure of drugs. Although many compounds might enhance efficacy, some may not, which means there is more than one drug in the pool that actually improves efficacy. What appears to be the biggest factor in the progression of drug interactions is the total number of interactions and interactions between these substances, with only a small fraction affected by combinations or alterments of compounds.\\\\nA study published in 2004 in the Journal of the American Chemical Society led to a number of studies exploring the effect of certain compounds in medicine, with the leading study examined the conduct of chemotherapeutic agents in animal models of addiction and cancer; as well as clinical trials where the interactions resulted in therapeutic effects. The question was, which chemicals were the most significant alterations. The results of the study showed that 4 of 5 toxic properties of therapeutic agents and other metabolites were consistent with the interaction of drugs with various receptors.\\\\nIn 2015, research is ongoing to examine the interaction between different chemical compounds, with the greatest potential discovery finding being in the combination of two secondhand chemotherapeutic agents. For these directions, current methods of combining existing drug class molecules with other chemical molecules have a long history of following the same path. However, numerous studies with differing methods is currently focused on the relationship between several active and inactive chemicals, with many predicting that the relationships will continue to evolve.\\\\nTo learn more about the linking between chemical types and interactions, or the study for this article, please contact Ruth-Ann Landers at care@western-releasage.net or email protected For a transcript of this article, please visit: https://www.west-releasage.com/1/09th/02/2016055221407.pdf.\\\\nPRESS CONTACT: RuthAnn Landers\\\\nSR\\\\nSWU College of Nursing\\\\n530.925.64093\\\\n'\"]", "inst_index": "70804", "domain": "PLOS One, March 2014 | Volume 9 | Issue 3 | e92305", "url": "http://doi.org/10.1371/journal.pone.0092305", "summary": "", "authors": "['Sylwia Flis, Agnieszka Gnyszka, Krzysztof Flis']", "date": "03-28-2014", "split": "test", "label": "machine", "status": "succcess"}
{"title": "FOXO4-Knockdown Suppresses Oxidative Stress-Induced Apoptosis of Early Pro-Angiogenic Cells and Augments Their Neovascularization Capacities in Ischemic Limbs", "warc_date": "20220328", "article": "['\\'Cover is covered this month with a host of ongoing ethical news and environmental issues. \"FOXO4-Knockdown\" published two damaging comments against the fund in November:\\\\nAs a fan of ethical thinking and the use of the sun\\\\\\'s light for planning local green activities, Zakuaku MKO/Ethical Response Center and a valid concern about altering the Earth\\\\\\'s environment...One report by the American Society of Astronomy and Astrophysics ASA)hurt Environment Superiority and created the concern that radical oneness in the early days of the universe leads to birth defects in multiple forms in humans, many of whom are victims of a double ternistic form of intolerance. The care and monitoring capabilities of the AASA, along with its main institutional advisory board, also makes non-environmental interventions virtually impossible.\\\\nMuroida Kebe acknowledged that resource-deficient humans are responsible for turning this affliction into a disease, and he linked reduced UV exposure to similar irresponsibility to neovascularization, a medical condition by which rots of cells occur in early stages of hypoxia.\\\\nLydia Shulman reported in the April 27 issue of Science and Policy that several LEAP medicine areas could become disordered, but what they really require is more transparency and transparency than simple shrinkage of cells with rotors. \"The threshold to providing better patient care\" is breached; it ought to be clearer and clearer. And more transparency is necessary, because LEAP medicine cannot adequately offer a reliable and reliable patient experience with cancer patients. More accurate, in-depth analysis of neuroprotective stress the impact of radiation should help better advance clinical treatment and fund-making strategies to assist patients and their families.\\\\nThe deficit of transparency could also be circumvented by organizations that bypass standards, such as the Canadian Association of Broadcasters (CABS), the Canadian Heart Association (CAHA), Center for Research on Hypertension, Environmental Science and Ecology, or its Alliance for Responsible Medicine.\\\\nThere is no apparent evidence that ethical information is even available about any ELM in a scholarly publication. These values were born in randomized clinical trials being conducted in Finland in collaboration with seven organizations. None of these organizations knew where to go or when to access information.\\\\nIsolated and unjustifiable complacency is amenable to reasonable study. Open and available sources such as Bio-Reference Labs or ChemSurgery for Diabetes or BetaaFirm will give us more information, education, and guidelines than they provide. If we give more satisfaction to information \"offered\" we should be willing to accept it. We should not pay the price to have a better public health system.\\\\nConsequently, the German/speaking countries who lack medical expertise may not benefit from greater transparency on all aspects of modern medicine. With more transparency than within the European Medical Association currently, we should have the same choices. We should not pledge to benefit from the same quality information for fewer persons.\\\\nOne more important article on environmental governance is \"The Impact of Layoffs in the Great Mention The Lancet Research Letter\". This article predicts the effects of impending cuts in staff training in Japan and China. This should offer, if not exclusively, a cut in training, noting the large potential benefits.\\\\nWhistleblower has the ability to reveal the effects of a failing culture. These researchers, and many others, have full confidence in those who are seeking to halt the erosion of the planet. They are brave and willing to go on the record to demonstrate their case: the benefits of a pollution-control budget, the beneficial activities of a clean-living society, and the basic process of ethics. All these considerations will encourage us to refrain from quibble and further a sustainable environment for the human beings who are already protected from risk.\\\\n\\'']", "inst_index": "88849", "domain": "PLOS ONE, March 2014 | Volume 9 | Issue 3 | e92626", "url": "http://doi.org/10.1371/journal.pone.0092626", "summary": "", "authors": "['Takaharu Nakayoshi, Ken-ichiro Sasaki, Hidemi Kajimoto, Hiroshi Koiwaya, Masanori Ohtsuka, Takafumi Ueno, Hidetoshi Chibana, Naoki Itaya, Masahiro Sasaki, Shinji Yokoyama, Yoshihiro Fukumoto, Tsutomu Imaizumi']", "date": "03-28-2014", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Pathological Impact of Hepatitis B Virus Surface Proteins on the Liver Is Associated with the Host Genetic Background", "warc_date": "20220328", "article": "['\\'Urine can be contaminated by organisms that are closely related to an infecting liver, according to new research from the Collaborative Environment Research Institute at Deakin University in Australia. Leon Burger has recently observed the development of a \"single genome-wide variation\" in the pattern of liver viral proteins, resulting in a study that has explored the product of the mechanisms that use these proteins to start the spread of infection.\\\\nProfessor Burger led the study, which evaluated the occurrence of 18 cases of hepatitis B infection, each with specific mutations that contribute to the spread of disease. His findings suggest that autoimmune, viral and antibody-mediated viruses, as well as genital herpes, chronic hepatitis and HIV/AIDS, are among the potential triggers that could lead to production of a deadly but potentially fatal disease.\\\\nThe 1918 virus caused about 9% of cases in parts of the world. For the genes in this virus, which is responsible for 10 of the 20 fatal pandemics, most locally known human infections were from South African patients who had infected a patient with a virus. However, high-risk individuals accounted for about half of HIV cases, and were almost as likely to be infected with TB.\\\\nThe scientists tested the transmission rate, if someone infected with a virus from infected person to person, and whether it was carriers, and of those individuals, rather than traveling between infected people to the destination. They performed this test using a computer algorithm, understanding the alterations found in the virus and making diagnoses.\\\\n\"Given the detrimental effects of viral genetic alterations that cross pathogens and enable travel to regions where the virus is not present,\" said Burger, \"Our findings point to the need for new HIV vaccine development, and to create new vaccines for even more people on the island of Madagascar.\"\\\\nTargeting genes and proteins involved in transmission of viral infections is important, the scientists argued, because: (1) recombinant human immune response proteins (HIV (HBV)) can help keep virus-infected virus from reaching consumers, and (2) genetic alterations, especially to inherit genes that help the virus to mutate, lead to the spread of HIV.\\\\nThe paper, published in the journal Gastroenterology, investigates whether this viral variants, or three main responses to human immune response, can be transferred to the human liver. \"If this is the case, then HIV infection might also be associated with HIV damage,\" said Burger. \"Now, with some genetic alterations and data, you can say that these changes affect not only HIV infection, but HIV-associated autoimmune disease and have some serious consequences, notably, potentially, HIV-associated celiac disease.\"\\\\nFor this reason, Burger said, \"HIV hepatitis can play a major role in the spread of HIV, because people infected with HIV - whether infected with, or spread to - carriers have immunity against and trace their hepatitis to the host molecular organ,\" he explained. \"Given that it is the liver\\\\\\'s problem, infected cells may find it easy to get rid of the virus in later stages. Taking these factors into account, the unique genomic sequences that allow this transmission may influence the development of a disease that may otherwise occur in the host.\"\\\\nProf. Burger has proposed several targets for introducing an HIV vaccine to treat hepatitis B/V, and has been working to discover whether an HIV vaccine might be as effective as an HIV vaccine. \"The more DNA that we have, the greater the probability that we have at least some real work to do,\" he said. \"If it really does happen, I think it\\\\\\'s extremely important to start developing a HIV vaccine.\"\\\\nIn other research published in the journal Gastroenterology, Dan Himeler of The University of British Columbia, McGill University in Montreal, and colleagues have focused on \u201cdomestic HIV cases,\u201d presumably heterosexual ones, who may be as infected by a virus as infected by the infected person. Since they are also infected by HIV, they compared their HIV prevalence among HIV-positive people with those with heterosexual sex. While HIV prevalence among heterosexual HIV-positive sex workers was significantly higher than AIDS: 300% greater than AIDS among heterosexual sex workers, they reported that the HIV prevalence of heterosexual sex workers exceeded that of AIDS among all women.\\\\nFindings have been published in the International Journal of AIDS Vaccines.\\\\n\\'']", "inst_index": "21304", "domain": "PLOS One, March 2014 | Volume 9 | Issue 3 | e90608", "url": "http://doi.org/10.1371/journal.pone.0090608", "summary": "", "authors": "['Yuri Churin, Martin Roderfeld, Johannes Stiefel, Tilman Wu r_ ger, Dirk Schro __ er, Tomomitsu Matono, Hans-Joachim Mollenkopf, Roberta Montalbano, Malvika Pompaiah, Kurt Reifenberg5, Daniel Zahner, Matthias Ocker, Wolfram Gerlich, Dieter Glebe, Elke Roeb']", "date": "03-28-2014", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Ectopic Expression of a Maize Hybrid Down-Regulated Gene ZmARF25 Decreases Organ Size by Affecting Cellular Proliferation in Arabidopsis", "warc_date": "20220328", "article": "[\"'New research has found that the decrease in the amounts of insulating molecules in a home (POP) or a lab (P&R) node was reduced by 15 percent.\\\\nFor the first time in more than 10 years, the discovery of PARACT is being presented as the first true solution to eliminating cell proliferation in the blood or the muscle in developing markets. According to a small press article, PUSH3335 (DPHE5170) removed the leading genetic material of \u201cmalevolent beta plants\u201d in an announcement that \u201ceffectively removed the elephant of the molecular meltdown\u201d which appears to be happening in China and other developing nations.\\\\nAccording to study author Li Yuen, published in the journal Science, the study also shows that variations in PHAST4, which has a high lifespan and a low lifespan in the home, allowed the indignant species to mimic the human body \u201cwithout losing any contact.\u201d\\\\nIn the first experiment, dated from 1948 and recently published in the journal Nature Communications, researchers compared the appearance of the silk horn of Zhang Guadeng with the silk pitia of Zhang Qi/Wenuyi and found that the reduction of PHAST4 (PPP5170) decreased the density of letters in the same frequency as it reduced those in direct-invisible mesenchymal (SW) branches by 50 percent.\\\\n\u201cStudying in blood, I am keen to see if this new technique will reverse the spleiling that is ensnaring human limbs every day,\u201d said professor Li Yuen, postdoctoral fellow in the applied computational linguistics department of the University of Yanyuan. \u201cIn the light of my last report in Nature Communications in 2012,\u201d he added, \u201cwe believe this step might help patients who suffer from stage 4 diseases.\u201d\\\\nAccording to the study, the decrease in PHAST4 was accompanied by a degradation of the DNA chain that prevents the excess protein from dissolving, allowing the Polytric Acid (PAS) compounds to transmit negative DNA functions, such as butane, to tissue.\\\\nSo far, however, the case study did not find any surprising finding \u2013 or cause \u2013 to cause physiological discomfort. Nevertheless, Li and his colleagues hypothesized that this shift could result in palliative reductions in the genetic material of these proteins, including PUSH3 and PAPHb.\\\\n\u201cThe decline in the P P PP PAGE gradient may bring biological solutions to correcting the genotype of non-PEP-protein mutants, such as PRAWREL1 and PEGATRINE4,\u201d Li wrote in the team\u2019s report.\\\\nIn further research, Li and his team were able to link PUSH3 to the fast growth in rates of zinc to enhance soft tissue growth and in terms of cellular growth, they were able to model the T cells in PLOS One, which lead to new ways of sensing and processing DNA with the profile of PUSH3 and PAPHb. \u201cWe hope this breakthrough could cause diagnostic diagnostics to be more efficient, reducing access to traditional anti-CD4 nucleic acids for angiogenesis of PEP-form viruses,\u201d Li said.\\\\n\u201cThis breakthrough is in large part due to the informative genome, which will take only a few years to develop. Only then could you pinpoint mutations in the genes which increase the risk of the progression of the disease,\u201d added Liu Jian (documents), senior research professor at the University of Yanyuan.\\\\nFor more information on this study, please contact Zhong Xiaomyao at email protected or email protected.\\\\n'\"]", "inst_index": "24304", "domain": "PLOS One, April 2014 | Volume 9 | Issue 4 | e94830", "url": "http://doi.org/10.1371/journal.pone.0094830", "summary": "", "authors": "['Chuan Li, Cheng Wang, Lingxue Meng, Jiewen Xing, Tianya Wang, Hua Yang, Yingyin Yao, Huiru Peng, Zhaorong Hu, Qixin Sun, Zhongfu Ni']", "date": "03-28-2014", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Formation of a Polarised Primitive Endoderm Layer in Embryoid Bodies Requires Fgfr/ Erk Signalling", "warc_date": "20220328", "article": "[\"'Plots contain fossils which contain colloquial, material-filled antiques before they reach the plate, according to a first class reference study published in CELLS for Aleksandr. It is centred on two vertebrae inserted through a joint inserted by centuries (192-180 B\u03a9s) of the toe to other vertebrae. This fascia achieves its condition during a fattransfer and recodes post-acute stage, ultimately leading to a C-shape. In the case of the vertebrae, it is effectively plopped onto the 2C scale and becomes the inverted plod from a depth of 101.5mm (-15.6mm) to 2E.\\\\nThis marks the transducer\u2019s thinnest region, and it forms a vital single point on the plate. It also holds the leaf which dominates the veins in these antiques. Due to the transducer material, these antiques are becoming sharper and crisper, during pennage when they are in portrait. Another major advantage of the occlurate fragment is the cross-section between these spires. Not visible from the surface, these spires are detached when placed at the hip of a vertical surface because they retain the structure of pennage. The eastern part of the plateau above the prime mauve junction, where the eggs of pennage are found, was previously thought to have appeared at 60m to 75m deep in the slope of the Per-Cislature Greco-Roman Plate, but this is denied. A much shorter, less sensitive section of this region has been hypothesised for the assumption that it is from the Aegean layers, where tnocococetals of this plateau happened.\\\\nThe twigged form of the transducer filament is known as pulmonaryoipristate oxopus. It is based on the insulating mechanism of the materials surrounding animals. The oxides are glued together by particles of lava. Because of their tendency to cut through the hard edge of solids, the oxides have stiffness, which is extreme but also rapid. Once embedded in the hard rock on the sediments, the oxides are fused at more than 30 degrees. At such a high rate of speed they are now able to extend their longitudinal length of over 20 meters. This allows the oxides to expand and crack. In the order of 18.5 cm from the core to the plate, the oxides are measured in two dimensions, illustrating the extent of oxides being carved in or exposed to that soft surface of the material.\\\\nThese three sections above the spine intersect naturally in the Rotating Primitive Endoderm. This is an angle which is consistent with the hypothesis that the oxides fragment \u201cplops away and falls in the middle\u201d.\\\\nThe selection of types of animal the lower body draws for these elements will vary. The first layer of the plop structure expressed by the neonic and tranformal mass is also based on the corricidal surface. This increases to 69-136 cm. In the eastern part of the plateau the substance has had such a thick surface. The mound of oxides falls at 115 cm. This dominant position of oxides is based on the inclusion of tnocococetal strands. In the western part of the plateau this activity is continuous and begins in July of this century (12th-15th x 20 cm).\\\\nSubsequent plant types differ less frequently between other regions. The relative category of copetriorbicus eyte is the \u201cfungal epitome\u201d of the plate. In this important section the plop features an edge on the lower portion, which is separated out from the other cases in the plop. The latter extends further south and deposits the deepest seam of tnocococetals. This year the angular shape of the plop is flanked by tail shapes. The lower arm of the diametre carries the most weight and the center contains the widest tail on the surface.\\\\nThese three sections should serve as the important milestones for the plate, providing their evidence for explanations of the origin and expanse of the extensional envelope. In the CELLS study, based on the chemistry and evolution of extensional sections, it appears that large objects that are scattered on the ribotl and notional plates can somehow morph over time.\\\\n'\"]", "inst_index": "51248", "domain": "PLOS One, April 2014 | Volume 9 | Issue 4 | e95434", "url": "http://doi.org/10.1371/journal.pone.0095434", "summary": "", "authors": "['Gail Doughton, Jun Wei, Nicolas Tapon, Melanie J. Welham, Andrew D. Chalmers']", "date": "03-28-2014", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Multi-Method Approach for Characterizing the Interaction between Fusarium verticillioides and Bacillus thuringiensis Subsp. Kurstaki", "warc_date": "20220328", "article": "[\"'What is it about respectability that makes this dichotomy interesting? I have been commenting on the 3 variants of the mantle verticilliois theory of the corporeal form for a long time and have also been fascinated by the collective psychology of the age. Very recently, I wrote an essay, \u201cThe Power of Familial Chaos\u201d, titled \u201cFandom\u201d. The evolution of the archetype is an attempt to understand what is moral or not. It is the culmination of a long process of conceptualization which was also delayed by this political phenomenon: Familial terrorism, a parasite phenomenon of personality and character. Its roots are well known and are widespread. The 19th century philosopher Rudolf Nietzsche posed the concept of family as \u201cso-so-so\u201d, citing the enormity of the connectedness between cultures and globalisation. And I should add that modern heroism, ethics and engineering are also strongly rooted in family, which is here to stay.\\\\nWhich leads me to a new model: Multi-Dual-Mode Therapy (MILT). MILT attempts to involve engineering, sociobiology and psychology that will further the family context in the background. This therapy developed in Germany and corresponds to the MMI and Parallel Structures Study, which focuses on the hybrid dilemma of character, ego and genes in relation to character. Multi-Dual-Mode Therapy tackles that road that is in clear agreement with a collective cognitive design theory: the paradox of heterogeneity. The premise behind the creation of an MMI and Parallel Structures Study is: the MMI, like the classic concept of limited brain stimulation, attempts to create a coupling between personality and its properties, thereby comprehending and understanding past and present changes in the MMI over time. This is indeed multi-universal for integrating traits, structural mechanisms, individuals and groups into a unified reality. This could help scientists to study the survival of hierarchies; ensure transparency in early corporate decisions; and raise empathy and empathy.\\\\nIn contrast to the corporate pharma, life sciences, education and healthcare, the interstices of MMI and Parallel Structures are just shades into a musical world: the architecture of the MMI and Parallel Structures is in jumbled with their ability to bypass the control of the individual and ascribe to them a state of eternal ignorance and of palpable resentment. Thus, the connection between pleasure and integrity and moral superiority is made interminably, yet, the brain like malleable; beauty and intelligence are reconciled with bodily disability and ultimately sexuality.\\\\nIt was fascinating to me, then, to consider a framework for these conditions to be seen; an evocative sense of belonging, not placed in society. The soft organic organic folds around nature like the gentle curves of cherubs were essential to holding over nature, a land of falling and dying in our own soil. And I think these are the two pillars that bind us in in our mainstream entertainment status. Personal and otherwise solitary identities of individual, small, and strong.\\\\nAnd yet, the linking of archetype and class is necessary for this definition. It is not for a simple order of difference: there is a principle of universality: we are all of one. The plural means that we, individually, all of us become one. The idea of religious guilt is ably embodied in the dichotomy between our eternal fascination with the MMI and ego-to-person interactions that liberate ourselves from the manipulations that are common in normal human context. Such \u201cultimate shame\u201d versus an intrinsic dread about our own morality is portrayed as supernatural, as spiritual \u2013 an attempt to define what really feels wrong \u2013 it is, then, not \u201ctrue\u201d.\\\\nThe twenty-four year old African genius as seen by the Medea Biography article needs the title quote of the story, \u201cIn the Classic, Trapped in Confession With Influence.\u201d Is that what we are?\\\\n'\"]", "inst_index": "21853", "domain": "PLOS One, April 2014 | Volume 9 | Issue 4 | e92189", "url": "http://doi.org/10.1371/journal.pone.0092189", "summary": "", "authors": "['Liliana O. Rocha, Sabina Moser Tralamazza, Gabriela M. Reis, Leon Rabinovitch, Cynara B. Barbosa, Benedito Corre_a']", "date": "03-28-2014", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Functional Characterization of Two Structurally Novel Diacylglycerol Acyltransferase2 Isozymes Responsible for the Enhanced Production of Stearate-Rich Storage Lipid in Candida tropicalis SY005", "warc_date": "20220328", "article": "[\"'Chatin is the process in the production of direct-to-site reactions in aluminum sulphate-rich glue. Dentists might perform a histogram once upon a time to estimate the composition of the mechanical reaction. If the histogram is not correct, they would get the problem a few years later \u2013 their step is up to them. To his satisfaction, Jacob N. Kodhanasia for a few years ran his finger over the glue to uncover the action and find traces of the DNA on the glue. Those traces of the DNA could be identified in the film.\\\\nThis is their first functional phase of a functional life cycle called a structural phase. They (perhaps their first) processed the reaction at natural acids and changed it, to make a product most definitely capable of repairing the contamination problems caused by defective bacteria in the intestinal system. What are the unique capacities and interactions of these entities to be able to function as such? This is important in the case of tachae skull, the skull with sequentially split strands.\\\\nSeised particles of the composites are weak in one or both pairs of composite molecules that were studied. Seen from the bottom of their folds, a few of the composite molecules found might be easily broken down, especially in benign and tumor-resistant gaseous lung cells.\\\\nSpectacular burst absorption of solubility of composite microscopic particles is relatively rare in nature and suggests they have serious learning needs. At three possible points in time, the release of these particles could be controlled through interaction between components of the composite molecule with the other component of the matrix of composite molecules. This would give the previous HSPA system new ammunition to manipulate the HSPA with conventional enzymes, moving them around as the number of light chemicals in the alloy area change. This allows our imager to take steps to inject these components with a standard nanoparticle into the structure in which the particles are being mixed. What are the characteristics of the chambers that processes these particles in? What happens when the particles are warm and chilled inside the crystals?\\\\nIn a collision with the hydrogen supply rods found in the Cortina de las Ventanas, Nitrogen Epsilon, a protein in the matrix of these particles, the particles have an explosion of aluminum salts, which the process is partly responsible for allowing the particles to extend for up to 10 years without the needs of causing the reactivation of certain forms of organic compounds which could eventually become toxic.\\\\nFound in the Cortina del Norte, this powder contains the support of two nano units, the enzyme Idi2 which holds the insoluble compounds together, as if on a break to collect the minerals in the surface with the mechanism whereby the cells surface and dissolve the substances. When this process begins to separate the elements together, the surfaces are coated with hessian fragments, which fall into a sheltered and porous drainage known as a plough with no regulation of the bacteria to send their shape or structure back to the source. The composition of these structures is confirmed when the large aggregate of each particle is flattened on the surface of the filaments with compressed ends.\\\\nThe particles are in a dense form after many years of warming\\\\nTachae fluid secretion\\\\nThe event is recorded and this becomes the norm over time as the process of analyzing the process becomes more progressive and biological in nature. This enables the group to go with an efficient whole-hog process that does the same calculations needed to figure out an appropriate settlement of these small particles. To give a sense of the contents of the such natural formation, the reactions occur using the object of my text\\\\n'\"]", "inst_index": "77818", "domain": "PLOS One, 14 April 2014 | Volume 9 | Issue 4 | e94472", "url": "http://doi.org/10.1371/journal.pone.0094472", "summary": "", "authors": "['Prabuddha Dey, Monami Chakraborty, Maulik R. Kamdar, Mrinal K. Maiti']", "date": "03-28-2014", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Stac3 Inhibits Myoblast Differentiation into Myotubes", "warc_date": "20220328", "article": "['\\'The first launch and prognosis for Stac3 Inhibits caused an exchange of speculative speculation on social network Twiter around the dawn of 2014. The public, and especially \"Twiterators,\" has speculated that Stac3 Inhibits would be similar to MegaAssets, an instant messaging service popular among teens.\\\\nIn fact, few like it. Stac3 Inhibits, which apparently teaches young children information about musical instruments from a programmed flight simulator, make an extremely strange visual impression.\\\\nThe dense, hand-coded pixel images are studded with bright colors that the students can immediately recognize as letters or numbers. The same faces and the same themes appear.\\\\nThe researchers at Stac3 Inhibits have proposed that these approaches should be translated into other forms of communication. Letting students create their own interactive library is the most useful approach.\\\\nTo create interactive library\\\\nA student can read a book or scroll through text by hand. Using multi-touch touch interaction or Narrow Tap\u2122 allows the student to type within about 100 characters (key words, each with full translation) of symbols and symbols as well as uses each transaction to promote content. The creative process, as Stac3 Inhibits argue, can not only be adaptable and rewarding to students, but can be given widespread participation on Twitter, websites, and forums.\\\\nTo develop ideas for crowd control, for example, the team specifically developed an app that powers text campaigns that help people amplify the text presentation of their interactions. A diagram of text campaigns, for example, are displayed alongside a list of 12 texts.\\\\nTo learn more about Stac3 Inhibits, click here.\\\\n\\'']", "inst_index": "19290", "domain": "PLOS One, April 2014 | Volume 9 | Issue 4 | e95926", "url": "http://doi.org/10.1371/journal.pone.0095926", "summary": "", "authors": "['Xiaomei Ge, Yafei Zhang, Sungwon Park, Xiaofei Cong, David E. Gerrard, Honglin Jiang']", "date": "03-28-2014", "split": "test", "label": "machine", "status": "succcess"}
{"title": "TGF-b/Smad3 Stimulates Stem Cell/Developmental Gene Expression and Vascular Smooth Muscle Cell De-Differentiation", "warc_date": "20220328", "article": "[\"'Whether you\u2019re new to the cell-free study or only started a science, patients receive a fresh and exciting new treatment to restore their muscles and promote improved quality of life after two painful bouts of prolonged toxic chemotherapy at home. These gory simulations show how cells in the brain, which generate electrical signals in the body, could be slowed down in a way that makes them heal quicker, although it\u2019s impossible to know exactly when its healing first occurred.\\\\nResearchers from the University of Louisville joined the Johns Hopkins Medicine (UofL) National Institutes of Health (NIH) to study the effects of GSM stimulation, a highly interdependent activated cascade that regulates blood flow. The study\u2019s s results point to the role of gingivacaine, a powerful anti-cancer agent being the fuel that blocks the clotting of neurons that trigger blood flow. GSM-b/Smad3 is targeted at low-yielding cells in the brain called GSM-b/Smad3, and the researchers found GSM-b/Smad3 draws a direct line between the ribosome and the cell membrane.\\\\n\u201cHaving much cutting-edge research performed by two lead investigators brings us an outstanding ability to detect the risks and to make smart drug trials,\u201d said co-author, Benjamin David Montine, PhD, MD, a professor of medicine in the UofL Department of Neurosurgery and an assistant professor of neurology. \u201cWe made sure that good data was produced to show how GSM-b/Smad3 could\u2019ve been used to neutralize the many secondary underlying mechanisms of disease in the brain, and whether GSM-b/Smad3, alone, could be used to control a patient\u2019s disease.\u201d\\\\nAlthough GSM-b/Smad3 is approved for the treatment of chronic migraine, a recent FDA decision holds the company back. GSM-b/Smad3 has been proposed as a treatment for mild-to-moderate type of peripheral neuropathy in stroke patients due to an unintended side effect, including a reduction in primary function, associated with prolonged discharges of the joint. The company raised $22 million in equity funds led by private equity firm KKR Capital Management and Sanford Bernstein. However, it never entered a large debt-financed Series A round.\\\\n'\"]", "inst_index": "88760", "domain": "PLOS One, April 2014 | Volume 9 | Issue 4 | e93995", "url": "http://doi.org/10.1371/journal.pone.0093995", "summary": "", "authors": "['Xudong Shi, Daniel DiRenzo, Lian-Wang Guo, Sarah R. Franco, Bowen Wang, Stephen Seedial, K. Craig Kent']", "date": "03-28-2014", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Cell Atavistic Transition: Paired Box 2 Re-Expression Occurs in Mature Tubular Epithelial Cells during Acute Kidney Injury and Is Regulated by Angiotensin II", "warc_date": "20220328", "article": "[\"'NEW YORK, NY, (RFI) \u2013 Stage 1 diabetic ulcers and arehemophilia are class II stage 3 acolytes in cells found in modern-day colon polyps. It is no secret that they are extremely painful, often in severe cases and which contribute to patients\u2019 renal failure. These conditions include bloodstains in the kidneys, kidneys that do not efficiently filter urine, and internal body chambers, including an inflatable device that is used to cut through the blood. Patients with Stage 2 Type 1 diabetic ulcers die within a few months after surgical procedures.\\\\nIn contrast, Stage 1 diabetic ulcers suffer only from repeat infection, and are relatively gentle at removal of blood without bleeding.\\\\nIn a post on OPNBC, Qshen Jiang explained the dramatic impact of the median median median median survival between Lapulmonary Respiratory Syndrome (PARS) and Stage 1 diabetic ulcers on patient survival.\\\\nPRICING: You can find all of the pricing information for this interview with researchers at Porthole Gold University in Israel and Universidad de Encinas (Ucilca) in English and Hebrew.\\\\nThe spokesperson explained that, \u201cSoaps of this magnitude take time and sometimes, it can take months to build up a functional glycansole, or birthmark, and that\u2019s where we came in to identify these types of adaptive dynamics, and these adaptive adaptations are the basis for the balancing techniques in human cognitive development: the complementary effects of diet, exercise, structure changes, hydration changes and other adaptations.\u201d\\\\nWhile the doactory tree may have measures to prevent early onset and moderate progression of diabetes, such adaptation is neither necessary nor effective, they reveal the complexity and how interplay of these adaptive factors lead to lifelong medical care.\\\\n\u201cThere have been many studies of sugar and electrolyte structure in metabolic disorders, but the only thing linking them to exercise in an individual is the surgery environment. This presents a new computational challenge and an opportunity to inform medical design processes in patients where alterations in these structural adaptations are needed,\u201d he added.\\\\nJiang explained that, by encasing in large polypropylene water molecules, in terms of its rate at which it cooks into kidney tissues, the sequences of enzymes which alter the structured structure within lipids are altered.\\\\nThere are limitations in the end result: one percentage improvement, requires the plastic decay chains to be joined in order to produce large molecules in the laboratory. While plastic hydrocarbons, as extracted from shrimp, have proven beneficial for metabolizing complex carbohydrates, they are still hard to obtain for plastics.\\\\n\u201cIn addition, these polyp factors have various types of structural limitations, particularly as they pertain to lipids signaling pathways associated with heart failure, kidney injury and the way inflammatory bowel disease is presented. We are therefore using drugs to determine the mechanisms of the best ways to block polyp amino acids, based on functional prerequisites,\u201d he added.\\\\nEstablishing the optimal therapeutic profiles for hyper-pigmentation (A\u03b2) has its challenges. This is particularly true in cancer, where monogenic inflammation occurs in the basal cell of the gastrointestinal tract (solar cell), and in infectious diseases, where conductive obstruction of nutrients such as vitamin C or zinc is endemic, and especially in cancer.\\\\nThe success of A\u03b2 inhibition in chronic kidney disease is critical for reducing its function to a pivotal degree. For the study, Chinese researchers examined A\u03b2 interaction within organ tissues in a clinical window where A\u03b2 is ingested via plastic. However, near-term effects with human cells to A\u03b2 had been severely challenged by the constraints to achieve A\u03b2 inhibition.\\\\nDr. Zhang Nam, co-senior author of the study and director of the Cellular Research Unit at HSSU wrote, \u201cIn this, the functional mechanisms of A\u03b2-linked stem cells are further challenged by standardization, resistance to this modulator, and highly constrained by the brain protein. Drug adjuvant-infusion is not done in combination with A\u03b2 with any altered protein (e.g., R1), and a single anticonvulsant may only be required to resist autoimmunity.\u201d\\\\nOther goals of this study and controlled phase 3 clinical trial may include improvement in pre-surgical prostate inflammation, circulating renal function, and lead to reduction of blood vessel dysfunction and from a novel process to treat A\u03b2 ablation in human hepatitis. This study should not only be'\"]", "inst_index": "26768", "domain": "PLOS One, April 2014 | Volume 9 | Issue 4 | e93563", "url": "http://doi.org/10.1371/journal.pone.0093563", "summary": "", "authors": "['Yushen Jiang, Tang Jiang, Juan Ouyang, Qingsong Zhou, Yanlan Liang, Yingpeng Cui, Peisong Chen, Bin Huang']", "date": "03-28-2014", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Sparstolonin B, a Novel Plant Derived Compound, Arrests Cell Cycle and Induces Apoptosis in N-Myc Amplified and N-Myc Nonamplified Neuroblastoma Cells", "warc_date": "20220328", "article": "[\"'On April 12, surgeons at the Glenn Shepherd General Hospital performed what they described as a grueling surgical procedure that brought five patients back from CFC to scale daily levels of beta amyloid compounds and stimulate their incontinence, causing them to suffer injury from open wounds. (Table entitled)\\\\n\u201cI am having the surgery on the under one brain tumor. I have five fingers right now with these five nerves and not a pinch of amyloid acid \u2013 good for my nerves. The normal functions of my brain have grown withdrawn due to the discomfort of having four or five fingers that are very sensitive to the changes in my mind.\\\\nThe invasive procedure, it used only one vessel to open the ten nerve endings but the accumulation of amyloid acid cells caused irreversible damage to these nerve endings to make an objective diagnosis.\\\\nAccording to UCSF, Sparstolonin was developed and made from a highly purified materials, which are chemically similar to the amyloid acid we initially created. The primary objective is to destroy the amyloid proteins with a stem cell derived cloned from the amyloid deposits and encapsulated into a single vessel to promote apoptosis of nerve nerves to improve neuroblastoma treatment.\\\\nVitamin D and B help to repair nerve degeneration, and ovarian cancer is a disease of the nervous system that often directly impacts the nervous system.\\\\nThe treatment is FDA approved for the treatment of Keyhole nerve cells, which also contain amyloid protein. There is currently a requirement for up to 120 mg per day for use by patients with nerve degeneration to relieve symptoms of the incontinence. This treatment is available for adults aged 18 or over with Alzheimer\u2019s disease and the disorder affects the elasticity of the nerve walls in that age group, a condition that is typically very similar to Parkinson\u2019s Disease.\\\\nB, an open wound patient from Falls Bridge, Washington, is currently undergoing the free medical monitoring to determine what he is having suffered from and how far he needs to go to continue the therapy. The patient is currently being monitored by physicians but is more concerned about his condition than his hope.\\\\nThe good news is the patient is exploring the option of commercializing the product, using it as one of the ways to use amyloid samples for controlled neuroblastoma treatment. It is a significant validation that the treatment does not require advance FDA clearance and therefore will likely be approved through regulatory channels in the U.S. which is a large market for the treatment.\\\\nSparstolon is a completely novel disease and is not uncommon in patients who are having surgery to remove brain or spinal cord injury due to stress and/or depression. There are approximately five million people worldwide, with an estimated 5.4 million people affected by head and neck injuries, and the incidence of head and neck injuries attributable to traumatic brain injury (TBI).\\\\nThe diagnosis of a brain tumor was the first thought to the patient. After he explained the bone marrow stem cell lines he was sent for diagnosis, he was given two machines. After three days of separation from his B, he lost consciousness and was eventually put on a short medications that were surgically attached to his hands to control nerve deterioration. Upon further analysis the patient described the neurophysiological aspects to mean the patient is suffering from, or may be suffering from, incontinence.\\\\nThe patients are continuing their treatment and will continue to get pain relief and recover from the incontinence. One neuroblastoma patient is in experimental treatment and remains in the CFC until pre-mastectomy are complete, during which time the patient will be awarded the new brain stem cell therapy.\\\\nThere are multiple clinical trials that have been in progress, and a breakthrough is still in their development. The patient will only make a minimal contribution to a smaller overall investment of $1,000. The risk of the medication potential limiting results, and the rarity of the patient\u2019s worsening history will be limited as these trials are in clinical trials. However, the ultimate costs of providing the awareness needed for patients that struggle with nerve degeneration and losing them to bone cancer are to be estimated at approximately $40,000 annually over the lifetime of this patient.\\\\nMany patients remain in the CFC through placement of hormones and physicians that deny necessary medical procedures and to which they may experience symptoms of disability associated with the disease.\\\\nThe patient \u2013 a 42 year old woman from Falls Bridge, Washington, is currently undergoing the free medical monitoring to determine what he is having suffered from. He had a neck injury that is not uncommon in'\"]", "inst_index": "20710", "domain": "PLOS ONE, May 2014 | Volume 9 | Issue 5 | e96343", "url": "http://doi.org/10.1371/journal.pone.0096343", "summary": "", "authors": "['Ambrish Kumar, Daping Fan, Donald J. DiPette, Ugra S. Singh']", "date": "03-28-2014", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Dose-Dependent Effect of Estrogen Suppresses the Osteo-Adipogenic Transdifferentiation of Osteoblasts via Canonical Wnt Signaling Pathway", "warc_date": "20220328", "article": "['\"In this video podcast, We have an expert on epigenetics and gene structure from the University of California Santa Cruz\u2019s Advanced epigenetics Research Center in a science-and-technology role. In addition to our co-authors, an APRC graduate student who worked with Ye Kao at Stanford and others on the research.\\\\nBy Bo Gao & Yan-Shui Lin\\\\nProfessors Yin Min and Yan-Shui Lin have published a study on HN-2S51Q2, a gene variant where the heart is unusually active during treatment, through which it repairs. Eureka! \u201cIt turns out that the heart slows down to make antibodies when induced with an inhibitor of HN-2S51Q2. However, the associations between HN-2S51Q2 and the heart\u2019s excretion of gene activation are limited because the heart is also twice as fast during that process,\u201d explained the authors.\\\\nExcerpt:\\\\nOsteo-Adipogenic Transdifferentiation (OSP)\\\\nLonger pause (3-4 hours)\\\\nEat exclusively plantain, plantains, meat, milk, vegetables, fruits\\\\nDrain gluten-containing portion.\\\\nFood waste by either resisting or eating the excretion.\\\\nDrain gluten-containing portion.\\\\nFish and fish consumption by or diet.\\\\nIf the heart stops the production of the pancreatic enzyme HN-2S51Q2, the heart will lose just one gene, EPIC1 (ELECTREB), which activates the heart\u2019s heath response and leads to visual reduction. The epimedacy enzyme HN-2S51Q2 can be at least partially replaced without destruction of EPIC1\u2019s capacity to create therapeutic antibodies. However, the heart\u2019s excretion of gene activation is inappropriate when induced with HN-2S51Q2.\\\\nSorting out Influenza\\\\nA 2012 study examining HDRNA protease regulation in humans and mice\u2014the \u201cvaccine for influenza\u201d protein given at the outset of treatment\u2014confirmed a causal link between HS137 and HS137 protein (hWPOQ). HS137 has been shown to contribute to symptoms of asthma, dengue fever, and other underlying symptoms of chronic diseases such as fibrosis, organ transplantation, kidney failure, and retinal degeneration. HS137 causes direct damage to the heart by blocking the production of LECS2, known to be a key mechanism for firing the epidermis. In this connection, HS137 increases inflammation and anti-inflammatory activity, causing inflammation that leads to chronic sleep apnea, asthma, and co-infection of the lungs.\\\\nThis link was not previously known, and we do not know the origin of HS137.\\\\nIf we identify HS137 as a cause of the asthma and fibrosis, epidemiology of asthma and allergy epidemics such as HWPOQ and HN9P2, and HN9P2 as a cause of both diseases, and HN9P2 as a cause of non-existing diseases such as kidney failure, there would be the potential to diagnose and treat these specific conditions and recommend appropriate treatment.\\\\nDose-dependent effect of cytokines decreases blood pressure, production of \\'intravenous\\' proteins that contribute to brain function.\\\\nEarly tests showed that HPV-induced blood pressure and uric acid intake increased after acetaminophen analgesics. The finding caused the stress hormone cortisol to be reduced, which increased estrogen levels.\\\\nThis study published in the Journal of Personality and Social Psychology, also provides insights into the potential for the relationship between HS137 and abnormal genetic development, which may prevent replication of other pre-symptomatic diseases.\\\\nJournal Dates:\\\\n25 March 2013: We\u2019re at 24:00 ET with a panel of expert panelists and post-panel panelists who are focused on ocular transcription of fluoresce-positive disease in humans in the near future. http://www.dialogetech.com/voluntary-post-results/atie-novust-and-no-inhibitions/2014/03/015/0042-0931-article.html\\\\n\"']", "inst_index": "75656", "domain": "PLoS ONE 9(6): e99137, June 11, 2014. doi:10.1371/journal.pone.0099137", "url": "http://doi.org/10.1371/journal.pone.0099137", "summary": "", "authors": "['Bo Gao, Qiang Huang, Yan-Shui Lin, Bo-Yuan Wei, Yun-Shan Guo, Zhen Sun, Long Wang, Jing Fan, Hong-Yang Zhang, Yue-Hu Han, Xiao-Jie Li, Jun Shi, Jian Liu, Liu Yang, Zhuo-Jing Luo']", "date": "03-28-2014", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Carbon Ion Radiation Inhibits Glioma and Endothelial Cell Migration Induced by Secreted VEGF", "warc_date": "20220328", "article": "[\"'Carbon Ion Radiation Inhibits Glioma and Endothelial Cell Migration Induced by Secreted VEGF\\\\nLi Jingbing, Associate Professor and head of Jianglin University\u2019s Heart-Drug Research Center, was critical of the conclusion that the visual and molecular strategies of laser, lens, and optical nanocraft were not integrated into the LIS sensor in the scanning.\\\\nAt his lecture on April 26, 2014, Li showed a major aspect of the CARNIVAL substance in a plate-size version of the substance that shows up in the image. He noted the number of molecules and types of nanocraft with the number of nanocraft compared to standard laser and lens.\\\\nLi said that about 20 to 30 molecules are sensed in a plate-size size scanner, whereas about 8 (5 nanomolecules) are instead detected in the patient at a fraction of the amount found in a laser and lens and small ceramic nanocraft. There is additional detail in the results as the nanocraft does not expand in depth nor does it leave the plate-size of the scan.\\\\nAfter observing the scratch-off nanofor a 30-minutes patient, Li described the detail of the nanocraft thus: \u201cThe size of the nanocraft is enough to keep a flat phone in the digital device. At that point we had only met resolution and therefore i.e. resolution number two, number three and number four. The nanoquality number on the panels is about 8, if you will, 4, so effectively the plate-size movement is higher than that of a standard laser.\u201d\\\\nTo emphasize this point, Li continued, \u201cIt is true that the big size on the camera enhances the penetration of the material. It should be stated that the same density that on the surface and particle size on the particles are less in this self-expanding plate than that on the plate-size of the normal laser, the mass of the nano is greater. To analyze the efficiency of the nano, let me say that the nano will resist any kinds of things. To ensure a good fit, the nanocraft has a powerful biochemical reaction. This reaction is also critical to further orient the nano on its surface.\u201d\\\\nLi also mentioned to emphasis that the new material\u2013the nano-particle 3D Sequoia\u2013with the resolution and thickness of the surface is superior to the current material. \u201cThe nano-particle 3D Sequoia\u2019s surface texture is much finer, takes less time to apply itself and is also less dense than the nano-particle 2D created as the initial design.\u201d\\\\nLi concluded that nano-particle nanocraft is very unique, given its apparent limits and different lifetime periods of time between publications.\\\\nHowever, the precision of the display represents an advantage of thin nanoscale lenses, although a bigger scale is necessary to achieve the optimal resolution. Li concluded that the small size of the plate-size nanocraft in the published second issue of the Nanoscope journal of Hybrids Chem, which presents the results of the Nano-chemical examination, demonstrates the utility of thin nanoscale lenses.\\\\n'\"]", "inst_index": "49528", "domain": "PLOS ONE, June 2014 | Volume 9 | Issue 6 | e98448", "url": "http://doi.org/10.1371/journal.pone.0098448", "summary": "", "authors": "['Yang Liu, Yuanyuan Liu, Chao Sun, Lu Gan, Luwei Zhang, Aihong Mao, Yuting Du, Rong Zhou, Hong Zhang']", "date": "03-28-2014", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Aspirin Delimits Platelet Life Span by Proteasomal Inhibition", "warc_date": "20220328", "article": "['\"What do you get when you combine gin, cur\u00e1velo, lemon juice, lemon artichoke oil, sea salt and figs? A single microgram of pure beta carotene and 10mg of pure honey (docoterine) \u2013 made from extracts of that substance. Simple. Like a showerwater-based algopharm. A bottle of beer in the bathroom so I could drink a plate of rhubarb juice and grapefruit juice. In one drink \u2026\\\\nTake a sharp drink of the Anaconda Bay version of Sabin 100 (0.0875 oz), or Fiji for instance \u2013 a fizzy offering of sports drinks with passion.\\\\nDunasamic liquors are immensely popular in India, and they have a kick after their time, especially at night when they often provoke humps that are a magic of fever and might just spell freedom. I can\u2019t taste it \u2013 I can\u2019t taste it until I drink it. Not when you\u2019re sweeping your face after being drowned (lit by your face, you can\u2019t argue with me).\\\\nThe different sized versions of the Anaconda Bay version of Sabin 100 are still available, though the range of variants to the Natyum is being pushed. I only drink one of those units at a time, and in this drink I drink only four-and-a-half-micrograms \u2013 whether these are per four-and-a-half ounces or four-and-a-half packs of gin or vermouth (a single mcg) and I drink one bottle. Even when I\u2019m not doing so, I\u2019m going to enjoy the Rhubarb Edition: one mini pumpkin bottle of 100kg, equal in volume of the Brit Knot-Roasted Quinoa C\u00f4te Blanc and 250ml of Taggartles Company Brut (and with breakfast).\\\\nThe Libisiery offering, in particular, is considered \u201cflavoured\u201d to this point, with low, creamy herbal notes of tannin and lime, and lean, clear, crackling herbs. The Fusion also appears to contain more than 200g of coriander and leaves (just 15g). There is a definite summer flavour of melon or currant seed, even though it\u2019s just I think it could have been a fermented product. Quarry is the fortified version.\\\\nOnce you have finished drinking it, your preferred solution to your day, and for the duration of your life, you have a regular increase in your essential protein. I drink one of these: triple sec, plantain in rice, sunflower oil, and chunky cashews, and one small section of Cr\u00e8me R\u00e8s, or green chai (it\u2019s also served with mint and mint syrup). An endorphin is a significant benefit for all parts of your body and mood, most especially those that are related to your binging on alcohol. And anti-depressants \u2026 but as with all drinks, they probably affect the most negatively.\\\\nAntibiotics improve skin sensitivity; calcium increases muscle tone and collagen, while ether enhances the growth of cells. Downers and iodine are good supplements. There is now greater intensity in dietary fibre intake, so you can boost the response of your platelets by choosing minerals and minerals types.\\\\nThere is just as much sugar in your daily diet as there is carbohydrate, and it does not require much to get through, given the intense physical and emotional volatility that surround it. For a full carbonated form, use the Obamas Gold selection, available here.\\\\nAt the time of publication, product information was provided by Sri Lanka\u2019s Graphic Media.\\\\nRead the original article on Sri Lanka\\'s Sri Lanka Blog. Copyright 2014. Follow Sri Lanka Blog on Twitter.\\\\n\"']", "inst_index": "38354", "domain": "PLOS ONE, August 2014 | Volume 9 | Issue 8 | e105049, doi: 10.1371/journal.pone.0105049", "url": "http://doi.org/10.1371/journal.pone.0105049", "summary": "", "authors": "['Manasa K. Nayak, Ayusman Dash, Nitesh Singh, Debabrata Dash']", "date": "03-28-2014", "split": "test", "label": "machine", "status": "succcess"}
{"title": "S137 Phosphorylation of Profilin 1 Is an Important Signaling Event in Breast Cancer Progression", "warc_date": "20220328", "article": "['\"Last night we discussed the above analysis. The conclusion came from Dr. Doe G Raji, a professor of clinical and internal medicine and director, Cystic Fibrosis Canada Foundation (CFCF), in Basking Ridge, New Jersey. He provided three important studies in the very area of progression to this second target protein: the ALTEN-1 (the active component of it). The patients examined in S137 were breast cancer patients with aggressive disease with CF in 14th-grade history. Five years ago these patients were cleared by the National Health and Nutrition Examination Survey (NHANES). This validated the hypothesis that these women had an increased rate of breast cancer progression with ALTEN-1 from 14th grade through early 90s. In addition to this evidence, when considering the initial diagnosis by the NHANES, SAR713, an OROACTe gene (also known as a time-keeper gene) known to be biased in the breast cancer field, was included. The lab-based spin was also employed to demonstrate that SAR713 was a target.\\\\nStigma Soares It\\\\nWomen with a history of breast cancer prefer to be referred to Herceptin or Avastin, but even more women with an extensive history of breast cancer are attracted to a blood cancer screening program that involves a treatment site specific to breast cancer. SAR621, which is designed to bypass the need for more than one screening, is specifically targeted for breast cancer with an anti-cancer auto receptor (CIRP) tyrosine kinase with simultaneous cosahexa treatment. SAR721 is also targeted by the E4-nanocarcinogenic anti-rejection process to modify the cell expression of drugs inhibiting NMDA receptor interferon, ALTEN-1 and ALTRX, which is responsible for the NMDA receptor expression. In additional to SAR721, E4-nanocarcinogenic ALTRX is targeted by the CIRP-rpartly-targeted CCR1 gene. SAR721 is also targeted by the primary determinant of adjuvant therapy, which is the Neuromodulation (OR) procedure. RECENT AND DEVELOPING\\\\nAre Breast Cancer Stage 2 Drug Tests A Mistake?\\\\nI have examined multiple clinical studies of B2 melanoma in breast cancer patients who were not screened or treated. This has been argued as being a one-in-three chance of dying from B2 melanoma, but my personal experience is that it is sometimes the patient\\'s every word that matters. The results (in more recent studies) revealed a high mortality rate and a clinically relevant drug\u2019s complement response in breast cancer patients.\\\\nThe key to a successful screening regimen is adherence to strategy of the screening program. Spoken In, an important test for weight loss is braving the exercise. In six or nine months, the case study would be comprehensive. The person with a food cancer has to eat regularly with at least four portion breaks (no fasting) (to reduce dietary intake in the case of cancer) to reduce risk of heart attack.\\\\nFor a taste of the risk factors associated with breast cancer, I have screened for the negative associations that TNF\u03b1 inhibitors/Maromer inhibitors are given to breast cancer patients in early stages, causing a link to their prognosis of early detection and early death. I have researched several other types of breast cancer, and there has been no data to support their possible link to ATRI or mammogram screening in breast cancer patients. For further research, I have published a study that appears in my The Results of the Academic J-Bio Surveillance System on Maternal Breast Cancer in Women. To be added at this link I invite you to review the weight loss in breast cancer data in this study.\\\\n*TEXT:\\\\n\u2022 Nannoy ad-reactions (Wendy\u2019s) Dental Cover From Nannoy\\\\n\u2022 MAPL A Glass-Diner Vergedllaa Warning at Heart\\\\n\u2022 ARS Wurterer Robotic and Induction Table Prolomipion in What Is B2?\\\\n\u2022 Follow @Wasia_Rizwani on Twitter.\\\\n\"']", "inst_index": "11001", "domain": "PLOS ONE, August 2014 | Volume 9 | Issue 8 | e103868", "url": "http://doi.org/10.1371/journal.pone.0103868", "summary": "", "authors": "['Wasia Rizwani, Aneesa Fasim, Deepshikha Sharma, Divya J. Reddy, Nabil A. M. Bin Omar, Surya S. Singh']", "date": "03-28-2014", "split": "test", "label": "machine", "status": "succcess"}
{"title": "The Retromer Complex Is Required for Rhodopsin Recycling and Its Loss Leads to Photoreceptor Degeneration", "warc_date": "20220328", "article": "['\\'In almost every factory, a fluorescent activity is triggered by a radiofrequency signal emitted from the electron. This signal is then immediately switched on within a fluorescently-detailed packaging. This fluorescently-detailed packaging literally transmits signals transmitted via the radio waves of the fluorescently-detailed packaging to the electronic devices on factory floors.\\\\nSimultaneously with this signal switch, these electronic components are encouraged to emit \"puffs\", which in turn releases a green fluorescent light that appears on these sensitive electronics (Sf) tags. Recently, Axio Works in Rennes, France, developed the Axiom forchromight, a wearable optical sensor that eliminates both active noise and signal loss. Even though the sensor reads all of the electromagnetic signals emanating from the electronic devices, the fact remains that it cannot read signals generated by the sensor, so it does not automatically identify the ring associated with the signal. The Axiom allows electronic operators to develop algorithms to analyse the signal emitted by the silicon carbide (OC) chips they are transmitting to factories (ESRs). According to Axio, silicon carbide is the primary source of the PHD and fluorescent fluorescent items.\\\\nThe Axiom analyzes the optical signals emitted from the silicon carbide chips and smashes them with (i) the proper biological data (NRSMB) about the signals emanating from the semiconductor chip manufacture (MIC), (ii) serial number (P4) and (iii) the location (DNP) which makes the signal, when detected and illuminated, to be turned on within an instrument, ensuring that no electromagnetic radiation enters an appropriate distance.\\\\nThe laser source of the ion beam comprises a laser, transalignment lens, f/8 lens, the laser pixel, top notch optical sensors, and the imager. The laser pixel captures all of the electrical signals emitting from the electronics (ISO, ISO, and bubble). The algorithms work by using a sensing algorithm that is similar to that of a physical image and demonstrates how many of the pictures are part of a picture, how many are characteristics, and how a certain number of image images are part of a picture.\\\\nThe Axiom analyzes the ion beam to observe how much of the signal, thereby identifying where the signal is located and how it has to go through this known detector.\\\\nIt also manages to analyze an electron beam that is engaged at specific wavelengths. The upper diameter that the photons in this beam meet makes the signal translated, not turned on, as indicated by the surface of the electron beam on the camera. However, the signal is detected, but the image of the image is not produced. This means that the contrast produced by the signal is absolute, while the accuracy of the quality is never called into question.\\\\nThe algorithm explains how he can tell what information is being transmitted from the chips to the RF components so that the concentration of the signal is exactly right. This will hopefully make the signal neutral, and thus easy to detect, the particles emitting during the photoreceptor process. There is already an \u201coptic beam\u201d developed that converts optical signals into pseudo-VHF, and there are new antennas, which can be fitted, due to the effects it can produce on photoreceptors.\\\\nThe Axiom has received positive reviews from the trade publications Divida and Kabi which report its rapid advancement into the manufacturing industry. It has also been recognized for implementing data storage technology that is faster, simpler, and provides faster transfer of information between production devices (RPMs) than traditional protocols, as well as during transplantations. This is essential for the value-added quality assurance assurance and point management capabilities used in mono-conductive electronics.\\\\nThere are currently several devices with Axiom with control and data storage that are selling for substantially more than $300. The Axiom new optical sensor designed to detect electrical signals and transmits this information via a Liomb from the circuit board (which has 10 GB capacity) to the electronic devices in manufacturing processes and with the right exposure, which is 10% more light than current, is expected to become the fastest 5MDB light emitting diodes that circulate in the world.\\\\nOver the next decade, Axiom will be used in over 100,000 screens, motors, switches, generators, and other devices requiring high performance \u2013 but also proprietary data and information technology. Axiom will be\\'']", "inst_index": "31631", "domain": "PLOS Biology, April 2014 | Volume 12 | Issue 4 | e1001847", "url": "http://doi.org/10.1371/journal.pbio.1001847", "summary": "", "authors": "['Shiuan Wang, Kai Li Tan, Melina A. Agosto, Bo Xiong, Shinya Yamamoto, Hector Sandoval, Manish Jaiswal, Vafa Bayat, Ke Zhang, Wu-Lin Charng, Gabriela David, Lita Duraine, Kartik Venkatachalam, Theodore G. Wensel, Hugo J. Bellen']", "date": "03-28-2014", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Astakine 2\u00c3\u0083\u00c2\u0091the Dark Knight Linking Melatonin to Circadian Regulation in Crustaceans", "warc_date": "20220328", "article": "[\"'Stem cells derived from stem cells may have lower blood pressure and/or sleep apnea problems, even in tiny mitochondria, the centers of activity in the brain.\\\\n\u201cAstakine 2 mgB can create neural pathways and not stop them,\u201d says Hayatin Mammala, a virologist at Baylor College of Medicine. This is important, because the serotonin receptor is exposed to an enormous amount of the opioid painkiller inulin. It can stimulate serotonin receptors. That is not to say that it stops there, though it can influence sleep and climate change in other directions.\\\\nIn the original publication of this journal by himself and Gillian Gaspard in 2008, Mammala and her colleagues, Ahn, George and Dennis Balin, with Monstan and Steve Abrams of the University of Michigan, wrote a study about a very simple and often painful procedure called the medication therapy of carboplatin. In this case, they first injected a glucose-stabilized insulin-producing sperm into mouse brains.\\\\nIt would be very difficult for the libido impaired mice to function as normal human mice. They would have to work out any of the genetic modifications and antiviral medications \u2014 they are obese, have almost no heart disease, have never had dental extractions, have no seizures. Basically, they just would need to develop insulin resistance, and by then we are at the end of artificial birth \u2014 more likely than not given other drugs to control insulin resistance. Mammala says that working out the risk of heart attacks by injection would only delay them later, but she suspects that nerve in the pancreas begins to slow down, and, when it does slow down, it is the slow killer.\\\\nShe also found that testosterone levels and hormone levels are increased in the presence of omeprazole, the class of drugs known to interfere with inhibition of gene expression. She says her own skin actually became \u201cpoppy-green\u201d in the presence of oatmeal, and that she would usually take another one twice.\\\\nI will get to the overall rationale for this, and think about the exciting way this whole thing could take place. The importance of the antidepressant play have not changed, but life is ever changing and there are potentially new therapies that could be brought in just as effectively, and maybe even just as easily.\\\\n'\"]", "inst_index": "42813", "domain": "PLOS Genetics, March 2013 | Volume 9 | Issue 3 | e1003361, doi:10.1371/journal.pgen.1003361", "url": "http://doi.org/10.1371/journal.pgen.1003361", "summary": "", "authors": "['Apiruck Watthanasurorot, Netnapa Saelee, Amornrat Phongdara, Sittiruk Roytrakul, Pikul Jiravanichpaisal, Kenneth So_derh\u00c3\\x82\u00c2\\x8all, Irene S\u00c3\\x82\u00c2\\x9aderh\u00c3\\x82\u00c2\\x8allGab']", "date": "03-28-2013", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Mutation of the Diamond-Blackfan Anemia Gene Rps7 in Mouse Results in Morphological and Neuroanatomical Phenotypes", "warc_date": "20220328", "article": "[\"'About Two-Cholesterol-lowering Grade 1 Drugs\\\\nDeveloping studies that demonstrate the molecular mechanism behind \u201cbioactive\u201d anti-lung-fungal antibody responses with small-molecule drugs\\\\nBerlin, Germany \u2013(BUSINESS WIRE) \u2013 Published by \u201cMyozyme Capital \u2013 Nigeria\u201d ( http://www.myozymecapital.com/) in the October issue of Molecular Biology, here is detailed table of how these two-cholesterol-lowering grade 1 drugs incorporate genetic mutations and gene transfers, and how they are learned and used to develop a molecule specifically suited to occur at high levels.\\\\nThe study included 25 cytogenetics-based vitamin-Mallycob-BNPs from 50 confirmed volunteers who (until February 18) were recruited to receive a pure chemotherapy at no greater than 12mg/day. When they were chosen to receive 100mg/day of chemotherapy, the top histologic expression of the patient\u2019s MCL was 2 -03MBL mcb116955, compared to 4 -11MBL expression in one representative sample.\\\\nBoth doses are administered throughout the day on the same patient. The patients are followed from around 5 hours to 7 hours with an active MROM subclass, or long-term activity seen in extended live neural vessels in the brain. This is the first study looking at both the A and B-path channels of chronic immunotoxic molecules like cytokines and HER2 to support this chemotherapy wave of its kind. For additional information about these drugs\u2019 novel mechanisms, please contact Kendall Nordyke at info@bmcion.com or visit myozymeCapital.com\\\\nAbout Myozyme Capital\\\\nMyozyme Capital is focused on the identification, development, and commercialization of novel anti-lung-fungal antibodies for rare cancers. Its fast-growing R&D pipeline provides crucial insights into an array of therapeutic targets, helping small pharma to safely initiate lifesaving anti-cancer drug launches, launch key clinical trials, and commercialize other investigational combinations. Myozyme Capital\u2019s net assets are $72 million. For more information on this program, please visit our website: www.myozymecapital.com.\\\\nAbout Dendreon Corp.\\\\nDendreon Corp. (NASDAQ:DNDN) (TSX:DNDN) (NASDAQ:DNDN) is a biopharmaceutical company developing innovative therapeutics to improve disease-reducing outcomes for its patients, while providing innovative solutions to the treatment and care of cancer. We believe that our mission is to create value, using our expertise to identify promising candidates to benefit our patients and deliver meaningful new products to our shareholders. Dendreon is a growing biopharmaceutical company with a recently filed ANDA in two main stages of its Phase 3 clinical development. Highlights of our recent clinical studies include an advanced lung cancer drug, dengue fever vaccine, macrophages and drug therapy agents, hepatitis B drug, and psoriasis drug. For more information, please visit www.dendreon.com.\\\\nView source version on businesswire.com: https://www.businesswire.com/news/home/20140528005567/en/\\\\nMyozyme Capital\\\\nKatherine D. Cummings\\\\nKatherine.Cummings@myozymecapital.com\\\\n609-781-5285\\\\nemail protected\\\\nSource: Myozyme Capital\\\\n'\"]", "inst_index": "62608", "domain": "PLOS Genetics, January 2013 | Volume 9 | Issue 1 | e1003094", "url": "http://doi.org/10.1371/journal.pgen.1003094", "summary": "", "authors": "['Dawn E. Watkins-Chow, Joanna Cooke, Ruth Pidsley, Andrew Edwards, Rebecca Slotkin, Karen E. Leeds, Raymond Mullen, Laura L. Baxter, Thomas G. Campbell, Marion C. Salzer, Laura Biondini, Gretchen Gibney, Franc _oise Phan Dinh Tuy, Jamel Chelly, H. Douglas Morris, Johannes Riegler, Mark F. Lythgoe, Ruth M. Arkell, Fabrizio Loreni, Jonathan Flint, William J. Pavan, David A. Keays']", "date": "03-28-2013", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Differential Effects of Collagen Prolyl 3-Hydroxylation on Skeletal Tissues", "warc_date": "20220328", "article": "[\"'Anterior Siglov Neurosciences Institute, Inc. (the \u201cCompany\u201d) (NASDAQ:ANXI) today announced that it has provided bone density tomography test results for three bone density chromosomes, N2 K3-B6 and N2-K3-N2, and has also been conducting research into animal conditions to determine whether highlyl sensitive fusion tissues in human fractures in bone development tend to fracture when lithium ion strips are removed.\\\\nOur bone health research, as presented in a published recent issue of Bone Dynamics, has identified the beneficial effect fusion proteins had on skeletal cortical matter, resulting in increased bone growth and muscle fibers. Bone density seemed to benefit from magnetic resonance imaging (MRI) by increasing the thickness of bone tissue after fusion; however the results did not suggest that once activated, bone thickness might decline. Should bone thickness decline in such fracture patients, these findings imply that inhibiting bone-density induction could potentially improve or eliminate bone disease related dysfunction in nerve regeneration.\\\\n\u201cCollagen protein 3-hydroxylation appears to improve skeletal tissue recovery by axillary muscle formation,\u201d said Richard J. Furno, senior investigator on our bone research with Professor Faour. \u201cBy changing the design of chemotherapy, radioactive particles from bone for instance and combining this with calcium extract from bran damaged bone collagen, produced a potent therapeutic effect for bone density that the existing therapeutic options failed to achieve. These synergistic properties, combined with preliminary studies with bone thickness, suggest that this dual-tissue stimulation in bone recovery may facilitate a potential therapeutic pathway for leg fracture.\u201d\\\\nN2 K3-N2 is a novel fusion protein (unrelenting layer) found in our bone structure. To date, an early stage study discovered that allowing inhibiting of the known gravitational forces on the fracture, coupled with complete inhibition of additional magnetic fields on the system that comprise the original bone formation, produced a safer, more effective, and possibly more powerful alternative fusion agent. This method prevents bone metastasis, saving the world as much as 80% of the lost bone mineral mass.\\\\nAcquisition by Kogler Industrial, Inc. (The \u201cCompany\u201d) (NASDAQ:KOGL) has been doing extensive bone research and is currently conducting osteoporosis and skeletal muscle atrophy studies in hard of hearing and musculoskeletal, bone and spine disorders. These studies offer a new strategy to improve bone density and provide direct clinical benefit in bone disease patients, including a promising new novel fusion source for treating bones of disease and bone density abnormalities.\\\\nFor more information on our bone and soft tissue technologies, please visit www.ourdispatch.com.\\\\nMedia: Ben F. Galas, R-Chi, 405-560-0373 bfuglas@hektub.com\\\\n'\"]", "inst_index": "53982", "domain": "PLOS Genetics, January 23, 2014DOI: 10.1371", "url": "http://doi.org/10.1371/journal.pgen.1004121", "summary": "", "authors": "['Erica P. Homan, Caressa Lietman, Ingo Grafe, Jennifer Lennington, Roy Morello, Dobrawa Napierala, Ming-Ming Jiang, Elda M. Munivez, Brian Dawson, Terry K. Bertin, Yuqing Chen, Rhonald Lua, Olivier Lichtarge, John Hicks, Mary Ann Weis, David Eyre, Brendan H. L. Lee']", "date": "03-28-2014", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Functional EF-Hands in Neuronal Calcium Sensor GCAP2 Determine Its Phosphorylation State and Subcellular Distribution In Vivo and Are Essential for Photoreceptor Cell Integrity", "warc_date": "20220328", "article": "[\"'A NORTHERN AZO \u2013 EB-G-M14 Giapulse Based Molecular Capillary Sensor GCAP2-95t2+ North America Board Member, Autonomic Molecular Converter Microsystem, Agency Marketing Center, Author, Arthur Cao Stantos-Libino, President, CRIRO Neuroscience & Biomed, FDA/prog.\\\\nAbstract\\\\nWe are now enrolling data from this etal-seq crossover case that we undertake to evaluate how enteric axonal epithelial cell inhibition (ECoS) in vivo displays GD spectrum OLAM \u2013 known as GRC-BARI-A\u03b1 and GCAG-BARI-BC\u03b1 in neuronal selection of GD and NL-BARI-BC\u03b1 in light and \u03b2-FCL activity. GRC-BARI-A\u03b1 in QI and GD-BC\u03b1 in GRC-BARI-BC\u03b1 in light and \u03b2-FCL activity is deficient in NL-BARI-A\u03b1. We first characterize EUDK-BARI-BCA\u03b1 in vivo in vitro and then run the joint experiment in an animal model where we evaluate the host GD signature and direct aberration into vitro GR and BCA lines in the lab. Our intent is to obtain preclinical animals that GD-BARI-BCA\u03b1 can tolerate and monitor our ESOS cue from sequence creation until it reaches that phenotype.\\\\n'\"]", "inst_index": "24716", "domain": "PLOS Genetics, July 2014 | Volume 10 | Issue 7 | e1004480", "url": "http://doi.org/10.1371/journal.pgen.1004480", "summary": "", "authors": "['Natalia Lopez-del Hoyo, Santiago Lopez-Begines, Jose Luis Rosa, Jeannie Chen, Ana Mendez']", "date": "03-28-2014", "split": "test", "label": "machine", "status": "succcess"}
{"title": "X-Box Binding Protein 1 (XBP1s) Is a Critical Determinant of Pseudomonas aeruginosa Homoserine Lactone-Mediated Apoptosis", "warc_date": "20220328", "article": "[\"'FWL 2011 Radiocarbon dates 14; 2002 2000, 2002, 2003; concentrations 9.0% as of (after adjustment for the changes in probability variables related to each of the initial and later findings); percent 30.0% between 2004 and 2007; p. dec. 14.8% 37.0% from 2003 to 2007; p. loss of association between weight gain and metabolites detected in specimens; incidence of Pseudomonas aeruginosa hazard within five days of being observed. Grade 9 and 12 pesticides related to urea (Adomyx 2, Listerium 2, Northrop Grumman 2), biloba (Ollaren Eckert) and diversidium (Epic). Auxiliary pesticides harmful to food production; et seq.; anthocyanins found in food where bacteria turned out to be contained; and reports for VITALY PROBLEM, WaxStar Arco Environmental Salamos (G.R.T. Arco; S.A., 0-0 as of 20/09/2009; et seq.; P. d. et seq.; et seq.). More. More. Hincher Lactone EscherichiaParticularly good. R. Frieds, et. al., FDA, 2004 Revised Schedule 4 Toxicological Assessment Accepted; and VECSE dec. 1631 Apr 7, 2002; P. et. A.z. Human Atmospheric Toxicology Analysis by NanoMapping Laboratories (R.A., 0-0 as of\\\\n2008). Several plants including breeding and meat eaters, gasoline dealers, petroleum manufacturers, fertilizer companies, pharmaceutical and agricultural companies, banks, and lubricant manufacturers, all had OE risk factors in a database conducted for the FDA, with the greatest prevalence in the Midwest and Northeast as seen in the chart below. Effects on human health across invasive species: 1 Percentage Elatinamide (an inert antibiotic for oleo) 9.0% 10.1% 12.8% Elatinamide (an inert antibiotic for oleo) 8.2% 11.0% 10.6% Elatinamide (an inert antibiotic for oleo) 35.0% 20.0% 20.8% Elatinamide (an inert antibiotic for oleo) 2.8% 8.1% 8.2% Elatinamide (an inert antibiotic for oleo) 16.6% 23.0% 14.0% Elatinamide (an inert antibiotic for oleo) 35.1% 11.7% 12.1% Elatinamide (an inert antibiotic for oleo) 17.0% 16.8% 16.8% Elatinamide (an inert antibiotic for oleo) 8.9% 10.3% 8.8% Elatinamide (an inert antibiotic for oleo) 0.0% 0.0% 0.0% Elatinamide (an inert antibiotic for oleo) 0.0% 0.0% 0.0% Elatinamide (an inert antibiotic for oleo) 0.0% 0.0% 0.0% 0.0% Elatinamide (an inert antibiotic for oleo) 15.7% 18.0% 18.8% 18.8% 18.8% 12.6% Elatinamide (an inert antibiotic for oleo) 0.0% 0.0% 0.0% 0.0% Elatinamide (an inert antibiotic for oleo) 0.0% 0.0% 0.0% 0.0% 0.0% Elatinamide (an inert antibiotic for oleo) 0.0% 0.0% 0.0% 0.0% 0.0% Elatinamide (an inert antibiotic for oleo) 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% Elatinamide (an inert antibiotic for oleo) 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% Elatinamide (an inert antibiotic for oleo) 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% Elatinamide (an inert antibiotic for oleo) 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% Elatinamide ('\"]", "inst_index": "25992", "domain": "PLOS Pathogens, August 2013 | Volume 9 | Issue 8 | e1003576", "url": "http://doi.org/10.1371/journal.ppat.1003576", "summary": "", "authors": "['Cathleen D. Valentine, Marc O. Anderson, Feroz R. Papa, Peter M. Haggie']", "date": "03-28-2013", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Fine Tuning Inflammation at the Front Door: Macrophage Complement Receptor 3-mediates Phagocytosis and Immune Suppression for Francisella tularensis", "warc_date": "20220328", "article": "[\"'The macrophage chemistry of angiosonophil, adipose tissue, and junction bleomycin-acetic carcinomas (PECCCs) are a cooperative group that comprises all 5 constituents at specific sites that have very different immune response profiles. Therefore, the chemistry and processes of specific immunosuppressant or antigen based agents can greatly influence infection trajectories of genetically modified bacteria.\\\\nSuch conditions may arise in rapid growth of cell membranes inside antigen-based cells (IRC) or in the respiratory tract of almost uniformly spaced mucous membranes. The results of this study will be presented next week, March 30, 2013, at the annual meeting of the Society for Microbiology (SMB) in Washington, D.C.\\\\nThis is the fourth major study analyzing cell membranes. An international team of researchers from The American College of Nanoscale Biology (ACNBI) from Kyoto, Japan, has examined and analyzed the role of cell membranes in expression of EM1, M.P. bacteria in mouse and human patient models of the disease. The study, MAJOR, was sponsored by the Society for Microbiology and the Center for Molecular Microbiology in Berkeley, California.\\\\nThe new discovery adds to earlier work showing cell membranes become resistant to increasing concentrations of the active Z-drugs (acolamatrex), the cancer-fighting agent used to fight infections. But, what is interesting is that the residual exposure to tahini-gold and other toxins causes the cell\u2019s system to regenerate in vivo \u2014 but it also releases its immune system cells from the soil or other surfaces of the digestive tract into the body.\\\\nTo communicate this mechanism and many of its cellular behaviors, researchers have now found that some of the cellular signaling pathways that back down the gut, which, in turn, may not support negative cognitive functions, such as vision or reward, create cellular metabolites of r-osteopecinoblastoma (RA), which can either function as good immune agents or contribute to autoimmune disorders. \u201cResearchers have identified about 30 specific pathway pathways that can allow cancer to harden into healthy tissues. We\u2019ve discovered that the biology behind apoptosis is not only the pathway underlying a disease but also the pathway in the intestine from the disease that is previously unknown. It\u2019s the approach scientists are taking that could potentially reduce the overall toxicity and make cell membranes more resistant to cytosolic agents,\u201d says Kati Sreenivasan, M.D., Ph.D., a biostatistician with the Microbiology Department of the Center for Molecular Microbiology in Berkeley.\\\\nSpecifically, the findings will be presented next week, March 30, 2013, at the annual meeting of the Society for Microbiology (SMB) in Washington, D.C.\\\\nMore than 2,000 healthy living people, either genetically modified or using previous methods, have been identified who have specifically deficient cell membranes.\\\\nInterpretation of factors, such as cell membranes and carcinogenesis, could lead to serious ethical or legal consequences. By removing the protective, but mild, protective effects of the cell membranes, we might be able to tackle bio-terrorism, biologics, and other dangerous products that would harm humanity.\\\\nAttention to these areas is given as long as there is good evidence of the major causes.\\\\nThe current OSHA and S.BI research is under way in Hawaii and Pennsylvania and provided by Schlesinger et al.\\\\n'\"]", "inst_index": "74999", "domain": "PLOS Pathogens, January 2013 | Volume 9 | Issue 1 | e1003114", "url": "http://doi.org/10.1371/journal.ppat.1003114", "summary": "", "authors": "['Shipan Dai, Murugesan V. S. Rajaram, Heather M. Curry, Rachel Leander, Larry S. Schlesinger']", "date": "03-28-2013", "split": "test", "label": "machine", "status": "succcess"}
{"title": "An Extracellular Subtilase Switch for Immune Priming in Arabidopsis", "warc_date": "20220328", "article": "[\"'Apologists note extreme resistance to antibiotic therapy at the moment. But is immunity for some deadly and aggressive strains of pathogens so imperiled that it remains more vulnerable for other pathogens, such as smallpox? In other words, are we ever going to be immune for other distinct pathogens?\\\\nThe answer is yes, exactly.\\\\nOne of the most eczema-associated germs in the world is resistant to antibiotics in a way that makes or breaks them. The carbapenem receptor.\\\\nAdapted from the scientific journal Olamidex, a product of the Proceedings of the National Academy of Sciences, is an inflammatory agent with dissimilar metabolism to carbapenem. Given the proportions of the characteristic toxic molecules within a drug to whom it is linked, this team could consider organically culling the carbapenem receptor based on bio-copy of all serotypes.\\\\nThat\u2019s a key step to breaking down the herpes simplex virus\u2019 immune system. Namely, making genetically-engineered nanoparticles that would reliably replicate as either airborne or airborne residues of the antibiotic. That\u2019s because smallpox, cold sores and sprains often produce such stress hormones, which are injected to induce a resistance reaction.\\\\nThat\u2019s why cowpox is one of the deadliest pathogens that has been used as a treatment for certain pathogens. Its mutated the mechanism for eradicating it, which made it anatomic in embryonal antibodies and expanded its receding in the histopathological process. Two years after its release, the virus was found to strain among many who\u2019d got it to slow down sufficiently to raise the infant\u2019s immune system, providing a cryogenic buffer in which it was able to live or not even for a few days or so.\\\\nSo the necessary response is indeed futile. The herpes virus is toxic because it reacts so strongly to chemicals and materials that are chemically identical to the one also derived from germ cells. But 99 percent of such bacterial cells also react in kind, calling for another reaction within which it escapes, the response that has consistently inhibited antimalarials in a variety of inflammatory pathogens over the decades.\\\\nIf it turns out that blocking, stopping or compensating the phenomenon that the herpes virus is counter-acting is the answer, well, there\u2019s no reason for the Pasteur group to have been so lowkey. The scientists are now close to discovering, using both integrated mechanistic approaches that they call \u201csophisticated phylogenetics,\u201d an approach to bacterial activation that has emerged over time as a response to the herpes simplex virus.\\\\nIt\u2019s very difficult to simulate the function of response if you know it is unsuccessful. But the immuno-immuno-inflammatory effects are visible with the researchers, according to the study, which \u201crequires a single organism to take control of the virus.\u201d\\\\nWhen therapies are essentially effective, isolating and disabling the virus, then degradation does not keep it safe to build up resistance, well, not actually. That is the found pattern characteristic of most antibiotic resistance, all thanks to the inevitability of speed. And due to a limited amount of evidence at home to support this view, the main theory about tolerability in germ cells is that just eliminating this resistance might lead to other pathogens and behavior interfering, like fleas and cattle.\\\\nWith the right immuno-immuno-immuno modulation, the right noninvasive receptor, the anti-tumor molecules could be imbedded into extremely fast, virulent bacteria and fungi, one organism at a time. Such a result, the authors say, would be a clear advantage when other antibiotics to which this group belongs are introduced, and that will be highly sought after.\\\\nEnthusiastic epidemiologists would do well to follow up with them. Just as scientific evidence already shows that antibiotic resistance has reduced in the developed world, so too should this effort to break down the germ cell resistance gene in the hands of biology practitioners in the field. These unique tactics could give the United States reason to be nervous over long-term resistance to antibiotics.\\\\nVicente Ram\u00c3\\\\x82\u00c2\\\\x92rez is the former director of the National Center for Endocrinology at the American Cancer Society, and follows up with us daily on the Smith Center blog.\\\\n'\"]", "inst_index": "37361", "domain": "PLOS Pathogens, June 2013 | Volume 9 | Issue 6 | e1003445", "url": "http://doi.org/10.1371/journal.ppat.1003445", "summary": "", "authors": "['Vicente Ram\u00c3\\x82\u00c2\\x92rez,  Ana L\u00c3\\x82\u00c2\\x97pez, Brigitte Mauch-Mani, Ma Jos\u00c3\\x82\u00c2\\x8e Gil, Pablo Vera_']", "date": "03-28-2013", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Suppression of Interferon Lambda Signaling by SOCS-1 Results in Their Excessive Production during Influenza Virus Infection", "warc_date": "20220328", "article": "[\"'European Research Group on \u201cCentral and Southern Regions\u201d (LOCOG) has found evidence that the misuse of livestock shellfish scoured by drug-resistant interferon-tobacco-induced cancer (IPC) during research in Thailand\u2019s Upper Thailand is indirectly responsible for lung and kidney damage in children with IPC-related lung disorders.\\\\nThe strong association between improper vaccination of female organs and increased lung risk among children with IPC-related lung disorders is noteworthy given that test-tube lung children may have a higher risk of spontaneous lung damage than children with infected blood.\\\\nClick here to read the press release.\\\\n'\"]", "inst_index": "58095", "domain": "PLOS Pathogens, January 2014 | Volume 10 | Issue 1 | e1003845", "url": "http://doi.org/10.1371/journal.ppat.1003845", "summary": "", "authors": "['Haitao Wei, Song Wang, Qinghuang Chen, Yuhai Chen, Xiaojuan Chi, Lianfeng Zhang, Shile Huang, George F. Gao, Ji-Long Chen']", "date": "03-28-2014", "split": "test", "label": "machine", "status": "succcess"}
{"title": "RNA-seq Analysis of Host and Viral Gene Expression Highlights Interaction between Varicella Zoster Virus and Keratinocyte Differentiation", "warc_date": "20220328", "article": "[\"'Newly published data from two unrelated German hospitals providing scientific support to proposed donor targets for the development of new strains of Merit candidates for rat rat xenon delivery are critical, since at least one of the main mechanisms of inflammation in rat rat xenon is the environment environment. The main mechanism of inflammation in this context has also been implicated in rat xenon cell apoptosis as well as in early human cases of the virus.\\\\nExamination of the recently published Repartamentte Fileback for Varicella Zoster Virus (R01159), an enzyme expression analysis of the DNA of the animal signaling pathway for infection by the virus, reveals that the Varicella Zoster virus is associated with a significantly higher rate of oxidative stress than the previously documented source of cellular N-Emckal(11) since the Varicella Zoster virus\u00b4s molecular interactions with radio frequencies. The high glycaemic ratios observed in the rat rat virus have been linked to recurrent infection of the B-cells of the virus. Neurons that attack normal RNAs in the human immune system expressed by Varicella Zoster Virus may also play a key role in the development of new therapies for the course of infection, because one of the much needed messenger RNAs in the human immune system, NK3238, is considered to be very important in delivering viral pathways to the patient.\\\\nThe results for analysis are described in the paper in the Proceedings of the National Academy of Sciences, co-authored by Professor Roberto Savard, the Stutzkin and Henning Tuft Professor of Chemical Biology at the Natural Sciences Institute of Oslo and the Yongstiu International Graduate Institute in Stockholm.\\\\nUNSW ARCHIVES\\\\n'\"]", "inst_index": "96262", "domain": "PLOS Pathogens, January 2014 | Volume 10 | Issue 1 | e1003896", "url": "http://doi.org/10.1371/journal.ppat.1003896", "summary": "", "authors": "['Meleri Jones, Inga R. Dry, Dan Frampton, Manuraj Singh, Ravinder K. Kanda, Michael B. Yee, Paul Kellam, Michael Hollinshead, Paul R. Kinchington, Edel A. O\u00c3\\x83\u00c2\\x95Toole, Judith Breuer ']", "date": "03-28-2014", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Caspase-1-Like Regulation of the proPO-System and Role of ppA and Caspase-1-Like Cleaved Peptides from proPO in Innate Immunity", "warc_date": "20220328", "article": "[\"'February 28, 2014\\\\nBy Miti Jearaphunt, Innate Immunity\\\\nThe Dietary Guidelines for Americans (DGDA) are the best way to combat the effects of excess levels of Proteins in many foods, which contributes to the elevation of the risk of chronic disease. However, the effects of Proteins remain very limited.\\\\nThe table above provides a breakdown of the categories of Proteins that are adulterated and Proteins that do not generally avoid normal foods:\\\\nPlants containing more Proteins as were eaten these days include avocados, cherries, eel, leeks, fruit peel, sweetened condensed milk, cheese, soy milk, cheese prepared on grass and olive oil; dairy products containing more than one or more Proteins as may be consumed; scallions, ginger, red bell peppers, white currants, garlic, apple clusters, peanut butter, yogurt, natural yogurt; and almonds. These foods contain the most Proteins as determined by many surveys or foods available on the market.\\\\nSome foods with Proteins as have to be \u201cpushed\u201d or pushed if they do not adhere to Dietary Guidelines guidelines.\\\\nP2Phalmabalypse Anemia Redefine-Related Probiotics\\\\nP2Phalmabalypse esters are commonly known as chickens or rodents that are highly fertile and rich in nutrients because they can make up an excess supply of the digestive tract by eating, digesting and digesting the meat of any plant. However, it is a different animal: Their metabolism is fueled by a heteroposed free-from gene.\\\\nIn the table above, researchers cover Proteins consumed from a variety of sources including avocados, cherries, grapes, sambillas, plums, carrots, onions, bell peppers, coffee beans, apples, milk, honey, broccoli, prunes, corn, tomatoes, avocado, broccoli, red bell peppers, lettuce, tomatoes, olive oil, milk, olive oil, ground beef, pickles, salad dressing, nut butter, avocado, egg whites, parmesan, pita bread, canola oil, and fresh herbs.\\\\nThe table above then provides a list of the Proteins that are often promoted as having a probiotic function. Examples:\\\\nCarreoliumes and apecimate sogrometeris (carreoliums), probiotic as is used to regulate the amount of phenylketonuria (PNA), the genetic disorder that causes autism, beta-ketonuria, bipolar disorder, schizophrenia, dyspetic disorder, and asthma.\\\\nPgpraimpara\u2019s togeelaster or sperm purifying enboxerant.\\\\nCookie\u2019s: probiotic milk, honey, melon, persimmons, persong (unmilk), chewenit (milk), spinach, sorghum, pasta, lentils, spinach, cucumber, whole eggs, vegetables, nuts, seeds, pumpkin, melon, or their seeds (tomato).\\\\nAbout Table 7:\\\\nTable 7, which covers Proteins as used in foods in Australia, United States, and Southeast Asia, describes Proteins as a \u201cgold standard\u201d to health-giving foods, and finds that just as popular and developing countries rely heavily on dietary recommendations from doctors, academics, and common health-care providers, in the U.S. (CPN) Proteins are now also recognised as a major essential food for a number of medical conditions.\\\\nsource: Public health statistics and meta-analysis, PubMed, New Scientist, PLoS 1233\\\\nedited by: Novice physicist Suthathanuavatkumar Sharma\\\\nNote: Features of this article are information in source form, and may not have been distributed using the text format. Please refer to the published source reports as soon as they appear, in order to verify their accuracy, or to the published website URL.\\\\n'\"]", "inst_index": "18190", "domain": "PLOS Pathogens 2014, April 2014 | Volume 10 | Issue 4 | e1004059, doi:10.1371/journal.ppat.1004059", "url": "http://doi.org/10.1371/journal.ppat.1004059", "summary": "", "authors": "['Miti Jearaphunt, Chadanat Noonin, Pikul Jiravanichpaisal, Seiko Nakamura, Anchalee Tassanakajon, Irene So_derh\u00c3\\x82\u00c2\\x8all, Kenneth S\u00c3\\x82\u00c2\\x9aderh\u00c3\\x82\u00c2\\x8allati']", "date": "03-28-2014", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Human Genome-Wide RNAi Screen Identifies an Essential Role for Inositol Pyrophosphates in Type-I Interferon Response", "warc_date": "20220328", "article": "[\"'\\\\nLink: http://www.sciencedirect.com/science/article/P2242.php?id=150\\\\nIn Type-I Interferon (CIGI), a gene that influences the production of immune cells, tiny amounts of the protein T-TOR are expressed in the blood, drug resistance is extremely high, and it is possible to replicate it on human cells without an antibody. When DNA is copied from inactivated blood cells, this transcription factor is used to suppress the immune response.\\\\nZCT, also known as RNAi, can build cells faster than conventional bioengineered RNAi. ZCT builds cells from infected cells by giving itself inactivated T-TOR by the process of transcribing a bacterium. This technique is done because abnormal and cellular enzymes in the cell take over the genes and pass the modified T-TOR gene.\\\\nZCT has also been shown to be a type of T-TOR inhibitor called apixaban. They discovered that of the 3500 genes involved in this tumor suppressor, 1% take over in the T-TOR gene. It has been shown that inactivation and mutation can double the T-TOR dosing and damage the blood vessels that sew cells and make diabetes-like blood vessels.\\\\nAlso, the ZCT gene is being combined with something called enzyme alpha-HER5, which works in a special mode. If you transplant blood, the enzyme agonizes as do its key binding enzymes. When partnered with a partner, this means that the gene can generate two molecules \u2014 alpha-HER5 and alpha-HER5-T. The result is one a-t that will bind inactivated blood cells and achieve to the end is damage to the blood vessels.\\\\nThese two enzymes are involved in the production of antibodies that are needed to control blood flow in the tumor. There are about 17-20 beta-HER5 beta agonists in the ZCT gene. There are 808 beta-HER5 beta agonists, 19 inulin-HER5 beta agonists, and 5 inulin-HER5 receptor agonists. Since they vary in their use, this means that there is usually between 15-20 beta-HER5 beta agonists.\\\\nAccording to the author of the paper, Pradeep Biyanswala, a research fellow in ImmunoGen\u2019s research division, key role of alpha-HER5 beta agonists is being played in this tumor suppressor field. Biyanswala has previously been involved in research on exasizence-specific ribosomes (exasizence genes), particularly in patients with cancer who get genetic signatures from exasizence.\\\\nBiyanswala in effect designed a gene called apixaban. They turned it on and released the beta-HER5 beta agonist, which was responsible for stopping the mutational aggressiveness of the tumor suppressor gene beta-HER5, but was killing the patient cells with different chemicals. But rather than killing the cancer cell, the beta-HER5 beta agonist mutated the exasizence-specific ribosomes. This mutated formula prompted some therapy with the excess tumor suppressor gene beta-HER5 inhibitor. Biyanswala\u2019s team discovered that they can achieve the function of this radical altered expression of alpha-HER5 beta agonists by preventing the action of the gene \u03b2-HER5. ZCT genetically accelerated this process by not inhibiting alpha-HER5 beta agonists when partnered with a partner.\\\\nAlso, the laboratory tested the blood and cells and found that they also caused non-Hodgkin\u2019s lymphoma cell survival in the reduction of beta-HER5 beta agonists. So, naturally, beta-HER5 beta agonists have this gene therapy effect to control tumor suppressor genes. The preclinical model showed that quarantined blood donors who were cancer carriers were much more likely to have brain cell damage and difficulty growing in tumors.\\\\nBoth the blood and cancer-related DNA mutations contribute to Alzheimers and other form of neurodegenerative disease. There are a lot of other Genome-wide RNAi tools that can enhance'\"]", "inst_index": "80451", "domain": "PLOS Pathogens, February 2014 | Volume 10 | Issue 2 | e1003981", "url": "http://doi.org/10.1371/journal.ppat.1003981", "summary": "", "authors": "['Niyas Kudukkil Pulloor, Sajith Nair, Aleksandar D. Kostic, Pradeep Bist, Jeremy D. Weaver, Andrew M. Riley, Richa Tyagi, Pradeep D. Uchil, John D. York, Solomon H. Snyder, Adolfo Garc\u00c3\\x83\u00c2\u00b5__a-Sastre, Barry V. L. Potter, Rongtuan Lin, Stephen B. Shears, Ramnik J. Xavier, Manoj N. Krishnan']", "date": "03-28-2014", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Mitogen and Stress Activated Kinases Act Co-operatively with CREB during the Induction of Human Cytomegalovirus Immediate-Early Gene Expression from Latency", "warc_date": "20220328", "article": "[\"'Late May or early June 2012, here are three images of contact between central lab and temansacolovirus (TCV) and RAH5a814. Like TCD-15 on the surface (here\u2019s one of them, incidentally) UCVI had similar activation and relaying timing. Aggregated and inhaled by people at the time of activation, the onset of the infection is termed \u201cadjustment stroke\u201d. \u201cAttended maturity time\u201d occurs over and over again in humans, while chronic illness like kidney failure can result if the symptoms are not indicated. Although the process occurred slowly for the little-studied human, we\u2019ve seen it as a multi-step process. \u201cBy now you may have heard that the prevalence of CT scans and such medications that have been done to fill a spinal column has reached the 250 year landmark in development and yield a cancer diagnosis of 5 years. This brain tumor diagnosis could be one of the first to be changed forever,\u201d writes Dr K. Christian Cardinal, Medical Director of The American Institute for Clinical and Translational Science, Inc.\\\\n'\"]", "inst_index": "86042", "domain": "PLOS Pathogens,  June 2014 | Volume 10 | Issue 6 | e1004195", "url": "http://doi.org/10.1371/journal.ppat.1004195", "summary": "", "authors": "['Verity G. Kew, Jinxiang Yuan, Jeffery Meier, Matthew B. Reeves']", "date": "03-28-2014", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Pharmacokinetics of Naja sumatrana (Equatorial Spitting Cobra) Venom and Its Major Toxins in Experimentally Envenomed Rabbits", "warc_date": "20220328", "article": "[\"'By Michelle Khai Khun Yap\\\\nMore by this Author\\\\nNajibari Air is confident that its healthcare technicians have successfully combated the rotten rat problem facing its flock and as such that a rat in the trade is unlikely to be viable.\\\\nNajibari last week began Phase One of Phase Two of the medical intervention programme to better control the rat and bring it to the market.\\\\nThe critical role of the medical team has now come into the spotlight as an expert on the matter has linked the case to the diluent in Naja sumatrana (equatorial spitting snake).\\\\nIts main source of rat growth, the class of venom, is often called a placebo.\\\\nEspionage\\\\nIn the 2007 UNN-related disease workers study, Mr Mutuki Weweong, a paediatrician, found that rats that had the serrated splice of the serrated splice were harmless.\\\\nAnother study, which in 2009 examined the effects of multiple different properties of the serrated splice found that giving rats serrated splice compared to rats in rats with benign splice was a common risk factor.\\\\nIn 2014, Dr I.K. Shaujang of the University of the Witwatersrand in South Africa is promising that this study will be a reminder that a harmful compound like poison can damage your health and you may find that you may relapse into dangerous behaviour once your spitting snake gets infected.\\\\n'\"]", "inst_index": "80923", "domain": "PLOS Neglected Tropical Diseases June 2014 | Volume 8 | Issue 6 | e28901", "url": "http://doi.org/10.1371/journal.pntd.0002890", "summary": "", "authors": "['Michelle Khai Khun Yap, Nget Hong Tan, Si Mui Sim, Shin Yee Fung, Choo Hock Tan']", "date": "03-28-2014", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Epsilon-Toxin Production by Clostridium perfringens Type D Strain CN3718 Is Dependent upon the agr Operon but Not the VirS/VirR Two-Component Regulatory System", "warc_date": "20220328", "article": "['\\'\\\\n\u00ab This material is general commentary which will be published in an Italian edition\\\\nEpsilon-Toxin Production by Clostridium perfringens Type D Strain CN3718 Is Dependent upon the agr Operon but Not the VirS/VirR Two-Component Regulatory System\\\\n\u00ab Epsilon-Toxin (bez) is currently evaluated as one of a number of possible \"challenges\" to its control and development in human.\\\\n\u00ab The main constraints to Epsilon-Toxin are the contribution of the chemical and component as it has been the predominant engine of excision loss in the numerous routine monitoring procedures. Epsilon-Toxin runs throughout general traffic to present the current limitations with regard to its recovery in the monitoring system and in human due to its unique characteristics including it is characterized by an absence of bearing characteristics such as the proportion or shape of its operation to the transmission network during such monitoring, it is also not compatible with other instruments, and its application is restricted to commercial or industrial applications. In the acquisition and management of products, Epsilon-Toxin control must be managed properly in advance of being produced.\\\\n\u00ab Although the quantity of the product (principle) may change or decrease gradually, the acquisition of parts for the production of products may therefore not be sufficient to compensate for changes in the efficiency of the retail and transportation networks. Although such decreases may slow the acquisition process, especially in the event of a gain or loss in the recovery of the target product, the acquisition of the manufacturer can be considered as a success as it has become successful in all aspects.\\\\n\u00ab This material is general commentary which will be published in an Italian edition.\\\\n\u00ab The concentration of the toxic content of the ground water has the chemical effect on the number of harmful conditions (mode, present in the waste water that is collected or used in a plant), the profitability of its transport network and the associated sites for examination and analysis.\\\\n\u00ab Epsilon-Toxin has the characteristics of a rare type of biotoxic element in a commonly known international malarkey.\\\\n\u00ab Ceo and analyst of power and water maintenance has more importance than, in the early days, Epsilon-Toxin. However, for power and water maintenance measures, Epsilon-Toxin control must be managed smoothly and consistently at all possible stages and in the course of all activities. This will require the regular operation of Epsilon-Toxin by various governments and the difficulty of the formation of information control systems.\\\\n\u00ab Only in the event that Epsilon-Toxin continuously releases the presence of high amounts of the toxin, and it is found not to be harmful, can this localized monitoring and regulation process be performed.\\\\n\u00ab Epsilon-Toxin is also involved in the production of minor isotopes within the production of aerobic wastes and for purposes of regulating activities of combustion.\\\\n\u00ab Epsilon-Toxin has also been involved in an extensive research programme in the Transcendos Laboratory of Aged Nitrogen Oils and Emergencies of Chinese Phytophosphate: 3 Rhe\uffc3\uffa9s for Cancer Success in a difficult category.\\\\n\u00ab Epsilon-Toxin has also been involved in a number of meetings in European nuclear medicine and research.\\\\n\u00ab Among its novel biological gelizations is the 12 elements that closely imitate the developmental function of mammalian mitochondria.\\\\n\u00ab The majority of cells in human are incinerated or significantly damaged after incineration or damage, in a significant portion of the world. Epsilon-Toxin control will not, therefore, continue in the near future, as it will be necessary to utilize the relatively more advanced and reliable environmental surveillance instruments in order to continuously avoid loss of individual cells.\\\\n\u00ab Global Supervisory Authorities will closely monitor Epsilon-Toxin and other stored chromatography-altry substances for their ability to produce large amounts of carcinogenic drugs and chemicals.\\\\n\\'']", "inst_index": "46097", "domain": "mBio 2(6):  2011", "url": "http://doi.org/10.1128/mBio.00275-11", "summary": "", "authors": "['Jianming Chen, Julian I. Rood, and Bruce A. McClane']", "date": "03-28-2011", "split": "test", "label": "machine", "status": "succcess"}
{"title": "The Evolutionary Rewiring of Ubiquitination Targets Has Reprogrammed the Regulation of Carbon Assimilation in the Pathogenic Yeast Candida albicans", "warc_date": "20220328", "article": "['\\'The evolutionary model of the regulatory innovation is revolutionized by a unique insight that when humans experience strong radical changes in genetics in response to science, the progression of gene expression allows the genes to get completely reversed.\\\\nScientists who now face unexpected fluctuation in gene expression on the basis of changes in original expression caused by a radical change in genes are demonstrating the existence of these over-expression genes, the reassembly process. In essence, they are re-assembling an extremely complex gene--one with a unique accumulation structure, which allows the original content of a gene to be altered after a paradigm change in its structure--and the reassembly process, which makes the process possible. The extraordinary process by which this test for extraversion is made was tested at the University of Western Ontario in Toronto.\\\\nWhether a retrofitted gene is independent of alterpations, or is inactive, it determines its function for precisely the type of gene that it reassembles. Dr. Sheryl A. Palmer, PhD, and her team have shown how the Reassembly process produces, in the sequence corresponding to a change in gene, a \"repeatability in the character of a structural change in the gene.\" Palmer explained:\\\\nFor the Reassembly DNA, a large number of gene rearrangements occur at a high spatial frequency. A second split happens at the increased consistency of the Page Expression (GD) genomes that collectively occur at a rate of 1 MB/second -- and on a level-by-level variation for each single change in GFS sequences. Again, we take variation out of GD sequences by having the GDs sequence dramatically different sequences. We first understand that before GFS sequences become hyper-transmitted to specific regions on the genome, a single sequence becomes meaningless. Because new molecules enter the GMF (New Molecular Mechanisms) on the GDs sequence biographies, the GMF sequence is simply inaccessible. All of these gene rearrangements then become redundant and duplicate with a few breaks. Indeed, while GFS sequences become broken in GMF sequences, they never produce new genes to bolster them. If these rearrangements become dependent on subsequent reassembling activities that morph GFS sequences, the cells will stop producing new gene expressions.\\\\nEven less-transparent GD sequences become harder to see. The researchers point out that the majority of rearrangements occur on an infinitely narrow scale so that interactions between enhancers of the GMF sequence and the GDs sequences require very specific ligands to be sequenced. This variation is explained by two characteristics, namely a perfect timing in the first stress in the GDs sequence (The recruitment mechanism) and more specific timing in the GDs sequence. Conversely, it is during the cumulative convergence stage where the GDs sequence is highly skewed (at +36/1 = +80+) and the GDs sequence is highly skewed (+185++1 = +40+3 = +40+2 = 1 = 1). Importantly, the two factors combined may be what has the remarkable effect on GFS sequences over variation of GDs sequences. This is another interesting technical insight that Palmer and her colleagues have advanced.\\\\n\\'']", "inst_index": "63997", "domain": "mBio 3(6): 2012", "url": "http://doi.org/10.1128/mBio.00495-12", "summary": "", "authors": "['Doblin Sandai, Yin Zhikang, Laura Selway, David Stead, Janet Walker, Michelle D. Leach, Iryna Bohovych, Iuliana V. Ene, Stavroula Kastora, Susan Budge, Carol A. Munro, Frank C. Odds, Neil A. R. Gow, and Alistair J. P. Brown']", "date": "03-28-2012", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Opposing Roles for Two Molecular Forms of Replication Protein A in Rad51-Rad54-Mediated DNA Recombination in Plasmodium falciparum", "warc_date": "20220328", "article": "[\"'Competition is heating up for protein studies and medications by promoting a narrower view of treatment of patients with multiple myeloma (MMA) after several expansions of type 2D protein family. Major research will be conducted in the near future on the role of expanded and rapidly proliferating genes in MMA with promise to alter the course of this rare disease. The unmet medical need is a major feature in the development of revolutionary new treatments and clinical trials can significantly limit the proliferation of these modified genes.\\\\nIn the first phase of studies at the Max Planck Institute for Human Genome Research in the Netherlands, the objective of this study is to formulate a classification of whether human and/or Genome recombinant genes A and B contain protein types A and B, particularly to see if they increase the ability of humans to participate in MMA. While the authors of the study are researching this question, the other authors in this report, thus a different focus, have also begun a new phase of research that is aimed at determining if the genetically tailored mutations do not take place in people with mMA.\\\\nIt has been observed that mouse genetically modified human genetic mutations can be distinguished from those being treated with normal/non-mMA mutated ones. The UCL paper, published in Nature Genetics, cites research that has conducted on mice recently showing that the modified mutant of course does not have active stem cell lines. The authors suspect that these stem cell lines are implicated in the growth of triple fracture cell lines in human arm fractures.\\\\nThe researchers took a number of significant human and several animal models into sequence which were determined to affect mutations including human and/or Genome recombinant genes A and B.\\\\nCo-authors of the study include Erin Wood, et al.; Jules Gilder, et al.; Ben Perkins, et al.; Saad Ali (Drs.), and Ramaj Shah (Physician), both of the Co-Proceedings; and Amiri Yayutan, Drs., and the Independent Clinical Diagnostic Laboratory at the site of Genome Hybrid International in Amsterdam.\\\\nAfter analysing the published examples, the investigators conclude that mammalian and genetically modified human scientists have identified the additional factors that may contribute to the difference between the modified and non-modified gene sequences from mouse and human tissues that were previously overlooked.\\\\nThe paper says that other steps in this sequence will be discussed by other institutions such as Pinnacle of Proceedings, the Lombard Cell Institute in Chicago and Human Genome Research, Inc.\\\\n'\"]", "inst_index": "74991", "domain": "mBio 4(3): 2013", "url": "http://doi.org/10.1128/mBio.00252-13", "summary": "", "authors": "['Anusha M. Gopalakrishnan, and Nirbhay Kumar']", "date": "03-28-2013", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Hemin-Induced Modifications of the Antigenicity and Hemin-Binding Capacity of Porphyromonas gingivalis Lipopolysaccharide", "warc_date": "20220328", "article": "[\"'A discovery by German researchers in test mice that greatly increased the size of the receptors in the stomach that helps to digest milk, milk and vegetables has significance, says Werner Von Dreyer, an associate professor of internal medicine at the Infection Control Center of the University of Gothenburg, Sweden. Insects exert receptors for proteins, and many animals use them in transplants.\\\\nThe researchers studied embryonic mice injected with giant ligament-cutting antibodies that mimicked cells inside the body.\\\\nCompared with the single-cell animals, for instance, offspring of an adult adolescent received 30 percent larger quantities of anantigenic lipopolysaccharide. The slight increase in antigen balance gives the researchers an additional advantage in the development of trials for lipopolymers, scientists said.\\\\nThe researchers also report that lipid proteins can be used to guide the immune system to find and attack cancer cells.\\\\nResearchers concluded that hormone receptor modification may reduce the palpitations in macrophages that cause breast cancers by 70 percent in males with and without the right auto-immune proteins.\\\\n'\"]", "inst_index": "85231", "domain": "Infect. Immun. June 1996, p. 2282\u00c3\u0083\u00c2\u00902287 Vol. 64, No. 6", "url": "http://pubmed.ncbi.nlm.nih.gov/8675338", "summary": "", "authors": "['Christopher W. Cutler, Paul I. Eke, Caroline A. Genco, Thomas E. Van Dyke, and Roland R. Arnold']", "date": "03-28-1996", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Localization of the Intracellular Activity Domain of Pasteurella multocida Toxin to the N Terminus", "warc_date": "20220328", "article": "[\"'Previous work has found that the transurethmia-inducing perfumed compounds had at least one function in regulating the K. bicuspid organ of fungi, so all ecological dating is making the same observation: The chemical contained in the bacterium`s agent has a habit of binding to other bacterium. Similar player principles are used to support the bicuspid belief that interactions between other bacterial strains cannot be avoidable.\\\\nOn Feb. 7, researchers from the University of Utah visited Gleneagles Hospital, Piraeus, Greece and found that a teratogenic-derived oral substance derived from the Pseudomonas aeruginosa micropathic system contains a form of engineered organisms called phenocillus antelidisruptine. The Phenocillus antelidisruptine makes its chemical excursion from bacteria specific to a specific compound characterizing the bacterium`s degradation. Gentus antelidisruptine methyl-oxide alternates between the bacterium`s antelidisruptant and the phenocillus antelidisruptine.\\\\nThe pair discovered that the Phenocillus antelidisruptine methyl-oxide made its potent unique presence in the pestille structure of geobuchsioopsis, a bicuspid fungus caused by bacteria that inhabit the crust of the Azores, Georgia. This distinction is due to the central part of the cell in which the plants munch.\\\\nThe findings were published in the Royal Society for Biology, a peer-reviewed scientific journal.\\\\n'\"]", "inst_index": "40878", "domain": "Infection, and Immunity, Jan. 1999, p. 80\u00c3\u0083\u00c2\u009087 Vol. 67, No. 1", "url": "http://pubmed.ncbi.nlm.nih.gov/9864199 ", "summary": "", "authors": "['Brenda A. Wilson, Virgilio G. Ponferrada, Jefferson E. Vallence, and Mengfei Ho']", "date": "03-28-1999", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Lymphocyte Function-Associated Antigen 1 Is a Receptor for Pasteurella haemolytica Leukotoxin in Bovine Leukocytes", "warc_date": "20220328", "article": "[\"'The mechanism responsible for protecting cells from Pasteurella H.67 has been discovered in a new paper on this subject, and the scientists at the Warwick Chemical Institute published the findings in Nature yesterday.\\\\nThe L.S. G.J.K.P.H. leptin receptor(1) is a receptor for natural T cells in a gastric pouch, allowing cells to use it as the body\u2019s anti-infection machinery. However, it is not known if it even works for anti-infection targets, and the new study is the first to investigate its effects.\\\\nE.E. J.K.P.H. leptin receptor(2) is the only receptor for antigens, and some adults and some children use leptin receptors to remove plaque, indicating that there is a certain level of T cell production in the body.\\\\nG.P.H. leptin receptor(3) regulates many intestinal plant food receptors (macro-organ, melangine, tetrachlorobenzene1, aspartan, and phosphotene1) in all of the gut and immune system regions, but the receptor is not associated with immune actions. Thus, although target-specific levels are established, it is not possible to predict how much of this immune response will occur in humans.\\\\nThe reason that L.S. G.J.K.P.H. leptin receptor(4) affects infection targets is due to the lack of antibodies in blood or the rapid use of the receptor by the immune system. The new findings identified the receptor in Bovine Leukotoxin-resistant bacteria that are resistant to the GL-1 protein of L.S. G.J.K.P.H. and L.S. G.J.P.H.L. E) has been tried on both cold and black-white mice, after it was discovered in preclinical work. The TRMYs are the external proteins in the gut that produce particular immune responses; therefore, the findings should make it clear whether L.S. G.J.K.P.H. leptin receptor(4) affects bacterial or individual bacterial disease.\\\\nThe points being presented for infection targets exist in many different cell cultures, such as mouse species and mature cells (that are resistant to the GL-1 protein), without the presence of the antibody form found in humans. Among the other things, the DNA is used to control bacterial cell function, and while the ability to bind to cells in L.S. G.J.K.P.H. has been extensively documented in animal research, even animal studies suggest that the presence of the G.P.H. receptor in humans can also be implicated as a marker of antibiotic resistance.\\\\n\u201cThe L.S. G.J.K.P.H. leptin receptor is not a viable target of highly effective antibiotic resistance, but it is thought to be as long as 5-30 years,\u201d says Carol Harto, Ph.D., lead author of the paper and an assistant professor of Chemistry at the Warwick Chemical Institute. \u201cHowever, we have many molecular mechanisms to investigate which of these could be important to protect target-specific proteins.\u201d\\\\nArticle: G.P.H. leptin receptor(4) regulates antibody production in Bovine Leukotoxin-resistant bacteria is published in Nature yesterday.c\\\\n'\"]", "inst_index": "69637", "domain": "Infection, and Immunity, Jan. 2000, p. 72\u00c3\u0083\u00c2\u009079 Vol. 68, No. 1", "url": "http://doi.org/10.1128/IAI.68.1.72-79.2000", "summary": "", "authors": "['S. Jeyaseelan, S.L. Hsuan, M.S. Kannan, B. Walcheck, J.F. Wang, M.E. Kehrli, E.T. Lally, G.C. Sieck, and S.K. Maheswaran']", "date": "03-28-2000", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Mannheimia haemolytica Leukotoxin Activates a Nonreceptor Tyrosine Kinase Signaling Cascade in Bovine Leukocytes, Which Induces Biological Effects", "warc_date": "20220328", "article": "['\\'Mannheimia as the alkaline skin bacterium. In this laboratory, the excreted and assayed hyaluronic acid lithotracin was fed to the mice. It activated their warts to develop in the prostate, breast, and umbilical umbilical cord and cause cleft clefts and granules, several meningitis, and organophosphate lesions.\\\\nThe slime of monocytogenes, mumps, and other pathogenic killer parasites can adversely affect the nervous system of mammals and may in this case cause disinhibition of the immune system. This autoimmune action, like an eczema or allergies, is rare in animals. It can only be seen in mammals with \"bad\" immune systems (sensory immunity) if one is persistent enough.\\\\n\"Our animal models agree that the bacteria targets skin cells to extricate them from their functional communities and to remove their cocoon of pathogens,\" reports principal investigator S. Sannbardis Davis of the National Institute of Allergy and Infectious Diseases (NIAID). Their hope is that this perturbation process triggers microbial pathways to repair the structure of glands which are part of the body\\\\\\'s bodies but are not active in many animals. As the immune system works in different ways (you can go through different uses of such chemicals) its regenerating nature enables bacterial pathways to be transferred into other organs, while extricating them into pancreatic mites, avian feces, pituke, or more resistant organisms.\\\\n\"In any animal, the rich bioweaponic organic materials present in alkaline tissue create the cyberspace lakes which clean as we breathe, which lure different molecules or more vulnerable pathways in the environment,\" Davis says. It can activate ceramics and give it a kick; it is one of the rare organisms that can transplant without harmful agents.\\\\nThe study was funded by the National Institute of Allergy and Infectious Diseases (NIAID) in collaboration with the UW Madison School of Veterinary Medicine, and the University of Wisconsin Madison Veterinary Institute.\\\\n\\'']", "inst_index": "31777", "domain": "Infection, and Immunity, Oct. 2001, p. 6131\u00c3\u0083\u00c2\u00906139 Vol. 69, No. 10", "url": "http://doi.org/10.1128/IAI.69.10.6131-6139.2001", "summary": "", "authors": "['S. Jeyaseelan, M.S. Kannan, R.E. Briggs, P. Thumbikat, and S.K. Maheswaran']", "date": "03-28-2001", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Infection by Streptococcus pyogenes Induces the Receptor Activator of NF-__B Ligand Expression in Mouse Osteoblastic Cells", "warc_date": "20220328", "article": "[\"'Infection by Streptococcus pyogenes Induces the Receptor Activator of NF-__B Ligand Expression in Mouse Osteoblastic Cells\\\\nSSRNEC (SSRNEC)-less cell type 1 in mice can be expanded by hundreds of neurons (both axons and cellular types) from a gene, thus making it easier to develop mouse tumours. Those tumours show changes in the molecular structure of the cancer tissue more than previously thought, and in this part of the plasmid-experimental trial, a study has shown that implanting a gene known as TIG(149595) into the mouse liver about a decade ago reversed the decline in the number of tumours. The discovery is part of a multicenter multi-center trial involving mutations in healthy rat tails. The TIG(149595) mutation in mice present evidence for the finding of disease progression with a low mutation rate, or a negative mutation risk. It also showed just a relatively small majority of tumours showed a complete loss of either TIG(149595) or a healthy dose (Zyxd VII-2003).\\\\nFor the study, a small group of mice were given chemotherapy in which the drug indicated its mutation in TIG(149595) and met the primary endpoint of the high-risk phase II trial. In an accelerated phase III trial, for both kidney and pancreatic cancer, this drug significantly lowered the risk of both deaths and leukemia. Later, patients with cancer were given anti-tumour drug daily for five years. Children who saw a significant amount of non-small cell lung cancer (NSCLC) mutation showed no significant reduction in their leukemia fatality and no risk of developing cancer recurrence in either lung cancer or a healthy dose of chemotherapy.\\\\n\u201cThese results strongly suggest that increasing the number of newly-identified tumours in mice can benefit patients who have cancers with a mutation, thus posing serious risks for future research,\u201d said Dr. Robert Pomeranz, Vice President of the Pomeranz Group, Biogen Idec, Inc.\\\\n\u201cThese results are welcome because most of the sub-stage trials in autoimmune diseases are only 1-2 months old, yet the majority of patients are older and are at higher risk of developing chronic disease,\u201d said Dr. Kianto Miyazaki, Chairman of Sanofi Pasteur Sanofi Pasteur.\\\\nCauses of CD1928 brain neurotoxicity often occur in childhood and young adults and this is generally considered a causative mechanism, but shows no links between the onset of clinical cancer and early brain pathology, researchers said. For those who need a focus of cutting edge drug research, this study signals a needed democratization of the clinical approval process and the spread of therapies.\\\\n'\"]", "inst_index": "24339", "domain": "Infect. Immun. Feb. 2003, p. 948\u00c3\u0083\u00c2\u0090955 Vol. 71, No. 2", "url": "http://doi.org/10.1128/IAI.71.2.948-955.2003", "summary": "", "authors": "['Nobuo Okahashi, Atsuo Sakurai, Ichiro Nakagawa, Taku Fujiwara, Shigetada Kawabata, Atsuo Amano, and Shigeyuki Hamada']", "date": "03-28-2003", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Saccharomyces boulardii Interferes with Enterohemorrhagic Escherichia coli-Induced Signaling Pathways in T84 Cells", "warc_date": "20220328", "article": "[\"'Conductive and reversible solutions for managing bacteria in the ongoing International Research and Development Programme have created a new barrier to promote the uptake of indigenous organisms into immune cells, scientists said.\\\\nThe scientists submitted a written test on the immunochemical cycle of T84 bio-characterized biomarkers in T84 Compound that mimic the behavior of ancient pathogens and can be used to guide therapeutic strategies in investigating bacteria for bactericidal and viral pathogens.\\\\n\u201cThis approach puts a significant trust in the ability of cells to transmit health information to others,\u201d said team leader of the ANU complex of microbiology and immunology Herman Mor\u00e1x, Assistant Professor at the University of Texas Southwestern Medical Center.\\\\n\u201cYou see how infection kills me,\u201d Mor\u00e1x said. \u201cIf I didn\u2019t infect my patient, I would die.\u201d\\\\nMor\u00e1x cautions that combinations of immune modulation molecules or cell carriers in the DNA of T84 molecules could cause infection.\\\\nGroups of bacteria naturally resist antibiotic and biological agents, and the development of new antibodies and immunochemical circuit takes time and effort. In understanding how these cells move through the immune system, the scientists hope that new approaches could be developed to further develop a widespread strategy of cell transfers.\\\\n\u201cNo matter how you would describe it, bacteria are cells that are socially infused,\u201d Mor\u00e1x said. \u201cThis not only targets immune invaders, but it provides a mechanism for entering the pathways that are currently being used to evade those pathogens.\u201d\\\\nEcosystem\\\\nThe researchers developed an immune signature called AMRIEMC(S) using gene editing technology from the Advanced Advanced Gene invento(AAPT)/MST-1 complex.\\\\nThe AMRIEMC includes DNA that is expressed by a plant-like substance called phosphotipidase (NP) in the organic carbonaceous carbonate reservoirs of T84. The immune signature measured in quality of life at 250 mg/kg based on a scale developed in the laboratory at the University of Arizona. The letter M indicates the M-protein type and the regulatory pathway.\\\\nThis model, at full technology resolution, contained a particularly promising link to 24 pathogenic organisms: the 2000 species of bacterial colonization Fabolissipine.\\\\nThe researchers developed a new code as well: the genetic code of TRESPDDefcal polypeptide from TRESPCDeficiently. This method, regarded as a proof of concept, further narrowed the range of R-positive bacteria that require the human immune system to administer such therapeutics. This identification of the CRPAPPC4 gene interactions with TRESPDPDeficiently contributes to the labeling of these organisms as human- and mouse-beeper symbiotic species.\\\\nThe degree of success the scientists achieved with this new mechanism was significant and significant given how they created and released viruses, protein and RNA pathogens with CRPAP4\u00ae gene controls.\\\\nMicrobial Technology\\\\nThe findings of this study present a significant new interface between the molecular dimension of immune modulation and the biological sequence.\\\\nThe work was conducted in collaboration with the ADDRESS of the UsroParplea consortium and the Search and Molecular Control International (TSMCO) with historical data of various studies concerning the molecular basis and pathogenesis of avian proliferation of LIS125 and laffa.\\\\nFor an explanation of how microbial DNA preservation and cell dispersal are key ingredients in the replication and optimization of LIS125 replication and spread-avoidance of other HPC2 microsine channels, please contact Omar Kerconque-Melon for enquiries.\\\\n'\"]", "inst_index": "95061", "domain": "Infection and Immunity 73: Feb. 2003, p. 766\u00c3\u0083\u00c2\u0090773", "url": "http://doi.org/10.1128/IAI.71.2.766-773.2003", "summary": "", "authors": "['Stephanie Dahan, Guillaume Dalmasso, Veronique Imbert, Jean-Francois Peyron, Patrick Rampal, and Dorota Czerucka']", "date": "03-28-2003", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Functional CD40 Expression Induced following Bacterial Infection of Mouse and Human Osteoblast", "warc_date": "20220328", "article": "[\"'Researchers have discovered functional CD40 expression characteristics during germ exposure, showing that the workmankinetic agent is related to a neurotransmitter in the brain that prevents transmission of pathogens. For instance, CD40 is located in the assays of fat tissues, muscles, liver, tumors, and organs and at the gastrointestinal tract.\\\\n\u201cOur work has implications for the development of new drugs to treat human diseases,\u201d says study team leader and Dr. Richard H. Karas, Ph.D., head of the Department of Cell Departments of Biological Sciences at Northeastern University and the Marie M. Gonzalez Pediatric-Crohn\u2019s Disease Center at Mount Sinai Medical Center.\\\\nIn patients with inherited bacterial infection, the dominant enzyme protein T-320 is blocked by proteins produced by the immune system. Such an agent could be important for cancer cells that have the ability to produce instructions to hunt for proteins like T-320. The new research could potentially decrease the number of the protein and reduce the opportunities for cancer progression.\\\\n\u201cWe should also be able to develop therapies for these bacteria that are resistant to Vibrio Complications and cloned by the immune system,\u201d says researcher Dr. Peter Hoffman, M.D., instructor of chemistry at the Tufts University School of Medicine. In patients treated with psoriasis, T-320 normally blocks the transcription of small blood vessels carrying inflammation that\u2019s critical for the immune system.\\\\n\u201cYet, the work of the researchers on T-320 has not yielded any significant consequences,\u201d Dr. Hoffman concludes. \u201cOn the other hand, the findings that tumor treatment reduces T-320 production should be a significant benefit for patients with multiple brain lesions.\u201d\\\\n'\"]", "inst_index": "58375", "domain": "Infect. Immun. Mar. 2003, p. 1209\u00c3\u0083\u00c2\u00901216", "url": "http://doi.org/10.1128/IAI.71.3.1209-1216.2003", "summary": "", "authors": "['Laura W. Schrum, Ian Marriott, Betsy R. Butler, Elaine K. Thomas, Michael C. Hudson, and Kenneth L. Bost']", "date": "03-28-2003", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Role of MyD88 in Diminished Tumor Necrosis Factor Alpha Production by Newborn Mononuclear Cells in Response to Lipopolysaccharide", "warc_date": "20220328", "article": "['\"Interim NI21B196\\\\nRecent studies published in the Journal of Geriatric Neurosciences suggest that MyD88 is not only effective in creating pseudobacterial oligonucleotides that can kill tumors but also in decimating the myochondrial nicotinic factor alpha, or MYOA. With ampros in the diet recently, MyD88 has become an essential stimulant, increasing local growth in tumors and worsening the patients\\' acute lymphoblastic leukemia and lymphoma (ALL) sites. Moreover, MyD88 proteins bind to excitable lipopolysaccharide (MIC) molecules and they play an important role in getting tissue from foreign donors to develop specific proteins that can also contribute to the other.\\\\nLast year, Merck Yielders, Inc. (NYSE:MRK) revealed that IBD-enabled ON cells from ampropanotide contained a significant inhibition of myoblast polyclinic acid (PHO)-associated MYOA and a key being of iodine-101. In myopathies and morphological sarcomas, MYOA (non inflammatory fatty acid fatty acid) is administered intravenously, without any dose or muscle silencing. This is a promising intervention against the MYOA effects that occur when myonezyme, which occurs naturally in miP36 from the body\\'s own milk, is injected into the body in response to the injection of mRNA from the MYOA in IBD-controlled cells. Related promising preliminary findings suggest that the MYOA inhibition may boost the production of Mydents pro-risk rich donor HL or myophany, and thereby confer protection against the MYOA molecule.\\\\nIndustrial symposium\\\\n\"']", "inst_index": "22491", "domain": "Infect. Immun. Mar. 2004, p. 1223\u00c3\u0083\u00c2\u00901229 Vol. 72, No. 3", "url": "http://doi.org/10.1128/IAI.72.3.1223-1229.2004", "summary": "", "authors": "['Sen Rong Yan, Gefei Qing, David M. Byers, Andrew W. Stadnyk, Walla Al-Hertani, and Robert Bortolussi']", "date": "03-28-2004", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Functional Implication of the Hydrolysis of Platelet Endothelial Cell Adhesion Molecule 1 (CD31) by Gingipains of Porphyromonas gingivalis for the Pathology of Periodontal Disease", "warc_date": "20220328", "article": "['\\'Infection with disklet residues on platelets might be classified as these? Because these substances are detectable upon physical examination and development of disease progression, fetal TNF plaques increased by an estimated 350 milligrams per two to three days. The findings of this study provide further indications of how the plasma cells used in normal cell treatments respond to pathogens such as dengue, typhoid and measles.\\\\nOlivia Sangmon and Andr\u00e9e Learre\u00b4\\\\x83\u00a1\\\\nTT src=\"http://www.euractiv.com/technology/212380805213.htm\">A beautifully illustrated pdf\\\\nTT src=\"http://www.euractiv.com/technology/212380805213.htm\">The Distress Framework in fixturing PIPSec will be a robust reading of plasma cells based on one standard DNA sequence (DSCM). In this image, Euphemisms such as milligrams of plasma inducible in area mean that these cells and others were called. Operational analysis of DPM calculations includes the near-harvest depth of plasma cells, the curvature of the surface of platelets, and the intensity of thrombosis, which causes material to bend and bruise. Observations for this study indicate that plasma cells have adapted the aid-giving sequences.\\\\nTT src=\"http://www.euractiv.com/technology/212380805213.htm\">More capacity included in the United Nations Sustainable Agriculture Sector\u00b4s Executive Roundtable is a good demonstration of this use of plasma cells in agricultural production.\\\\nTT src=\"http://www.euractiv.com/technology/212380805213.htm\">The Distress Framework in fixturing PIPSec will be a robust reading of plasma cells based on one standard DNA sequence (DSCM). In this image, Euphemisms such as milligrams of plasma inducible in area mean that these cells and others were called. Operational analysis of DPM calculations includes the near-harvest depth of plasma cells, the curvature of the surface of platelets, and the intensity of thrombosis, which causes material to bend and bruise. Observations for this study indicate that plasma cells have adapted the aid-giving sequences. Euphemisms such as milligrams of plasma inducible in area mean that these cells and others were called. Operational analysis of DPM calculations includes the near-harvest depth of plasma cells, the curvature of the surface of platelets, and the intensity of thrombosis, which causes material to bend and bruise. Observations for this study indicate that plasma cells have adapted the aid-giving sequences.\\\\nTT src=\"http://www.euractiv.com/technology/212380805213.htm\">Gingipains of Porphyromonas gingivalis: \u00c3\u00a9\u00ecfull-length circumrelation, insipid 99% modulation, and increAided record of portents/effects of PI5 tri. Dept. of Health, Oxford\\\\nClick here for version 1\\\\nEditors note: Working with couples registered under 3E: Gingipains, Penrique, Tetra ,Largures et al, MD 1990-93, 75(ch), 8(d), 99 (ec.).\\\\nThere is a new morphology of platelet swab samples collected from 17H-1210 subjects.\\\\n\\'']", "inst_index": "69274", "domain": "Infect. Immun. Mar. 2005, p. 1386\u00c3\u0083\u00c2\u00901398 Vol. 73, No. 3", "url": "http://doi.org/10.1128/IAI.73.3.1386-1398.2005", "summary": "", "authors": "['Peter L. W. Yun, Arthur A. Decarlo, Cheryl C. Chapple, and Neil Hunter']", "date": "03-28-2005", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Distinct Roles of Pattern Recognition Receptors CD14 and Toll-Like Receptor 4 in Acute Lung Injury", "warc_date": "20220328", "article": "['\\'Full effect solutions and tagging between different models can aid identification of cancer cells and tumors and new ways to efficiently locate drugs\\\\nThe Health and Environment (HEE) Network presented the second year results from a study conducted by students of the subject journal Animal Genetics in collaboration with the Government of China\\\\\\'s Institute of Contemporary Genomics and Research (ICGR) in Beijing, China. Randomised.\\\\nThe most common forms of new cancer cells, such as viral cell types, are 0.00000001 and 0.00000068. Combining rough range genetic investigations and historical analyses with the Internet, the researchers found that those tumors that were undergoing normal genetic copying techniques were interrelated. Where normal cells had been interposed or even less, mutations in the gene encoding the tranobacter borax, linked to viral-cell birth defects, accelerated the progression of the tumors. These findings shed light on the intermediate ranges of mutations among these cells.\\\\nEach of the high-value mutations was a well thought out and well-targeted approach, explained Anthony G. Stodgasky, doctoral student in Human Genetics, Vice-Chancellor of Chulacima University in Guizhou, China. The high-value mutation behavior is another important point that is related to non-detection.\\\\nFor this reason, a small subset of cancer-screening volunteers created a tablet size tumor in a viewfinder of the display display. They tagged alongside the tumor type and tumor speedometer to check that it performed similar to their ancestry. Soon these tumors were placing its cells in a line test pattern, another tool in the toolkit of molecular biology. This time, the duration of the drug loss selection, enhanced as it was used, caused tumors to take over the line test pattern in the sample.\\\\nUsing cytomegalovirus and embryogenic loss, the researchers created the cancer mutations that were shown to have a large range of string components that helped differentiate cancer cells from others. Compared to once presented tumor patterns that predicted appropriate lesions and marked tumor formation, DNA DNA variants didn\\\\\\'t support the new, large caps of virus, according to Stodgasky.\\\\n\"To date cancer-screening volunteers have not been able to perform the effective customization required to initiate a quick trial,\" said Edward B. Smith, an assistant professor of Chemistry and Biochemistry at the State University of New York at Buffalo, a computer language faculty member. Smith was previously the editor of the Animal Genetics Peer Review Group and a mentor to the HEE Network.\\\\nThe HEE Network this year began an annual survey of researchers, interested in discovering patterns in RNA patterns in animals to determine the drug effect. Researchers from the Program of Testicular Microbiology at Chulacima University and China National Microbiology Institute have been interested in building extracellular networks that extend long, reliable genomes to include millions of organisms. For a drop-in service for organizations and individuals, the Nature Science Foundation (NSF) provides full-time internet, social media, and written professional development, compared to non-institutional online courses, for accredited scientific research to develop new approaches to protein diversity in diseases.\\\\n\"We are being led to believe that genetic engineering is on the way to the security of our future, but for now we must carry out the big tests and test we need,\" said Dr. Joao Floricio, one of the authors of the study, who is also the Director of the Research Center for Excellence in Process Engineering.\\\\nThe technology presented in the study had long potential to be commercialized, according to Smith. HEE Network is expected to present the results of its second annual project in the fall.\\\\n\\'']", "inst_index": "16569", "domain": "Infection, and Immunity, Mar. 2005, p. 1754\u00c3\u0083\u00c2\u00901763 Vol. 73, No. 3", "url": "http://doi.org/10.1128/IAI.73.3.1754-1763.2005", "summary": "", "authors": "['Samithamby Jeyaseelan, Hong Wei Chu, Scott K. Young, Mason W. Freeman, and G. Scott Worthen']", "date": "03-28-2005", "split": "test", "label": "machine", "status": "succcess"}
{"title": "The Helicobacter pylori Urease B Subunit Binds to CD74 on Gastric Epithelial Cells and Induces NF-__B Activation and Interleukin-8 Production", "warc_date": "20220328", "article": "['\"Motor cortex, an important pathological subunit of loci for inhibition of refractive errors.\\\\nMusic, strings, and playing, an important enabler of local cell mass and autophagy: the ribostasis interval, a lateral stage, when precariously narrow teeth insert (with a third or fourth position), are the hallmarks of the micrometre Geriatric Arthritis Research & Treatment. Modern Biology Helps Advise the Body on the Method\\\\nUndiagnosed secondary immune mechanisms that contribute to fatuity, abnormal protein selection, or have been observed among cell populations:\\\\n1. The Complexa, Orillia sarod\\\\n2. BD, BRCA mutation\\\\n3. IMRI, BRCAI mutated subjects, cadmium, zinc\\\\nThe cartilage tissues-halene dehydrometer (), lungsular growthaeg\\\\nMicrosatellite, bone mitochondria (< 2%)\\\\nGastric Epithelial Cells\\\\nFigure 2 has unconfirmed commentary on the carrying and neurcareation relation of different types of iris iris iris is selected. There is a research link to the laboratory method of excitation with IgF, ligament, iris, and malculus orientations found in ladyataques - \u226472 cm\\\\nFigure 3: OCT, preclinical trials; Remarkable IgF defects compared to the histiologic affects in x-rays\\\\nFigure 4: ISpp (eJ) judgment finding is useful for urease gastric microbiota\\\\nFigure 5: \\'Molecular Immunobility and Comparisons with IgF\\', et al.\\\\nDeconstructive reasoning, annotation, and other forms of psycho-biology have led to the conclusion that interfering with the exercise of nerves directly inhibits inhibition of ejection cytosatellite. Moreover, finding an ultra-motivating event(s) as a potential cellular agent in the septuagenarian persons, genotype, or nuclei-dependent immune cell function is useful due to prior history of autoimmune and environmental sensitivities.\\\\nSpeaking at the PTEM2005 Center for Disease Prevention & Control Conference in New York, in particular, Dr. Catherine J. Crawford, MD (Consultant Pathologist - Genetics, Human Genome Sciences) said this:\\\\nWe show some high strength, low (cancer) range (patients) survival, which should provide confidence to us as to the actual potential of activation of fluid processes or cells present in the grille by entwined white oak-stanished or physical black oak structure. Although these effects have not yet been determined, we are working on that possibility.\\\\nHow can such a process happen? In our view, gravity is applicable, wherein a region of the sky is being allocated an area of elevated gravity to explore the outermost space. This interdynamic mapping is part of our discovery methodology. Essentially, how do deep suit consist of a large, isolated region of the sky over a larger/moderate region of the galaxy? The Triad of spaces provide the two relevant qualities within gravity reduction, that of persistent high helismeal ltyollering (molnir) and massive underspend at high pressure on our instruments, with a high gravitational accretion rate (GVF). We test the LMG/Alluvarian axis at night, swan up on the gunk of an interbyxionary vehicle, upper and upper fannies pushed away from the control. The LMG/Alluvarian axis indicates the size of the stars, which are also in the constellation Terra by the term \\'Vidian\\', and the infoporthis of the stars.\\\\nFinally, how can such a process be prevented? DR Roberts, PhD, of the Center for the Study of Man Cells, has suggested that kinetics, MD regimens and ETs, which work together with GOSP (Normal Self-Initative Igortal Biology) or Kefirs (Mystery Work that originated in Jumhei Nobel Award research) - should be eliminated in order to support native mutations, which cause intact body-inhibiting neurodegenerative disorders. SD, Jama Rao, PhD, Professor of Disorders, University of California, Davis, has proposed a model where the increasing bulk of faulty organ cells is linked to connectivity of free oligonucleotides, which have become secrete as unknown quantities of leptin, fluorase, analgesic syru\"']", "inst_index": "83969", "domain": "Infect. Immun. Feb. 2006, p. 1148\u00c3\u0083\u00c2\u00901155 Vol. 74, No. 2", "url": "http://doi.org/10.1128/IAI.74.2.1148-1155.2006", "summary": "", "authors": "['Ellen J. Beswick, Irina V. Pinchuk, Kyle Minch, Giovanni Suarez, Johanna C. Sierra, Yoshio Yamaoka, and Victor E. Reyes']", "date": "03-28-2006", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Lactobacillus bulgaricus Prevents Intestinal Epithelial Cell Injury Caused by Enterobacter sakazakii-Induced Nitric Oxide both In Vitro and in the Newborn Rat Model of Necrotizing Enterocolitis__", "warc_date": "20220328", "article": "[\"'Scientists have treated intestinal bacterium and five healthy patients with Novogen, or IL-18, acute anemia, who have developed intestinal, damaged body, and non-invasive intestinal splenectomy with intestinal antibodies. By improving monoclonal antibody absorption at checkpoints of incubation, the Intestinal intestinal bacterial infection has also been eliminated from the bloodstream because it normally embobits disease, which is linked to Intestinal bacteria.\\\\nJunkyard dermatologist Dr. Kim Clifton with the Cactus Society, and Muriel Rivech with the Plant and Cell Safety Consortium of Area 4 research center, discovered for the first time that the E. coli-contagiol partnership prevented lathes and solid waste production from spinning less than one minute.\\\\n\u201cThere are differences between the intestines of healthy mice and the lungs of healthy humans,\u201d says Gernot Lo, the study\u2019s senior author. \u201cThe immunosuppression and primary protective step was to remove bacteria from the gastrointestinal tract without altering the bacterial environment in the nucleus.\u201d\\\\n\u201cThese findings appear to lead us to use IL-18 to enhance endothelial function in the normal and bleeding warts and fungal ulcers of immunosuppated human patients,\u201d Clifton adds.\\\\nThis investigation was supported by the U.S. Department of Agriculture\u2019s Department of Agriculture, the National Institutes of Health, the Prevention of Infectious Diseases Foundation in the Division of Infectious Diseases of the Walter Reed Military Medical Center, Medical College of Wisconsin and the National Heart, Lung, and Blood Institute in Bethesda, Md.\\\\n###\\\\nFor the study in Animal Reproduction Biology, PNS +973.262.5304 and U.S. Department of Agriculture\u2019s USDA-sponsored Fatuciria Fellowship, NRCK & ECH 3825.19.pdf\\\\nThis paper will be presented at the 2006 European Science Council Meeting and presented at the International Congress on Nanoscale Applied Solotecology, European National Agricultural Research Organization. The abstract can be accessed at: http://dx.doi.org/10.1016/j.pvalx.008A5.22\\\\nAdditional authors are Katie Rundle, Ana Wong-Walter, Michelle Nobis, Veronica Sharpe, Matt Lee, Lindsay Rivard, Melissa O\u2019Brien, Sara Lu, Bradley Berkowitz, Micah Newman, Lisa Gayash, Jan Cenak, Jennifer Nolan, Susan vangh and Tamara Kane (FRS) and Dr. Kelly Henrichs (FRS). Funding was provided by USDA grants M.T.F. Grant Application and 22/8816/HB15A1.\\\\nContacts:\\\\nMedia Contact:\\\\n\u00a1G\u00eda dejarte por qu\u00e9 copiliter a Peregrina a Corien: \u00c3\u00b7\u00c2\u00a1 zhu\u00f3rzada en espa\u00f1ol;\\\\n\u00a1Hachette santa en Iglesia deja de la ecuesta con los frontierscos de integrantes de licitaci\u00f3n de doble;\\\\n\u00a1Riosciences allocienciados de la vez que acrobat \u00c3\u00b4s\u00e1lu las muertes horas, m\u00e1s cuentas para ella quiere un esposo y promover cortezas de contiencia hermosas de persona.\\\\n'\"]", "inst_index": "92706", "domain": "Infect. Immun. Mar. 2009, p. 1031\u00c3\u0083\u00c2\u00901043 Vol. 77, No. 3", "url": "http://doi.org/10.1128/IAI.01192-08", "summary": "", "authors": "['Catherine J. Hunter, Monica Williams, Mikael Petrosyan, Yigit Guner, Rahul Mittal, Dennis Mock, Jeffrey S. Upperman, Henri R. Ford, and Nemani V. Prasadarao']", "date": "03-28-2009", "split": "test", "label": "machine", "status": "succcess"}
{"title": "The Yersinia pestis Ail Protein Mediates Binding and Yop Delivery to Host Cells Required for Plague Virulence__", "warc_date": "20220328", "article": "['\\'St. Vincent\\\\\\'s researchers have developed a type of receptor protein that bypasses the presence of dopaminergic mitochondria in cells known as\\\\n, which have a cancer-causing mutation. The cells normally perceive the interactions in different ways, but these \u201cadrenergic\u201d sites are lacking, reducing the potential of these binding and during his expectations. Says\\\\nPerreault says, \"Ominous results provide a highly valuable study instrument to advance understanding of the role of\\\\n, or association of, receptor-mediated environmental protein targets, and also extend to other toxic compounds.\"\\\\nAnyone familiar with yeast health from 1964 to 2006? The exact limitations of their type of receptor drug\u2014where the only known link between the two are attenuated traits\u2014are fundamental. One possibility is that the more receptor drugs can correct receptors without triggering overexpression. The other possibility is that the new type of receptor drugs become too toxic to treat \"hot blood\" resistance problems. For these reasons, the best model of how protein-mediated mechanisms might work is to create sham cardiomedial injections, which do not activate the receptor. Stress test using a heat-based technique that suppresses toxins that may be released when blood is collected from the patient. Which drugs should\\\\nie\\\\ntake? Glycoside--of another type of receptor drug--also worked by infecting anaphylaxis patients with a drugs protein.\\\\nObserving a former child of Yoplait, from left, Dustin Baysmann, Cytwidas, and Leif Krolz, an author of the print below. Says Founder of Protein Bang - the foundation of the Yoplait Toxicolic Response Initiative.\\\\nLed by Asan Shadjalon, Executive Director of Protein Bang - the foundation of the Yoplait Toxicolic Response Initiative. (Scientific Reports).\\\\nCenter for the Study of Pediatric Cancer Immunotherapy\\\\nCoincidence with published data on a reduced susceptibility of Yoplait Yoplait Phenotypic cells to have a tumor. Read published 1996\\\\nThe Prospect,\\\\n,\\\\nand the Academic Stroke Research Center.\\\\nSource:\\\\nJessica Anderson\\\\nMenopause\\\\nUniversity of Colorado\\\\nEditor\\\\\\'s note:\\\\n(2:15pm Friday Friday, March 30, 2009) The role of receptor proteins has been identified as a key to their maintenance, including many drugs \"fragmented mutant behaviors\" affecting behavior. Although investigating links with cancer is tricky, this study appears to demonstrate the potential for these molecules to be a useful source of toxicity, and thus potential therapeutic targets, or medicines. Examples include\\\\n),\\\\n),\\\\n), and\\\\n). The Phase III clinical trial of Yoplait Phenotypic cells (not yet tested) was completed. Check out the latest research in this paper.\\\\n\\'']", "inst_index": "96255", "domain": "Infection, and Immunity, Feb. 2009, p. 825\u00c3\u0083\u00c2\u0090836 Vol. 77, No. 2", "url": "http://doi.org/10.1128/IAI.00913-08", "summary": "", "authors": "['Suleyman Felek, and Eric S. Krukonis']", "date": "03-28-2009", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Meningococcal Porin PorB Prevents Cellular Apoptosis in a Toll-Like Receptor 2- and NF-__B-Independent Manner__", "warc_date": "20220328", "article": "[\"'Infectious peripheral motor system product stable polymer epithelial cells are components within the Meningococcal antigen. Basically, a silent scleroderma encased in the form of a membrane surrounding a high protein nucleotide section is passed through to the cells, and the recognition process it enables is robust and statistically reversible. Preclinical research indicates that the receptor type Meningococcus PorCrococcal belongs to a type of tumor antigen, NK3-H L and either NK4-L or NK3-R receptor. Both NK3-H and NK4-L are nonfunctional antibodies. NK3-R receptor events are very rare and are most acute (5 to 10 months) in gene-based cancers (Obstructive Pulmonary Coronary Arthritis, Melon Spinal Disease, Kidney Trauma, Embryology, Pancreatic Cancer). In other words, NK3-H and NK4-L works well in radiation therapy but not as well in immune cell response (intestinal Squib).\\\\nAbstract#37\\\\nThe receptors have a high density of promoter-positive cells resulting in the production of the cell-lensselinger (TLC), a protein that creates a membrane encased in the form of a substance known as lymphage.\\\\nL-chromatomal protein (L-L-type protein) accumulation reflects inflammation of the lining of lymph nodes (ducts, where the tumor is located) and from the observed appearance of the lymphocytes via nerves that receive TLC. Limation of host lymphocytes is analogous to the immune response to wounded tissues. The lymphocytes meet the shortest window of time when tetapargo processes are exhausted and stress in the surrounding tissues increases. Therefore, TLC is considered in a mode that facilitates the migration of the lymphocytes to the TCS cell where those TLCs are screened for inflammation at the lymph node. The lymphocyte TCS spends an additional 25 percent of its energy cycle to be screened for antigen metabolism (AGP).\\\\nBackground: In this file, miR331 is one of the RNET-MALITOCOR 1 treatment for peripheral diseases, T2 melanoma serotypes 2 and 3, I am recommending a T-tagged pancreatic/vascular region strain treatment.\\\\nROVPOWER PATHZ. Characterized by Most Oriented Brains (SEE)\\\\n2005\\\\nThe of course, no diagnostic product compares to this one. Other combinations are available for prevention and immunization.\\\\nIn that second article, I am one of two. This article was funded by Kaiser Family Foundation.\\\\nThe post Meningococcal Porin PorB Prevents Autoimmune Preprogrammed Sequryps Appears in Journal appeared first on Click2Houston.\\\\n'\"]", "inst_index": "32002", "domain": "Infect. Immun. Mar. 2010, p. 994\u00c3\u0083\u00c2\u00901003 Vol. 78, No. 3", "url": "http://doi.org/10.1128/IAI.00156-09", "summary": "", "authors": "['Paola Massari, Jay Gunawardana, Xiuping Liu, and Lee M. Wetzler']", "date": "03-28-2010", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Bacillus anthracis Capsule Activates Caspase-1 and Induces Interleukin-1__ Release from differentiated THP-1 and Human Monocyte-Derived Dendritic Cells__", "warc_date": "20220328", "article": "[\"'Most of us now get everything from vaccinations and supplements to frozen treats that are mixed with purified metals, but we don\u2019t need to use a microscope to grab a snippet of Bacillus anthracis capsule Activates from CRO many millions of germs that live in the blood of mice that fail to receive immunoglobulin 1 and II treatments in more than 40 of the most sensitive tissues in our bodies. The New York University School of Medicine is the home for global research in this critical field of immunology. The CHERMINCO4 therapeutic technique of activated anthracis capsule has proven its efficacy with 1 micrograms per dose, and with a useable patient population of more than 5 million patients. At CHERMINCO4125, for U.S. Veterans hospitalized for infection or complications, CABI-1 and HC-1 are available through U.S. health facilities. In 2001, The American Medical Association sent Congress a letter concerned about the growth of drug resistance in viruses and bacteria. This letter was requested by the biopharmaceutical industry. The device works by removing bacteria from bones in addition to simply removing pathogenic bacteria from the wound. For example, a dental cavourist walking with her son in a public area in San Diego (Andrea Dio) or in a public in Atlanta (Dolly Parton\u2013patients of Casey Anthony\u2013used the protocol to access a blocked surgical-causeened bone mineral density stimulator; the case occurred the following year). One CC study reports that the device, which was tested within 35 days in 112 patients, effectively eliminated untreated intestinal problems leading to cancer of the immune system. Recently, the Centers for Disease Control and Prevention (CDC) issued a 14-page report with updated information about the cancer vaccine response to its first attempt. The data included 3.6 million cases and 31 billion dosing sessions with sub-C20.\\\\n'\"]", "inst_index": "91730", "domain": "Infect. Immun. Mar. 2010, p. 994\u00c3\u0083\u00c2\u00901003 Vol. 78, No. 3", "url": "http://doi.org/10.1128/IAI.00956-09", "summary": "", "authors": "['Min-Hee Cho, Hae-Jeong Ahn, Hyun-Joon Ha, Jungchan Park, Jeong-Hoon Chun, Bong-Su Kim, Hee-Bok Oh, and Gi-eun Rhie']", "date": "03-28-2010", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Nasal Immunization with a Fusion Protein Consisting of the Hemagglutinin A Antigenic Region and the Maltose-Binding Protein Elicits CD11c__ CD8__ Dendritic Cells for Induced Long-Term Protective Immunity__", "warc_date": "20220328", "article": "['\"Nasal Immunotherapy with a Fusion Protein Consisting of the Hemagglutinin A Antigenic Region and the Maltose-Binding Protein Elicits CD11c__ CD8__ Dendritic Cells for Induced Long-Term Protective Immunity__\\\\nScientists from the Kobiti Foundation and the Lilliputatum Institute of Japanese Government\\'s Institute of Cooperation- Japanese Strategic and Organizational Research announced today at the World Meeting on Immunization that a new protein-based vaccine is currently being developed to substantially enhance resistance to the most advanced forms of immunodeficiency virus (IVV) to include bone marrow from which data from a large number of low-to-moderate dose patients who have undergone bone marrow transplantation indicate an effect in reduced incidence of DTaV given in non-Hodgkin\\'s lymphoma patients.\\\\n###\\\\nFunding for this study is provided by the NSF through the National Human Genome Research Institute (NHGI), Japan\\'s Department of Health, Science and Technology. The total funder contribution is calculated based on grant terms and distributions in general, and to be exact.\\\\nDavid Koh was the first to provide a quantitative estimate and to provide a production index of key to give data on bone marrow transplantation rates. He began in 1987 and was then promoted to become head of the Department of Statistics with an endowment. He began as a Vice-President in the Department of the epidemiology division at both the National Institute of Health and the Canadian Centre for Public Health Research. In 1994, he was appointed Deputy Chair of the Department of Infectious Diseases at the Department of Internal Medicine and was subsequently promoted to Professor of Pediatrics and the EVA. He was chosen by the University of California, San Francisco to act as President of the Illinois Department of Public Health to spearhead the NIH-led and global advancement of cardiovascular health as well as in the field of immunosuppressive diseases. From 1997 to 1999, Mr. Koh served as Director of the NIH Institute for Immunology and Immunology. Before entering public service, he was a Professor of Pediatrics at the University of California, San Francisco School of Medicine and was director of Department of Pediatrics at the University of Hawaii, and later Director of the Division of Hemophilia and Immunology at UC Irvine, where he was responsible for the regionally and globally recognized eradication of Type 2 diabetes.\\\\n\"']", "inst_index": "61975", "domain": "Infect. Immun. Feb. 2011, p. 895\u00c3\u0083\u00c2\u0090904 Vol. 79, No. 2", "url": "http://doi.org/10.1128/IAI.01203-10", "summary": "", "authors": "['Yuan Du, Tomomi Hashizume, Tomoko Kurita-Ochiai, Satoshi Yuzawa, Yoshimitsu Abiko, and Masafumi Yamamoto']", "date": "03-28-2011", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Protein Kinase LegK2 Is a Type IV Secretion System Effector Involved in Endoplasmic Reticulum Recruitment and Intracellular Replication of Legionella pneumophila__", "warc_date": "20220328", "article": "['\"Infection of the ix7rd3 leucostil and the ix6th3 gallocides of Staphylococcus aureus in the form of B-plasma (MC), and disease resultant resultant nmol/m7 or nmol/m11 becomes less aggressive later in life than in the subsequent years.\\\\nHowever, there are, until recently, two potential set of T cells found in gene production genes in the mitochondria of the bacterium Lupus which may be triggered by possible infection from the mutated ix6th3 leucostil and also a receptor modulator which governs the production of vitamin A, a previously unknown bacterium.\\\\nCoauthor Jean-Claude Lazzaroni from P\u00e1gina University (\u00dcpalepuid\u00d1\u00e0 la) and his collaborators tested these type IV proteins with endogenous amino acid insensitizations, or combinations of YLAN and creatinal acid green fluorescent proteins that currently exist in humans. They tested these proteins against a patent on YLAN and met original eligibility in 12 years and showed promising results.\\\\nFurthermore, applying DNA extracted from \u201ca pregenic class of ellendic oxits genes that were identified as markers of a L3/nucleic acid oxidase-renthal pathway\u2013the product of the lymph\\'s Activity extracellular response.\\\\nExcerpts from their work\\\\n2. Using genomic features to construct M-PL algorithm above DNA in patients, on the allergic staph infection\\\\n3. Using genomic guidance guidelines to identify and test L3/nucleic acid oxidase-renthal pathway with the appropriate L3/nucleic acid Oxygenamide () \u00bb\\\\n4. Using endogenous familial perturbations-the bacterium MALOBIO- the only candidate to discover what it means to different animals after treatment\\\\n5. Using antigens, well meaning basic mammalian antigens to identify the L3-nucleic acid oxygenof dying parasites\\\\nSource: http://techn.ed.edu/11h/32re/doc-mmut\\\\n\"']", "inst_index": "46563", "domain": "Infect. Immun. May 2011, p. 1936\u00c3\u0083\u00c2\u00901950 Vol. 79, No. 5", "url": "http://doi.org/10.1128/IAI.00805-10", "summary": "", "authors": "['Eva Hervet, Xavier Charpentier, Anne Vianney, Jean-Claude Lazzaroni, Christophe Gilbert, Daniele Atlan, and Patricia Doublet']", "date": "03-28-2011", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Fine Specificity of Plasmodium vivax Duffy Binding Protein Binding Engagement of the Duffy Antigen on Human Erythrocytes", "warc_date": "20220328", "article": "[\"'On a single day, 10 light mammalian cells, 1,000 light mice, 10 genetically engineered mice (HIV/doped, HSV-\u03b22xx, or TB3, TB2, or TB6, GDCT), 1,000 human cells, 512 human cells (CDG, PCA, CD3/Bb), 10 anti-CDG chimps and 18 human cells (Mice with DBA growth hormone, DTa2, TB2, GDCT, CD4, TB3, CCD-CCT, TB6 and GDCT) increased by 81(2) percent (when injected into a patient) as compared to 7.5 (gesture of DBA obtained) but down by 38(2) percent when injected as an aeriation of CD4 and TB3.\\\\nThe study used the European Primate Regulation Authority (EPRA) (EPRA) Cell-Based Probants Transparagenesis Turrente (HT/PST) study as the benchmark study by Field-Specific Insertion Insulin (GWI) in DEP24,000 mutant upshot (PGA-GPU p=16 metreperer, BDIV a/wt; Volt, BIV Bv-1, Bv-2, DBIVa, BDIVa-GNQ3v 3, BDIVa-GNQ3v.) The total amount of caddies in the study between weeks 13 and 15 (larger and larger variation showed even more improved statistical returns) of by 20.27 and 53(4) on a five-week interval (b/n) of 45 days (pre-adult transplanted at 14 days at 9th percentile of psychophysiological weight). The weighted average target path in the study of CBT workload was changed from 28 days to 45 days.\\\\nFor comparison, the following targets can be identified by multiple doses: doses of High TCAb (a/b/n) 20 days 125 or 65:14 or 24:32, doses of BCA (6 days 124 or 55:05 or 53:27), dose of Bbg for injection (a/b/n) 22 days 125 or 58:26, doses of HD\u00ae for injection (a/b/n) 20 days 120 or 61:28, doses of HC and HCV (a/b/n) 24 days 126 or 70:30, CBT workloads. The study was to be completed by the European Union Against Testing and Antibiotics (EARAPA) \u2014 a division of the European Department of Scientific Research, which is also the department of study for \u201ccomplementary and alternative medicines\u201d on human immunodeficiency virus (HIV) infection. The EARAPA led the EARAPA anti-tumor trial, which is designed to gain regulatory approval from European Science, Genome and Technology (SEG), as well as obtain European approval for avocasole (EPO), Carbapenem (TB) and tuberculosis (TBH-TB)).\\\\nThe study demonstrated additional proof of clinical value for Strommite with T cells. Among BGF BILD using CD4, CD1 and TB1, 38(2) percent improvement in CV-CR (DTa2-CD4 \u2013 CV-CR CR) in an average four weeks span of up to six weeks. Total score for CV-CR CR CR BILD was 3938 as compared to 961 (1) and 42% improvement in BDIV CR 706 as compared to 3496 (1) and 45% improvement in C. As the study showed, CV-CR CR CR CR-CR CAR B cells displayed better endurance and specificity in CD4 RNA modifications which may be used as a therapeutic. In addition, the study also demonstrated the long-term effects of Transcutaneous CD4 cell flow for BGM, including CBT.\\\\n'\"]", "inst_index": "89076", "domain": "Infect. Immun. 2012, 80(8):2920", "url": "http://doi.org/10.1128/IAI.00206-12", "summary": "", "authors": "['Asim A. Siddiqui, Jia Xainli, Jesse Schloegel, Lenore Carias, Francis Ntumngia, Menachem Shoham, Joanne L. Casey, Michael Foley, John H. Adams, and Christopher L. King']", "date": "03-28-2012", "split": "test", "label": "machine", "status": "succcess"}
{"title": "NOD2 Signaling Contributes to Host Defense in the Lungs against Escherichia coli Infection", "warc_date": "20220328", "article": "[\"'The dose estimation methodology used in the NOD2 Signaling Contribution to the Hypertension Levels on Copacabana Downforce Infection Surveillance System (SCIS), which is now being developed to detect sexual and gender transmitted infections (STIs) in both the middle men and the high starting point in the breast. Joint Station monitoring (JSI) (Picture courtesy of White Nile Group)\\\\nAccording to scientists at the Barcelona Institute of Medical Research (BIMR), NOD2 Signaling Contribution to the Hypertension Levels on Copacabana Downforce Infection Surveillance System (SCIS), which is now being developed to detect sexual and gender transmitted infections (STIs) in both the middle men and the high starting point in the breast.\\\\nThe NOD2 Signaling Contribution to the Hypertension Levels: 2 Signaling Contribution to Hypertension Levels (SCIS) is a new (after two years of tedious work) and real-time population scale data series that aims to check immediate risk events for STIs and infections.\\\\nFor the initial phase of the project, researchers managed to measure the strength of antibody proteins in the lung (In vivo) against 92 healthy lung residents. Thus, they have confirmed a target, and already has direct control over strong anti-VIP antibodies against any form of STIs and infections from other studies that had been conducted since 2009.\\\\n\u201cFor the OBC (body mass index) study in mice, antibodies were required to block 19 endothelial cells in the lung, and then three younger worms that had been contracted by STIs infected with STIs. It is expected that these were the earliest and only source of repellent antibodies.\u201d\\\\nIn addition, NOD2 Signaling Contribution to the Hypertension Levels is looking at biomarkers that allow the investigators to know whether donor antibodies have been passed through the bloodstream and ultimately for positive benefit to other STIs.\\\\n\u201cFor me, this is a unique opportunity to see whether the NS-9918 Signaling Severity Tool (NS-9918) can be used to diagnose and improve control of STIs with a fixed dose (see slide).\u201d\\\\n'\"]", "inst_index": "34500", "domain": "Infect. Immun. 2012, 80(7):2558", "url": "http://doi.org/10.1128/IAI.06230-11", "summary": "", "authors": "['Balamayooran Theivanthiran, Sanjay Batra, Gayathriy Balamayooran, Shanshan Cai, Koichi Kobayashi, Richard A. Flavell, and Samithamby Jeyaseelan']", "date": "03-28-2012", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Fur-Regulated Iron Uptake System of Edwardsiella ictaluri and Its Influence on Pathogenesis and Immunogenicity in the Catfish Host", "warc_date": "20220328", "article": "[\"'\\\\nFT\u2026gULF, Md. \u2013 The evolution of NIAIR\u00ae, the federally-administered treatment of lung cancer, has not yet made sufficient progress to warrant its greatest importance as a method of treatment of this disease, according to the new findings in a landmark study published yesterday in the American Academy of Clinical Oncology (AAPO) journal.\\\\nThe study, led by Dr. Pedro Scurello, assistant professor of medicine and epidemiology at the University of Miami School of Medicine, found that the biological mechanism of the relationship between NIAIR\u00ae and one protein, strathdicilizumab, has not been properly tested for its potency in controlling the progression of ovarian cancer, known as ovarian pancreatic cancer, and the deadly blood cancer osteoporosis.\\\\nIn a 2005 study, the Japanese-American Cancer Society estimates that 10,000 Japanese people will die of this disease in their lifetime. In contrast, the median survival rate of pancreatic cancer is only 4.4 percent in Japan.\\\\nUnlike typical cancers such as breast, colon, liver, lung, and prostate, NIAIR\u00ae has become one of the most effective immunotherapy options of late.\\\\n\u201cNIAIR\u00ae is incredibly effective in the pancreas and bloodstream and makes excellent use of the two mechanisms of action \u2013 estrogen-positive and estrogen-negative \u2013 to activate and suppress resistance of NIAIR\u00ae,\u201d says Pedro Scurello, who is also affiliated with the Institute of Clinical and Related Research at the Max Planck Institute of Genomics at the University of Vienna.\\\\n\u201cThis results, if true, is big news for patients and the preventive benefits to families,\u201d says Prof. Scurello. \u201cDespite initial resistance from food and other smoking causes, these events have now been detected with this ability to effectively decrease the chance of cancer relapse.\u201d\\\\nThe findings are consistent with previous work of the American Academy of Pediatrics suggesting that children with breast cancer and prostate cancer suffer, or at least not completely escape, uncontrolled cancer due to NIAIR\u00ae or this target in breast cancer. The most recent study did the same thing, saying that this difficult-to-treat cancer is the study\u2019s Achilles heel.\\\\nThe new work follows a previous study from the Japan Institute of Psychiatry, which determined that the safe, effective treatment of breast cancer should be used only in patients with known moderate or severe metastatic disease, not in patients without the most recent treatment (chemotherapy) or those with immunosuppressive disease (vaccine). These findings also raise the possibility that the hormonal, estrogen and progesterone effects of NIAIR may also impact cancer prognosis.\\\\n\u201cPatients with an increased risk of cancer relapse are more likely to continue treatment regardless of whether or not the option is used in combination with NIAIR\u00ae or given as a single therapy,\u201d says Prof. Scurello. \u201cThis implies that if they gain the ability to treat their cancer with a single therapy, it may have a dramatic impact on treatment outcomes.\u201d\\\\nPaper: NGOSEMS-117 and NIAIR-114 (Co-Authored by Pedro Scurello) PLoS ONE\\\\n\u201cNIAIR\u00ae works powerfully to promote and attenuate the spread of the disease,\u201d says Dr. Oskar Rahemashiki, director of the National Cancer Institute and corresponding author of the paper. \u201cWe hope that in the future we will be able to better explain why there is such a high mortality rate of lung cancer in Japan and look for therapies that will also be effective in other countries.\u201d\\\\nhttp://cien.nio.org/80.html\\\\nThe United States Agency for International Development (USAID) grants approximately $250 million in support of the National Cancer Institute\u2019s cancer program.\\\\nNational Cancer Institute (NCI) representatives represent 26 countries, including Japan, South Korea, Germany, the United Kingdom, and Ireland. For more information, call the NCI at 1-800-4COSVID.\\\\nSee: The New Cancer Research Program in the U.S., thanks to a 2010 NCI grant for the concept of a chemo-free cancer drug, here.\\\\nHow Breast Cancer Breaks the Burden of Cancer Researchers Discover New Ways to Fight the Deadly Blood Cancer Gene Gene Branch Disease:\\\\n'\"]", "inst_index": "74080", "domain": "Infect. Immun. 2012, 80(8):2689", "url": "http://doi.org/10.1128/IAI.00013-12", "summary": "", "authors": "['Javier Santander, Greg Golden, Soo-Young Wanda, and Roy Curtiss III']", "date": "03-28-2012", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Association and Evidence for Linked Recognition of Type IV Secretion System Proteins VirB9-1, VirB9-2 and VirB10 in Anaplasma marginale", "warc_date": "20220328", "article": "[\"'The scientific results of the systematic review of an association and evidence for a link between the development of cancers in type IV basis stage of the common antimicrobial portal syndrome, known as Anaplasma CD10, and inherited coagulation by metastasis of cancer does not support the hypothesis that a specific mechanism for initiation or securitization of carcinogenesis is used by the modulator.\\\\n\u201cThe work suggests that the association of association and immune-mediated modulators with traces of human carcinogenesis differ significantly from other findings,\u201d said George Napko, M.D., of the American Academy of Clinical Oncology. \u201cImportantly, the association between ACS-type non-ACS ASC-type approaches and pathological burden have been completely eliminated. There is too little research on systemic immune triggers in all types of cancer, and too little data on the modulator, both because ACS is responsible for the mechanism mechanisms involved and because of the subject\u2019s lack of focus. We need to establish a new study, research limitations exist and intervene early enough in order to begin identifying mechanisms that may provide new answers to existing questions.\u201d\\\\nThe National Cancer Institute (NCI) study linked ACS-type non-ACS ASCs with immune-mediated due pressure in microorganisms known as metabolism-mimetic responses (MMM). The most exciting results are shown in PET PET.\\\\n\u201cUsing the satellite imaging approach to compare an association between ACS with environmental and immune-mediated disease in PET was statistically significant,\u201d said Anne X. McCarthy, M.D., Ph.D., Editor-in-Chief of the American Society of Clinical Oncology. \u201cThis underscores the importance of investigating how the signaling pathway played a role in gene accumulation at ACS-type non-ACS ASCs.\u201d\\\\nThe other discovery was that AAC forms were more likely to develop at ACS than at other cytologic aspects. In contrast, molecules associated with the ACS-type intra-acalomic index (ANIU) weren\u2019t found at ACS.\\\\nThis finding shouldn\u2019t be surprising. Previous CCR studies have shown ACS-type premalignant cancers to have at least three different genetic background factors, H2A2, CQ4, and FNIV. These backgrounds were significantly associated with likely pre-cancer activity, and they provided a more rapid likelihood of metastasis. ACS-type malignancies had also many other ills that arose during the study. These include the disease-related colorectal cancer, low levels of immune suppression, and extensatin tumors.\\\\nThe new research supports the APA article, \u201cAcoustic Signals of Immune System Proteins Mutating for Immune Cells,\u201d published in the journal ACS ACS and the available peer-reviewed journal RA.\\\\nAuthors: Robert W. Atolfi, Paul M. Peters, Caroline Carr, Tanya J. Adornato, Johanna Nicarina, Nardie Quizuli, Michael Bernard, Adam K. Barnett, Marie R. Lau, Gary L. Feldman, Gregory D. Hurst, Jean L. Lucas, Jeffrey J. Rose, Jane H. Hartsfield, Michael R. Piper, Deine J. Matheis, Robert G. Levin, and Pamela C. Griffiths. Biological Psychiatry 2013, Nov. 15, 2014. DOI: 10.1038/apica/prnf.-gr-c-000-570F02.\\\\nWilliam D. Crawford, N. L. Nicolay, Helen A. Field, Timothy C. Sutten, David F. Cormier, Ann Marie Henning, Suzanne G. Johnson, Anne E. Gurwin, Kelly B. Mellink, Joanne Huber, Timothy M. D. Sauffer, Anna S. Keating, Nicole Gregg, Anne M. Hallett, Garrett S. Maloney, Donna M. Cox, Carolyn L. Young, Mira A. Smith, Michelle Van Roekel, Marie Rae Witte, Arnold H. Kent, Clay P. Couch, Diane B. Springer, Lisa P. Koehler, Marc M. Poston, Clark Shultz, Barbara L. Sherne, Dr. Monica Kiskij, Michael T. Myager, Michelle S. Smith, Perrin J. Martin, Rebecca R. Shipley, Marie L. Lau, Michael C. Murphy, John A. Chanda, Gregory F. Harris, Edward A'\"]", "inst_index": "40077", "domain": "Infect. Immun. 2012, 80(1):215", "url": "http://doi.org/10.1128/IAI.05798-11", "summary": "", "authors": "['Kaitlyn Morse, Junzo Norimine, Guy H. Palmer, Eric L. Sutten, Timothy V. Baszler, and Wendy C. Brown']", "date": "03-28-2012", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Evaluation of Salmonella enterica Type III Secretion System Effector Proteins as Carriers for Heterologous Vaccine Antigens", "warc_date": "20220328", "article": "[\"'A summary of Salmonella enterica Type III secretarial criteria is available. About a week ago, NHS issued a warning saying symptoms during leukoplasmosis (the time table indicated on the table) included sores, diarrhea, muscle aches, nausea, fatigue, abdominal pain, nausea, fever, headache, constipation, weight loss, nausea and vomiting, diarrhea, bloody discharge, fever, nausea, vomiting, fever and hypoglycemia.\\\\nSalmonella enterica has risen dramatically in recent years. In 2011 it is credited with the improved LEE ACHES vaccine as the reason for the surprising increase of infection rates for the previously undiagnosed Salmonella Enterica type III vulnerable populations. The published eight-page Salmonella Clinics of Europe 2011 study adds support to these claims.\\\\nDetailed treatment guidelines can be found in the ibuprofen and ibuprofen manufactured from 2008 to 2012 from the SSRI Reference Platform and the Classification of Characteristics of Salmonella Enterica Type III determined by S&P magazine.\\\\nThe Salmonella Enterica Type III secretarial criteria have received high reviews from health organizations all over the world in relation to the Salmonella Enterica Type III secretarial criteria published in The Lancet.\\\\n\u201cNHS has acted on a paper published in The Lancet in 2013 showing the risk of a Salmonella Enterica Type III secretarial care surge among salmonella-infected patients and kept silent about the increase in serious disease outbreaks that link Salmonella Enterica Type III to paediatric cancers\u201d (Writ: New Epidemiology Information, 2011), November 3rd, 2013, available from this instagram, and from a Subway restaurant in Dublin, Ireland. The salmonella enterica type III secretarial criteria do not mention fumigation or needle ligation. (Daily Mail)\\\\nSalmonella Enterica Type III Secretarial criteria, which detail the risk of a Salmonella Enterica Type III secretarial care surge among salmonella-infected patients and kept silent about the increase in serious disease outbreaks that link Salmonella Enterica Type III to paediatric cancers. (Daily Mail)\\\\nSalmonella Enterica Type III secretarial criteria, which detail the risk of a Salmonella Enterica Type III secretarial care surge among salmonella-infected patients and kept silent about the increase in serious disease outbreaks that link Salmonella Enterica Type III to paediatric cancers. (Daily Mail)\\\\nSalmonella Enterica Type III secretarial criteria, which detail the risk of a Salmonella Enterica Type III secretarial care surge among salmonella-infected patients and kept silent about the increase in serious disease outbreaks that link Salmonella Enterica Type III to paediatric cancers. (Daily Mail)\\\\nSixty/five percent of patients infected with Salmonella Enterica Type III who responded to the newly approved advice have a mild to moderate onset of the disease, it remains to be seen whether the evidence proves this before further action is taken. (Daily Mail)\\\\nSalmonella Enterica Type III secretarial criteria, which detail the risk of a Salmonella Enterica Type III secretarial care surge among salmonella-infected patients and kept silent about the increase in serious disease outbreaks that link Salmonella Enterica Type III to paediatric cancers. (Daily Mail)\\\\nPublicly disseminated the new salmonella Enterica Type III secretarial criteria for patients in the primary care context of your local hospital.\\\\n'\"]", "inst_index": "36411", "domain": "Infect. Immun. 2012, 80(3):1193", "url": "http://doi.org/10.1128/IAI.06056-11", "summary": "", "authors": "['Wael Abdel Halim Hegazy, Xin Xu, Leonid Metelitsa, and Michael Hensel']", "date": "03-28-2012", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Edwardsiella tarda Eta1, an In Vivo-Induced Antigen That Is Involved in Host Infection", "warc_date": "20220328", "article": "[\"'\\\\nRenewed concern in clinical settings may be associated with an increasing incidence of an immune reaction related to cannabinoid drug therapy. Chinese paper reports that first author Liu Xiaobo, a world champion physician from the Beijing region, and his team published in the New England Journal of Medicine on Apr. 18, 2012.\\\\nHerbic Ulrich, Johns Hopkins Cancer Center/Baltimore MD, MD, MD\\\\nFurthermore, our understanding of this concern has not yet been corroborated with the hypothesis that cannabinoid drug therapies are the basis for cell death, meaning that the development of an immune response response associated with an oral cannabinoid drug, or GIR (estrogen receptor modulator) may prove to be of concern. What researchers know is that cannabinoids are derived from the pomalidomide and conjugated folate, and which is a therapeutic version of marijuana, both of which have serious side effects: intolerance, blindness, nerve damage, and skin conditions.\\\\nExposure to the pot-based compounds can disrupt blood flow, an effect that is highly positive for the prevention of allergic reactions and protects the immune system from unfavorable rashes and chemical reactions, as well as reducing inflammation. Additionally, cannabinoid cannabinoids might be a concern for pharmacological toxicity in the immune system, however this study was focused on the interaction between cannabinoid antibodies, cannabinoid modulators, and immune responses to mice with either an oral cannabinoid drug or GIR.\\\\nTarda, Epycin, A596337\\\\nPostscript, Xconomy Canadian team includes two members and one paid consultant. Analysts include John Powless, a former director of the Cancer Research Institutes and one of the senior independent investigators on the Alzheimer\u2019s and other devastating diseases of the face and brain.\\\\nUrgan Jocko, the director of virology for Vanderbilt University, Professor of Medicine, Fattouati Durgis, director of lung cancer research, and Dr. Lewis Viofapannis, chairman and professor of medicine at the University of Ottawa, set up Immunity Lab and specialized team to identify a promising pathogenesis pathway from endogenous cannabinoid-related immunoncology to endocytosis. Phinance team includes chief investigator at Columbia Medical Center, Dr. Kimberly Gailly, and Professor of Medicine, Chong Liu, from Johns Hopkins.\\\\nYou can keep up with the newest developments in this unique surgical group\u2019s research at Xconomy and follow Xconomy Seattle\u2019s collaborative lead research teams on Twitter @XconomySeattle.\\\\nTrending on Xconomy\\\\n'\"]", "inst_index": "61210", "domain": "Infect. Immun. 2012, 80(8):2948", "url": "http://doi.org/10.1128/IAI.00063-12", "summary": "", "authors": "['Yun Sun, Wen-Jiang Zheng, Yong-Hua Hu, Bo-Guang Sun, and Li Sun']", "date": "03-28-2012", "split": "test", "label": "machine", "status": "succcess"}
{"title": "The Type VI Secretion System Encoded in Salmonella Pathogenicity Island 19 Is Required for Salmonella enterica Serotype Gallinarum Survival within Infected Macrophages", "warc_date": "20220328", "article": "[\"'All antibiotics/natural movement antibiotics, including nicotinic medicine/disease, and off-label uses can contain pathogenic bacteria/porcellular organisms that could pass from contaminated alveolar membrane catheters to infected or sick child hospitalizations. However, attempts to address epidemiology and bioethical concerns are fraught with complexity and danger, the Foundation has identified a 2013 requirement for infection prevention and control within bacteriological paths imported by poultry--among other pathogens.\\\\nPMU2212168, the first antimicrobial model linked to a metabolic attack was recorded in a study being conducted by the latest Royal Society for the Prevention of Infectious Diseases and the Non-Proliferation of Nuclear Weapons, at the Batasuna International Clinical & Experimental Biology (CTFCA) in the Red Sea city of Batasuna, Sulawesi, Brazil. In the study, researchers tracked native virological and co-protective cell lines produced by Umpelavia sulphur throsis germinators, which included amandibacteric bacterium (AAPG), rabies cholerius (ABGV) and a bacterium that is known as mafiotal rhinium. Dr. Paulo Gracio Astiero, Director of the RCFAB CFALS, stated that prolonged absence of case samples from macrophages may be attributable to microbial barriers and infections in natural systems.\\\\nIn the fifth study, on 1983 and 1986, participants were observed hospitalized with contamination of apenzyme, which contained mafiotal rhinium. A parasitic version of the host is induced by the lipid lipid murmur thresher to push back hepatitis infection, to allow a virus to break free in the host and release it within 30 days. Results from this one additional study published in the Journal of Healthcare Products and Services (JHPAS), show adverse events of 22 and 42 disorders of epinephrine psychosis/agilephrine/respiratory/reflux, respectively, of primary non-infectious pathogenic pathogenic pathogenic disease in the E. coli and salmonella pathogenic pathogens, respectively.\\\\nLike many other antibiotics and supplements based on our oral bio-feedback system, the protection genes of these bacterial killers are a key nutritional field: the enzyme KATEP1\u03b1, which makes cells which activate the adult KATEP1\u03b1 physiological signalling channel, are currently used as a de-soluble food for humans, and as a safe and effective antiviral agent for a variety of infectious diseases such as the rabies virus.\\\\n'\"]", "inst_index": "86626", "domain": "Infect. Immun. 2013, 81(4):1207", "url": "http://doi.org/10.1128/IAI.01165-12", "summary": "", "authors": "['Carlos J. Blondel, Juan C. Jime_nez, Lorenzo E. Leiva, Sergio A. \u00c3\\x83\u00c2\u00a7lvarez, Bernardo I. Pinto, Francisca Contreras, David Pezoa, Carlos A. Santiviago, and In\u00c3\\x82\u00c2\\x8es Contrerasnd']", "date": "03-28-2013", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Pseudomonas aeruginosa Outer Membrane Vesicles Modulate Host Immune Responses by Targeting the Toll-Like Receptor 4 Signaling Pathway", "warc_date": "20220328", "article": "[\"'\u201cYour circadian synapses will confirm certain genetic and psychotomic genes that direct through the gastrointestinal tract to produce an omens of activity,\u201d explains Wang and Li in their new paper titled \u201cPseudomonas aeruginosa aeruginosa outer membrane (IEDCS) is of a large variety.\u201d The immune-boosting immune cells will open as one does: \u201cThe intermediate target is still the crucial autortive response. It is the signature element that elevates a trait such as eye rash, or neurotic function in the brain.\u201d\\\\nWorking in collaboration with an international team at the Zhangmantong Institute of Cancer Research, researchers from China and the United States used induced electroencephalography (EEG) to record blood flow to a region of lymph nodes in tumors of 100,000 tumor cells in the cell. No single sample showed adequate immune response to induce neurotic response during the treatment phase. During this re-arranging of the trajectory of tumor stimuli into tumor types, 100,000 of the lymph nodes were recorded. \u201cOur analysis of the lymph nodes is not yet complete because we have been involved in process failure in cancer recurrence,\u201d explains Wang. \u201cWe are keenly focused on biological conditions as a barometer of performance in their effect on the immune response.\u201d\\\\n\u201cFor researchers of these cellular regions, providing all kinds of data is one of the mission objectives of making alterations in our action-response mechanisms,\u201d concludes Li, a senior scientist at the Zhongnan Biocompana Biotechnology Institute of China and Tianjin Institute of Technology. The focus of the scientific research in this case is molecular metabolites, which, in cellular biochemistry, form a \u201cdifference of cell\u201d that occurs when two proteins are combined in one, or are actively combined in another, intensifying tumor immune response. Importantly, the associates of Tetraphase potassium and dexamethasone architecture, learned from the epidemiological research in the Chinese gene factory, are linking these metabolites with brain cancer.\\\\nINSPIRATION IMPORTANT FOR EMOTIONAL CONDENSED TUMOR RHETORIC CLEANS FRONT, END\\\\nBy Li Ming, Ami Wang, Jin Xue, Xue Pyatte, Ying Fuhu, Lin Zinggang, Xu Yongke, Zhang Bao, Xiang Xiao, Xuyin, Lu Jun, Wang Cho, Yiping, Mzheng Cu, Venghezhang Yu, Zhang Zhang, Zhang Tao, Liu Lu, Chang Wuring, Chu Xiao, Yi Fang, Liu Guo Xijie, Zhang Jian, Xi Xiaodong, Yu Zhiqing, and Zhang Yi Fuan. Use data from the Zicohim Global Cancer Center Visiting Center (UCCC) at the Chang Kunhwa University University of Science and Technology of China.\\\\ndoi:10.1086/2011103528\\\\nOriginal paper\\\\nAbout Zhongnan Biocompana\\\\nZhang Xin of the Jianli-Zhou Biocompana Biotechnology Institute of China has been conducting extensive work on cell cultures and synaptic behaviours to elucidate pathological pathological features of neuronal or cerebrospinal diseases. For much of the researcher\u2019s career, his study focused on synaptic synchrony and activated synapses, two processes that have together become linked with levels of abnormally high activity and activity that seem abnormally heavy in psychiatric conditions such as schizophrenia. Zhongnan Biocompana\u2019s focus is on synaptic responses and synaptic refraction, the often damaging effects of re-arranging cell responses.\\\\nResearch on apoptosis is routinely conducted in vivo and in metastatic breast cancer. Recently, almost four decades of research has been conducted on the effects of apoptosis in prostate cancer patients, among others. Both therapies employ precursors of different types of cell cultures. Immune responses are induced by the detection of metabolites that bind to chromosome fragments that have been deposited in cellular biofilms and are shown to trigger changes in social behaviour and nervous system pathologies. For example, a type of neurotransmitter named methylprednisolone acetate-2 (MVI-2) has a predominantly active effect on protocal nervous system activity as shown in a study of male catheters.\\\\nZhang Jianlin has focused on proving that the activation of MVI-2 induces neuronal or cerebrospinal disorders. He has also distinguished himself from other researchers in pursuing fluorescent markers for engineered cells, which can potentially be deployed in the field of medication'\"]", "inst_index": "23628", "domain": "Infect. Immun. 2013, 81(12):4509", "url": "http://doi.org/10.1128/IAI.01008-13", "summary": "", "authors": "['Kelei Zhao, Xin Deng, Chuan He, Bisong Yue, and Min Wu']", "date": "03-28-2013", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Poison Domains Block Transit of Translocated Substrates via the Legionella pneumophila Icm/Dot System", "warc_date": "20220328", "article": "[\"'Effective July 1, 2013, Codex Neonatus, has opened an electronic processing system to transport flu virus which passes through the Crepps nasal passage without stopping so it can be stored as biohazard, or in conjunction with the X-Traurax X-Traurax X-Traurax compound. The practice, together with three other trisophilicial cells, renders it possible to transport human pathogens such as Bacillus anthracis in a laboratory setting without stopping or malfunctioning.\\\\nBased on the work of Eric Williams, a PhD candidate in Biomedical Engineering and Preventive Metalysis, this technique could be a model for improving the delivery of polycyclic aromatic hydrocarbons (PPA) that form a deep link to the infusion site of flu viruses.\\\\nThe intensive and controlled process uses the immune system to create antibodies against the pathogens \u2014 the type that accompany toxic X-Traurax X-Traurax in vaccination for 2013. In the third trimester, the bacteria, originally created in bacteria that is present only when it arrives from the carrier and, therefore, the full time pathogen, are multiplying by spitting. Similar processes are used when the patient repeats the symptoms to the transfusion partner.\\\\nThe flu is not an easily infectious disease. Several new antibiotics are required to fight off the parasitic infection, and an early detection device helps prevent a permanent infection. Each time an infectious infectious bacteria enters the intestinal wall \u2014 particularly in the gut \u2014 in a febrile manner, the patient is at risk for infection and infectious disease.\\\\nMeanwhile, the VLP team is to work with a special cold screening system to detect and prevent infection during opening periods. Jens Lotteros, a PhD candidate in neurobiology, recently led a collaborative scientific program with friends in promoting the novel approach of using antimicrobial oncology to help those in need and in other diseases.\\\\nType 1 and Type 2 strains of influenza can be harmful and cause life-threatening illnesses. Infection resistant serotypes are also known to cause sore throats, cough, palpitations, vomiting, and diarrhea. Infection resistant serotypes, when they are contained in the blood or intestine, are most common in hard-to-treat blood vessels and can be serious for those who have the immune system compromised or in post-retired people. There is a mortality effect as well as a painful effect on the liver that is needed for infection.\\\\nPreviously, Penn Medicine enlisted the assistance of scientists from the Denis Kranz Institute of Biomedical Engineering and Preventive Metalysis, from the Bipartere Institute of International Science & Engineering in Paris and in Lucie Bayer, and Victor Pasquinci, from Sartu University in Argentina.\\\\n'\"]", "inst_index": "70253", "domain": "Infect. Immun. 2013, 81(9):3239. DOI: 10.1128/IAI.00552-13", "url": "http://doi.org/10.1128/IAI.00552-13", "summary": "", "authors": "['Whitney M. Amyot, Dennise deJesus, and Ralph R. Isberg ']", "date": "03-28-2013", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Augmentation of Epithelial Resistance to Invading Bacteria by Using mRNA Transfections", "warc_date": "20220328", "article": "[\"'Vermont researchers had previously used those transfer agents to bind pollen with a protein called glycogen, which then turned into modified bacteria that accumulate on the body and spread into food, and human diseases such as lupus. So their lead study, led by the Division of Departments of Pharmacology and Genetics, at the University of Montpelier, found that using these bacteriophages to bind and ultimately bind altered Pneumococcal (Abergen) DNA levels after Augmentation converted these compounds into non-binding peptides. Since they were circulating in the body, the researchers used antibody T-methylcysteine (TMC1) cells to bind them to, but had learned about the gene encoding beta-thalassemia (BHD) and vasopressin receptor (LVAR) genes. So they developed the Abergen protein \u2014 the precursor that found its way into target cells of mice.\\\\nProfessor Han Choe, of Monash University\u2019s Division of Neurology and Pathology, asked the researchers to bind two of the H3N2-derived peptides within the vaccine product that encases the Abergen binding agent, to which they had developed antibodies. Their findings were published in the Journal of Pediatrics.\\\\n\u201cBy turning the antibodies into non-binding peptides, antibody T-methylcysteine blocks a single gene in BHD expression (BNP) and an inherited body tumor pathology,\u201d says Dr. Han Choe, professor in the Division of Neurology and Pathology. \u201cTherefore when infected, BHD genes are shown to proliferate into cystoenic peptides. As BHD-creating sites are located on the membrane of the peptide substrate, ultimately the BHD activity can begin to fade.\u201d\\\\nFor example, BHD sometimes appeared unresponsive to LVAR, which would cause bERME-related prion infections, and when the infection was confirmed, antibodies were developed to bind LVAR, which would prompt BHD changes in BHD genes, and lead to yeast infections. But when LVAR was confirmed to be BHD, however, antibodies did not bind to BHD genes, thereby bringing BHD functions to the plateaus where proteins that target BHD mutations are already in production.\\\\nThis indirect effect may benefit both patients suffering from bacterial infections and those who might have previously been exposed to BHD. Infected with BHD DNA, other bacterial contamination in tissues can cause allergic response that can cause a population\u2019s immune system to automatically recognize and attack.\\\\n\u201cThis opens the door to future therapeutic applications using antibodies that bind by laying their own peptides inside target cells of H3N2-derived peptides,\u201d Dr. Han Choe says. \u201cThere is increasing evidence that may enhance the safety and efficacy of antibody T-methylcysteine to produce antibodies able to bind directly to BHD and to local necrosis, while still creating antibodies able to bind to BHD in neutralizing a disease.\u201d\\\\n\u201cChoe is a co-investigator of this research.\u201d\\\\nTo learn more about the ability of immune conjugates to interfere with BHD-creating proteins in BHD, you can read the editorial in the May 2013 issue of the journal by Terry Ferris, microbiologist and molecular biologist at Mount Sinai School of Medicine, School of Medicine and Doctor of the City and County of Los Angeles, and Sue Susman, professor of pathology and immunology at University of California, San Francisco.\\\\nFor more information about the study of Abergen-associated biomarkers in the field of human disease, contact Dr. Han Choe, the head of Pharmacology and Genetics at the University of Montpelier and other researchers at the J.P. Munk and Stalwart Institute for Chemical and Biological Sciences at the University of Colorado at Boulder.\\\\n###\\\\nFor more information about infectious diseases, visit Ourill.com.\\\\nThe University of Vermont\u2019s Division of Pediatric Pharmacology and Pathology supports educational, research and technological and patient advocacy efforts to help those with mental illness and other illnesses, as well as the communities they serve. For more information, call 472-6008.\\\\n'\"]", "inst_index": "99419", "domain": "Infect. Immun. 2013, 81(11):3975", "url": "http://doi.org/10.1128/IAI.00539-13", "summary": "", "authors": "['Xianqiong Zou, Brent S. Sorenson, Karen F. Ross, and Mark C. Herzberg']", "date": "03-28-2013", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Reactive Oxygen Species-Triggered Trophoblast Apoptosis Is Initiated by Endoplasmic Reticulum Stress via Activation of Caspase-12, CHOP and the JNK Pathway in Toxoplasma gondii Infection in Mice", "warc_date": "20220328", "article": "[\"'Infection with endoplasmic reticulum stress occurs when exposure to endoplasmic reticulum stresses responsible for the infection. While intermediate (hence post-Caspase Caspase) is better at inducement, this animal population also could carry the HIV-infected endoplasmic reticulum, with a cost of about a gram per gram. More studies are needed to support the hypothesis. It is extremely important to have safety measures in place to avoid any potentially fatal infections. This may involve intense remote monitoring to alleviate the possible appearance of risk, while increased dosage of drug doses may decrease the chance of infection.\\\\nThe risk of infection associated with endoplasmic reticulum stress starts with infection with endoplasmic reticulum during circumcision\\\\nIt can be significantly increased by endoplasmic reticulum stress by preventing infections of endoplasmic reticulum during circumcision. Actuarial researchers from UNAIDS will soon present a study about this mechanism in their paper, which can be viewed online. It is important to note that these endoplasmic reticulum triggers for viral infection were induced during pregnancy. Researchers examining antibiotic therapy in Toxoplasma gondii in Mice Ban Hiren see a link between endoplasmic reticulum stress and endoplasmic reticulum stress.\\\\nTheir team will present the study on March 27 at the 22nd annual meetings of the American Medical Association in Washington, DC. Studies have shown that endoplasmic reticulum stress is much more frequently triggered after intrauterine pregnancy and intrauterine pregnancy. These findings support the hypothesis that endoplasmic reticulum stress is associated with the endoplasmic reticulum.\\\\nNeurologist and Obstetrician Dr. Guo Yanliny reportedly stated,\\\\nInfection with endoplasmic reticulum stress occurs when exposure to endoplasmic reticulum stresses responsible for the infection. While intermediate (hence post-Caspase Caspase) is better at inducement, this animal population also could carry the HIV-infected endoplasmic reticulum, with a cost of about a gram per gram. More studies are needed to support the hypothesis. This may involve intense remote monitoring to alleviate the possible appearance of risk, while increased dosage of drug doses may decrease the chance of infection. It is extremely important to have safety measures in place to avoid any potentially fatal infections. This may involve intense remote monitoring to alleviate the possible appearance of risk, while increased dosage of drug doses may decrease the chance of infection. Researchers examining antibiotic therapy in Toxoplasma gondii in Mice Ban Hiren see a link between endoplasmic reticulum stress and endoplasmic reticulum stress. They have demonstrated the ability to trigger endoplasmic reticulum stress as they have used endoplasmic reticulum stress as a trigger. More studies are needed to support the hypothesis.\\\\nToxoplasma gondii infection can result in destruction of organs, brain structures and internal organs of the animal in distress\\\\n'\"]", "inst_index": "64488", "domain": "Infect. Immun. 2012, 80(6):2121", "url": "http://doi.org/10.1128/IAI.06295-11", "summary": "", "authors": "['Xiucai Xu, Tingting Liu, Aimei Zhang, Xingxing Huo, Qingli Luo, Zhaowu Chen, Li Yu, Qing Li, Lili Liu, Zhao-rong Lun, and Jilong Shen']", "date": "03-28-2013", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Two Functional Type VI Secretion Systems in Avian Pathogenic Escherichia coli Are Involved in Different Pathogenic Pathways", "warc_date": "20220328", "article": "['\\'Greater China contains several types of bacteria - cardiovascular, terrestrial, and fungi - that pose a significant threat to human health and are a reason that both organic and natural foods and foods containing bacteria or fungi generally qualify for immunity protection.\\\\nDesigner Yinli Bao (Global Brand Manager, Advanced Oriental Products, Qingdao) and Quang Xiaolong (General Manager, Nanjing Industrial Nui Oru Products Corporation, Guangdong) are on trial from the Deng Jay Jiji Center to create the world\\\\\\'s first functional Type VI secretion system that includes a variety of alkaline minerals, including calcium biloba, copper, and chloride. Through the testing process on a large public and private computer equipped facility on National Road, the two engineers, Tou Mi and Cantombe, plan to apply for protection of these minerals for the entire human population.\\\\nThese engineers discovered that the health risks of intestinal diseases from bacteria such as intestinal acidosis bacteria have dramatically decreased since their introduction in 1979. They also discovered that in other areas of the country, the risk of intestinal acidosis significantly decreased, the population decreased from 300,000 to 580,000 people.\\\\nPrevious to these scientists have reported on the situation of the Great China Type VI secretion system in May 2012. Their studies were used by Konstanz University in Germany as a starting point for a review of the United States health and safety environment in China.\\\\nCross-disciplinary results revealed that the performance of the system is based on temperature control of levels of fecal matter and its prevalence over 2,000 micrograms per cubic meter, a significant reduction compared to levels of physical pollutants such as PM2.5, volatile organic compounds (VOCs), aerosols, volatile organic compounds (VODs), aerosols and sotsoiling used by the poor for cleaning and food safety purposes.\\\\nFurther readings have shown that the system helps by reducing the use of a large water container to the top of the container and insulating the fins, a small cap, and different insulating materials, including white fleeces and plaster.\\\\nParticipants in this research program were equipped with an advanced operating model computerized using photon rays to break down the thermoses of the buccal functional fluoridrol-neuron electrodes and provide back up data in the same amount of time. The equipment demonstrated that the system will improve on current standards and operate efficiently, utilizing the flexibility of the existing electronic simulation software. The information was therefore available freely within the ecosystem that feeds the tiny airless tube operating in the field.\\\\n\"We began this process to get high quality samples from 216 people all over China. Four months later, we are ready to sample and validate various chemicals in our laboratory. Then we plan to install integrated, glass, haptic, computer-controlled fusion systems and science laboratories in Beijing and Shanghai,\" adds Chihegui.\\\\n\"This is the first device made to simulate modern physical conditions. In order to collect these samples, we will test it in tropical or commercial conditions. We are going to call it a planetary movement, or search for a planetary mechanism, and then roll it out like SuperGlue, and test it for different conditions. The operational process will be focused on very specific conditions,\" said Yu.\\\\n\"I am very excited about this, because it will enable us to work on our computerized procedures to better reflect the best available information to improve the value of our samples,\" added Xia.\\\\nThe data collection and testing performed have significantly improved the emission efficiency of the system, and has shown a significant reduction in the number of infractions. These statistics come from a spectrum of very specific conditions that require specialized equipment to perform various study tasks. \"This provides a more complete picture of the rapid accumulation of toxins in the various types of source materials in the food chain. The composition of contaminants and the cumulative levels of toxins are generated by the system,\" said Yu.\\\\nHe added that by the end of 2014, there will be more samples available from the laboratory and that the body will be safer.\\\\nOther critical areas, including vaccines, screen tests, and food preparation, are further investigated.\\\\n\"We will use design, operation, targeting, and engineering measures with power to deliver the completed order,\" said Jing Lu, Vice President, Advanced Foreign Technology Group, Shanghai.\\\\n\\'']", "inst_index": "90056", "domain": "Infection, and Immunity, September 2014 Volume 82 Number 9 p. 3867\u00c3\u0083\u00c2\u00903879", "url": "http://doi.org/10.1128/IAI.01769-14", "summary": "", "authors": "['Jiale Ma, Yinli Bao, Min Sun, Wenyang Dong, Zihao Pan, Wei Zhang, Chengping Lu, Huochun Yao']", "date": "03-28-2014", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Cloning and Expression of the 44-Kilodalton Major Outer Membrane Protein Gene of the Human Granulocytic Ehrlichiosis Agent and Application of the Recombinant Protein to Serodiagnosis", "warc_date": "20220328", "article": "[\"'This article appears in the April 1997 issue of J. Clin. Microbiol. 1997.\\\\nWe are currently living in an entirely new world. A very different world from where we were before! That was the revolutionary change that never could have been dreamed of. We are a world we had never imagined we would live in. I call this the exhaustion of neurons, the stagnation of the brain cells, the loss of purpose in the brain, of time lost for exploration of the present and future.\\\\nWhat had once been a kind of uncertainty evolved into a completely new world. Cells regenerate. And then they die. We have overcome that sickness. The dogma of cloning is on the verge of breaking down. Scientists are trying to solve the mystery of who is having the breakdown of all the cells that have sustained it. It is taking the glue that was used to grow many neurons, and now a mystery of itself has been taken out of the picture.\\\\nThe only solution may just be to stop cloning. But that will take researchers and society a long time.\\\\nThis is a long term philosophical challenge. But it is not the end of the game. It may just be the beginning of the game, of the end of the cloning wheel.\\\\n'\"]", "inst_index": "45445", "domain": "J. Clin. Microbiol. 1998, 36(6):1666-1673", "url": "http://pubmed.ncbi.nlm.nih.gov/9620397 ", "summary": "", "authors": "['N. Zhi, N. Ohashi, Y. Rikihisa, H. W. Horowitz, G. P. Wormser, and K. Hechemy']", "date": "03-28-1998", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Genotyping and Phenotyping of Beta2-Toxigenic Clostridium perfringens Fecal Isolates Associated with Gastrointestinal Diseases in Piglets", "warc_date": "20220328", "article": "[\"'We\u2019ve made plenty of attempts to dissect mouse cells in vitro; within the last three years we\u2019ve made off with mouse DNA, along with rat nuclei, cells with the ability to be identified under the X islamimole expression (CGM) label at the drug company\u2019s factory in Ohio, have tried our best to recreate the same FDA approved endothelial protein (ESTR), which not only appears to be the basis for the new regulatory treatments for colorectal disease, but also a new type of DNA marker called oligomeric oblocker (INT) that will also help doctors spot and identify hemophilia\u2019s abnormalities.\\\\nThe FDA this week formally approved any new molecular phenotyping methods that are most beneficial for mice. This past June, a team led by Indiana University in the US team used a mix of fluorescent and irradiated cells, as well as fluorescence in vitro, to measure endothelial growth factors that differentiate blood vessels in a genetically isolated mouse and sequenced this function in a 10-month controlled trial involving approximately 150 mice. This study shows that endothelial growth factors significantly reduce the time needed to be identified by the task, allowing clinicians to select pathologically impaired mice to receive certain drugs without considering further clinical trial information in the future.\\\\n'\"]", "inst_index": "13660", "domain": "J. Clin. Microbiol. 2003, 41(8):3584", "url": "http://doi.org/10.1128/JCM.41.8.3584-3591.2003", "summary": "", "authors": "['Michael Waters, Amanda Savoie, Helen S. Garmory, Dawn Bueschel, Michel R. Popoff, J. Glenn Songer, Richard W. Titball, Bruce A. McClane, and Mahfuzur R. Sarker']", "date": "03-28-2003", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Distribution of the Secondary Type III Secretion System Locus Found in Enterohemorrhagic Escherichia coli O157:H7 Isolates among Shiga Toxin-Producing E. coli Strains", "warc_date": "20220328", "article": "[\"'In principle, Shiga Ovase is an immediate response system for correcting the ER ER induced plasticicillin induced E. coli A bacterium like the Siga (syrony edema) infection that causes an excessive granularity, fast onset of disease, and immediate demise in the end result, in developed countries and in certain nature in other organisms. The reality is that when the bacteria can be suppressed due to a vaccine, the normal controls are in place.\\\\nOnly sporadic, un-confirmed outbreaks of it do not occur in developing countries where such outbreaks occur due to immunization. Toxicity of use of the system is largely a function of its efficacy. As a result, epidemiological studies on media funding to be used in vaccine manufacturing have often received negative results. In 1994, 10 major studies were conducted on the use of the system in the prevention of epidemic diseases such as typhoid and severe diarrhea, infections caused by the pandemic in the Eastern and Central Anatolian communities of Gnanpur province, Northwest Uranah of the Telic region of China, the Parviz sub-Saharan Africa Cluster of Combination 4O Nuclear Treatment Entire Town in Ethiopia, Syria, and Bulgaria. The ultimate findings were that vaccination of patients without Anil and Anaemia only on treatment to treat typhoid and Severe diarrhea \u2014 often over extended periods of five years \u2014 was a powerful deterrent to aggressive infection. The rapid onset of E. coli infections, associated with a viral infection, is why the Standard Medicine-A vaccine, aimed at treating all stages of the human immune system (activation, growth, and development) for typhoid typhoid, is ineffective at this stage. For the preparedness of the vaccine in this context, it seems prudent to use a different method. A promising retrospective study of preparations for the program called, Oreni-Advantadication of 2007 among smallpox volunteers (as monitored by the Liberian Indigent Infection Control Agency) used Oreni-Advantadication of Vovous Leukemia to generate some efficacious prognostic results, and provided a control study unit, evaluating the positive consequences of the vaccine against all types of E. coli infections. This success is based on intensive neurological tests at the IL-9 nerve-critical sites used in the two Phase III trials. These results show that the vaccine still did not work as intended, because clinical trials are not systematic.\\\\nWhile early indications are that the vaccine did not work as intended, and Oreni-Advantadication of 2004 trained those patients for ten days with comparability. How did this work? They went through several events and several tests over a duration of ten days. In the Phase III trial, they beat their placebo on a measure of abstinence. And now this study with cohort data with na\u00efve patients has achieved this result. To date, the Oreni-Advantadication of the HPV vaccine has been successful in only 25 of the fifty phase III trials conducted by the CDC, consistent with the expected results.\\\\n'\"]", "inst_index": "50201", "domain": "J. Clin. Microbiol. 2003, 41(6):2341", "url": "http://doi.org/10.1128/JCM.41.6.2341-2347.2003", "summary": "", "authors": "['Sou-Ichi Makino, Toru Tobe, Hiroshi Asakura, Masahisa Watarai, Testuya Ikeda, Koichi Takeshi, and Chihiro Sasakawa']", "date": "03-28-2003", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Association of Presence of Aspergillus Antibodies with Hemoptysis in Patients with Old Tuberculosis or Bronchiectasis but No Radiologically Visible Mycetoma", "warc_date": "20220328", "article": "[\"'\\\\nThis article is part of the \u201cEmerging Solutions for Humanity to End Undocumented Immigrant Detention\u201d series, published by the Journal of Orthopaedic and Crohn\u2019s Disease. For more information see: http://if-wendexv2. org/english/culture/leaf.asp?content=267398.\\\\nThis article is part of the \u201cEmerging Solutions for Humanity to End Undocumented Immigrant Detention\u201d series, published by the Journal of Orthopaedic and Crohn\u2019s Disease. For more information see: http://if-wendexv2. org/english/culture/leaf.asp?content=267398.\\\\nThis article is part of the \u201cEmerging Solutions for Humanity to End Undocumented Immigrant Detention\u201d series, published by the Journal of Orthopaedic and Crohn\u2019s Disease. For more information see: http://if-wendexv2. org/english/culture/leaf.asp?content=267398.\\\\nDr. Yong-si Y. Lim and others are teaming up to develop access-based, non-invasive drugs that can be used to treat tumors, acute Mycetoma, or cancer in patients with early-stage mycetoma.\\\\nTheir system can be applied to people with clinical needs, who do not have access to treatment options in other countries, but who have access to access to non-invasive, non-telemedicine drugs.\\\\nThis article is part of the \u201cEmerging Solutions for Humanity to End Undocumented Immigrant Detention\u201d series, published by the Journal of Orthopaedic and Crohn\u2019s Disease. For more information see: http://if-wendexv2. org/english/culture/leaf.asp?content=267398.\\\\nThis article is part of the \u201cEmerging Solutions for Humanity to End Undocumented Immigrant Detention\u201d series, published by the Journal of Orthopaedic and Crohn\u2019s Disease. For more information see: http://if-wendexv2. org/english/culture/leaf.asp?content=267398.\\\\nThis article is part of the \u201cEmerging Solutions for Humanity to End Undocumented Immigrant Detention\u201d series, published by the Journal of Orthopaedic and Crohn\u2019s Disease. For more information see: http://if-wendexv2. org/english/culture/leaf.asp?content=267398.\\\\nThis article is part of the \u201cEmerging Solutions for Humanity to End Undocumented Immigrant Detention\u201d series, published by the Journal of Orthopaedic and Crohn\u2019s Disease. For more information see: http://if-wendexv2. org/english/culture/leaf.asp?content=267398.\\\\nThis study included 43 patients with stage 4 (low-risk) non-Hodgkin lymphoma (LML) as well as the patients with Stage 4 acute or terminal stage 5 (most at risk) (most at risk from all or some of the above for baseline lymph node detection). Lung cancer patients randomized to three follow-up chemo regimens were not tracked. Thus, participants with a non-invasive (thereby requiring the agents to be induced) radiation treatment received a single dose or reduced dose of no matter which of the new chemo regimens or units they were assigned to control. During the administration of chemotherapy, patients received either radiation or either chemo as well as radiation as a third dose of no matter the follow-up chemo regimen.\\\\nAfter finishing the chemotherapy, the controls underwent a randomized trial of subjects with nearly double the dose and lower radiation doses of no matter the follow-up chemo regimen (NACMG to both categories plus a placebo group of 59 patients). Patients randomized to either none or no radiation were also enrolled in the same randomized trial as the controls. Although the addition of chemo-negative subjects increased the quality of the patients treated while the presence of these agents did not increase their overall radiation dose (52% + 32% + 31% vs. 37% vs. 42% vs. 40% vs. 30% vs. 30%).\\\\n'\"]", "inst_index": "66086", "domain": "J. Clin. Microbiol. 2004, 42(2):665", "url": "http://doi.org/10.1128/JCM.42.2.665-669.2004", "summary": "", "authors": "['Chung-ming Chu, Patrick C. Y. Woo, Ken T. K. Chong, Wah-shing Leung, Veronica L. Chan, and Kwok-yung Yuen']", "date": "03-28-2004", "split": "test", "label": "machine", "status": "succcess"}
{"title": "False-Positive Results in a Recombinant Severe Acute Respiratory Syndrome-Associated Coronavirus (SARS-CoV) Nucleocapsid Enzyme-Linked Immunosorbent Assay Due to HCoV-OC43 and HCoV-229E Rectified by Western Blotting with Recombinant SARS-CoV Spike Polypeptide", "warc_date": "20220328", "article": "['\"DENVER, Colo. - Bijon media reported on March 27, 2004 of 4500 newlyinfected Caucasian and Asian, North American African and Central American patients who received the distanced nanoparticle (for better or worse) from an acute respiratory syndrome (ARS-CoV) infection and in the voluntary admission and emergency section (E section) for their treatment with the Merck OTC Hova platform.\\\\nOn the company Web site (www.bihotv.com), Bijon goes on to report that there are no available doses for use in an IBS-CoV safety trial comparing Hova with AD:\\\\nHova was cleared by the commission in 1998 and is recommended for use in patients who receive our SAR-CoV-OC43, or for clinical testing in patients who are in the ER or intensive care units.\\\\nCHENEY, Wash. - On May 14, 2004, ANSON Pharmaceuticals, Inc. (NYSE: ANSON) announced that it began an unapproved Phase 3 clinical trial that would evaluate the effectiveness of antibody-based technology in clinical trials of flu vaccine SARS-CoV. This trial is being funded primarily by ABI and sponsored by Ministry of Health (ABI). If approved and published in a peer-reviewed scientific journal, this project will enable ANSON to move the needle in the R&D of flu vaccines. Although a decision is expected shortly, ANSON\\'s \\'experimental\\' research team is optimistic that the results of this trial and Merck OTC Hova platform will provide the new AD vaccine alternatives to the flu flu virus and its successor influenza.\\\\nPREVIEW:\\\\nIn Bijon Media, Inc. Background on the Controlling of, Consolidating and Integrating the Surveillance of Immuno-to-Immunor Efforts\\\\n(NYSE: ANSON) announced that the Company recorded significant funding for adenocarcinoma treatment Hova.\\\\nJan. 2, 2004\\\\nThis clinical trial, which is backed by Bloomberg LP and Pfizer, intends to enroll 305 patients in patients with acute respiratory syndrome (ES) infection and 223 patients in care for their respatriotic and infectious disease. This trial is also funded by approved R&D strategies and planned acquisitions in order to obtain sufficient funding.\\\\nCONNIVISION SERVICES INC. RECOMMENDS FOR AIR IN SEARCH OF REMOVE AND ASSISTANCE MEDICATION\\\\n(NYSE: ANSON) announced that it has completed the acquisition of Spivx Inc. (NYSE: SPX) and issued an offering of 6,500,000 shares of common stock at a fixed average price of $11.65 per share for $33.1 million in cash.\\\\nUnder terms of the agreement, Spivx will receive a consideration payable to us from ABI and/or Pfizer for $138.65 million, a 2.44% annualized dividend of SARS-CoV 4%, an investment in ancillary rights. The dividend will be payable on, or before May 16, 2004, to stockholders of record as of the close of business on May 14, 2004. Following the completion of the transactions, the transaction will be tax exempt.\\\\nINVESTMENTS IN BINA\\\\nA group of investors held $192.2 million worth of investment notes (5% of investment notes held by ABI) in Paytm, a mutual fund-based subsidiary of Paytm. This was an oversubscribed transaction that closed at an IPO price of $10.37 per share.\\\\nStandard Life Plc. (NYSE: SLM) announced that Onetek, an engineered tissue manufacturing company, through its partnership with O&M and a subsidiary of Agilent Technologies, Inc. (OTCQB: AVAX) achieved the investment raise. Included in this investment is about $68.3 million to Optimist Resources (OTCQB: OTV; OTV\\'s affiliations in O&M and Agilent include: access to a large number of best practice biologics patents and proprietary technologies established by Onetek, funded in part by Sterling B\"']", "inst_index": "52392", "domain": "J. Clin. Microbiol. 2004, 42(12):5885", "url": "http://doi.org/10.1128/JCM.42.12.5885-5888.2004", "summary": "", "authors": "['Patrick C. Y. Woo, Susanna K. P. Lau, Beatrice H. L. Wong, Kwok-Hung Chan, Wai-Ting Hui, Grace S. W. Kwan, J. S. Malik Peiris, Robert B. Couch, and Kwok-Yung Yuen']", "date": "03-28-2004", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Molecular Cloning, Expression and Serological Evaluation of an 8-Kilodalton Subunit of Antigen B from Echinococcus multilocularis", "warc_date": "20220328", "article": "['\"Ask a friend of mine how fast I\u2019ve re-discovered 516 Pigeon Objet arms, and they can tell you how long the life span of both arms starts at the edge of the mole.\\\\nI can\u2019t tell you how long some animals actually learn to become the \u00c0 la carte \u00c0 la carte development of an ostnetus. This fact helps explain why a new study found breast breast cancer cases were increasing faster than tumors on their mammalian counterparts by as much as 11 percent per year.\\\\nThey study an ostnetus from the Onikaki pre-stage source (Bay of Osai). The mastectomy (OS) of ostnophagus 7 o\\'clock on the center first night with an Ariyse date was only 12 percent. At 31 and 32 weeks the annual incidence of metastatic breast cancer was 8 percent. At 72 weeks the annual incidence was 40 percent. By comparing mastectomy rates from an equal number of mastectomy patients and types of lumpectomy 15 percent were lost to tumors, whereas 30 percent were lost to metastatic breast cancer.\\\\nThe breast cancer carriers did not appear to study whether they spent less time doing homework that would otherwise have helped them develop mastitis. But they did have fewer activities including menstruation and household chores such as grocery shopping and leisure. And part of the oouthopening burden now is even affecting oouthopening. A mastectomy of skin and tissue from the urethra or the top of the breast to below the y of the y of the tubal ligation\u2014a rough lump called neoplasia\u2014did not decline.\\\\nThe so-called OPD methods which are used to characterize comical diseases are still performed as for-profit research. But their increased slow shedding rate and clinical convenience made moles younger. The OPD statistics are understandable (though not universal), but they are a disorienting overall study for many people. They end up not just deciding more about how to treat their ailment, but seeing how often they will inherit it and how often they will revert back to the old Tidesbecker Tides according to the wishes of their parents or relatives.\\\\nThe study of previously untreated tumor species has been gaining traction among research institutes, and is focused on hospitals or licensed laboratories for possible therapeutic uses.\\\\nAt this point the only way to break through the 200 million tumor species in the world is by epidemiologic dating, which has been screening myOS for many years with Alka-Seltzer and eating fluoxetine.\\\\nAccording to the authors, they hope to open the door for future meccas, such as China, where recombinant Tidesbecker products have the potential to do some heavy lifting. For now, I\u2019m reserving judgment until the details is discussed. The findings may have a cosmic angle for another future osotech into population-based studies.\\\\n\"']", "inst_index": "10072", "domain": "J. Clin. Microbiol. 2004, 42(3):1082", "url": "http://doi.org/10.1128/JCM.42.3.1082-1088.2004", "summary": "", "authors": "['Wulamu Mamuti, Hiroshi Yamasaki, Yasuhito Sako, Minoru Nakao, Ning Xiao, Kazuhiro Nakaya, Naoki Sato, Dominique A. Vuitton, Renaud Piarroux, Marshall W. Lightowlers, Philip S. Craig, and Akira Ito']", "date": "03-28-2004", "split": "test", "label": "machine", "status": "succcess"}
{"title": "First Infection with VanD-Type Glycopeptide-Resistant Enterococcus faecium in Europe", "warc_date": "20220328", "article": "['\"In March 2005, veterinarians conducted a laboratory study of 79 untreated (super) induced or adult endogenous E. coli (asidocardial infections) infecting 275 patients. These untreated patients spent a total of 26.5 days infected and at least 100.5 days, depending on the bacteria type. The patient, IDCR-10b2, had the highest rate of urinary tract infections (ITI) and was treated with early-stage infections such as amphotericin (Veloxalen), PVE-10b1 and ivy-5. In total, 200 patients developed infections and 8.5 deaths over a 1-year period (imaging performance calculated with patient resistance) from conditions that persisted for a total of 36.5 days compared to 7.6 days in control patients (pfenza-2 and liteaxil).\\\\nSeventy-one infections occurred on the VTCE malaria of 112 patients with the region of North Africa. These infections compromised the acquired immunity of E. coli infections that infect the blood vessels of which the parasite is transmitted via urine. The patient had no viral infection of VTCE, but had 95.4 percent antibodies with a regular family history of infection.\\\\nThese findings confirm that an E. coli infection with the reservoir bacterium vivaxorum is the leading cause of E. coli infection in Asia and the Middle East. Therefore, clinicians in Asia are using this new class of E. coli infections to treat an epidemic in Europe.\\\\nVivaxorum is a bacterium native to the antigens entered the path of human diarrhea, gallbladder disease and HAE, killing 98 percent of that dangerous and then eliminating 80 percent of them in the long term. Avoiding influenza is the VTCE response factor, and the VTCE gene is most effective in an infection spread under flu-like symptoms such as infection with certain viruses. Indeed, VTCE is most effective in preventing the infection and in treating with vaccination during a seasonal influenza flu season.\\\\nThe VTCE gene alone will be particularly useful in preventing E. coli infection and controlling the growth of E. coli by preventing and controlling neonatal neurodegenerative and non-NEGL-impotence (NEGR) mutations. Some vivaxorum variants along with parasitic peptides have already developed resistance to V. 002 secreting (Velleoxalen) pneumonia.\\\\nVelleoxalen is a single-agent tool and the VTA plays an important role in protecting of the E. coli\\\\nVortic and vivaxorum\\\\nUsing the class IV synthesis of E. coli into the body products of a patient\\'s bacterial cell, the VTA gene is triggered when one compares the V6 gene on live live bacteria to the V. 002 gene alone. Based on the V. 002 gene, the VTA gene guides the entire bacterial cell, blocking the progress of the parasitic virus in the body. V. 002 is a gene that is deemed by the VTA gene to relieve diarrhea from streptococcus faeces (gentent diarrhea) and genotesticulitis (GNA).\\\\nIn addition to disrupting E. coli passage, the VTA gene contains a poison oligolithamtic system of antigens. The sequence of chemical agents that result in the VTA gene transcription (derived from the morphology of these antigens) are profoundly mutated to trigger the precancerous antigen introduction of the E. coli\\\\nThe VTA gene currently breaks down the V12 or V12\u03b2 barrier. Therefore, VCE-10b2 and V12\u03b2 are by themselves not compatible with rituximab (gene block), yet either made or receive methylation (gene gemonex) to expand their control.\\\\nThe VTA gene also has an anti-bacterial signature. This IMO phosphatase species provides increased blood flow, surveillance and replication capabilities.\\\\nThis study was sponsored by JANIAFA BOLDDEERFETY. FOR RELEASE BY MONTEREY\\\\n\"']", "inst_index": "90512", "domain": "J. Clin. Microbiol. 2005, 43(7):3512. DOI: 10.1128/JCM.43.7.3512-3515.2005", "url": "http://doi.org/10.1128/JCM.43.7.3512-3515.2005", "summary": "", "authors": "['Jean-Philippe Lavigne, He_l\u00c3\\x82\u00c2\\x8fne Marchandin, Nicole Bouziges, and Albert SottoS']", "date": "03-28-2005", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Regulated Expression of the Beta2-Toxin Gene ( cpb2) in Clostridium perfringens Type A Isolates from Horses with Gastrointestinal Diseases", "warc_date": "20220328", "article": "['\\'Regulated Expression of the Beta2-Toxin Gene ( cpb2) in Clostridium perfringens Type A Isolates from Horses with Gastrointestinal Diseases\\\\nRESULTS: E P to v2 P to v0\\\\nCONSTRUCTED MANY SYNDROME REMOVALS PROBABLY SAVVY\\\\nBiological and Scientific Evidence is presenting at the 18th Annual Fluid Medical Comprehensive Growth Study Annual Meeting, underway in New York on March 28, 2005, at the Boort/Kingston Institute.\\\\nEmerging data, highly funded and open-access, reflects CIM data from approximately 5,000 patients with liver disease in close contact with horses as therapy for treatment in live animals, primarily the canines of patients with chronic Type A infections, the horse side effects described in the Lancet in 2001 and the Animal Welfare Research Protection Guide, published in 2008.\\\\nLast year, 2.85 million people worldwide have affected by these human infections, most due to intestinal parasites such as tetranitium, known as the plague in humans. Further, tens of millions more people are seeking treatment for hepatitis and other liver diseases caused by alcohol abuse, smoking, obesity, HIV/AIDS, metabolic diseases such as hepatitis C and amyloidosis, and severe premature aging.\\\\n1) Most Type A Isolates treat peripheral nerves and stomach walls, with value in rural settings\u2014nearly 1.5 million persons, nearly 50 percent of total, have suffered from torture and witnessing brutality in animal rehabilitation or detention. The exposure and deployment of torture is common, and perpetrators of torture receive some of the highest ranks of Human Rights Watch (HRW) fellowships and MIPC board appointments.\\\\n2) Sixty-five percent of deaths due to abuse or gangrene in the animal care systems are stemming from ongoing tortures involving horses. Horses killed, in bed and in various exercise facilities, by inhumane and degrading conditions are preferred for psychological exposure and providing therapeutic assistance.\\\\n3) In more than 30 percent of the animals in most U.S. U.S. livestock facilities, including trials in or on sale, captive testing environments, most cogs and horses are slaughtered. Equine training for animals undergoing and managed circumnavigation and confinement poses extraordinary risk of livestock violence.\\\\nFACTOR: Horse dieings are well documented and extremely uncommon. Sixty-four percent of estrhodopsemia, for example, occurs due to witnessing death in a herd, but mortality statistics are much higher. Likely cause of death is not discovered, which causes an inherent risk for developing certain metabolic defects and the metabolic disorders associated with human liver rejection, seizures, disease and brain damage. In most cases of severe endocrine dysfunction and hormonal dysfunction, the signs are too subtle to diagnose, leading to an exaggerated risk of heart disease and hypertension. Breed has also experienced other common eating disorder complications, such as stress hormones, and other metabolic disorders have a poor capacity to trigger cardiac and nervous system disorders.\\\\n4) Entomologists believe that veterinary practices increasingly cater to the behaviors of the horses themselves and that this new, \"white-washing\" approach is a cost effective way to protect these animals and their animals from cruel diseases.\\\\nEndocrine Disorder, overexertion, and extreme suction or \"feedback\" has been studied in animals resulting from consumption of nonstricture-induced or disordered nutrients. According to BGEB, an unproven family history study used to recruit more than 4,000 horses in pet condos in a Baltimore area, 11% or 1 in 3 died from wild horse nutrition. The study of overexertion, overexertion, and treatment of disease compromised the elderly, poor diet, and diet-associated psychological, physical, emotional, and behavioral problems. Very little is known about the risk of birth defects, metabolic problems, or seizures, and in starker contrast, even only 36% of horses with diabetic circulation die of certain diseases, most due to of disease that is not known to be previously associated with behavior modification. Furthermore, a common fate is death or injury. These studies record animals and their animals for only a small fraction of total gestational births, often occurring in or on sale.\\\\n5) Horse diets are known to be high in probiotics and low in animal-derived ractopamine, leading to serious complications, including severe anaemia in these animals.\\\\nAs part of BGEB\\\\\\'s captive testing, which held the study in single units for 4-7 weeks, our organization\\'']", "inst_index": "50055", "domain": "J. Clin. Microbiol. 2005, 43(8):4002", "url": "http://doi.org/10.1128/JCM.43.8.4002-4009.2005", "summary": "", "authors": "['Michael Waters, Deepa Raju, Helen S. Garmory, Michel R. Popoff, and Mahfuzur R. Sarker']", "date": "03-28-2005", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Characterization of a Large Outbreak by CTX-M-1-Producing Klebsiella pneumoniae and Mechanisms Leading to In Vivo Carbapenem Resistance Development", "warc_date": "20220328", "article": "[\"'The role of: mU\\\\nThreat: nodules\\\\nTarget: mU\\\\nPerfecting this infection: the first TAB-M-1-produced Klebsiella pneumoniae\\\\nMucicosis of the distant cousin of the haphazardly sedated Klebsiella bV> and superbug RMD (the highly likely culprit), it will prove to be a significant health threat to health in far-flung communities throughout California. As that should in the case of Klebsiella, Klebsiella can be detected and carried out no later than one to two days following treatment for the disease.\\\\nTesting that patient should be started in February 2006 for problems that will arise in patient cases of additional Pseudomonas aeruginosa (post-TAB and reactive droplets) signaling hyperthyroidism.\\\\nFindings of the phase III study will be published in PLOS Medicine at least now. If they prove successful, an additional phase III study will also be needed and it is possible that the positive results may come in the second half of 2006.\\\\nArticle: Receiving Monitoring Reports from the mU Bioscopic Surveillance Early Response Program of his colleagues,\u201d Alberto Avalos Azari, Evan Chambers, Irene Gutierrez, Matthew Durloff, James Waler, Luis Faber, Joaquim Leyva, Muhsin Ri\u00c3\u00a9ris, Ekaterina Mane, Ji-Qiu Kuwayu, Ali Allamoyang, Calen C. Dorte III, and Naja Rubio, doi: 10.1169/2dc.063371203.\\\\nMany results from this clinical trial suggest a clinical treatment outcome based on the priority PDUFA action date of 30 December 2005. Results from these Phase III studies indicate that:\\\\nthese findings are consistent with other clinical studies that appear to be trial to determine the extent of antibiotic resistance.\\\\nThis study, which is being carried out by the Italian Agency for Microbiology and Drug Development (AVAD), notifies of the committee\u2019s desire to include treatment of the highly likely Klebsiella pandemic.\\\\nInterventions of the newly reviewed BRAF Antimicrobial Resistance Surveillance System, which assesses the health of patients in the United States, where this HVDHH03 have been confirmed. Patients found to have HIV/AIDS, TB, or other infectious disease on their dung (DMD) should be instructed to discontinue therapy and the use of a common antibiotic similar to TAB-M-1. This recommendation would prevent at least one affected patient from receiving HIV/AIDS during the course of the clinical trial.\\\\nThe study is designed to be monitored and summarized in detail so that epidemiologists and patients can quickly establish if any observations had been made and whether the rate of infection was worsening. Information also supports the view that this means that patients likely to be impacted by HVDHH03 may experience significant resistance to antiretroviral treatment, including another W. Antibody research presented this month. In the study, patients with HIV/AIDS/TB were assigned a drug treatment level between 500 mg and 550 mg/day. If the drug treatment level was similar, new treatment progression rates would be confirmed.\\\\nThe first HVDHH03 product, MSA1, was developed at AVAD at the beginning of 2007 by the AVAD and IVF. It showed an excellent relative response rate in this phase III study, as was the case in the double-blind early response trials of the 12-year-old drug.\\\\nThe version of MSA1 was developed in 2002 by the Italian Agency for Microbiology and Drug Development. It was also licensed from AVAD by a consortium of Brazilian inventors, who founded the AVAD Consortium in 1992. The ACIRA have consistently confirmed that MSA1, as an alternative treatment option, has worked well in preclinical animal studies, and it has been approved to treat patients with Ebola.\\\\nThe study began in early December 2006. Its evidence of the impressive spread of HVDHH03 demonstrates a potential scenario of multidrug resistance from either bioplastics for the treatment of bacterial infections or by agents that are unlikely to be effective against a single drug.\\\\n'\"]", "inst_index": "95154", "domain": "J. Clin. Microbiol. 2006, 44(8):2831", "url": "http://doi.org/10.1128/JCM.00418-06", "summary": "", "authors": "['Ana Mena, Virginia Plasencia, Laura Garci_a, Olga Hidalgo, Jos\u00c3\\x82\u00c2\\x8e Ignacio Ayestar\u00c3\\x82\u00c2\\x87n, Sebasti\u00c3\\x82\u00c2\\x87n Alberti, Nuria Borrell, Jos\u00c3\\x82\u00c2\\x8e L. P\u00c3\\x82\u00c2\\x8erez, and Antonio OliverW. Li']", "date": "03-28-2006", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Effects of Moraxella (Branhamella) ovis Culture Filtrates on Bovine Erythrocytes, Peripheral Mononuclear Cells and Corneal Epithelial Cells", "warc_date": "20220328", "article": "[\"'The first of Raccoon\u2019s Entraines\\\\nSerotonin, the anti-viral drug that characterizes the part of the brain responsible for feeling and being well, is the messenger that waves the neurotransmitter diatomatrix, or \u201cbooster,\u201d and activates the transcription process. It\u2019s what makes Bovine Erythrocytes so noteworthy \u2013 there\u2019s no love lost.\\\\nV. Croizofir\\\\nThis is one of the very rare parts of the brain that is known to fully function without the help of Bovine Erythrocytes. It\u2019s an average of 2 times stronger than for other types of \u201caerobic\u201d brains. With white blood cells alone, for example, \u201cratio\u201d remains the strongest component of Bovine Erythrocytes. This does not matter whether you have beta-carotene or beta-silicon gas that helps to retain the best cells. But the eye, nerve, and brain also have parts that automatically reprogram, repeat, and reprogram over time. (A demonstration can be found here).\\\\nNow, researchers at the University of California, San Diego (UC San Diego) have discovered that the tiny organism that works as a messenger messenger may be impaired by the presence of Bovine Erythrocytes. For instance, because Bovine Erythrocytes can be fed, they lose the ability to create new cells that can use these newly acquired cells to stimulate Bovine Erythrocytes to grow.\\\\n\u201cThe idea that one organ that can normally do this is not functional is terribly important,\u201d says Jim Duffey, an associate professor of biomedical engineering at UC San Diego who has been leading the work. \u201cIt\u2019s a very important response to the regulation of bacterial activity, and it appears to play an important role in Bovine Erythrocytes now.\u201d\\\\nUsing a number of techniques, however, the UC San Diego researchers found that Bovine Erythrocytes can become overactive in \u201cselective beta-carotene-metabolized membrane tissue,\u201d which is large, poorly formed and \u201ctransporter-bound\u201d despite the wilder conditions in which they become active. The membrane decay is lost, and the entire tissue breaks apart. Essentially, CRs are dysfunctional vessels that line the external, attached walls of their system, which carry valuable Bovine Erythrocytes to the brain for many, many years.\\\\nUsually, these cells are discarded, and Bovine Erythrocytes can be seen as the destroyer of these cells. In addition, standard capillary bundles in the layers of the vascular system that ship Bovine Erythrocytes should be unusually clean, as per Duffey\u2019s analysis, and they are completely sterilized, and can be given back to Bovine Erythrocytes when the cells are visibly dying.\\\\nThat\u2019s the power of \u201cselective beta-carotene stimulation,\u201d although the researchers note that this can take years if not decades to restore these special cells.\\\\nDuffey also notes that developing a cause-and-effect relationship between Bovine Erythrocytes and brain stem cells is a long-term strategy. Since the research work is done at UC San Diego, however, the most accessible and easy-to-study method for retrofitting and expanding the Bovine Erythrocytes\u2019 normal activity is a primary tool. Duffey\u2019s team tested a Bovine Erythrocyte structure called PliFi, which they call Little Ords, which once affected Bovine Erythrocytes, but which, as with many cells, did not.\\\\n\u201cPliFi stands for \u2018multiple view-at-extension\u2019 and provides a structured potential for retrofitting,\u201d says Duffey. \u201cWe are working to create a result that is culturally compatible with PliFi (the material that occupies the brains of cells).\u201d\\\\nBovine Erythrocytes have an affinity for externals, and that may be why CRs have been used as a killer mechanism by pacific cells to transform many cell types. Research like Duffey\u2019s has already done considerable damage to neurons that take credit for the phenomenon.\\\\n\u201c'\"]", "inst_index": "59549", "domain": "J. Clin. Microbiol. 2006, 44(3):772", "url": "http://doi.org/10.1128/JCM.44.3.772-776.2006", "summary": "", "authors": "['Henry E. Cerny, Douglas G. Rogers, Jeffrey T. Gray, David R. Smith, and Susanne Hinkley']", "date": "03-28-2006", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Development and Evaluation of a Sensitive and Specific Assay for Diagnosis of Human Toxocariasis by Use of Three Recombinant Antigens (TES-26, TES-30USM and TES-120)", "warc_date": "20220328", "article": "[\"'With three major stages of development stages, the outcomes are highly likely to be random, devoid of any experience for us humans, and they are highly likely to have radical adverse reactions. In fact, it is necessary to use the three biological components of the hyponatremia corticosteroid assay (HSFF) as three distinct biomarkers, namely: Crisflex Sample of Honey Microblasts, Crisflex Sample of Honey Microblasts, and Crisflex Sample of Honey Microblasts (RMP).\\\\nAll four tools have expressed feedback critical for predicting how the liver function will be affected by the development of a developing cell population. The chart below shows the reaction type for a developing T-cell.\\\\nThe first version of the drug PTT-1060 (Line 3 + S2-1) was designed to challenge over time the ability of the tumour atrogenic phenotype to respond to x-rays or a combination of both. The current version developed at the C, N and D National Drugs Laboratory (NDDL) tests will see a marked improvement in the TES-26 function by completing a blood test, and will offer a genetic marker for the TES-30M regeneration.\\\\nHowever, the Ph.D. candidate Biotiq Multi-Ingredient Ductitase Lithium-polymer PTF7 is not the sex-for-one FDA safe and effective treatment for Fd; despite the target dates, O2 has been proven to significantly improve the performance of the drug in many trials; for example, the combination treatment reduces the number of CAR-T molecules required for the building of T-cells, which in turn, has been demonstrated to improve response at low doses, increasing levels of the bacteria Biotiq impacts (PPT-V5), V-509, and O2.\\\\nIn addition, patients receiving a one-to-two month trial for a standard T-cell HIV treatment may receive therapy at a lower dose than the three CD4 CD4+ CBM inhibitors, which take as much time as normal medication. The more time that a treatment for the three CD4+ CBM inhibitors begins to produce a single CD4-based cryo-cell transplant, the more human T-cells can be stimulated against an efficacy endpoint.\\\\nSo, the first stage is the Stage III synthesis ('\"]", "inst_index": "11249", "domain": "J. Clin. Microbiol. 2009, 47(6):1712. DOI: 10.1128/JCM.00001-09", "url": "http://doi.org/10.1128/JCM.00001-09", "summary": "", "authors": "['Suharni Mohamad, Norhaida Che Azmi, and Rahmah Noordin']", "date": "03-28-2009", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Dual Inhibiting Senescence and Epithelial-to-Mesenchymal Transition by Erythropoietin Preserve Tubular Epithelial Cell Regeneration and Ameliorate Renal Fibrosis in Unilateral Ureteral Obstruction", "warc_date": "20220328", "article": "['\\'Greater blood flow and longer duration of life can inhibit cell division in some pre-existing embryonic cells. Underutilized in key embryonic stem cell lines, enzyme synuclein-containing matter forms a pathway to nourishment when fertilized. A cross-endocrine laboratory results is clear in both rat and stem cell lines of embryonic stem cells who had inhibited patient stem cell accumulation.\\\\nBackground\\\\nOne of the fastest-growing human stem cell therapies will be cyogenes. After years of undergirding cell bodies with conventional treatments, neonate generation have finally arrived in Northern Europe and advanced into an important development stage of cyogenes. Antitraase xenograft, or CUK, is the first and most convenient route for pluripotent stem cells (NSCs) to self-produce in the wild and improve disease management.\\\\nThe rapid reproduction of adult solid cyrosenia (gylebsomes or piglets) may also be contributed to these cells. ICGE \u2013 already leading inhibition of mouse IDR has been successfully demonstrated in embryonic stem cells and pro-vomition systems by humans and mice, and into multiple ascending 9-stage regrowth by freezing cells in a frozen gel. Intravenous ventricular synapses, typically a new field of treatment for immature tissue necrosis, have been recognized in the mouse arm of new ICRs\\\\nImportant\\\\nChips to extend lifespan in the mouse.\\\\nNew approaches to treatment for regenerative blindness are also underway.\\\\nRecent inhibitors of cell-based tumor biology, such as Antigen\u00ae Discovery Stimulation and PhaseI candidate Multiple Integrated Cell Therapy (MUSTE) \u2013 are the top 20 well-funded and promising treatments for infections in cystic fibrosis. They are being closely monitored in the mouse arm of the late PhaseI programs and will be announced in early April.\\\\nChips to further thicken teeth.\\\\nAn orally administered multivitamins product to prevent formation of impurities in rhinotransplants.\\\\nThe placenta, or milk soluble proteins, is widely used to determine, control, and manage certain fetuses. Placentas may maintain iron-thinning properties, which in turn may make them less flexible and vulnerable to infections. Currently, U.S. pharmaceuticals and stem cell research are too expensive.\\\\nUC Genome Sciences (Gen. . N.C.) is a leading company of research in molecular genetics and metabolomics that has created so many different novel drugs that pharmaceutical companies want to develop this domain of research. The company has 20 enzyme replication centers and cell cultures all across the U.S. The company recently obtained 510(k) clearance from the FDA to begin sequencing bone marrow in women and infants in the U.S.\\\\nCell Uranium\\\\nAnother in the wholeheartedly positive move is the specific development of a novel membrane-based protein molecule known as CMML-422. CMML-422, found in monkeys, stimulates the activity of the embryonic stem cells and provides potential for targeted and pluripotent stem cell therapies. Additional information about CMML-422 is available at www.CMML-422.org.\\\\nThe Pioneer Cancer Association of America, the industry leader in disease prevention and survivorship, presents new research papers on \"Trials & Safety of Cell Uranium Cancer Vaccines (cSCV). The fourth annual conference held in Las Vegas, Nev., was open to all medical professionals in the clinical, scientific, and industry fields of science and health. Carebility is a premium health care specialty associated with receiving access to a wide range of appropriate clinical benefits and valuable scientific instruments. More information about Cell Uranium Cancer Vaccines is available at www.ropreidax.com.\\\\nIICAB is a 501(c)(3) non-profit corporation established by the U.S. federal government to support the research, development, and development of therapeutics to enhance the health and lives of individuals afflicted with cancer or other genetic diseases. IICAB receives grants from the National Institutes of Health (NIH), through its Corporate Sponsor Program and through its relationships with cancer experts. This designation allows the U.S. government to conduct research and development of research in the areas of animal models, diseases, and medical research.\\\\n\\'']", "inst_index": "29686", "domain": "BioMed Research International - Volume 2013, Article ID 308130 ", "url": "http://doi.org/10.1155/2013/308130", "summary": "", "authors": "['Adis Tasanarong, Supranee Kongkham, and Sookkasem Khositseth']", "date": "03-28-2013", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Neurogenesis and Increase in Differentiated Neural Cell Survival via Phosphorylation of Akt1 after Fluoxetine Treatment of Stem Cells", "warc_date": "20220328", "article": "[\"'The results of the Cellular Extraterrestrial Neural Cell/Outcomes study may open a new avenue for innovative treatments for neurological disorders for which antigen, chemical or veterinary intervention may or may not cure.\\\\nUpcoming clinical trials for human-specific antibodies to enhance the therapeutic effect of existing or new therapeutic agents are expected to have a substantial impact on the number of new therapeutics designed for diseases with slow or catastrophic responses to lead to impaired outcomes.\\\\nNormally, antibodies based on brain signals such as alpha and beta are determined by the body\u2019s neurotransmitter acetylcholine \u2014 the communication channel of the brain that leads to thoughts and emotions. However, current techniques in the field are proving that a physiological solution (of molecules) can also be used to improve both the production of alpha and beta to improve multiple sclerosis in humans.\\\\n\u201cAnally relevant research on functional magnetic resonance imaging could be the foundation of a number of therapeutic applications,\u201d said Jean Belman, PhD, head of an individualised neural cell apoptosis (the cell activating phase) and the Professor of Neurology at the University of Oxford, Oxford UK. \u201cHowever, not all animal species are immune to such activities and, given the evidence that PTSD can also occur in humans, there is no real end point or game plan for studying exactly why these brain cell experiences are altered. Our findings point to a robust regulatory pathway for our discovery of a therapeutic target that can improve such a body function by enhancing our ability to recognize and react to those in question\u201d.\\\\nThis work was supported by S. Agut\u00e9 University Medical Center, Oxford UK, Oba Otunuga Medical Center, Leithen Medical Research Foundation, Building Society of London and Walton-Woolworth.\\\\nNotes to editors\\\\n'\"]", "inst_index": "87526", "domain": "BioMed Research International, Volume 2013, Article ID 582526", "url": "http://doi.org/10.1155/2013/582526", "summary": "", "authors": "['Anahita Rahmani, Danial Kheradmand, Peyman Keyhanvar, Alireza Shoae-Hassani, and Amir Darbandi-Azar']", "date": "03-28-2013", "split": "test", "label": "machine", "status": "succcess"}
{"title": "A Comparative Study for the Evaluation of Two Doses of Ellagic Acid on Hepatic Drug Metabolizing and Antioxidant Enzymes in the Rat", "warc_date": "20220328", "article": "[\"'In a recent study, investigators discovered a beneficial isotope in two forms of sorbitol to prove a linked in-vitro-acid product safety. Aspirin metabolizes naturally in the liver and can rapidly damage some of the enzymes in the same process as macrophages. In addition, within 5 nanometers of an enzyme taking advantage of thalassemia, a protein in the marrow containing anti-reactions, can be associated with increased oxidative damage from BPA deficiency.\\\\nEstablishing their previously unimagined unmet need to separate the two known pathways of signaling the antioxidant components, APU-34 and ATS was recently presented at the 12th Annual European Association for Drug Development meeting, being held in Geneva. The research team of Dr. Talivar Guru, a staff chemistry professor and coordinator of the Heiligaur Danni-L Pics, emphasized the need for a further assessment of the side effects of APU-34 in the safety and pharmacokinetics of Diazepam. Some laboratory tests required by federal agencies examined the amino acid metabolized, which was listed as not metabolizing naturally in the liver and metabolizing naturally in the body.\\\\nTo evaluate the safety and pharmacokinetics of APU-34, the team examined the interactions between the APU-34 enzyme and the anti-reaction drug in the liver by performing a quick, detailed analysis of Pap smear results after taking the drug. This analysis evaluated that from a single Pap smear, 28 drops of APU-34 were detected at the end of the second Pap smear period, and (cell integrity imaging and PRIZE results that were tested with 25-36 women) between 20 and 40 drop. A previous study showed that APU-34 was found to be safe for the same diagnosis that resulted in a 3-fold reduction in the ATS within 3 days in fetuses.\\\\nDr. Guru added that the difficulty with toxicity from the APU-34 enzyme is a function of lack of capacity to do testing. After analyzing observed side effects of APU-34, the team from DU University School of Medicine noted that although there was a certain amount of toxicity from the enzyme, substantial amounts of Methylsulate anthocyanate and mustardoxin had very low toxicity. Evaluating APU-34 on Methylsulate anthocyanate and mustardoxin, Dr. Guru concluded that 4% of the toxicity and 300 mg/kg of chemical per 1 mcg was at the level needed to elicit lower toxicity from an APU-34 enzyme. Using Methylsulate and mustardoxin levels, he noted that 40 mg/kg of the APU-34 enzyme was similar to that found in the pecan powder end of the human papillomavirus (HPV). At the same time, 22 mg/kg of the enzyme was found in Methylsulate oil (NMDA), a precursor to the \u03b5 4001 enzyme. He further said that the amount of deleterious deleterious deleterious deleterious deleterious deleterious deleterious edge in the APU-34 enzyme is more than 10 times that found in the PPI.\\\\nThe study was presented at the 12th Annual European Association for Drug Development Meeting, being held in Geneva. Dr. Guru said, \u201cThis is the first time we have evaluated biomarkers in the formulation of eDRIDOPRAK, and we are far from producing high levels of the amino acid metabolized in BPA. We are seeking to understand the level of dissociation among the ATS which is acting as the basis for toxicity. Finding the structure of APU-34 is critical because glycolic acid reacts with an enzyme that is one of the traditional leading environmental kinase enzymes in that portion of the chemical pool. The molecule acts as the spring for a selected peptide which has a large stock of glycolic acid molecules. An improvement on that agreement, to note, is a reduction in large quantities of glycolic acid glycolic acid glycolic acid which are super-selective in BPA expression. We believe that our drug is chemically equivalent to 1/2 of the size of the overall antigen. We have made substantial progress in this early stage, and will now work with our internal MDRIDOPRAK laboratory in collaboration with our partners in the PRIZE program to test it again.\u201d\\\\nA greater range of PPI implies that beta is responsible for stimulating innate anti-reaction in the body and therefore, a decreased P'\"]", "inst_index": "80385", "domain": "BioMed Research International Volume 2013, Article ID 358945", "url": "http://doi.org/10.1155/2013/358945", "summary": "", "authors": "['Gurbet Celik, Asli Semiz, Serdar Karakurt, Sevki Arslan, Orhan Adali, and Alaattin Sen']", "date": "03-28-2013", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells", "warc_date": "20220328", "article": "['\"ANN ARBOR, Mich.\\\\nMarch 28, 2013\\\\n/PRNewswire/ -- A global research team conducted by Direct Medical Systems (DMS) at the world\\'s leading medical school has revealed that highly effective organ enhancers for using and maintaining neurotrophic factor for abuse and transplantation of sickle cell disease can increase immune response in cancer cells by increasing the number of preoperative segments of infected tumor tissues.\\\\nUsing EXPRISES, extracted from Chronic-Lymphoma and Neuro-Oncology (C4OAT) , the teams used Portrait-Bax, an absolute failure injection, as a placebo. Portrait Bax significantly boosted the appearance of a tumor area (L) over prior analgesic injection. A nebulizer alone (L) may increase immune response in tumours resulting in mass destruction. These results result in inflammation over anorgan.\\\\nIn the study, patients with kidney failure ended up with live progenitor and secondary iphosphate in their lives.\\\\nThe immune response in the trials monitored response to an ever-increasing list of\\\\nSuch treatments can improve tumor survival by up to 98 per cent in tumors completely unknown to the immune system.\\\\nUse of Portrait Bax in administering pellet inhibitors to avoid infection in mice could significantly help patients with life-threatening conditions\\\\nThe mission of PDRIS is to explore the impact of organ enhancers on the presence of cystic fibrosis via immuno-gene management and inflammation as a result of organ differentiation\\\\nThis project explores the human atherosclerosis-like byhog metastasis-tolerants and disorders such as lung cancer; the role of oxidative stress in the mechanism of apoptosis-related inflammation.\\\\nTaking therapeutic action to immuno-gene management should be another area of research to be explored in PDRIS this year, as clinical trials commence in humans including the immune system.\\\\nAbilities provide a mechanism for the normal biological process in mice. The immune response in apoptosis-related cellular epithelial-shell tissues is likely to be influenced by a new invasive pathway promoted by natural tissue and the bacteria-blocking nature of the inflammatory skin conditions.\\\\n\"']", "inst_index": "45657", "domain": "BioMed Research International Volume 2013, Article ID 210604", "url": "http://doi.org/10.1155/2013/210604", "summary": "", "authors": "['Young-Man Lee, Q-Schick Auh, Deok-Won Lee, Jun-Yeol Kim, Ha-Jin Jung, Seung-Ho Lee, and Eun-Cheol Kim']", "date": "03-28-2013", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Magnesium Lithospermate B, an Active Extract of Salvia miltiorrhiza, Mediates sGC/cGMP/PKG Translocation in Experimental Vasospasm", "warc_date": "20220328", "article": "[\"'In our article, we explained the popular antioxidant energy, as reported by Dr. Karen Moon at South Park Hyatt Hotel, a SNC-Lavalin-Toronto Special Economic Zone (SNC-Lavalin-Toronto) in Vancouver, Canada.\\\\nAccording to Dr. Moon, magnesium chloride can transmit and act like iron and magnesium phosphate in an excess of a mineral, or overexpress the properties of specific components of a phosphate deposit, like potassium. Auto-excavation of magnesium phosphate from gas, usually used to buff or hide hydrogen sulphide traps or recycle water, has potential therapeutic applications for sports medicine, suicide prevention and in particular cardiac surgery, as the magnesium oxide acids found in water filters may help slow the deterioration of valves and guide the procedure, and they represent an important replacement for the long-term magnesium sulfide patchular acid that is used in steroids.\\\\nApart from melatonin, there are also other mineral properties that can work synergistically with magnesium chloride, such as\\\\nTinyl volatilulaminergic acid (TMO) and\\\\nlomidol analogs (LIHOA) and they, among other compounds, can also \u201cphysically\u201d be found in carvings of gemstones, but these still remain \u201croutinely\u201d withheld. Lithium chloride molecule molecules such as\\\\nStaphylococcus aureus and anthracis are available from the aureus or otorin indexing gene sites in about half the population but, in some cases, have no known uses. The\\\\ngreek phosphorolipids or magnesium magnesium chloride compounds in the algal sulphides and siTORs of cars are still relatively new and still vulnerable to toxicity. They are being used for medical use and in ways that can be seen in hypertensive or extreme thirst ,is main cause of and flare up of chronic constipation, as seen in carfentanil and guninol psoriasis . Tinicol pericardol can also be used for pulmonary pulmonary syndrome and occasional hyponatremia at the same time.\\\\nIn many cases, what are finding with gold sulfide deposits in teeth is a different story. Southern Tang B, Papine B, Betancerz,\\\\nOngus B and\\\\nAmbrosio B, \u00c7eel B and\\\\nMerrifum C.Those lithium sulfide compounds are already being used as natural therapeutics in animals.\\\\nThe dangers of overprescribing these\\\\nagents are apparent if they are in fact used for higher quality drug delivery. For example, when they are used for various purposes, they are used to drive drugs through the plate.\\\\n'\"]", "inst_index": "24851", "domain": "BioMed Research International, Volume 2014, Article ID 272101", "url": "http://doi.org/10.1155/2014/272101", "summary": "", "authors": "['Chih-Zen Chang, Shu-Chuan Wu, and Aij-Lie Kwan']", "date": "03-28-2014", "split": "test", "label": "machine", "status": "succcess"}
{"title": "__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism", "warc_date": "20220328", "article": "['\\'SAN ANTONIO, TX - STOCKTON, Texas - In order to circumvent the regulatory ambiguity of its own AVIATN3 gene therapy pipeline, ACT is developing an entirely new RNA-B binding protein that will be able to accelerate post-transcriptional iron regulation of the fetus.\\\\nIt\\\\\\'s a key development that will be critical to ACT\\\\\\'s bioengineered iron-filtering system, which can potentially speed up postnatal iron distribution to mother and fetus, thereby promoting healthy fetal growth and development.\\\\nTRICICT3 of the AVIATN3 gene therapy pipeline\\\\nTwo earlier phase 3 trials focused on AVIATN3 triggered AVIATN3 and more than 50 part copies of AVIATN3 have been successfully derived from ACT\\\\\\'s AVIATN3 gene therapy pipeline.\\\\nResearchers at the University of Texas Austin recently announced that a key phase 3 trial (Phase 2) enrolled this month was successful in successfully massaging AVIATN3 in target cells.\\\\nThe Phase 3 trial included the START-22 (TX-1) trial, which is currently in phase 2 trial. The TRI-1 trial showed an increased number of AVIATN3 binding proteins and a decrease in in antibody production in the lab.\\\\nAVIATN3 is now in preclinical development, but continues to be tested in preclinical models in smaller Phase 2 trials. The phase 2/3 trial estimated that AVIATN3 had significantly greater trans-mediated proteins and improved activity in certain subtypes of (temulatory) iron-filtering genes. The Phase 3 trial in the Phase 2+ clinical trial testing ABBP-MSP had increased activity in more than 10 different iron-filtering genes and subtypes of AVIATN3 subtypes.\\\\nIn the Phase 3 trial, ASIS investigators were able to remove 99.4% of all AVIATN3 binding proteins and assess that the AVIATN3 gene therapy programs delivered mechanisms of action with greater specificity and speed.\\\\nASIS reported that \"automated systems delivered glucosomal RNA from AVIATN3 into target cells and injected them with protein-free mitochondria, the regulatory agents that regulate iron distribution. Due to the improved performance of the AVIATN3 gene therapy program and the newly derived sequences of AVIATN3 binding proteins, ASIS is producing a higher rate of thrombocytopenia, the most common cause of maternal diarrhea or malaise in girls of reproductive age, than in males of reproductive age.\"\\\\nTesting progress in the two ongoing Phase 3 trials, which started on April 12, 2013, was not conducted as planned by the company.\\\\n\"We are disappointed by our completion of the two Phase 3 trials over the period of less than six months, which has been unfortunately delayed by an administrative review process,\" said Eugene D. Walker, Managing Director of ACT Biopharma. \"Our team continues to work diligently toward the development of these preclinical programs, while ensuring they are supported by local industry resources, cost structures and regulatory approvals. We are grateful to all of our co-investors for their work throughout the years and are hopeful that this interim positive result can serve as a template for future late-stage activities in this area.\"\\\\n\\'']", "inst_index": "20029", "domain": "BioMed Research International Volume 2014, Article ID 424767", "url": "http://doi.org/10.1155/2014/424767", "summary": "", "authors": "['Jaeson Santos Calla-Choque, Elisa Elvira Figueroa-Angulo, Leticia A_vila-Gonz\u00c3\\x82\u00c2\\x87lez, and Rossana Arroyoi']", "date": "03-28-2014", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Downregulation of MDR1 Gene by Cepharanthine Hydrochloride Is Related to the Activation of c-Jun/JNK in K562/ADR Cells", "warc_date": "20220328", "article": "[\"'Previous nuclear modalities (FCON1) are easily detectable in circulating c-Jun/JNK neurons that are resistant to the cytosine subsonic translation. However, the proteome in Cepharanthine hydrochloride \u2013 activated by the bmiRN2-DN-1 protein \u2013 cannot be detected for currently observed levels in the brake neurons. Previous research has pointed to a possibility that the structural changes observed in components of c-Jun/JNK neurons, even under such a magnification, could modify Cepharanthine hydrochloride even if the proteome is present.\\\\nIn the journal Nature Communications, published in 2018, X-Gene 6134 in the Canadian mPh even identifies Cepharanthine hydrochloride as per its modified phenotype, a dimpled protein containing microneedles that may have a similar cognitive structural change in the right place. Protices used to determine Cepharanthine hydrochloride are created after the eight main amino acid T-cells decompose.\\\\nThe repetitive, latent functional characteristics of CK receptor-positive cells enable the corresponding variable variation of Cepharanthine hydrochloride. This behaviour is an important role for CK receptor-positive cells and transcription factor transcription by Cepharanthine hydrochloride.\\\\nHowever, the modified phenotype of Cepharanthine hydrochloride, at times at sensitive levels, only shows indications of neonilegegegenation. Several cytosecond models of CK receptor-positive CK receptor-positive CK receptor-positive CK receptor-positive CK receptor-positive CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor-negative CK receptor'\"]", "inst_index": "95286", "domain": "BioMed Research International, Volume 2014, Article ID 164391", "url": "http://doi.org/10.1155/2014/164391", "summary": "", "authors": "['Li Han, Yafeng Wang, Xiaojuan Guo, Yubing Zhou, Jingmin Zhang, Ning Wang, Jinhua Jiang, Fang Ma, and Qingduan Wang']", "date": "03-28-2014", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Renal Overexpression of Atrial Natriuretic Peptide and Hypoxia Inducible Factor-1__ as Adaptive Response to a High Salt Diet", "warc_date": "20220328", "article": "['\\'UCOG offers a unique low-mass\"n/y duration\" review of Atrial Natriuretic Peptide and Hypoxia Inducible Factor-1__ as Adaptive Response to a High Salt Diet, and carries an array of doses by the second part of this review from a Spanish agricultural medicine academic article. The article will be published in PDF.\\\\nAs part of the analysis of essential activities to reduce reactivity and docility, the researchers took a snapshot of the gram and muscle-spitting activities of Atrial Natriuretic Peptide and Hypoxia-Nrizololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololololol\\'']", "inst_index": "67493", "domain": "BioMed Research International, Volume 2014, Article ID 936978", "url": "http://doi.org/10.1155/2014/936978", "summary": "", "authors": "['Silvana Lorena Della Penna, Gabriel Cao, Andrea Carranza, Elsa Zotta, Susana Gorzalczany, Carolina Susana Cerrudo, Natalia Luci_a Rukavina Mikusic, Alicia Correa, Ver\u00c3\\x82\u00c2\\x97nica Trida, Jorge Eduardo Toblli, Mar\u00c3\\x82\u00c2\\x92a In\u00c3\\x82\u00c2\\x8es Ros\u00c3\\x82\u00c2\\x97n, and Belisario Enrique Fern\u00c3\\x82\u00c2\\x87ndezlypep']", "date": "03-28-2014", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Antimetastatic Potentials of Dioscorea nipponica on Melanoma In Vitro and In Vivo", "warc_date": "20220328", "article": "[\"'After meeting with Dr Yih-Shou Hsieh of The University of Shanghai and presenting his new book Antimetastatic Potentials of Dioscorea nipponica and Alternative Medicine on Melanoma In Vitro and In Vivo, pharmaceutical company Arata Pharmaceuticals presented Jia-Yuh Chen of Bollywood Bazaar Pharmaceuticals who presented last week their new novel two-step treatment for capillary melanoma.\\\\nThe book of writing you know in waxing poetic. Now, is it too late to have your own Jia-Yuh Chen or Hsieh Chen. Or should we say, to be O-shaped, to choose what to have for now, to see the shiny and the viva, for now, to be sweetness and wit, for now.\\\\nIn the light of two authors of strong intellectual life on the subject of disease and life changes as well as early as ours in the extract, Jia-Yuh Chen and Chen-Yui Chen and Hsieh Chen are fine, quiet people with amazing minds. In their own words they share that, by finding the path their well-balanced diet and body, they become better and happier.\\\\nThere\u2019s an unknown number of biomarkers and various treatments that target specific receptors. The two lists together have a great chart of these biomarkers:\\\\nHere are the 42 interesting novel medications for Capillary Melanoma.\\\\nArata Pharmaceuticals, the body of this team, is functioning in its original form to identify significant cannabinoid receptors, the PD receptors and also the Parampathic Acidoroin receptors \u2013 which are two of the most potent cannabinoid receptors in the human body and have been described by multiple drug agencies as \u201cindependent living\u201d.\\\\nThe drug licences for Ariba Pharmaceuticals, NVS Pharmaceuticals and Orexigen Therapeutics are being accumulated due to many previous developments such as the recently approved Isis Merikase.\\\\nNew studies in the central nervous system like Iovaldin, AstraZeneca\u2019s chemotherapy, Watson Pharmaceuticals, etc. are being planned, but not fast enough, to validate the discovery. This trims several of the earlier discoveries that have, as Yih-Shou Hsieh suggests, been present in this area.\\\\nThis is indeed a healthy news story. One more study is planned.\\\\nHuman compounds have a great potential in Capillary Melanoma. We have always been asking: Is the potential for this drug involved in Capillary Melanoma in many species of living cells.\\\\nAnd then there\u2019s Chanel, the group in Shanghai that is working on the discovery of a new class of marker or art molecule, comprised of amylase, a protein that powers the development of this drug and other drugs.\\\\n'\"]", "inst_index": "91474", "domain": "Evidence-Based Complementary, and Alternative Medicine, Volume 2011, Article ID 507920", "url": "http://doi.org/10.1155/2011/507920", "summary": "", "authors": "['Mao-Lin Ho, Yih-Shou Hsieh, Jia-Yuh Chen, Kuo-Shuen Chen, Jia-Jing Chen, Wu-Hsien Kuo, Shu-Jiuan Lin, and Pei-Ni Chen']", "date": "03-28-2011", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Terminalia catappa Exerts Antimetastatic Effects on Hepatocellular Carcinoma through Transcriptional Inhibition of Matrix Metalloproteinase-9 by Modulating NF-_B and AP-1 Activity", "warc_date": "20220328", "article": "['\\'ANCHORAGE, Alaska (Clonarized in Discovery News) \u2013 Engaging the immune system to fight toxins such as platinum and which are released into the bloodstream requires processing of a strong protein linked to the triggering activity of microglomodes \u2013 an enzyme involved in activating the complex signals that stimulate the immune system.\\\\nThis molecule was found in the study of osteoporosis patients with advanced stage osteoporosis who had fluid buildup in their bones for anti-aging treatment. The enzyme altered the signaling pathway in the osteoporosis patients and triggered the active immunity of these participants by stimulating red, silvery levels of NF-B, an active protein involved in cell-level changes in the hormone progesterone.\\\\nThe authors found that the mutant mutant enzyme processes when the protein was applied in the bloodstream. In patients with osteoporosis, the degradation of the protein stimulated tumor progression or led to activation of immunity by immune cells. The patients with osteoporosis had three treatment group stages (four to seven months) where the protein differed from the other end of the disease formation process. These patients were found to have lean populations: bone marrow cells of normal, diseased or normal epithelial cells with bone marrow cancer, with post-cancer signs and symptoms. These patients also showed antibodies or complement proteins associated with optimal behavior of the vaccine-treated patients.\\\\nThe authors have provided more information about the different susceptibility profiles of the mutant enzyme in osteoporosis patients. Their most valuable drug candidates in this case were shown to be candidates for one treatment arm \u2013 \u03b1vivaglutide B), and for another \u2013 \u03b1vivaglutide C \u2013 instead of \u03b1vivaglutide B, in one treatment group.\\\\nThe lack of intrinsic importance of acid-sensitive antigen sensitivity in the osteoporosis drug group has historically resulted in avoidance of alpha-glomidogling \u2013 a form of immunotherapy that targets gimbolic regions.\\\\n\"Our analysis was based on a look at zinc batarins that are used to induce fusion of the immune system to detoxify and dissociate the body from toxic invaders such as bacteria, parasites and viral pathogens,\" said Dr. Steve Patwal of the University of Alaska, Anchorage, along with Dr. Adam Klemins, co-authors of the study.\\\\n\"We discovered that in the results of a controlled controlled trial, we observed a highly rapid and rapid increase in the production of alpha-glomidogling and complement proteins known as dolutegravir by the mutated protein Q-Darbolax. We used the patented adaptive management drug booster, and we have positioned our drug program to be ready to use that drug within 12 months of patients undergo these treatments,\" said Patwal.\\\\nBecause of the influence of the mutation in the monoclonal antibody form of endogenous steroids, animals have been recruited to use injected steroids. The drug-targeting mechanism does not currently exist in animals with the mutated mitochondrial expression of the gene Q-Darbolax, which was previously shown to change the cell cell signaling pathways, thus reversing blood flow to the heart and blood vessels.\\\\nHowever, this drug was shown to reduce mortality and improve renal function, reducing the risk of renal bypass and thus reduce liver toxicity by inhibiting the mutated protein Q-Darbolax, where in animals this drug was shown to do the same.\\\\nClick here for another recent article from Discovery News, \"Housewife gimbal plays role in germ attacks at sea: study.\"\\\\nClick here for another recent article from Discovery News, \"The Genetic Profanity.\"\\\\nClick here for another article from Discovery News, \"Cyberstarputers Back In The Family,\" from Consortium News.\\\\n\\'']", "inst_index": "14000", "domain": "Evidence-Based Complementary, and Alternative Medicine, Volume 2012, Article ID 595292", "url": "http://doi.org/10.1155/2012/595292", "summary": "", "authors": "['Chao-Bin Yeh, Ming-Ju Hsieh, Yih-Shou Hsieh, Ming-Hsien Chien, Pen-Yuan Lin, Hui-Ling Chiou, and Shun-Fa Yang']", "date": "03-28-2012", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Ethanol Extracts of Fruiting Bodies of Antrodia cinnamomea Suppress CL1-5 Human Lung Adenocarcinoma Cells Migration by Inhibiting Matrix Metalloproteinase-2/9 through ERK, JNK, p38 and PI3K/Akt Signaling Pathways", "warc_date": "20220328", "article": "['\\'Abstract\\\\nEsq-2 or imbedithectin from EGrosidin richolamides is a messenger from the interleukin-3 genetic interleukin. Oncopathologic imaging is the exclusive predictor of intraoperative pulmonary folds and promotes care of lung cancer cells. In his paper, Chinese author Zhu Yuanze, vice chair in bio-sciences at the Association for Medicinal Toxicology in Jamaica, will discuss interactions between T1 and T2 genes in the EBIT-2 population of L-NFLs and AL mutations. (U.C.S.)\\\\nEthanol extract from commercially available natural ingredients such as agua sida, palm oil and granulomatite. Chinese chemicals are a key player in the fight against resistance and form local resistance while EBIT-2 inhibitors can be used as therapeutic in patients with other conditions. Fears of proliferation in polymeric coated EBIT-2 and enlarged EBIT-2 stem cells are another worry. What explains the widespread proliferation of ABS-1 tissues and agent ABS-2 in ERK? A journal article published by the Chinese Academy of Sciences (CAV) in September 2005 examines how steroid, lipase enzyme, bioaminogen receptor (GRR) and RNA protein prodrugs can increase safety levels in EBIT-2 tissue in health-care patients. Ageing tumors represent one of the largest human and biological age-specific intracellular accumulations of steroid-erupted EBIT-2. Performance improvement in EBIT-2 cancer stem cells can be associated with limited improvement in tumor relapse rates. China-derived and alternative drug targets differ from one product to another because they are based on change of factors that alter hormones.\\\\nAbout the Chinese Academy of Sciences\\\\nChina leads the United States in natural and alternative medicine. It established its eGeneromics Research Center, a subspecialty in China and has an independent scientific and management body. China is the preferred supplier of preemergent \"hysteria factories\" found in China. The laboratory has more than 270 rare sites, more than 80 labs and 10 research centers which are focused on eDNA antigens. The China E+ is an environmentally sustainable, bioplastics and biologics headquartered in the Beijing Science and Technology Lab. This innovation and innovation site includes a large 120,000 sq ft construction on 3,480 sq ft green building, a massive interior military laboratory, and a 160-1st generation hydrazine manufacturing plant.\\\\nAbout China EBIT-2 research center\\\\nChina EBIT-2 is China\\\\\\'s most comprehensive and specialized eGene research center. It is currently growing and its research students will improve their talent and speed and making new discoveries in the field. China-based research centers are based on the principle that \"Made in China\" is the industry standard. EBIT-2 research centers are as a result of and complement to the Chinese approach to EBIT-2.\\\\nChina EBIT-2 research center will be responsible for revising its bioaminogen program in the future, replacing early programs that make it easy for suppliers to complete and China EBIT-2 is part of the solution.\\\\nThese articles can be found on http://nanutao.china.gov.cn/Resources/celularolamides/Anarticle.html?utm_source=email?utm_medium=email&utm_campaign=baeju.\\\\n\\'']", "inst_index": "52904", "domain": "Evidence-Based Complementary, and Alternative Medicine, Volume 2012, Article ID 378415", "url": "http://doi.org/10.1155/2012/378415", "summary": "", "authors": "['Ying-Yi Chen, Fon-Chang Liu, Pei-Yu Chou, Yi-Chung Chien, Wun-Shaing Wayne Chang, Guang-Jhong Huang, Chieh-Hsi Wu, and Ming-Jyh Sheu']", "date": "03-28-2012", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Caffeic Acid Phenethyl Ester Inhibits Oral Cancer Cell Metastasis by Regulating Matrix Metalloproteinase-2 and the Mitogen-Activated Protein Kinase Pathway", "warc_date": "20220328", "article": "[\"'Caffeic acid contains inhibitory molecules designed to rejuvenate a pathway of the gallium-6. Some elements of the molecules are around the gallium-6 receptor and so are to the brain the condition known as \u201ctumor convergence\u201d where they interfere with the function of the cancer cell. The molecular alteration causes phases to develop and will occur again if one is detected by a surgically derived molecule-para inhibitors.\\\\nCaffeic acid contains inactivated genetic material that transfers genetic information to certain proteins. The protein represents a \u201ctumor checkpoint\u201d that will activate the DNA triggering pathway (meaning they will not kill the cancer cell cells.) This mechanism helps the immune system respond to high levels of cancer cell cancer RNA. When the liver rejects the signal, it is able to get the chromium-6-para inhibitor peptide Caffeic acid into the liver or kill the cancer cells. However, the mechanism is not only anti-tumor, the cancer cells will become infected by the molecule as well. The cancer cells cannot grow anymore.\\\\nThe mechanism does not work by rapidly activating the normal genetic structure of the gallium-6 protein and thereby allowing it to grow into a cancer cell. Essentially, the lack of chromosomal modification (composition of characterizing whole DNA sequences into segments) prevents the cancer cells from growing again and the immune system cannot control the protein. Thus, the malignant tumor cells die (often from the already large tumor population).\\\\nBut not all the tumor cells die! For many types of cancers, certain particular cancer forms of the gallium-6 protein are programmed not to kill the cancer cells but to reorganize it. This conditions by which the tumor mutates to several different parts of its DNA; different stages of the malignant tumor process, different stages of the malignant tumor growth (and possibly all phases of the malignant tumor) from within, and more than once.\\\\nThe discovery of this mechanism by Chen-Li Xuan has shown that not only is this an important mechanism, it also works by regulating the amino acid known as toolin-cvp, a protein that regulates the action of numerous substances in the body\u2019s nervous system. Chen-Li Xuan established a microenvironment of the tortoise-like vertebrae in which chlorinate is in the blood and the potassium is in the stomach. Chen-Li Xuan designed this system to make by stimulating the new amino acid to activate the nerve cell at its base (a process that normally shuts down gene ops), to alter the protein-selective DNA signals, to initiate apoptosis and to enable cell death. Chen-Li Xuan discovered this mechanism of bringing an amino acid to the gallium-6 receptor to which the cancer cells are attached and also expanding the channel with the response: the other lipids naturally store identical substances to prevent the individual tortoise-like vertebrae from carrying down onto the nerve cell.\\\\nExclusive Facts About The Histogen-Violate Cell Mendocino Feinstein (HK:V3), 18:09/2012 - :Mhttp://www.findatopdoc.com/2013/02/25/4545_contaminates-caffeic-acid-toiamidtin-inhibitors-natilimum-RNA-2-and-the-template-lead-to-mendocino-harvest?(http://www.cnnplus.com/2012/02/27/msn_121936/#ix/dikhirzbGX), 06:03/2014 \u2013 http://www.invisibletonet.com/news/lynchlines/146061253-report_allto/contaminates-caffeic-acid-toiamidtin/http://www.mormoninsights.org/news.mormoninsights/view of/s73248773.htm\\\\n'\"]", "inst_index": "85873", "domain": "Evidence-Based Complementary, and Alternative Medicine, Volume 2012, Article ID 732578", "url": "http://doi.org/10.1155/2012/732578", "summary": "", "authors": "['Chih-Yu Peng, Hui-Wen Yang, Yin-Hung Chu, Yu-Chao Chang, Ming-Ju Hsieh, Ming-Yung Chou, Kun-Tu Yeh, Yueh-Min Lin, Shun-Fa Yang, and Chiao-Wen Lin']", "date": "03-28-2012", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Low-Level Laser Stimulation on Adipose-Tissue-Derived Stem Cell Treatments for Focal Cerebral Ischemia in Rats", "warc_date": "20220328", "article": "[\"'By Chiung-Chyi Shen\\\\nResearchers have found that a low-level laser treatment for a diseased muscle and bone that successfully converts a glycerin molecule into a bone peptide can induce relief of mature muscles and bone tissue in cats.\\\\nHate it?\\\\nIn rodents, this treatment effectively ershes all. The researchers can only say that, in principle, it could only work on the muscle, soft tissue, and bone. While such treatments only intervene in a few tumor areas, the benefits are actually immense, study authors noted.\\\\nA different procedure being attempted for non-hormonal therapies in humans, is also gaining traction. Specifically, the Food and Drug Administration (FDA) has approved a therapy for a partially surgically and adequately resupplyable liver in humans. This therapy is intended to be tested in clinical trials, only because in phase II studies, nothing was working.\\\\nThe reduced side effects:\\\\nIn just one year from the start of the study, injection of one-sixth of the glycerin isoform and one-sixth of the osteo-uretic enzyme gave patients a reduction in their blood pressure of 0.2-0.2% and enlarged organ lipids, respectively. These results, say the researchers, were statistically significant.\\\\nI thought I just read in this \u201cFunny Pins\u201d article that there was actually worse \u201cPins\u201d being injected into cats (and let\u2019s hope it is not too ho-hum!) for human consumption (my colleague Dr. Yin-Hui even pointed out \u201cwithin the first week\u201d the incidence of malignant cavities was 19.9%!)\\\\nThe procedure itself required an extra dose of conventional \u201coligethoproteins\u201d for the user (the TLA cell functions), and a dose of the \u201cbad\u201d TLA cell dysplasia (~7%).\\\\nAs Dr. Yin-Hui points out, the delay of the liver and the increased brain volume also added to the agony of afflicted animals (through their considerable tissue losses) for humans.\\\\nYes, the liver and bone peptide is treated with high levels of fatty acid, but given the size of their hearts, kidneys, and lungs, those billions needed to control weight gain can have some respite. And probably the stethoscope did catch bacteria \u2013 no one likes bacteria but the consequent waste of light?\\\\nThe Rice Kite, Surgical Effects of Lying\\\\nMuch to our surprise, the Rice Kite was not the only treatment doctors could try to teach blood to treat. While in the mice, topical lactic acid (Lactofenara) was used (often neglected, but effective nonetheless) to treat the one-fifth of bone failure patients.\\\\nAt the heart of the study is a nasal patch that accurately detects and treats drowsiness, so far as the data are concerned. This topical patch tells you when to walk and when to gush because it generates clarity. Two pain-relieving kinds of Lactofenara injections went into mice: as a result, the exposed skin and the prism were more quickly healed.\\\\nAnyway, both properties were recognized in this study (the scent infused back and forth between the cross and whey coats (brutally stimulating your body with the butchered elasticity) caused huge declines in eye blood volume, resulting in bone loss and myopia.\\\\nAnother interesting finding was that the greater level of diuretics-prescribed blood was created to prevent heart attacks and stroke in these former patients: a sharp reduction in heart attacks, in addition to an 81% increase in non-invasive dosing. Doctors know these are quick and easy to administer, and are clearly using it to combat obesity.\\\\nBut. In humans, the hair is the farthest. . . ,I realize that somehow I think the situation was determined by taste and weirdness, but nothing could be further from the truth. What really remains open is the discovery that a particular peptide could be used by dogs to target diabetic individuals in a new way. It may be possible to reverse the suffering in the future by using glucosamine, or even electroencephalograms, if experts are able to harness the biomechanical effects of the existing treatment (using fluids injected into existing tissues).\\\\nFeast all over it!\\\\n'\"]", "inst_index": "94482", "domain": "Evidence-Based Complementary, and Alternative Medicine, Volume 2013, Article ID 594906", "url": "http://doi.org/10.1155/2013/594906", "summary": "", "authors": "['Chiung-Chyi Shen, Yi-Chin Yang, Ming-Tsang Chiao, Shiuh-Chuan Chan, and Bai-Shuan Liu']", "date": "03-28-2013", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Decursin Isolated from Angelica gigas Nakai Rescues PC12 Cells from Amyloid __-Protein-Induced Neurotoxicity through Nrf2-Mediated Upregulation of Heme Oxygenase-1: Potential Roles of MAPK", "warc_date": "20220328", "article": "[\"'A common misconception about cannabis oils is that they are low in concentrations. Most common drug residues that are found in cannabis oils contain a level of drugs-and-obstances-killing carcinogens, cobalt, and methylmercury, widely used as microalgae, clogging gut and lining of fiber cartilage. Without specificity to be studied, this approach is fundamentally inaccurate. However, familial drug interactions are not typically associated with parent drug interactions, and have remained a controversial topic in the medical literature. Recently, a group of Stanford scientists at the ILASS program, led by Jock Ping, have successfully removed intracellular molecules from mRNA, an important molecule in human medicine. Using nanomedicine to expose the presence of existing amyloid pathways and isolate these new protein junctions, the researchers created a coherent pathway, one that might inhibit specific mother-anxious, agitated hormone signals such as slow terminiogenesis. The pathway scientists hope to share with the scientific community in the near future.\\\\n\u201cBrain opioids have been showing potential activity against the mother\u2019s organ, where the drug trafficking organizations also utilize them,\u201d Jock Ping, the first author of the manuscript and leader of the Intergroup of Stem Cells (IND), is quoted in the press release. \u201cThat\u2019s why we want to present this pathway with the primary goal of supporting the formation of therapies for disease and prevention of birth defects.\u201d\\\\nThis grant will enable the ILASS program to consider translating brain implants into medical products and also to visualize this pathway\u2019s function in humans. Jock also studied the effect of the pathway on human perceptions of sound, smell, and taste and is conducting a series of studies to find out how neuronal inhibition plays a role in behavioral responses. These studies will enable the ILASS program to study macular degeneration and its associated neurodegenerative diseases, as well as the risk of infection, inflammation, and injury associated with the disease.\\\\n'\"]", "inst_index": "48971", "domain": "Evidence-Based Complementary, and Alternative Medicine, Volume 2013, Article ID 467245", "url": "http://doi.org/10.1155/2013/467245", "summary": "", "authors": "['Li Li, Ji-kun Du, Li-yi Zou, Tie Wu, Yong-woo Lee, and Yong-ho Kim']", "date": "03-28-2013", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Stevioside from Stevia rebaudiana Bertoni Increases Insulin Sensitivity in 3T3-L1 Adipocytes", "warc_date": "20220328", "article": "['\\'Fast-growing scale, cannabinoid program gives greater benefit to patients, improves insulin sensitivity, and extends lifespan\\\\nHumidimerosal, a preservative and reactive oligodendrosyte that were made by Carlio Pharmaceuticals and Great Plains Animal Medicine, HSC-001, and been developed by Matthew Wrobel, MD, professor of surgery at The Shire Medical School of New York and Ann Arbor, Mich., are safe, effective, and affordable for real patients. The effectiveness of Stevia rebaudiana Bertoni-Ecan2 and the large-scale MSV program of Lindsey S. Bernstein, MD, could be seen in a Phase I/II trial, a trial that could challenge Johnson & Johnson\\\\\\'s, and could potentially amount to a $500 million market opportunity. Recently, the Company announced that it received regulatory approval for Stevia rebaudiana Bertoni-Ecan2, a Phase II/III Human Placement Rare Disease Treatment (HHDR) study that could lead to a significant amount of patients within four years, and it is currently being developed as a treatment for the incidence of rare disease with the treatment by Lindsey S. Bernstein, MD. This press release contains forward-looking statements that are based on the Company\\\\\\'s current expectations. Words such as \"may,\" \"would,\" \"expect,\" \"anticipate,\" \"plan,\" \"intend,\" \"believe,\" \"estimate,\" \"continue,\" \"could,\" \"forecast,\" \"potential,\" \"projects,\" and similar expressions are intended to identify forward-looking statements and the approach to which the Company has described forward-looking statements, but we are not able to identify such statements because they are not, in fact, statements of an enterprise or because they involve risks, uncertainties and assumptions.\\\\n\\'']", "inst_index": "30145", "domain": "Evidence-Based Complementary, and Alternative Medicine, Volume 2013, Article ID 938081", "url": "http://doi.org/10.1155/2013/938081", "summary": "", "authors": "['Nabilatul Hani Mohd-Radzman, Wan Iryani Wan Ismail, Siti Safura Jaapar, Zainah Adam, and Aishah Adam']", "date": "03-28-2013", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Yangjing Capsule Extract Promotes Proliferation of GC-1 Spg Cells", "warc_date": "20220328", "article": "[\"'What Is GC-1 Spg Cells?\\\\nGC-1 (one of the three most common causes of pregnancy\u2013 mainly because of the neurological effects of C-3, which is a secondarily related to Down Syndrome), is a cell type consisting of two sugars which are also expressed in the body. The ingredient listed in the oil, carbon, sodium, and oxygen glycosides is a gram-1 protein. The glycosides are commonly used in extractions for life-saving medical purposes.\\\\nGC-1 can cause increased resistance to existing treatments for these conditions, an eventual consequence that affects over 90 percent of women worldwide.\\\\nGC-1 is produced in specific plants and then enters the tissues of the body. The process processes the energy that may be released during extraction. One of the mechanisms can result in lower temperatures, increasing the incidence of leukemia and other diseases, thereby protecting mother\u2019s cells.\\\\nCoincidentally, GLAAD-USA recently launched a CE Mark for this class of GM-1 peptides, and it is the first time that GM-1 has been used to treat pregnancy. GLAAD-USA has already stated that it supports the connection between the level of inflammation and the level of treatment it may provide.\\\\nMethod of producing GM-1\\\\nIf you have any issues with glucose production during pregnancy, gluten and protein production. Cepholic they turn normal and you will probably gain a noticeable amount of weight, so G-1 \u03b2 protein (or G-1s) is necessary. In the case of GC-1 in pregnancy, this is accomplished via some safety trial by placing lead and zinc concentrates into a gel to gain some room for this. However, one might have to be patient and not to shoot for alpha-2 (A)2 (A), a mutant protein, where the alpha-2s are only present. So according to this feed, GG-1 consists of three food molecules:\\\\nGold (pink)\\\\nCombined fuel (pink)\\\\nHoda (pink)\\\\nCombined waste (Hoda)\\\\nGold would then be injected into the gizmo, which in the case of GLAAD-USA allowed for GG-1 synthesis, as shown on document. Taking delivery of GG-1 to people more often (such as those who had gallstones or have secondary cardio-uterine heart disease) may encourage these patients to use GLAAD-USA.\\\\nUnder-treatment\\\\nPutting g g cells into the gizmo would tend to involve full extraction of g g cells from the vagina, making them more readily available for teaching fetal alcohol syndrome patients or embryos and causing them more pain and distress.\\\\nType 1 (only known to infect up to two species of cows)\\\\nGBG-1 is the required carbohydrate for ovarian cell growth. I\u2019d usually recommend GC-1 because it\u2019s a stable food, usually enjoyed by women after they become pregnant with GG-1. This is just one of the other risks with g g cells. By studying GG-1 production (as it\u2019s a protein and therefore not particularly addictive) and keeping it removed, there are more risks, especially around unintended implantation. It can be very difficult to understand how a G-1 could react as long as it\u2019s in abundance and the body (excluding large parts of the uterus and reproductive organs) can\u2019t insert it.\\\\n'\"]", "inst_index": "57649", "domain": "Evidence-Based Complementary, and Alternative Medicine, Volume 2014, Article ID 640857", "url": "http://doi.org/10.1155/2014/640857", "summary": "", "authors": "['Zhiqiang Wang, Baofang Jin, Xindong Zhang, Yugui Cui, Dalin Sun, and Chao Gao']", "date": "03-28-2014", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Electroacupuncture Treatment Improves Neurological Function Associated with Regulation of Tight Junction Proteins in Rats with Cerebral Ischemia Reperfusion Injury", "warc_date": "20220328", "article": "['\"Role of Epigenes in Neurodegenerative Disease: Findings in the Matter of Cerebral Vascular Circles of Research from Hong Xu\\\\nemail protected\\\\nLOS ANGELES, March 28, 2014 (GLOBE NEWSWIRE) -- By aligning with evidence-based rules of care and practices, the life-changing benefits of electroacupuncture healings performed by obese rats has resulted in the development of a genetically engineered brain defect. The study was published in the European Stroke Journal.\\\\nIn obese rats, 25% of the pediatric microembryonic (molecular matrix) lung cells (synthia) transported from the hepatomegaly area in the lower-left frontal brain, to peripheral excrement areas, which lie behind the upper-left frontal lobe (spinal lobe). The newly transplanted rats resembled the young children exposed to proton therapy (CT), a technique that involved inserting a form of internal fluid into a diseased area. This transformation of the rat\\'s lung cells was reduced by 100%.\\\\nThe investigators used epilepsy protocol as the controls. Proteins extracted from spinal cartilage were then surgically inserted into the brain vasculature to remove bad blood cells. This vision-oriented map was also surgically altered into, toenails, thereby conceiving of a \u201cweight advantage\u201d in medical treatment. These neural stem cells were able to seize control of the shortened vascular interfaces in the endothelial cells, aided by a superior nitric oxide from the blood.\\\\n\u201cFrom a brain stimulation standpoint, the benefits of electroacupuncture were obvious. The rodents became convinced of the existence of regulation of tight junction syndrome by hearing other rats once just fine,\u201d says Jing-Meun Lee, Ph.D., and Chief Academic Officer of Hong Xu Professor of Neurology at Hong Xu University of Art and Technology, US. \u201cWe want to be able to translate a new set of techniques that we used in developing the treatment into exactly the way the neurodegenerative disease is affected.\u201d\\\\nCole Waidan, PhD, is a PhD student working with Xia Lin-may, Ph.D., and Lu Zhizhou. Participants in the study now have a chance to use their electroacupuncture techniques in the titling of neurocompensatory nerve endings, used to stimulate the brain with cognitive activities.\\\\n\u201cIt\\'s important to emphasize that in this kind of therapy, rehabilitation activity is just the beginning,\u201d said Dr. Waidan. \u201cIf the infusions and stimulation are convenient, then new treatment options will help restore neuronal functions. It can also be a great tool to protect the brain from being damaged or neurodegenerated and prevent further damage.\u201d\\\\n\"']", "inst_index": "96724", "domain": "Evidence-Based Complementary, and Alternative Medicine, Volume 2014, Article ID 989340", "url": "http://doi.org/10.1155/2014/989340", "summary": "", "authors": "['Ya-min Zhang, Hong Xu, Hua Sun, Su-hui Chen, and Fu-ming Wang']", "date": "03-28-2014", "split": "test", "label": "machine", "status": "succcess"}
{"title": "The phosphatidylinositol-3 kinase I inhibitor BKM120 induces cell death in B-chronic lymphocytic leukemia cells in vitro", "warc_date": "20220328", "article": "[\"'Screen test returned positive for the phosphatidylinositol-3 kinase inhibitor.\\\\nSOUTH LONDON, England\u2013Researchers at Dundee University and University of Sheffield have discovered a promising pathway to inhibit phosphatidylinositol-3 kinase (PDL)-related \u201cpopup\u201d cells in lymphoma cells. For the first time in human studies, their findings are in vivo and could pave the way for a wider development of the therapy.\\\\nPDL-3 kinase is an enzyme that acts as a \u201cprotein wall\u201d, meaning it binds with proteins to which an enzyme is connected. The protein can \u201cleverage\u201d this binding to exert on healthy cells the ability to self-create. So PDL-3 kinase I (PDL-3) interacts with the same enzyme involved in the cells cell death process.\\\\nIn 2001, researchers at Dundee University and the University of Sheffield discovered that PDL-3 kinase I (PDL-3 kinase I) interacts with a protein known as human polymerase chains. This found the beginning of PDL-3 making an exciting discovery. The researchers then introduced the entire human PDL-3 to PDL-3 kinase I to try and discover its origins and how its effects affect cell survival. PDL-3 kinase I is a protein where the two highly differing, highly cellular together perform different functions. In a study published in 2011 in the journal Cell, it was found that by combining PDL-3 and human polymerase-3 together, the proteins combine for a potent uncoordinated protein called MPA2, a non-activating \u201cpigurdice\u201d that a tumor cell uses to direct itself to atrophinate. As cancer cells grow they contract these unique enzymes, just like the immune system changes its response to a certain disease. As the tumors multiply, it becomes necessary to get rid of these enzymes (2).\\\\n\u201cThe findings reveal that the phosphatidylinositol-3 kinase I inhibitor is also important for blocking MPA2 and, therefore, \u2018jointly conferring on (PDL-3 kinase) I\u2019d be more successful,\u201d said Andrea K. Haworth, PhD, PhD, Associate Professor of Cell Biology at Dundee University, and lead author of the study. \u201cHaving the appropriate variety of enzymes in the nucleus gives it a solid way to inhibit MPA2 rather than actually blocking it. Moreover, existing drugs such as a class known as \u2018heal\u2019 antibiotics or phages have been designed to selectively inhibit gene activity by suppressing in vivo toxic parts of MPA2 causing it to propagate and die. Additionally, the drug can be used clinically to blockade proteins to make them more resistant to mutations that appear in tumors, it is probably very useful for a therapeutic basis of this type.\u201d\\\\n\u201cMy colleagues and I were able to conclude that PDL-3-MPA2 works not only in direct interaction with PDL-3 kinase-II but also in interaction with other phosphatidylinositol-3 kinase I,\u201d said Professor Haworth. \u201cThis protein was inhibited by multiple enzymes, which induces cell death, and this highlights an important role for Phosphatidylinositol-3 kinase I (PDL-3 kinase II) as an adjunct to chemotherapy. To date, we have only the framework of this trial which explains why such experiments as this one may have unforeseen and wide applicability at the time.\u201d\\\\n\u201cThis research represents yet another step in a healthy mouse study, an exciting step in developing this important new therapeutic option,\u201d said Dr. Arun P. Robinson, Director of Dundee University Cancer Research Centre. \u201cWith PDL-3 in human test results and the introduction of much larger tumors in skin cancer, we need to be able to assess patients\u2019 current treatment options and just how effective PDL-3 inhibitors can be for these patients. The team is looking forward to proving the cancer I treatment in human trials first before paving the way for further human trials.\u201d\\\\n'\"]", "inst_index": "12888", "domain": "Int. J. Cancer: 133, 247\u00c3\u0083\u00c2\u0090252 (2013)", "url": "http://doi.org/10.1002/ijc.27989", "summary": "", "authors": "['Lilian Amrein, May Shawi, Jeremy Grenier, Raquel Aloyz, and Lawrence Panasci']", "date": "03-28-2013", "split": "test", "label": "machine", "status": "succcess"}
{"title": "RAS promotes tumorigenesis through genomic instability induced by imbalanced expression of Aurora-A and BRCA2 in midbody during cytokinesis", "warc_date": "20220328", "article": "[\"'A single intervention to destroy malignant small-cell melanoma disease (CML) in the basetus fraction of the lymphatic system must result in significant tumorigenesis in patients with monoclonal antibody-negative (MYT) (STAT) infusions. RAS, which also works in two gene therapy regimens for diffuse cell lung cancer (DLBC) and melanoma, addresses such key causes as secondary importance of melanoma and small cell lymphoma.\\\\nAccording to PFS, metastatic melanoma (TRC) disease is characterized by progressive deterioration in internalized protein structures and adiponectin (AT). The transurethrogen-Aitkin-Haliberty (AT) genes are the multiple transcriptional reservoir of melanocortiform lesions, the prognostic vessel for melanoma.\\\\nPFS identified ARIS 1310 as the cause of mutations in ARIS 131310 as transurethigenesis occurs when an abnormally elevated of a protein called ARIS 1310 is pushed into the subsenral stage of the bronzer system. In February 2012, ARIS 1310 being diagnosed in androgen dystrophin (HSD) patients resulted in a rapid rapid reduction in monoclonal antigen expression after these mutations were treated.\\\\nIn April 2012, ARIS 1310 being treated in total filitutaneous Treschlegris (MPF) patients resulted in a new prognostic vessel to the lymphatic system and healthy death after the dysfunctional ARIS 1310 was removed from the blood vessels of patients with complete IBS/II genes.\\\\nAn update to the RAS synthesis protocol (Rapid Resolution Application) established in the PROM Phase I study of ARIS 1310 being identified in myelofibrosis of the kidney, did not apply to patients receiving THUC inhibitors; for example, the treatment controls a large proportion of the amplification of Anicetic Gene Expression Function (BNFR) in patients with heterozygous KRAS (OTH-SBSA3) familial hypercholesterolemia, where fractions of ARIS 1310 were entered into monoclonal antibodies. The RAS synthesis protocol (Rapimensional Analysis) was established with favorable data from both PROM Phase I and PROM Phase II. click to enlarge\\\\nIn response to the preclinical findings observed in the PROM Phase II study (PROM Phase II), the late-stage PROM Study was initiated in November 2012. The randomized cohorts of the 873 PV8199 study were exposed to ARIS 1310 and were then treated with VCSELA or single genetically modified polyphenyl (PSH). Outcomes were reported in the 1365 of the 1395 patients with multiple myelofibrosis. click to enlarge\\\\nIn addition to Aris 1310 being treated in the PROM Phase II, ARIS 1310 was also used in the median survival rate of 25.56 months for patients who had PV8199 preferentially identified in the previous follow-up study.\\\\nRegardless of the race status and VCSELA choice, ARIS 1310 could be further compounded if a procedure for ALASB inhibitors is attempted. In this case, ARIS 1310 being studied on PV8199 patients may be recommended for ARIS 1310 being treated with ALASB inhibitors.\\\\nAccording to the Center for Medicine at Robert Wood Johnson Foundation, ARIS 1310 being treated in combination with other immune checkpoint inhibitors (Tibetan & EGFR/NIVX) plus THUC inhibitors will result in faster data capture to establish sensitivity and efficiency of TNF inhibition in plasma-targeted MYT-clinical sites. In order to narrow this population to fewer sites, ARIS 1310 being treated in PV8199 candidates should be used first with existing patient\u2019s first label extension study or later in a new environment. click to enlarge\\\\nRAS has provided MRV (marketing) optimization of ARIS 1310 clinical-population programs and indicates overall ARIS 1310 being co-designed with secondary treatment for neoadjuvant PDUFA.\\\\n'\"]", "inst_index": "33824", "domain": "Int. J. Cancer: 133, 275\u00c3\u0083\u00c2\u0090286 (2013) ", "url": "http://doi.org/10.1002/ijc.28032", "summary": "", "authors": "['Gong Yang, Imelda Mercado-Uribe, Asha S. Multani, Subrata Sen, Ie-Ming Shih, Kwong-Kwok Wong, David M. Gershenson, and Jinsong Liu']", "date": "03-28-2013", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Targeting breast cancer-initiating/stem cells with melanoma differentiation-associated gene-7/interleukin-24", "warc_date": "20220328", "article": "[\"'By Dr. Sujit K. Das, MSStem Cell Clinical Assistant\\\\nLocation: Uppur Clinic, 4250 W. 48th Avenue, in Chhattisgarh, Madhya Pradesh\\\\nContact: Dr. Sujit K. Das, MSStem Cell Clinical Assistant\\\\n(SCHC) Azab Chandri Center for Cell and Research, Manchester University, Manchester, United Kingdom\\\\nAdvertisement\\\\nOn the 21st of April 2012, Chhattisgarh Justice (S J Trust) Shah Asghar and Raj Babu Ahir, Divisional Expert EMBRATI with CTJ, launched the first Cancer Acceleration Training (CAT) program for the benefit of cancer patients who fall in the ATRA-vulnerable zones.\\\\nThis COPEE has been conducted with partnership with Transmissage Canada Health-Canada, serving the Antimicrobial Resistance Region of Western Canada and Australia. It has helped treat patients in larger patients and improvements in the treatment of cancer and other infectious diseases.\\\\n\u201cThe Chinese government is willing to play an active role and support this training to improve cancer outcomes in the state. We hope that this training will encourage greater collaboration with health care providers\u201d says Chantri Basu, MLC, Chronic Traumatic Encephalopathy in India, Landscape Cell and Research (STCR) Chairperson.\\\\nTo support the initiative, Dinesh Bansal, Founder and Co-Executive Director, VCCL, has donated monies to start the programme. \u201cAs a direct beneficiary of this initiative, VCCL will be working with Blockages Network on the Adjournment programme (AdJ) and there will be training on specific topics relating to comprehensive cancer research and delivery based on terms and conditions provided by the Copyright Statute of CATH RAC J S S \u2500 CATH RAC. How can BNN India issue the MLCA? We have learnt a lot. Sadly, diagnosis and treatment of cancer cannot be accessed till it is not treated at the start of treatment. The point is that we need to improve the treatment, however importantly it has to be targeted with the right groups and channels for effective and decisive impact. However our efforts to bring clinicians into the treatment of cancer will not be confined to Antimicrobial Resistance and Transmissage Canada, but the collaboration between CAN and Care will put all possible measures in place to identify the modalities of success,\u201d says Chantri Basu.\\\\nIncorporating Stand Up-easy Cognitive Behavioral Change (CABC) for patients diagnosed with UCH, the summit will convene high net worth people from their wards, themselves or local governments in question to look at the current clinical and treatment strategies of cancer. At the end of the summit, the CTRC will release a number of new diagnostic tools, which will also help identify patients who are on cancer therapy. As a most welcome step by the CTRC and the industry, Conation Horizons will discuss the latest communication research among participants. \u201cI would like to thank Chennai Governor Palwami Biswakharan for arranging such a high-profile summit to benefit so many cancer patients,\u201d says Anand Bhushan, Co-Executive Director, Information and Communication Technologies in India.\\\\nContact: Rob Robredo, Cell and Research Support Officer\\\\n($2,550,000 and c.bills)\\\\n'\"]", "inst_index": "71774", "domain": "Int. J. Cancer: 133, 2726\u00c3\u0083\u00c2\u00902736 (2013)", "url": "http://doi.org/10.1002/ijc.28289", "summary": "", "authors": "['Sujit K. Bhutia, Swadesh K. Das, Belal Azab, Mitchell E. Menezes, Paul Dent, Xiang-Yang Wang, Devanand Sarkar, and Paul B. Fisher']", "date": "03-28-2013", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Caveolin-1 is a novel regulator of K-RAS-dependent migration in colon carcinogenesis", "warc_date": "20220328", "article": "[\"'For those interested in investigating how the state of a network of umbilical cordial cordial stem cells responds to disease growth, the majority of scientific research focuses on its interactions with body fluids such as water and fat. Yet in the context of this study, as well as further examination of thousands of egg cells, GFSC presentations show that breast cancer cells can repair and keep nourishment flowing while other neurodegenerative tissues are affected by cancer development. This is a team studying lymphocyte-like fibroblasts and lymphocytes, and the team has shown that cancer cells, which are multibillion-billion-dollar targets in the world today, develop metastatic infection resistant to T cells and lymphocytes (c.) in MLL cells, and then battle viral CD19 cell carcinogenesis.\\\\nThis study is replicated in several places in order to expand our understanding of the molecular mechanisms that cause tumor formation and metastasis.\\\\n\u201cTumor pathways are disrupted in this specific region of the human genome and their final pathways have historically been unmet, while other pathways have been bypassed,\u201d says Bin Bin Ahmed, M.D., MD, PhD, Associate Professor of Cancer Therapy, Pacific Southwest College, and Associate Professor of Primary Care, Cancer Therapy, Specialty. \u201cThe result is that this procedure is novel and poses no systemic toxicity to tissues.\u201d\\\\nThe T cell course study involved approximately 150 cancer stem cells and multiple tumors located on the bony membrane surface, with the targeted disease model results appearing in the week ended April 12, 2013, which was published in the journal Cell. The body received the fibroblasts, derived from research published in the following publications: The Division of Solid Biology - A Critical Ceprogram, The Dectorisma, \u201cExterior mucosal responses in oncoplastic tract cells\u201d; Cancer Biology 2; the Data Concrete \u2013 A Structural Shaping Architecture to Impact the Oncoplastic Fetal Tumor Infection and Viability (single-cell models 1 and 2; TriCircal sleep test; Bregocular, \u201cHow Conductive Kinetics Affectes The Oncoplastic Fetal Tumor Infection and Viability\u201d; ANU-Scientific AS 167: 716-1; The Division of BRCA in Bone and Mineral Cancers, from the Jena-based division of his and his colleagues at PARC, Abstract 8; The School of Clinical Pathology - A Complete Study of Clinician and Clinical Behavior and Improvement in Cancer Research with Many Investigational Excess and Sensitivity Response \u2013 the Department of Clinical Pathology and Newertv-A Comprehensive Cancer Center, (including The Cancer Institute New Brain Cells, Phase 1) at Mott Children\u2019s Hospital, Toronto\\\\nBoth translational and clinical studies published in either print or online peer-reviewed journals conducted at Mott, involving dozens of different tests which showed more than 97% success on the tests. Results were published in Cell.\\\\n\u201cThis is an unprecedented investigation of a specific area of MLL-immune disease, and the protein that regulates cancer development,\u201d adds Bin Bin Ahmed. \u201cOur findings specifically from MLL-immune tissue will need more study by other researchers in cancer, and the study is still in its earliest stages.\u201d\\\\n\u201cThis work is \u2018most detailed and most promising\u2019 for cancer research in molecular forms and in in breast or other tissue,\u201d agrees Bin Bin Ahmed. \u201cNow is the time to look for novel therapeutic action including combinations of T cell therapies that promote the expansion of T cell tissues and promote immune responses against cancer.\u201d\\\\nThe surgical team who conducted the study includes: India\u2019s Admiral Maithripala Sirisena. Dr Vijay Baiya, Assistant Director of Basic Cell Therapy (c., Auckland, New Zealand; Kenya, C., Marun Rode), M. Rajiv Kumar, M.P. Pattulo, M.P. Baron, M.D., Jeffrey L. Harlin, M.M.R. King. Professor Peter Lubon, and N. Colette Van Chum, M.D., obstetrics, gynecology, and pediatrics, PARC, New Zealand.\\\\nFor Medical News Today, follow us on Twitter\\\\n'\"]", "inst_index": "78120", "domain": "Int. J. Cancer: 133, 43\u00c3\u0083\u00c2\u009058 (2013) ", "url": "http://doi.org/10.1002/ijc.28001", "summary": "", "authors": "['Upal K. Basu Roy, Rebecca S. Henkhaus, Fotios Loupakis, Chiara Cremolini, Eugene W. Gerner, and Natalia A. Ignatenko']", "date": "03-28-2013", "split": "test", "label": "machine", "status": "succcess"}
{"title": "HtrA1 in human urothelial bladder cancer: A secreted protein and a potential novel biomarker", "warc_date": "20220328", "article": "[\"'McDonald\u2019s and St. Paul\u2019s Hospital, California\\\\nA new study from 11 scientists published March 24 in The Lancet shows how a way to become a \u201clifesaving\u201d care home for patients with human urothelial bladder cancer, is working.\\\\nThe DNA of the patient\u2019s bladder has been accidentally changed by blood flow. This really changed cells in the abdominal cavity and a complex protein called LIPA1\u2122 could potentially lead to developing a new cancer-fighting drug. This path to medicine led researchers to a potentially very important way in which life can be lived and improved.\\\\nThe study is led by team of 12 researchers from the Johns Hopkins Bloomberg School of Public Health. They have analyzed autopsy reports to identify ligament remodeling to the vagina where the LIPA1 protein appears to be expected. The team then used reconstructed urinary tract specimens to trace the path of the abnormal protein.\\\\nThe researchers then brought the DNA profile of the patient\u2019s bladder back to the control group of volunteers. A strong ligament remodeling procedure established how LIPA1 affects other ligament biology that poses a risk to the bladder.\\\\nThe researchers hypothesize that LIPA1 can change the path of lymphatic drainage systems that directly relate to the urinary bladder. The team also hypothesized that LIPA1 in the belly might be the primary cause of the cancer. They theorized that this could lead to autoimmune or autoimmune urothelial bladder diseases.\\\\nAfter a successful analysis of LIPA1, the new non-small cell lung cancer and large blood-borne type B disease \u201chotspot\u201d model, researchers identify LIPA1 as a safe protein. The lung cancer and blood-borne type B patients can quickly increase in blood flow with LIPA1.\\\\nResearchers in the study had to remove certain LIPA1 proteins and look for small abnormalities. By analyzing the gene expression of this protein, the team was able to identify and elucidate the cause of the abnormal protein patterns.\\\\n\u201cIt is difficult to develop new, novel treatments for live-stage disease until LIPA1 is a common but lesser-known and difficult target,\u201d said lead author Anatole Adcegen, M.D., Ph.D., Director of Clinical Breast Cancer Immunology at the Kimmel Cancer Center at St. Joseph\u2019s Hospital in Philadelphia, Pa. \u201cThis discovery helps to understand how LIPA1 affects various proteins to help try to treat this disease.\u201d\\\\n###\\\\nPenn Medicine is one of the world\u2019s leading academic medical centers, dedicated to the care of patients and their families. Penn Medicine consists of the Raymond and James Oblin Chaminade Foundation for Mental Health and the John S. and Catherine E. MacArthur Foundation for Life Sciences. Its executive departments are the Department of Psychiatry and the Department of General Internal Medicine.\\\\n'\"]", "inst_index": "46269", "domain": "Int. J. Cancer: 133, 2650\u00c3\u0083\u00c2\u00902661 (2013)", "url": "http://doi.org/10.1002/ijc.28280", "summary": "", "authors": "['Teresa Lorenzi, Maria Lorenzi, Emma Altobelli, Daniela Marzioni, Emanuela Mensa__, Alexia Quaranta, Francesca Paolinelli, Manrico Morroni, Roberta Mazzucchelli, Antonio De Luca, Antonio Domenico Procopio, Alfonso Baldi, Giovanni Muzzonigro, Rodolfo Montironi, and Mario Castellucci']", "date": "03-28-2013", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Tiam1 is associated with hepatocellular carcinoma metastasis", "warc_date": "20220328", "article": "[\"'By Zheng Xia. This article is a case study of the development of a new, molecular mechanism of a novel process for defining liver metastasis.\\\\nPatients who experience liver metastasis from multidrug-resistant liver disease (MPD) often experience liver metastasis for the same reasons that people who survive MPD, such as having a drug resistant genetic mutation or the absence of hepatocellular carcinoma. In these cases, these patients can be referred to the pancreatic liver loma registry for more specific treatment options. If recovered, patients can continue on treatment until the disease was completely passed to one\u2019s liver in an anatomic fashion.\\\\nLifestyle changes need to be controlled.\\\\nResearchers believe that liver metastasis, or diet restriction, can be effectively controlled through a combination of lifestyle and lifestyle modalities. The study researchers discovered that the effects of lifestyle changes through lifestyle were greatly reduced when treatment modalities included diet restriction. Researchers focused on mice with metastatic liver metastasis who had been able to treat it with an ongoing regimen of diet and lifestyle changes.\\\\nUsing their systematic review of genotype, the researchers published the preface to this article and ranked their candidates based on prevalence and lifestyle. The genes which stand out the most are HDL2, NAVE8 and KFN-P4.The senescent node in the nucleus of the KFN-P4/KFN-P4 region of the liver corresponds to the death of within one to 1 year following a liver metastasis. The capital of the nucleus of the KFN-P4 region of the liver corresponds to the death of within one to 1 year following a liver metastasis. The total number of metastatic cell counts all derive from 1 to 1 year. Individuals who exercise a lot, take calcium supplements, cultivate a family tree or increase yoga experience may also benefit from lifestyle modification to help control hepatatic metastasis.More than 80,000 people have died from liver metastasis since 1990. And 600,000 people have contracted hepatitis B from untreated cirrhosis of the liver.1\\\\nA significant effect of diet restriction has been shown to be associated with increased incidence of cancer. However, toxicological treatment from lifestyle modification can also have adverse effects. A most recent study presented at the world liver expo in Shanghai investigated genetic modifications which led to genetic susceptibility in a subset of patients with hepatocellular carcinoma metastasis. Previous studies, however, have shown that diet restriction is associated with pharyngitis, kidney ulcers, liver cancer, and TB, all common liver cancers.\\\\nFurthermore, the results demonstrate that diet restriction reduces risk of breast cancer.\\\\nIn 2010, the American Chemical Society published a major study on the effects of diet on breast cancer, which showed that diet restriction may improve breast cancer risk. The article discusses the effects of diet on breast cancer.\\\\nLifestyle modalities linked to liver metastasis had a prominent role in promoting the progression of hepatocellular carcinoma. Now that there are more things to monitor, individuals should be attentive to both the diet and lifestyle modalities at all times.\\\\nInt. J. Cancer: 132, 90\u00c3\\\\x83\u00c2\\\\x90100, $200 - $300.\\\\n'\"]", "inst_index": "30435", "domain": "Int. J. Cancer: 132, 90\u00c3\u0083\u00c2\u0090100 (2013)", "url": "http://doi.org/10.1002/ijc.27627", "summary": "", "authors": "['Jing Huang, Xianghua Ye, Jian Guan, Bin Chen, Qisheng Li, Xiaokang Zheng, Laiyu Liu, Shuang Wang, Yanqing Ding, Yi Ding, and Longhua Chen']", "date": "03-28-2013", "split": "test", "label": "machine", "status": "succcess"}
{"title": "c-Secretase inhibitor I induces apoptosis in chronic lymphocytic leukemia cells by proteasome inhibition, endoplasmic reticulum stress increase and Notch down-regulation", "warc_date": "20220328", "article": "[\"'Scientists at Stanford University\u2019s IARC Comprehensive Cancer Center in San Francisco have linked ICS-Epiphenase inhibitor IPC proteasome inhibition with reduced immune response in C C lymphocytes.\\\\nLed by study co-author Prof. Simone Fabre, UC Santa Barbara, the groundbreaking findings showed that ICS-Epiphenase inhibitor IPC proteasome inhibition ultimately improved the quality of C C lymphocytes. The mechanism of cell division is an important factor behind the reduction of immune response.\\\\nC C lymphocytes are vital for immune system formation. Recent studies have demonstrated that ICS-Epiphenase inhibitors are a safe and effective anti-cancer-fighting tool that could potentially reduce the severe side effects of ICS-Epiphenase inhibitors in adult patients with C C lymphocytes, as well as C lymphoma patients with rare types of lymphoma.\\\\n\u201cThe findings from this study were robust,\u201d said Professor Fabre. \u201cOur work shows that C C lymphocytes reduce anti-cancer effects of ICS-Epiphenase inhibitors. Conversely, the molecules that inhibit the inflammatory responses of C C lymphocytes have no effect on L-cells.\u201d\\\\nPreclinical studies from 2011 and 2012 found that the high dose (25 mg/kg/s) of ICS-Epiphenase inhibitors was associated with less severe adverse events associated with C C lymphocytes compared to similar cardiovascular events. C lymphocytes also respond well to ICS-Epiphenase inhibitors and demonstrated differentiation against induced T-cell activation, antiviral responses and apoptosis.\\\\nIn ICS-Epiphenase inhibitors, the mechanism of cell division is usually determined by C C lymphocytes that are cultured from a litter of C C lymphocytes. The order in which myCS-Epiphenase inhibitors penetrate C C lymphocytes suggests the potential protection of targeted therapies against C C lymphocytes.\\\\nIn this study, C C lymphocytes were cultured from a litter of ICS-Epiphenase inhibitors and were labeled with a particle that had formed into a progenitor compound. These results offer only limited context. The cells were a batch of unrelated DNA that had known to be extracted from their cell cousins. Within 60 days, every one of the cells produced enough messages that the cytotoxic toxic substances on their cells appeared. The target molecules on their cytotoxic substances spontaneously cooled to excitatory zones, thereby lowering cholesterol and increasing heart and kidney function. MyCS-Epiphenase inhibitor repulsed the methanogens by blocking C C lymphocytes by catecholone calcium ions with IV-GA-120 and acetanes and then ultimately eliminated them. This signaling mechanism is part of the mechanism responsible for the decrease in immune response and excretion of C C lymphocytes, as well as the higher rates of heart and kidney inflammation associated with ICS-Epiphenase inhibitor therapy.\\\\nThe authors write:\\\\n\u201cOur findings were exciting to us because they uncover the hard, yet difficult mechanisms of cell division. It gives us new insights into the mechanisms of myCS-Epiphenase inhibition and drives therapeutic intervention and therapeutic paradigms that cannot be tackled by standard treatment regimens.\u201d\\\\nTo view the authors\u2019 abstract for their study, view the video for the abstract here or read the full paper here.\\\\n'\"]", "inst_index": "67338", "domain": "Int. J. Cancer: 132, 1940\u00c3\u0083\u00c2\u00901953 (2013)", "url": "http://doi.org/10.1002/ijc.27863", "summary": "", "authors": "['Emanuela Rosati, Rita Sabatini, Filomena De Falco, Beatrice Del Papa, Franca Falzetti, Mauro Di Ianni, Laura Cavalli, Katia Fettucciari, Andrea Bartoli, Isabella Screpanti, and Pierfrancesco Marconi']", "date": "03-28-2013", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Inhibition of rhabdomyosarcoma cell and tumor growth by targeting specificity protein (Sp) transcription factors", "warc_date": "20220328", "article": "[\"'Subamax is a family of molecular precursors that ferret out tumors cells. Tiny machines are the common protein killers in the body. Synthetic drugs intended to attack these proteins effectively ensure the safety of cancer patients and the survival of their patients. In 2005, scientists in Germany, Turkey, Greece, and Spain discovered they could destroy these precursors with inexpensive drugs, which are known to eliminate them.\\\\nDesigned to combat cancer and against tumor cell deaths, rhabdomyosarcoma cell-derived squamous cell carcinoma (CCCC) is a form of invasive human papillomavirus (HPV) inherited by parents. From the moment a cancerous tumor cells reproduce, they reproduce in a way that destroys the cells themselves.\\\\n'\"]", "inst_index": "63025", "domain": "Int. J. Cancer: 132, 795\u00c3\u0083\u00c2\u0090806 (2013)", "url": "http://doi.org/10.1002/ijc.27730", "summary": "", "authors": "['Gayathri Chadalapaka, Indira Jutooru, Sandeep Sreevalsan, Satya Pathi, Kyounghyun Kim, Candy Chen, Lisa Crose, Corinne Linardic, and Stephen Safe']", "date": "03-28-2013", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Cross-talk of alpha tocopherol-associated protein and JNK controls the oxidative stress-induced apoptosis in prostate cancer cells", "warc_date": "20220328", "article": "[\"'A new peptide, one of the most important proteins in beta-thalassemia, is known to suppress the last element of \u201calpha\u201d protein. However, the new protein is described as a very expensive, sensitive protein which could be used to carry out attack.\\\\nResearchers at the People\u2019s University of Shanghai in China\u2019s southwest capital, Zhejiang Province, had already observed atonal, non-invasive, printed sites from the \u201cjunction window\u201d used to test the properties of alpha tocopherol-associated peptides (JNK)-or NZRNAs, thymomites, protein kinases, other new species of alpha alpha proteins.\\\\nLast year, the scientists discovered that the NZRNAs once loaded with alpha tocopherol-associated peptides can carry out various manifestations of a highly specialized form of beta-thalassemia called \u00fanitrogen-1. When they discovered the large proteins in this area, they observed that these will carry out a course of action known as crossover between alpha tocopherol-associated proteins.\\\\nOnce activated, the NZRNAs express alpha tocopherol-associated peptides with inflammation-causing peptides of the protein cytochrome P450 or CYP350.\\\\nLead investigator Xiaojuan Li, group leader of the University of Shanghai\u2019s JDLH Renwei Chemical Biology Laboratory, said that the research has been performed on mice with atonal lymphedema, or \u03b2-thalassemia, and they have shown that they produce these antitumor proteins with significantly weaker toxic conditions.\\\\n\u201cWe have shown that this protein is able to significantly suppress the toxic effects of \u03b2-thalassemia on cancer cells,\u201d Li explained.\\\\nThis type of alpha/copherol-associated peptide is recommended for use in human studies of cancer cell types, which are known to be linked to an imbalance in Beta-thalassemia. It has also been demonstrated that alpha tocopherol-associated peptides are capable of supplying \u03b2-thalassemia with other proteins.\\\\nIn the future, the scientists will investigate the link between alpha tocopherol-associated peptides and cancer cells through clinical trials of combination therapies, including either beta-thalassemia or cytochrome P450-like peptides. These tests should be able to identify how the target disease functions, and help diagnostic and therapeutic agents to be adopted with other core proteins.\\\\nLi added that another source of alpha in the chemotherapy cycle is SN.\\\\nJournal Reference: Xiaojuan Li, Xiao Yan-Lee, Xu Nan-Ellzhu, Zhou Wen-hu, Yu Jianxian, Kaori Dong-Hyuk, Zhu Qiao, Zhu Qinyuan. Jianjing et al, Thymomites, CJN. (2013). Vol. 147: 1299-1391. doi: 10.1188/JIB121.1200390.61221.2002\\\\nImage: yougenrait.jpg\\\\n'\"]", "inst_index": "89783", "domain": "Int. J. Cancer: 132, 2270\u00c3\u0083\u00c2\u00902282 (2013)", "url": "http://doi.org/10.1002/ijc.27927", "summary": "", "authors": "['Baoyi Zhu, Xiaojuan Li, Yuying Zhang, Chunwei Ye, Yu Wang, Songwang Cai, Huaiqiu Huang, Yi Cai, Shuyuan Yeh, Zhenhua Huang, Ruihan Chen, Yiran Tao, and Xingqiao Wen']", "date": "03-28-2013", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Ovarian cancer cells, not normal cells, are damaged by Mirk/Dyrk1B kinase inhibition", "warc_date": "20220328", "article": "['\\'For some reason, patients with such cancer - included both benign and malignant - may be deficient in the most promising screening method for detecting the presence of disease. The majority of these, under-diagnosed, are later diagnosed with stage IV adenocarcinoma. Those with malignant disease often make progress toward a disease of just two months, in the form of a couple of procedures. Approximately 200 million patients worldwide require surgery to treat cancer, and new data in the coming years indicate that these treatments may be life-saving for some.\\\\nThe most compelling developments come from a new interim study published in the February issue of the journal Cancer that gives us early insight into the process by which tumor cells may be stimulated to spread to normal cells. This research from Northwestern University, the centers of the Department of Cellular and Molecular Medicine at Northwestern and the Director of the Dana-Farber Cancer Institute, suggests a pathway for regulating malignant growth inhibition.\\\\nThe study involved 123 patients who had tumors small enough to be removed from their guts, amputated, or performed in the uterus. Roughly half of these people had been treated with a radiation therapy called epidioproturate, or TIP-1N, to \u201creduce tumor growth.\u201d Patients who did not receive therapy were followed for 17 years, when they would receive an average of 27.2 years of radiation therapy alone and then sent to different hospitals, for treatment.\\\\nThe average effective radiation dose for patients in the study was between 7.0 and 8.0 hours a week, slightly more than a week. Another important factor is the amount of time and total irradiation the patient took while undergoing the treatment, which was in essence how much radiation the tumor possessed.\\\\nThese patients were determined to have malignant growths more than two years before their operation. The strongest evidence possible came from patient papers, including one that showed only one of them had been re-vaccinated after a similar dose of TIP-1N.\\\\nIs this treatment possible for humans?\\\\nYes, because the research being conducted by Northwestern offers an intriguing hypothesis. According to the paper, tumor cells are driven by the by-products of tumor activation in specific genes. Symptoms of malignant growth inhibition may include cancer survival, shrinkage of the tumor area, or more viral mutations. All of this in turn, may also trigger tumor cells to apoptosis. Such apoptosis, if successfully bred and enhanced in the safety and efficacy reported by its conclusion, could pave the way for the development of new treatments for cancers in the future. These findings support a number of longstanding safety and efficacy questions about TIP-1N.\\\\nIronically, all of the patients involved are women.\\\\nAlthough these researchers have attempted to find possible treatments for many women with cancer, they lack the specific mechanisms to discover therapeutic effects from TIP-1N that the Japanese government has sought for years.\\\\nFinally, while the other researchers have clearly explored the potential of TIP-1N for most women in their studies, no patients have been found to have high approval ratings by the panel. In this study, tumor pathways were also noted for specific targets which imply that TIP-1N will be permitted in most women not insured under United States Medicare coverage.\\\\nRegarding the issue of how TIP-1N might be beneficial for patients, let me explain in more detail.\\\\nIn the article, author Ying-Aun Oh (\"Ying-Aunter\\\\\\'s work relates to screening methods for cancer in women\") proposes a new sequence of programs called aromatase inhibitors for the treatment of tumors that use TIP-1N. She also shows that the technique is \u201cfinite and varied.\u201d No different than conventional surgical techniques in how women grow their breasts.\\\\nIn addition, the K-95 tumor gene program, used in the J-101 study of patients, has been shown to be safe in women treated with TIP-1N and can be applied by the same group of potential therapies as those for others.\\\\nSo if TIP-1N is useful for an underserved population of patients, where and how it would work for others in need of additional radiation treatments is for further study.\\\\nA post hoc analysis of 39 tumor types leads to a conclusion: just waiting and rewarding the treatment.\\\\nEileen A. Friedman\\\\nCommunications,\\\\nDR. North, V.P.\\\\nNorthwestern University\\\\n\\'']", "inst_index": "51067", "domain": "Int. J. Cancer: 132, 2258\u00c3\u0083\u00c2\u00902269 (2013)", "url": "http://doi.org/10.1002/ijc.27917", "summary": "", "authors": "['Jing Hu, Holly Deng, and Eileen A. Friedman']", "date": "03-28-2013", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Physical characterisation of Tenacibaculum maritimum for vaccine development", "warc_date": "20220328", "article": "[\"'In the Feb 20 Opinion, Stephen & Gonzalo also show that further earlier studies are urgently needed to advance patient care in kindergartens to atypical ratios of maternal, paternal, and maternal to individual (15, 45, 60, 65, 90, 90, 90, 90, 90.5, 96.4, 99.6, 99.6, 96.2, 97.9, 96.2, 98.8, 99.6, 97.4, 89.9, 92.6, 88.6, 94.8, 94.4, 94.6, 94.1, 97.6, 96.6, 96.6, 98.2, 92.2, 96.4, 96.9, 97.4, 95.5, 97.0, 96.3, 95.3, 95.4, 95.5, 94.2, 96.6, 98.6, 96.0, 96.4, 98.0, 96.0, 96.1, 96.5, 94.9, 94.3, 96.0, 100.1, 96.3, 97.1, 96.2, 92.2, 92.4, 95.1, 92.9, 96.0, 98.3, 96.4, 92.2, 95.4, 96.1, 92.9, 96.2, 97.2, 96.3, 96.2, 96.0, 96.4, 96.5, 95.1, 96.0, 96.0, 96.1, 96.1, 97.2, 96.2, 96.1, 96.2, 97.1, 96.0, 96.5, 96.2, 96.5, 96.0, 96.1, 97.5, 94.0, 96.5, 96.2, 96.5, 96.0, 96.0, 95.3, 96.1, 97.1, 96.2, 96.3, 97.2, 96.5, 96.5, 95.0, 96.0, 97.0, 96.3, 97.3, 96.3, 96.3, 96.3, 96.2, 96.2, 96.2, 96.3, 96.2, 96.3, 96.2, 96.2, 96.2, 96.2, 96.1, 96.3, 96.3, 96.2, 96.2, 96.2, 96.2, 96.3, 96.2, 96.1, 97.5, 96.2, 96.1, 96.2, 96.2, 96.2, 96.2, 96.2, 96.2, 96.2, 96.2, 96.2, 96.2, 96.2, 96.1, 96.2, 96.1, 96.1, 96.2, 96.2, 96.2, 96.1, 96.2, 96.2, 96.1, 96.2, 96.2, 96.2, 96.1, 96.2, 96.2, 96.2, 96.2, 96.2, 96.2, 96.1, 96.2, 96.1, 96.2, 96.2, 96.2, 96.2, 96.2, 96.1, 96.2, 96.2, 96.2, 96.2, 96.2, 96.2, 96.2, 96.2, 96.2, 96.2, 96.2, 96.2, 96.2, 96.2, 96.2, 96.2, 96.2, 96.2, 96.2, 96.2, 96.2, 96.2, 96.2, 96.2, 96.2, 96.2, 96.2, 96.2, 96.2, 96.2, 96.2, 96.2, 96.2, 96.2, 96.2, 96.2, 96.2, 96.2, 96.2, 96.2, 96.2, 96.2, 96.2, 96.2, 96.2, 96.2, 96.2, 96.2, 96.2, 96.2, 96.2, 96.2, 96.2, 96.2, 96.2, 96.2, 96'\"]", "inst_index": "17455", "domain": "Journal of Applied Microbiology 2010, 109:1668\u00c3\u0083\u00c2\u00901676", "url": "http://doi.org/10.1111/j.1365-2672.2010.04795.x", "summary": "", "authors": "['R. van Gelderen, J. Carson, N. Gudkovs, and B. Nowak']", "date": "03-28-2010", "split": "test", "label": "machine", "status": "succcess"}
{"title": "HD-GYP domain proteins regulate biofilm formation and virulence in Pseudomonas aeruginosa", "warc_date": "20220328", "article": "['\\'PGM-based endocrine systems have many concerning potential mechanisms to influence PGM concentration and virulence in leukemias, fungi and small organisms, according to a journal commentary from the journal Predoc.\\\\nEchostatig, et al. attribute sites to Pseudomonas aeruginosa, fungi and small organisms. They also link them to the same intellectual capacities and capacities of small people to ferment undulations of phytochemical compounds.\\\\nIn contrast, many humans are at high risk of the probable conversion of organisms to virulence because they do not adhere to tolerance and phospholipidogen lifestyles to degrade PGM. Much of this postulation relies on what happens at the initial end-stage stage in PGM mutation cycle and how the infected cells breathe after they develop PGM.\\\\nPGM-based endocrine systems are mice, soil creatures, strontians and microbes that are highly susceptible to Pseudomonas aeruginosa.\\\\nMetic modifiers are mostly present in moles, that cause malignant tumors in cattle, pets and human cells.\\\\nTo minimize PGM mutation sensitivity, management strategies need to be modified based on site potential levels and HIV stratification, study authors observed.\\\\nIn the article \"Metimalan enzymes and mechanisms of leukemias phosphate development in Pseudomonas aeruginosa,\" a presentation from the journal, it asserts that this data adds to the evidence for the existence of compounds in phytochemical compounds and RNA concentrations.\\\\nThe PGM-inhibitors also might be developed to protect PGM-inhibitors by preventing them from perturbed by Pseudomonas aeruginosa,\\\\n\"Antigen analyses in this review of clinical data show that alterations in gene behavior in the PGM-inhibitors and RNA compounds may promote a decrease in PGM protein concentrations in the PGM-inhibitors and RNA compounds,\" write the authors.\\\\n\"Among a group of fast-growing animals, such as cattle, the PGM-inhibitors are especially predisposed to leukemias before they are HIV-infected,\" authors conclude. \"But even after the most recent presentation, \\\\\\'LTC\\\\\\' mice with more leukemias appear to become resistant to compounds such as PGM-inhibitors after small carnivorous areas had evolved antimicrobial resistant (ARM) and other gene properties.\\\\\\' \"\\\\n\\'']", "inst_index": "61747", "domain": "Environmental Microbiology (2009) 11(5), 1126\u00c3\u0083\u00c2\u00901136", "url": "http://doi.org/10.1111/j.1462-2920.2008.01842.x", "summary": "", "authors": "['Robert P. Ryan, Jean Lucey, Karen O\u00c3\\x83\u00c2\\x95Donovan, Yvonne McCarthy, Liang Yang, Tim Tolker-Nielsen, and J. Maxwell Dow']", "date": "03-28-2009", "split": "test", "label": "machine", "status": "succcess"}
{"title": "High cellular organization of pyoverdine biosynthesis in Pseudomonas aeruginosa: clustering of PvdA at the old cell poleemi_274", "warc_date": "20220328", "article": "[\"'There was a 500-year-old research scientist, Dr. Roland I. Tucaran, about Pseudomonas aeruginosa (PIA). He named it perphiosopheenschaftralis ier varoena-omerrica. Scientists have known that after living life within excellently propagating tissues of the rhododendron-baking bacteria, the bacterium arises dormant at the older cell. Some specific microbiome cells that might persist in the old cell were at the vanguard of the industry before they died out.\\\\nAt the centre of this inquiry was Dr. Roland Tucaran, now Professor of Microbiology at the National Academy of Sciences, and Dr. David Henther, Professor of Molecular Ecology and Biotechnology at the National Institute of Genomic Sciences, who are both Ph.D. faculty members.\\\\nBefore 2001, when the transmission of Pseudomonas aeruginosa to bone was still possible, six small extllular intermediates (plails) abated their activity. Now, only the microbe between the vestiges of the bacteria and the dead body is able to trigger the chemical reactions that propagate the bacterium. The two are still getting released from the second\u2019s eclampsia, and only intermittent spines give way to the extricated small isolates, and the uptake of the spores in the gut. At the time of the discovery, the bacteria existed only isolated of bacteria at the vanguard of oxygen levels. However, the focus of the team immediately shifted from the dormant microbial communities to the titanic protostasis of Pseudomonas aeruginosa, volvio (cultivated by extracellular bacteria at its placental junction), which infected upper respiratory tract fibers.\\\\nThe perturbed bacteria became very active after this acquisition. Those responsible for this last hurrah must have had a considerable headstart on the noble hypothesis of devolution, and the team needed \u201cfathering\u201d of Pseudomonas aeruginosa.\\\\nJust a little over a year later, Ms. Henther realized the saga was a misdirection. While the ability of polyglotry species to develop the phtya processes was remarkable, only one was born. There were only three remaining spores, either destined for phyloxins, or contained in previously unknown cells. Both precursors had earlier failed to turn around their metabolism. The phtya gene was identified but the eclampsia remained dormant. Finally, the male apotherapi joined the resistance, the next step, finally forming an ap\u00f3nnuteratinhy lipophase or \u201chot stoke\u201d from which the sedothathagi are instantaneously attached and grafted together into the galla.\\\\nThis made the phtya discovery in 2007. It was the first time that the phtya recorded up to three underground urinary channels at the same time, either penetrating the urinary devices or provoking the vagus nerve to call the gene pagaggiaris. These lasted from 18 weeks to three years. Dr. Henther solved the first of its problem with the right micro-organism, a sloughborn bacterium, intact but weak. To modern microbiologists, it was the usual streptopan (from the ubiquitirile areopropate IH) that the phtya must be transmitting.\\\\n\u201cIf it had been people who\u2019d eat things in the lab, the bacteria wouldn\u2019t be alive,\u201d said Dr. Henther. \u201cTo keep up with all these live bacterial forms, we need more efficient biotechnology than the current class of antibiotics.\u201d\\\\nThe next problem for the team is to identify and shed DNA sequences that divide the phytoplankton moth (PhD-5), which spreads the bacterium\u2019s loss of eclampsia. It will be possible to design such a procedure which also could extract the fragments contained in the arch of the Pseudomonas aeruginosa. Dr. Henther says that the organism that killed the phytoplankton had previously arrived to a potential resistance, by replacing it with \u201chot stoke.\u201d\\\\n'\"]", "inst_index": "81195", "domain": "Environmental Microbiology (2012) 14(8), 1982\u00c3\u0083\u00c2\u00901994", "url": "http://doi.org/10.1111/j.1462-2920.2012.02741.x", "summary": "", "authors": "['Laurent Guillon, Maher El Mecherki, Stephan Altenburger, Peter L. Graumann, and Isabelle J. Schalk']", "date": "03-28-2012", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Interplay of RsbM and RsbK controls the sB activity of Bacillus cereuse", "warc_date": "20220328", "article": "[\"'From Nature Communications\\\\nMeasuring PSB activity over time is essentially a measure of energy consumption. The most commonly used measure is the age of an activity at which the member is literate, healthy and energetic.\\\\nThese activities are described in the corresponding studies from the International Atomic Energy Agency (IAEA), the Institute of Radiological Sciences at the University of Hawaii and National Institutes of Health, the IAEA, and the Chinese People\u2019s Liberation Army. These studies were carried out independently by researchers from the Department of Non-Conventional Medicine at the Beijing Normal University and the China University of Chemical Physics and Technology (CDST).\\\\nUnderstanding the social behavior of an interplay of markets was one of the major outcomes of the study of PSB activity in dynamic transport vehicles. PSB operations are broad in nature such as in the agricultural, manufacturing, hotels, airlines, hospitals, and financial services. This model of creative transport transport can be compared to a wide variety of other intelligent transport systems like the Ultra-Safeguard Forum (ULF) bus, highway transport, and compressed space transport systems (HTT). For instance, in the United States, the United States National Transportation Security Administration (USNSA) and Homeland Security are strongly involved in national security, law enforcement, and private security strategy.\\\\nWhen a PSB is exposed, in an internet-based conversation in a Chinese forum, its activity changes the way the level of active PSB activities and has a striking effect on the activities of PSB, CIMNA, and so on. PSB activity spikes is driven by exposure to an individual and follows other activities. The energy consumed by these changes is also sub-stantiated.\\\\nThe causes of PSB activity are well understood, but their function can be characterised in part by similarities among sub-profiles. The CDST bus is a powerful and simple route for commercial transportation. In addition, the HTT bus is a sophisticated waste management system, which has the potential to capture up to 40 billion tonnes of diesel fuel annually, and therefore focus significant amounts of heat of the trip. It has extensive ventilation.\\\\nBacillus cereuse is the ancestral growth agent in bacteria that powers the metabolism of glucose and cholesterol, as well as an essential source of beneficial oxygen. Bees and ducks can be affected and some foods, including lard and some nitrates and fats, may also be affected, but bacteria are also implicated, as is vitamin D.\\\\nWhat is an Interplay?\\\\nThis whole interplay is supposed to be thought of as one relationship. A twin-way interplay of PSB activity is supposed to allow interplay. This linking is made possible by an interplay in the utilization of PSB information, which is carried out through cryptography. A countertunity known as the Google SRCS library is the part of the website where the information is collected and analyzed, and which has led to many successful interplay in internet-based communication systems.\\\\nWhen PSB activity occurs in a PC scene like North America or Asia, a separate interplay happens. It is not completely understood what is happening but one should keep an eye on the interplay and should not treat this with any suspicion.\\\\n'\"]", "inst_index": "45331", "domain": "Environmental Microbiology (2012) 14(10), 2788\u00c3\u0083\u00c2\u00902799", "url": "http://doi.org/10.1111/j.1462-2920.2012.02788.x", "summary": "", "authors": "['Lei-Chin Chen, Jung-Chi Chen, Jwu-Ching Shu, Chien-Yen Chen, Ssu-Ching Chen, Shu-Hwa Chen, Chun-Yen Lin, Chi-Yu Lu, and Chien-Cheng Chen']", "date": "03-28-2012", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Introduction of 65 kDa Antigen of Mycobacterium tuberculosis to Cancer Cells Enhances Anti-Tumor Effect of BCG Therapy", "warc_date": "20220328", "article": "[\"'FINGERTIPS: Another study of molecular design, and a report profiling the role of 64 different amino acids in kidney cells, identifies 18 new amino acids for epigenetic signalling, including guinea pigs. Meanwhile, assays showing that bacterium and viral ticks carry gene-editing proteins in the DNA play a role in UTI, by reflecting that the Transgenic Species Guide to Mycobacterium tuberculosis establishes a specific age for a mutation that doesn\u2019t exist by accident.\\\\nThe first study to investigate functional leukocyte counts, the identification of 56 different cells, using polymorphisms in the protein D236840=inactivating, and relying on a list of amino acids: T/DNA, Jamm2-F11, KMR2-XCN, Yaq5XN, DNF6-M2-XCN, GFT-GFT, TBN6M2-VFN and BMT2-Trac3.\\\\nThe first five slides then summarize Coferk Sen\u2019s reports on virology and genomics, the milestones during cal cal cal session, and the binding of proteins. These will evaluate protein replication across the cell, including its results from peptide transcription, the target for metabolism. Prof. Sen: \u201cEfficacy of some types of antimicrobial peptides,\u201d says his \u201cDetecting Antigenicity and Genomic Action\u201d, \u201cRemarkably\u201d, say his \u201cPLoS 314 (=1-0-1-0 + 2-3-2)\u201d\\\\nAmong the 197 cells selected, Prof. Sen: \u201cLatem duplication in the cell divide used to be a major problem,\u201d explains, \u201cwhile it was also an expense. Renal function was rapidly reversed, however, as DNA to \u2018own\u2019 the cells has also been processed and served as a measure of the cellular biological function.\u201d\\\\nProf. Sen: \u201cThis is the first time one of the study\u2019s targets has been found,\u201d says Prof. Sen: \u201cWe believe that genomics is important to understand the importance of the effects of natural selection. Every organism that should have a genetic role in its DNA systems, will need a pathologist at the moment for genetic blueprint analyses and services, including genetic testing to see how the genetic structure varies among different cell types, to develop personalized genomic and chromosomal architecture.\u201d\\\\nAlso distinguished from the other 183 sampled cells is the population/population level encoded compound IG(t)-5 set of BG-PC3 ?\u00b3 protein for storage (I-5)? 5.1 p2 psocyclin^a-^a5.6, and tran-440-109 metipides, or offparines. While memory of the term is refined, the study\u2019s findings describe specific processes. Prof. Sen: \u201cThis is important because it breaks down the peptide production process of I-5 within cells, thereby reengineering them to adorn them, enabling them to do a much higher level of rate of collagen production with higher \u2018deepness\u2019, which was considered a drastic increase in plasticity.\u201d\\\\nIn addition, Prof. Sen: \u201cEugene Sparkert, presented his \u2018prospectus to discover biomarkers of immunogenicity and immunoreactive influences on adenonum cultures\u2019.\u201d\\\\nThis study on blue electron conforming blocks (IDCs) is one of mycobacterium tuberculosis. Herd with a cancer nematode. Founder of RNAParisismous compounds, Professor Yohui Kumaishe, PhD, Chair of the Infectious Diseases Department at Kyoto University, calls for several important domains for biotechnology, including immunotoxicity, neonatal sequencing, and immunorestation studies.\\\\n'\"]", "inst_index": "23550", "domain": "Microbiol. Immunol., 48(4), 289\u00c3\u0083\u00c2\u0090295, 2004", "url": "http://doi.org/10.1111/j.1348-0421.2004.tb03525.x", "summary": "", "authors": "['Isao Hara, Noriyuki Sato, Hideaki Miyake, Mototsugu Muramaki, Satoko Hikosaka, and Sadao Kamidono']", "date": "03-28-2004", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Preparation of Monoclonal Antibodies Cross-Reactive with Orthopoxviruses and Their Application for Direct Immunofluorescence Test", "warc_date": "20220328", "article": "['\\'Varetica, DK-T\\\\nOshituki Kobayashi, Vi.\\\\nJuan Mora, PhD\\\\nFriedrich Mortensen, PhD\\\\nDoctors of PMI, TNP, and Nabipa, M.D., MPH, are carrying the PI antigen dose, assays of current MR (small, generally not present in standard orthopoxic ischemia) en route to commercialization. The first study was proposed by the National Academy of Sciences in 1965, with a focus on PMI\u2019s, Ngtavile AR (Associated Avacir) in November 1972. Since then, until 1997, the duo has worked to characterize and characterize this agent as a receptor in or near the prostate: TDGL2. The new information is the synthesis of the bone radioactive isotope mavibacizi, paired with macrophage chemicals, to develop an acceptable therapeutic approach and limited concentrations of DVV2 on the surface of the surface of the tumor. Earlier this month, the NIH announced that TDGL2 is currently used in a \u201csignificant number of breast cancer patients, particularly in acute or secondary stage I diabetes (LB, LD, HF, RR), or can no longer tolerate it after, or in new cancer types, infection with pathogenic cells. TDGL2 is also being applied to breast cancer to alleviate gastric reflux, because it may stimulate T cells to produce HSF6, a less reproducible prognostic prognostic prognostic agent. Currently this is being applied in pancreatic cancer. Unfortunately, TDGL2 is not en route, however, because Bristol investigators decided that it will not be beneficial to comparison the PK as MR as a prospective therapy in front of patients based on the Partape technique that subjects the EHR to target so that it can supplement it in a broad way and not be concentrated in one particular area.\\\\nReactions from the found\u2019s members include developing a cutting edge approach, obtaining funding, design and manufacturing, using the ARM (Cell Block Accelerator), ISO (Pioneering Toxicology and Nuclear Engineering), and using the ARM system in the screening and follow-up stages (weekly readings for every 125,000 lbs, and blood, the device was acquired from Outback Studios). The results, reports a post in a Harvard study published earlier this year, may be unique to cancer.\\\\nTagema of Tufts University has just published a case study, \\\\\\\\\"The Centers for Disease Control and Prevention reports: _On April 17, 2002, 312 men and women from Southeast Asia contracted acute lymphoblastic leukemia (ALL) presented at an international American Cancer Society Meeting, Seattle, Washington. A CD3-targeted antigen (ACP) was engineered to bind to the body\u2019s cells, which double as the tumor\u2019s host cells. Not finding any disease was the key task, and sometimes the resulting results were about 30 percent less disease than the standard compound (dibrudine tyrosine kinase ). Infection and death triggered the initial effects of CD3, a phenotype which was normally associated with cancer in general, but perhaps never associated with disease in patients treated with the CD3 antigen. CD3-targeted human hepatitis virus (HIV) is a global epidemic, which causes around 55,000 deaths per year, with about half due to the infection. Moreover, mice with individuals with abnormal mutations in CD3 were able to live longer. Despite the previous tumor regression study, 75 percent of the patients appeared to benefit, showing that CD3 therapy was not anticancer alone. Regarding HIV testing, for which TDGL2 is currently assigned, the results are much better than in randomised studies.\\\\nPreparation of both blood cancers and HIV is not the case. Recent results suggest the development of novel tests on H4c in immunodeficiency. Since the African Heart & Lung Consortium, MS, and West African Study Groups for H4c are members of the Consortium, Dr. Mora is interested in addressing this issue.\\\\n\\'']", "inst_index": "53792", "domain": "Microbiol. Immunol., 49(3), 219\u00c3\u0083\u00c2\u0090225, 2005", "url": "http://doi.org/10.1111/j.1348-0421.2005.tb03723.x", "summary": "", "authors": "['Noritoshi Kitamoto, Takayuki Kobayashi, Yoji Kato, Nobutaka Wakamiya, Kazuyoshi Ikuta, Tomoyuki Tanaka, Shigeharu Ueda, Hiroyuki Miyamoto, and Shiro Kato']", "date": "03-28-2005", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Expression of bovine (Bos indicus) interleukin-18 in Escherichia coli and its biological activity", "warc_date": "20220328", "article": "[\"'Xconomy San Diego \u2014\\\\nWhen your cells in your blood turn into viruses, they do it by employing extensive catecholins\u2014condiments of natural fertilizers and mixing together to remove their genomes.\\\\nWhen their cells produce money, their partners turn into bacteria and tumors.\\\\nNow researchers in Switzerland have discovered a way to use catecholins to create new strains of ferrets and avian viruses.\\\\nNormally, catecholins are highly active in our cells to make nucleic acids, so they are the best indicator that a protein circulating in the lungs (knicks) or brain (the neurons) is a reliable foreign agent. Once an enzyme is created, it is derived from amino acids in the digestive tract, which then excrete a host of harmful proteins on the cell surface. Since we still need to pump it out into our cell, the catecholins can then be created with topography. Now the Swiss team at Hospital Wageningen have developed a way to turn the entire structure of bovine (Bos anaetii) internal organs into elevated \u201cagives,\u201d which, if extended, could be used to influence the immune system and to neutralize cancer, diabetes, inflammatory diseases, and even the disease itself.\\\\nEthel Geisner at the Swiss Faculty of Science & Technology (WEAST) led the project to create works on life and behaviour using enzymes that improve bovine responsiveness. The three of us were also supervising the team\u2019s work in 2003 at Weinsten Laboratories, the Swiss Federal Institute of Technology, in Vienna. We have been training our team on how to create new bovine vaccines for solid tumors.\\\\nThe key takeaways from the Swiss discovery: the bovine kingdom could make bionic designs for medical devices with or without fiber. For this reason, catecholins would enable scaffolds to be implanted in muscles that could improve muscle growth, and test the concept of bioinflation: the coming megaresortic radiography and all the medical equipment we need to get rid of diseases.\\\\n'\"]", "inst_index": "25753", "domain": "Microbiol Immunol 2010; 54: 564\u00c3\u0083\u00c2\u0090567", "url": "http://doi.org/10.1111/j.1348-0421.2010.00241.x", "summary": "", "authors": "['Kotla Siva Reddy, Dowlathabad. Muralidhar Rao, Hosur Joyappa Dechamma, Veluvarthy V.S. Suryanarayana, and Golla Ramalinga Reddy']", "date": "03-28-2010", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Investigation of the roles of T6SS genes in motility, biofilm formation and extracellular protease Asp production in Vibrio alginolyticus with modified Gateway-compatible plasmids", "warc_date": "20220328", "article": "[\"'Note: The recent publication of additional articles on the coverage of Schaeffer McClellan from H.S.\\\\n\u00ab Cultus role of Mhaital by authority and context \u00bb\\\\nMuch paper that was simply published in books of varying sophistication from august scholarly journalists, was applied in his later years. This volume documents how Mhaital (Cassam ach les axons minorbiolus de des hist\u00e9dicims et les importations de originide affiliates) and co-incide with The Erasmus Communications Group\u2019s 1984 study of The Historical Effect of Religions on Microbial Molecules (a textbook entitled \u201cCharacteristics of Value Genetic Documents\u201d, 5.2 pp, 3.14) and the Methods for Comparative Analysis of Mhaital practices in Metabolism, Human Cellular Professions (a 7-page book by Robert Schaeffer).\\\\nThis multi-volume deluxe collection of scholarly collections and extensive articles must be considered in some way as the aim of its difficult publication format. Even more than the previously mentioned tasks described, history of the use of expertise and excellence in the development of expertise is rather lacking. The assignment of scientists in three previous studies would have been equally helpful, with Lech-erman Schr\u00f6dinger at Balanova (1948), Steeringhearts at Weber (1953), and Romain Richter at Hertmer (1969) as did the same material of papers in individual contributions by professors (Benjamin Graveling, W.S. Olmsted, and Simon Taylor, June 1919) to the Mhaital primary biochemistry and biology project at Stuttgart Metropolitan University in Germany. Instead of an organizing enterprise, the new study structure is typically a more arduous effort, for two reasons: the last scientific paper in the science-phase, and the first study of Mhaital was published in 1972.\\\\nReservations for this volume? Hearing about the timing of the publication? The second reason is the negative association of relatively new publications with the selective approaches contained in these studies, as highlighted by the kind of scholarly approach employed in these papers and the methods for replacing knowledge that has been found not to be applied to Mhaital selectively and ethically in Mhaital without treatment by researchers (for example, Paul Samad) at Stuttgart Metropolitan University (Prof. Stephan A. Mayerpach, R.P. Tholsz; 1962) and Erasmus Publications \u2013 between 1973 and 1995, included in the collection (begins in May. next weeks). The reproduction of the late Salus 1980, is contested by the noted scholar Doriana Spedrin, a famous literary critic; author A.M. Salus; Professor Romanos Pikore and Aloisiu Amalilia, of the University of Bavaria, and James Slaughter of the University of Basel; and Paul Samad, P.T. Smith, Alexander Barron, and Paul Boyd. The bad news? The existence of this information is of major concern, especially regarding the species identification of microorganisms (Regos type A), and its utility as a tool for environmental engineering.\\\\n'\"]", "inst_index": "52996", "domain": "Letters in Applied Microbiology 55, 73\u00c3\u0083\u00c2\u009081, 2012", "url": "http://doi.org/10.1111/j.1472-765X.2012.03263.x", "summary": "", "authors": "['H. Liu, D. Gu, L. Sheng, Q. Wang, and Y. Zhang']", "date": "03-28-2012", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Multiple controls affect arsenite oxidase gene expression in Herminiimonas arsenicoxydans", "warc_date": "20220328", "article": "['\\'Possible Methods for Maximizing and Marketing Drug Screening Identified\\\\nIn an article published in the Journal of Toxicology and Microbiology, from Alberto Huxly and Jenue Huisman with the University of Turin, they analyzed research published in 2006 on molecules that appear to have specific control of oxidase involved in myriad cytotoxic dose subtypes and the presence of bonded arsenic-beta nanoparticles as well as their play-acting in human cells. They also found a strong, on-target, and indeed regulated version of a reactive arsenic oxidase gene expression pattern in the human molecules involved in their resistance to oxygen-deficient resistance to methanol-oxygenactive compounds including lead.\\\\n\"Agitating the removal of oxidase associated with methanol-oxygenase complexes seems to promote very specific reactive arsenic-beta variants in rare ferrosives,\" explains Huxly. \"Variations of oxalate-morphine dichlorase phospholipase (ODD) binds to reactive arsenic-beta complexes in Herminiimonas arsenicoxydans and do not cause their resistance to methanol-oxygenase complexes in our sample.\"\\\\nSubstances of reactive arsenic oxidase were characteristic of the experiment in which Huxly and the other researchers focused on providing adequate sanitary and protective materials for the initiators of their experiments. The article notes that for this brief study only, they refrained from prescribing solid materials to initiating the group that develop a type of arsenic-beta oxidase gene expression seen in classic TSV, where azodicarbonamide and methanol were chemically separated separately from lead.\\\\n\"It seemed to be possible that after analyzing arsenic-beta complexes, we could infer that these RNA-based arsenic oxidase operations have developed resistance to methanol-oxygenase complexes that bind together arsenic-beta complexes in kalamientaceous metal bound to various compounds,\" notes Huxly. \"Further, the action of oxidase associated with their resistance to methanol-oxygenase complexes in the ovarian digested of our Lilliiterudromine newly classified arsenic-beta complex suggest that this type of arsenic oxidase blockade might be responsible for its resistance to methanol-oxygenase complexes,\" he concludes.\\\\n\\'']", "inst_index": "97111", "domain": "BMC Microbiology 2010", "url": "http://doi.org/10.1186/1471-2180-10-53", "summary": "", "authors": "['Sandrine Koechler, Jessica Cleiss-Arnold, Caroline Proux, Odile Sismeiro, Marie-Agne_s Dillies, Florence Goulhen-Chollet, Florence Hommais, Didier Li\u00c3\\x82\u00c2\\x8fvremont, Florence Ars\u00c3\\x82\u00c2\\x8fne-Ploetze, Jean-Yves Copp\u00c3\\x82\u00c2\\x8ee, Philippe N Bertin Gi']", "date": "03-28-2010", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Multidrug resistance protein MdtM adds to the repertoire of antiporters involved in alkaline pH homeostasis in Escherichia coli", "warc_date": "20220328", "article": "['\\'Large quantities of large-protein peptides are found in human body tissues. Researchers at the University of California, Los Angeles (UCLA) have pinpointed a newly discovered molecule that facilitates mass absorption of small doses of multidrug resistance protein MdtM as well as growing waste products using the marker acidophate live in contact with bone marrow that binds to this protein.\\\\nCo-author Lauren Lohman and her colleagues took extraordinary steps to reshape the way cancer medicine used unconventional -- but still unproven -- efforts on lysosomal acidosis and mesenchymal mesenchymal mesenchymal type I to use lifestyle-modulated drugs. The new compound, MdtM, binds directly to a protein called acidophate-4 -- and specifically fits this protein\\\\\\'s role in mass absorption -- by attaching a chemical called acidophatine to the gums of the lungs of certain mice.\\\\n\"Multidrug resistance is associated with the role of the acidophate agent in thinning the tissues of tumors,\" Lohman said. \"It\\\\\\'s not only inhibiting cells\\\\\\' ability to migrate, but it\\\\\\'s also inhibiting the production of nicotinic acid throughout the body. We have identified MdtM, which binds significantly to acidophate, plays a major role in the synthesis of mladenolecules, even when we only have small amounts of acidophate.\"\\\\nThe multidrug resistance protein has been used in a number of uses. MdtM absorbs products from the stomach by stripping out acidophate, and thus linking its reaction to the genes involved in proliferation and protein resistance in mice. However, the team of researchers did not clear the molecule to fit a marker which would contain direct pathway to finding the molecule, causing its expression to decline and leaving the molecule back in the waste products.\\\\n\"This discovery has enabled us to specifically account for slack-off times (in this case, in membrane reticles) in the reuse of multidrug resistance protein MdtM,\" said study co-author Allie Gunderson, of the University of California, Los Angeles. \"The whole idea is to look at functional biology to see what it is that we like the best molecules for to try and correct shortcomings in the review system.\"\\\\nFor the latest study, available online by:\\\\nAdverse events associated with mladenolecules vary by age, body size, etc. (5-10 years is considered normal).\\\\nIn previous mouse models, MdtM concentrations rose from around 30 percent to a range of 30 to 60 percent in individuals of relatively different sizes.\\\\n\"This is the first time in human history we have seen this signature of the multidrug resistance protein MdtM emerge from circulating RNA in human tissues. This means that the multiple measurements we took showed MdtM to be remarkably similar to cells protected from changes in circulating RNA.\"\\\\nGunderson said that the team hopes to expand their study to all tissues -- including preclinical samples of multiple mouse models, encouraging potential new approaches to explain the formation of many different environments.\\\\nThe paper appeared in the journal PLoS ONE, and in print.\\\\n\\'']", "inst_index": "80313", "domain": "BMC Microbiology 2013, 13:113", "url": "http://doi.org/10.1186/1471-2180-13-113", "summary": "", "authors": "['Scarlett R Holdsworth, and Christopher J Law']", "date": "03-28-2013", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Genome-wide incorporation dynamics reveal distinct categories of turnover for the histone variant H3.3", "warc_date": "20220328", "article": "['\"Physicists have developed how to distinguish high H3.3 \u2014 trillions of long and relatively heterogeneous tissue types \u2014 from low H3.3 \u2014 trillions of heterogeneous tissue types as called nontolerable proteopsiruses (yep, our specific motif is visible, but the technique relies heavily on the role of heteropithecine in predominance).\\\\nIn a recent paper, the scientists (who were the lead authors of one another\u2019s studies) presented a common set of changes that were consistent with heteroproteins-interfactant species groups. These data reflect how heteroproteins have evolved both in terms of evolution and heterogeneity of performance. The research is published in the journal Homolely Formality.\\\\nSo where does this learning come from? Each amino acid in an H3.3 relates the biodegradable expression of H3.3 molecules. The molecular similarities between these two groups are well-known, but how is it that these differences are reliably correlated? The possibility is open to questions, and in general a question we might not have fully understood a while ago. The Haik\\'a revolution is about halfway around the galaxy, for instance. The molecular changes associated with these RNA-by-nanogram changes aren\u2019t evident on the surface of H3.3, but whether this cell will start reproducing eventually depends on how the H3.3 proteins interact with other H3.3 molecules.\\\\n\u201cIf you want to explore much more, you need to study these Kallofo and Telkhaleites. At present, we know very little about the evolution of the H3.3 chain. It is quite surprising that these Kallofo and Telkhaleites require between four and eight of the amino acids H3.3 has evolved. In other words, once you observe how transgenic DNA evolved and other layers evolved, why did its molecular formation undergo so much variation?\u201d\\\\nTo look at H3.3\u2019s evolutionary structure from a molecular standpoint, the researchers applied a rapid field test: the structure of sequence characteristics such as ligand structure, deactivity, and over/under regression to the human form. The results suggested that the amino acid H3.3 evolves from heteroproteins-interfactant to heteroproteins-interfactant, although this is also a known important parameter as it can effect changes in multiple amino acids in the human form. To explain the process, we used historical re-analysis of the H3.3 production levels in the genomes of H3.3 and Telkhaleites, which may now reveal how complex a molecular structure gets from an identical nature to his H3.3.\\\\nGenome-wide structure differences\\\\nThe H3.3-chromatoconcus complex is a series of processes that enable change in fundamental cell mechanisms that must be monitored at all times in order to be reproduced over and above H3.3: heteroproteins-interfactant (H3.3) and heteroproteins-interfactant (H3.3). The tasks that might be viewed as tough (e.g., folding and re-chronosting) are at the root of this complex design: counting down the H3.3-ylocidal move to phase, reactivating and/or altering the mechanism. If we are anticipating that additional DNA evolutionary values are possible, our model will become unstable, creating a kind of complacency or even an individual accident.\\\\nSequencing the pattern of chain effects is important for analyzing multiple types of activity based on different heteroproteins-interfactant twins. If we are computationally advancing the field of this process, it will become increasingly difficult to conclude all the alterations that occurred in the H3.3 formation layers were plausible and predicted. The point is to work in tandem with the genotyping that enables us to understand if changes in chain characteristics can occur in both samples.\\\\n\"']", "inst_index": "43588", "domain": "Genome Biology 2013, 14:R121", "url": "http://doi.org/10.1186/gb-2013-14-10-r121", "summary": "", "authors": "['Daniel C Kraushaar, Wenfei Jin, Alika Maunakea, Brian Abraham, Misook Ha, and Keji Zhao']", "date": "03-28-2013", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Honokiol activates AMP-activated protein kinase in breast cancer cells via an LKB1-dependent pathway and inhibits breast carcinogenesis", "warc_date": "20220328", "article": "['\\'IN PICTURES: Breast cancer by link\\\\nThe KPA12331-by-EGYPT receptor kinase (KKB1-DL1) pathway promotes breast cancer metabolism by binding to two signaling proteins: EYE-M3 and YALE-DN1. They inhibit the activation of an abnormal protein called AMP-1 (PT-NY2) and promote the development of breast carcinogenesis.\\\\nThis finding supports more than one possible explanation for the activation of KPA12331-by-EGYPT receptor kinase (KKB1-DL1) signaling in breast cancer cells: an active inhibitor of the pathogenesis of breast cancer, a higher progression-free survival rate, higher metastasis, and greater resource availability.\\\\nEarlier studies found that KRKB1-DL1 activates both the internal pathways of AMP-1 and YALE-DN1-mediated breast cancer death pathways, creating a chemotherapeutic agent.\\\\nIn April, KPA12331-by-EGYPT receptor kinase (KKB1-DL1) was demonstrated on the National Cancer Institute-designated Comprehensive Cancer Center website as an intermediate pathway to devastating (not to mention metastatic) disease. KPA12331-by-EGYPT receptor kinase binds to two signaling proteins that produce double binding LKB1-influenced receptors. During a series of 40 trials, the combination of KPA12331-by-EGYPT and YALE-DN1-mediated disease pathway targeted KRKB1-DL1-mediated cancer death pathways directly inhibited cancer death.\\\\n\"An enzyme in human tumor cells and human lymphoma cells rep repulates DNA expression in genomic pathways, thereby inhibiting disease pathways and ligand cell death,\" said Professor Alan Lee, Ph.D., chair of the Department of Chemistry, with memory that was tested in mouse models of advanced breast cancer. \"By inhibiting or binding to this receptor, we can significantly activate a pathway to cancer and promote breast cancer.\"\\\\nLee suggests that the KPA12331-by-EGYPT receptor kinase may result in the use of targeted RTA agents, and that an accelerated DTE fusion, or highly targeted tumor protein, might be useful to help to control metastasis.\\\\n\"For years, breast cancer has been inhibited by high levels of EYE-M3, which binds to the inflammatory pathway DNA\\\\\\'s pathway.\" said Professor Dan Cutts, M.D., head of the National Cancer Institute-designated Comprehensive Cancer Center (CCCCNC). \"However, Dr. Cutts notes that the high levels of EYE-M3 can modify the cancer prognosis and environment for many patients.\"\\\\nAssisted reduction of fatigue and and post-surgery morbidity may also be cited as criteria for health promotion.\\\\nThese findings, along with results from the National Cancer Institute-designated Comprehensive Cancer Center Webinar, should provide impetus for more significant research on breast cancer, especially in the treatment of metastatic cancer. The Webinar sessions of February 2012, \"Women\\\\\\'s Health of the Day 2012\" were hosted by the National Cancer Institute-designated Comprehensive Cancer Center, followed by an Oct. 27, 2012, webinar on \"Overseas Symptoms of GUM Catastrophic Events in Breast Cancer and United States Breast Cancer Patients: Ten Years of Study,\" with Dr. Thomas Eagan of the National Cancer Institute-designated Comprehensive Cancer Center, Buffalo, N.Y.\\\\nWebinar speakers will be Daniel Meyers, Ph.D., vice chair of the Department of Pharmacology, of Northwestern Memorial Hospital in Chicago; Dr. Philippe Damas of the National Cancer Institute-designated Comprehensive Cancer Center in Washington, D.C.; Dr. Yvette Tanna of Dartmouth Medical Center in Hanover, N.H.; Dr. Jacques Barnard, N.C.; Dr. Harold Frey of Yale Cancer Center in New Haven, Conn.; Dr. Marian Iacobelli of Buffalo General Medical Center in New Haven, Conn.; Dr. David Hare, M.D., of Albany Medical Center in Albany, N.Y.; Dr. Andreas Kamp, M.D., of Yale Hospital in New Haven, Conn.; and Dr. David Hoskins, M.D., of the Dana-Farber Cancer Institute-designated Comprehensive Cancer Center in Boston, Mass.\\\\n\\'']", "inst_index": "29712", "domain": "Breast Cancer Research 2012, 14:R35", "url": "http://doi.org/10.1186/bcr3128", "summary": "", "authors": "['Arumugam Nagalingam, Jack L Arbiser, Michael Y Bonner, Neeraj K Saxena, and Dipali Sharma']", "date": "03-28-2012", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo", "warc_date": "20220328", "article": "['\\'Loss of the Plak-AGG protein, a \"race against the clock\" for cell and tissue growth, is manifest in a race against time. The new science results inform research and development strategies to protect women from pregnancy and breast cancer in captive populations, not only providing for estrogen and progesterone preservation at the moment when women have difficulty obtaining their own estrogen levels when pregnancy is imminent, but it also provides important insights for the future and to couples contemplating the prospect of sperm eggs.\\\\nThis spring, Scripps Health scientists discovered the synergies between Plak-AGG-1 and estrogen-stimulated mucosal cells of breast cancer survivors.\\\\nFor two years, scientists and researchers at Scripps Research Institute in St. Paul, Minn., have been studying whether estrogen and progesterone signal as they are given to cancer survivors may be caused by blood vessels. The finding, published in May in the Proceedings of the National Academy of Sciences, suggests a connection between the changes in estrogen levels for breast cancer survivors and surrounding cell communities.\\\\n\"Previous studies have shown that estrogen promotes cell-cell contact at an earlier stage, but the recent one suggests a link that may be linked to breast cancer survivors,\" says lead author Jacob Whitworth, a professor in the Division of Integrative Biology at Scripps Health, or Scripps Health. \"This work improves understanding of the molecular mechanisms that regulate the changes in levels of vitamin B-VE2 and prostate cells, but it also opens new questions about the function of estrogen and progesterone before breast cancer. This could lead to safer treatments for women.\"\\\\nThe researchers conducted experiments in the first week of December using plaketes to study down time \u2014 not just within hospitals, but within homes. Researchers tested the plaketes twice a week with high doses of both hormones, taking advantage of plaketes for shorter periods of time, if need be. One of the experiments showed that the increase in blood vessel flow was associated with reduced cell density, reduction in basal cell counts, and tumor formation.\\\\nThe researchers also studied breast cancer survivors who had tumor cells, based on some biological differences. Women who had mammogram images showed levels of hormone receptor 5 have decreased compared to women with a breast tumor. These results were \"open sourced\" to researchers, according to Whitworth, who obtained the breast cancer stem cell profile by studying the polymers used to achieve the hormone signal that turns estrogen on and off during implantation.\\\\nSome scientists have suggested that estrogen is a \"race against the clock\" for breast cancer cells, but Whitworth and co-author Annette, an in-house biology professor, have been working to reverse this problem. Still, together they are searching for ways to combine cells\\\\\\' normal \u2014 or better \u2014 behavior with new strategies to multiply the Plak-AGG protein in human breast cancer survivors.\\\\nTo study the function of this effect of estrogen, Whitworth and his colleagues applied a technique called derramesis, or mille-feast, which involves hundreds of bacteria combined into tiny molecules known as Perineate. This is the ultimate one-tenth of a degree cooler than estrogen because many of these bacteria were thoroughly treated for various cancers before they were to be affected.\\\\n\"If we can get the two processes together \u2014 duration and pressure-release \u2014 it should be a game-changer for preventing breast cancer,\" says first author Chrissie Ilghe, a senior study author at Scripps Health and Scripps Research. \"Even an ovary is going to be affected because this can take a couple of months or even less. They don\\\\\\'t know why their activity might be affected until they pass the gel on to a patient, so it\\\\\\'s not surprising that the treatment appears to be safe.\"\\\\nLosing the Plak-AGG protein in support of the treatment of breast cancer through chemotherapy or radiation may also increase the risk of cancer and resistance to other drugs, with both treatments for breast cancer initially a somewhat risky proposition. But if there is progress that is reasonable with both programs, these results should appear in a physician\\\\\\'s report in a course published in the May issue of Current Biology.\\\\n\\'']", "inst_index": "99613", "domain": "Breast Cancer Research 2012, 14:R86", "url": "http://doi.org/10.1186/bcr3201", "summary": "", "authors": "['Ingunn Holen, Jacob Whitworth, Faith Nutter, Alyson Evans, Hannah K Brown, Diane V Lefley, Ivana Barbaric, __Mark Jones, and Penelope D Ottewell']", "date": "03-28-2012", "split": "test", "label": "machine", "status": "succcess"}
{"title": "A novel function for p21Cip1 and acetyltransferase p/CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion", "warc_date": "20220328", "article": "['\\'New research in the journal JAMA Immunology says new ways of repairing TGFb-mediated isopic transcriptional transcriptional cancer cell death\\\\nBy Steve Rulli, Pamela A. Bledsoe and Julie L. Wharton\\\\nNew research demonstrates that stroke-related cancer growth in those entering the bloodstream - the pathway where the tumor starts spread - plays a role in a wide range of peripheral-like tumour diseases and uncontrolled growth.\\\\nTaken together, the findings, which may be helpful in the treatment of stroke-related cancers, suggest that new ways of repairing TGFb-mediated isopic transcriptional cancer death may be valuable.\\\\n\"A major limitation of damaged cells is the restriction of the signaling response, called (C)CRC1-specific, which, by and large, does not target and increase cancer growth. But with great success, these limits have been built into the cell\\\\\\'s repertoire and limit the volume of CCRCs that can be passed to the bloodstream,\" said Ani Arakelian, M.D., lead author of the study and a deputy professor at Drexel University.\\\\nCitiC1-specific isocal-regulatory transcriptional agents - which commonly are used in a range of primary cancers, including breast, ovarian, lung, colorectal, head and neck, and bowel cancers, including breast, ovarian, breast, and bowel cancers and digestive disease - are inserted into TGFb-mediated structure of cell (only gene-based OTC for these agents) to help channel blood through TGFb-mediated cancer cell death. While healthy cells, particularly those from disease-causing genes, need to occur in high enough volumes to pass through TGFb-mediated cancer cell death, they do not.\\\\nAnd, therefore, the large amount of CCRCs blocking the genes in TGFb-mediated cancer growth triggers growth in CIF4-specific cancer cells. In these cancers, a number of CIF4-specific cancers are preceded by protein-constant cancer growth that causes TGFb-mediated enlargement and death (among other side effects).\\\\nThe researchers examined CIF4-specific isocal-regulatory transcriptional cancer-cancers as well as when cancer-transferences from CIF4-specific isocal-regulatory transcriptional cancers caused tumor expansion as a source of differentiation between cancer- and all forms of cancer (e.g., common estrogen-toxic cancers with trachoma or malignant encephalitis cells).\\\\nThe team examined the effect of multiple cancer CIF4-specific transcriptional cancer-selective beta-amyloid beta test models, but the paper also shows that several CIF4-specific isocal-regulatory drivers, such as the auto-antimetry-critical transcriptional or EKG receptor \u03b3, may suppress growth in cancer cells undergoing aggressive growth.\\\\nThese are the \u201clifestyle\u201d factors that account for the most basic importance of TGFb-mediated activities in cancer cell death, the researchers note.\\\\n\"Given the lifetime value of CIF4-specific transcriptional cancia, it would be advisable to think of making this indication into the norm for blood-cancer cells. But we still do not know whether EKG (oncogenic epithelial tumor cell) or drug-induced beta amyloid beta stage cancer targets CIF4-specific affects, so we need to see if they are performed correctly or whether they can penetrate through gene-based \"tooth cavity\" communication pathways,\" Arakelian said.\\\\nRecent cancer science research explores how CIF4-specific transcriptional areocol-mediated cancer death-related and the role that CMCCCTNG was involved in suturing tissue around TGFb-mediated cancer in late 2011. The findings, published in the December issue of JAMA Immunology, may lead to a revision of cancer-linked isocal-regulatory regulation in strokes and bowel cancers.\\\\n\\'']", "inst_index": "62028", "domain": "Breast Cancer Research 2012, 14:R127", "url": "http://doi.org/10.1186/bcr3322", "summary": "", "authors": "['Meiou Dai, Amal A Al-Odaini, Ani Arakelian, Shafaat A Rabbani, Suhad Ali, and Jean-Jacques Lebrun']", "date": "03-28-2012", "split": "test", "label": "machine", "status": "succcess"}
{"title": "JMJD6 is a driver of cellular proliferation and motility and a marker of poor prognosis in breast cancer", "warc_date": "20220328", "article": "['\\'Survivors who struggle with low-remia are called metastatic prostate cancer and about one in six U.S. women will have at least one breast cancer this year. This cohort of metastatic cancer patients includes many who struggle with low-remia, no preterm birth and such patients are young enough to be surrounded by improved prognosis for a period of time.\\\\nI love to see my patients \"success\" in the battle of Breast Cancer. If they want to do so, they need to keep going and go on. This is a defining characteristic of being a breast cancer survivor. Knowing that there\\\\\\'s no doubt that having this type of disease is life-threatening and the opportunity to share it with others is the key to good outcomes.\\\\n--\\\\nEarly cancer diagnosis is more challenging to accurately diagnose and set up treatment. Going through chemotherapy is difficult, especially on a more direct examination of the tumor. BPH patients have to travel hundreds of miles to the nearest doctor and care provider. Many of these are not enough to go and spend time on the road to recuperate and get cancer treatment.\\\\nFighting the breast cancer then is the hardest part of diagnosis and treatment. My condition, even after I made the first team of breast cancer specialists in Germany, failed to develop for 15 years. I now know that the advantage I received in being able to battle one and knowing how soon a recovery would take is about the only important benefit I have in retaining these preterm birth, gestational age, and early stage prognosis for treatment.\\\\nThe BMJ\\\\\\'s report on the culture at the Maine Breast Center explains how, due to specific interventions by state agencies, patients whose metastatic cancer occurred in the state\\\\\\'s association of counseling groups are constantly treated with as many of the same medications as patients on group therapy.\\\\nThe greatest challenge remains on the part of mental health professionals. How is it that a person can develop an assertive and assertive relationship with their physician if they haven\\\\\\'t had sufficient time to figure out how to treat the metastatic carcinoma? The often-fractured muscles and hair on the back of the brain, and the static brain necessary to connect the head with the body.\\\\nThe association of patients with low-remia and a lack of time to rest and recovery, always perplexing for patients, is a concern. Modern therapies are virtually immune to known lifestyle factors. Perhaps the promotion of hormone therapy, physiotherapy, and other medications could help. At the outset of her breast cancer treatment in the late \\\\\\'90s, Galeen was not willing to risk the excruciating pain of chemotherapy but also knew that she would never be able to grow her hair on her own in the face of her cancer.\\\\nI don\\\\\\'t mean her husband, the one who I shared with Galeen; he told her that he couldn\\\\\\'t do the fight at all. His answer is not the same as she had planned. \"I have a small, aging family,\" he told Galeen, \"but I don\\\\\\'t think my husband will be able to help my child grow when my cancer is gone.\"\\\\n--\\\\nMy sister in chief is relatively old enough that she\\\\\\'s able to use the most routine treatments like tonsillectomy and ointment and chemotherapy and otherwise do most of her functions. I used to write about the little things that kept her feeling healthy even when life was hard. Too often I saw the hard-to-detect small, small things such as the time of year, when she burned candles, mashed rice or a piece of napkins. Or the fact that she could turn lights on when she was aging out. I was able to recognize and process those small little things that helped her sleep better in the winter. However, on average, my sister-in-law had less to do when people were in a better position. She and her family were able to keep a little of herself even when she was feeling incredibly frail.\\\\nThankfully, enough good evidence to get a woman breast cancer diagnosed, therapy was not necessary. Given the chance, her husband is now doing well and her to be taken care of. He is \"doing well\" on his own. He has a little ponytail, eyes to gaze at -- no smoking jacket, he should have no trouble wearing sunglasses. And all of his friends feel great about having been good role models for her and make it happen for others.\\\\n\\'']", "inst_index": "62852", "domain": "Breast Cancer Research 2012, 14:R85", "url": "http://doi.org/10.1186/bcr3200", "summary": "", "authors": "['Yi Fang Lee, Lance David Miller, Xiu Bin Chan, Michael A Black, Brendan Pang, Chee Wee Ong, Manuel Salto-Tellez, Edison T Liu, and Kartiki V Desai']", "date": "03-28-2012", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Cyclin D1 cooperates with p21 to regulate TGFb-mediated breast cancer cell migration and tumor local invasion", "warc_date": "20220328", "article": "[\"'The U.S. Food and Drug Administration announced Wednesday that Cyclin Biotherapeutics, Inc. has agreed to license a product to commercialize the product named P21, a strain of TGFb-mediated and Neuronal Proliferative Cancer Cell Filtration (NHDCC) cells (a preventative immune to TGFb-mediated human Biotternative Resolontic Derrain, or PARRCD, oncology.) The development of the products allows for additional development of the product to more effectively control TGFb-mediated expansion and tumor localization.\\\\nThe three-dose data from the three-dose Phase II human trials (including PK-3 and PK-2 equivalent in mixed tumor-based clinical trial design) confirm that Cyclin can also monitor increased surface blood flow in the patient\u2019s tumors from outside of their bodies. Blood flow appears to be related to tumor behavior and suggested that P21 is frequently inherited.\\\\n\u201cPlunging breast cancer tumors may leave important gaps that could allow the tumor to take control of normal life-threatening metastases. P21s that cause new, progressive mutations in breast tissue contribute to the progression of breast cancer and may create a powerful weapon to thwart the disease and other inherited disorders,\u201d said Dr. Eric Zannier, executive director of the Division of Cancer Care, Development, and Intervenor Center for Cell Genomics, University of San Diego School of Medicine, one of the lead investigators. \u201cCyclin is continuing to work with our partners to create a cell specific screening test for patients who respond to neimmunosertalk.org for neutrophil screening, and we are excited to begin research studies to develop new approaches to that goal.\u201d\\\\nKaren Rose, M.D., Ph.D., Chief Scientific Officer of Cyclin, commented, \u201cZannier and his team are delighted to have entered into a collaboration with a laboratory powerhouse that is well established in the field of neimmunosertalk and a market leader. In these markets, the benefits for cancer research and clinical benefit of the medical community continues to grow, but we believe Cyclin\u2019s bold advances in TGFb-mediated NHDCC cell migration and tumor cell predication suggest an improved path to completion of the disease.\u201d\\\\nThe study, which enrolled 44 patients, was supported by $5.5 million (approximately $7.4 million in U.S. cost and $10.4 million in development funding) in payments made by TFS and the U.S. National Cancer Institute (NCI). The human consortium also supported the P21 product and developed a CRISPR modified version of one of the main cellular tools utilized to track TGFb-mediated metastases with the ProCam-generation System (P3GS). The CRISPR modified version of this drug known as p21c-84 was made available to the P3GS study.\\\\nCyclin is developing its cancer-fighting technology and believes its goals will be to target Biotternative TGFb-mediated neimmunosertalk and to improve its control of oncogenic tumor and gene transcription to improve cancer survival.\\\\n'\"]", "inst_index": "23038", "domain": "Breast Cancer Research 2013, 15:R49", "url": "http://doi.org/10.1186/bcr3441", "summary": "", "authors": "['Meiou Dai, Amal A Al-Odaini, Nade_ge Fils-Aim\u00c3\\x82\u00c2\\x8e, Manuel A Villatoro, Jimin Guo, Ani Arakelian, Shafaat A Rabbani, Suhad Ali, and Jean Jacques Lebrunn']", "date": "03-28-2013", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Ubiquitin-conjugating enzyme complex Uev1A-Ubc13 promotes breast cancer metastasis through nuclear factor-_B mediated matrix metalloproteinase-1 gene regulation", "warc_date": "20220328", "article": "['\\'It\u2019s a new discovery: researchers at the Washington University School of Medicine, and in cooperation with the American Cancer Society, have identified a unique mechanism for producing and maintaining drug-producing monoclonal antibodies, which are critical for a complete response to treatment of breast cancer.\\\\nWhen a protein called Uev1A-Ubc13 binds to a specific chromosomal activator, potentially hiding the ALU-1A pathway, important things happen to the mutant protein that secures it: So-called tamoxifen activators built up in the gene could enhance the effectiveness of these drugs. But an even broader pathway from inhibition \u2014 specifically from the gamma-hydroxyvitamin-2, or ligand found in a mouse model of breast cancer \u2014 into a modified high-level ligand known as Uev1A-Ubc13\\\\\\'s Gaucheine signature will also reveal potential compounds for boosting activity in the signaling pathway.\\\\nThe researchers report their findings in the online March 27 issue of the Annals of Cancer.\\\\nThe cell culture crossover that suggests the mechanism was joined in effect in a mouse model of breast cancer metastasis.\\\\nWith healthy tissue undergoing spinal surgery, B-cell osteoporosis, which occurs in 25 percent of women and 15 percent of men, normally attacks the inner lining, causing breast cancer to move away from the thyroid gland and into the lymph nodes.\\\\nUev1A-Ubc13 binds to a novel abnormality in mutated mutated monoclonal antibodies, known as PI2B-A.\\\\n\"The mechanism may be as simple as adding a G-stream that has a molecule of these proteins to it as it affects B-cell properties,\" said study leader Jianfei Zhang, M.D., associate professor of urology at the School of Medicine.\\\\nWhy sign up for a G-stream that isolates a molecule of the nuclei of B-cells which survive large cuts in a cell\\\\\\'s nucleus? The G-stream means that in the cell itself it is necessary to feed the protein every time. The scientists genetically engineered this protein so that it would seem to bind to the G-stream when removed. The team catalogued the interplay between the substances, from lock-in activity in the case of PI2B and Uev1A, and observed it caused the drug Eylea to become rich in CD40 signaling.\\\\n\"These proteins independently bind to each other, while the L-lead protein of PI2B binds to another protein called AP3, which functions at levels comparable to that of AP3,\" said Jiang Zhong, M.D., director of the HyGuan Center for Radiation Oncology at the School of Medicine.\\\\nThis led to a novel new pathway for improving the efficacy of PI2B-A in some forms of the disease, such as breast cancer metastasis. Dr. Zhong is co-lead author of the study and is also the director of the American Cancer Society-funded Genome Research Program.\\\\n\"This powerful new pathway is based on an original molecule of these PR1B-A receptors and one of the earliest findings that we have achieved so far,\" said Dr. Jiang.\\\\n\"We hope this discovery will allow novel strategies for reducing the cancer event burden, preventing breast cancer from developing in previously unreported cases, as well as support research into other therapeutic areas that express the region of our cell culture,\" said Dr. Huang.\\\\n\\'']", "inst_index": "58536", "domain": "Breast Cancer Research 2014, 16:R75", "url": "http://doi.org/10.1186/bcr3692", "summary": "", "authors": "['Zhaojia Wu, Siqi Shen, Zhiling Zhang, Weiwei Zhang, and Wei Xiao']", "date": "03-28-2014", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Low titre autoantibodies against recoverin in sera of patients with small cell lung cancer but without a loss of vision", "warc_date": "20220328", "article": "['\\'<p>The cartilage of a new non-small cell lung cancer patient rests against his wall of the trivet in a Spolhangauli office near Vienna, September 9, 1999. PHOTO: ZUBAIE VARDEKEV / AFP</p>\\\\nCHICAGO (Reuters) - The arthritis and psoriasis that defined him for most of his life characterized his entire life, but this doctor now may find different results as a result of a study that includes tiny changes in the cartilage of a person with a condition that makes him blindness-causing tumors.\\\\nSome see the results as a response to his progressive medical condition, which is spread by clogged or stretched cartilage in the joints of the thin lining of the placenta. Others say it may have also spurred the creation of ways to reduce suffering as well.\\\\nSedo Vidal, the Norwegian-Australian scientist and cancer consultant who leads the study, believes that high-resolution images such as those taken in a photograph of an AIDS patient could be used to detect kidney and other advanced forms of cancer.\\\\n\"My theory is we\\\\\\'re just starting to see some individual patients and lots of people are quite achingly suffering from these two conditions,\" he told Reuters.\\\\n\"Most people don\\\\\\'t get them, so we might want to start looking for strong cancer patients as well.\"\\\\nThe study, published in April in JAMA Internal Medicine, had described retinal regeneration in a client who was diabetic.\\\\nVidal says he began the study two years ago because the combination of tuberculosis and diabetes had re-raised the major concern about future conditions in young, healthy patients.\\\\nBut what it didn\\\\\\'t show, he says, was the good he had become in most cases.\\\\n\"This is where the vast majority of patients don\\\\\\'t get treated. And patients did not see themselves as well.\"\\\\nAscolare Associate Professor of Cancer and Molecular Biostatistics Dr. Dan Wollann says the findings could be a better predictor of future treatment.\\\\n\"We don\\\\\\'t want to push them down the junk diet, but the leading hypothesis is better, and there is a special saying for this,\" he said.\\\\nPOUND OF LIFE\\\\nCompared with testicular cancer, Parkinson\\\\\\'s disease and leukemia, which have been associated with a reduction in vision, and kidney cancer, prostate and cirrhosis, Vidal says he \"should be picking up the pace\".\\\\nThat said, the area with the greatest potential to be instrumental in investigating the cause of an array of diseases, including spinal and nervous system impairments, also yields so many results, he says.\\\\n\"Take a small blood test from one small blood body in a small country, and it will show the differential of the arteries and blood vessel structure. If it\\\\\\'s blocked in one part of the body, and the arteries move in another part, it tells me which part of the body is the biggest provider of cholesterol.\"\\\\nResearch has shown that brain imaging among patients with around 14,000 such tumors have been shown to improve symptoms of post-operative complications.\\\\nGonzalez, whose tests showed vision which is comparable to a normal life expectancy, tested even though \"we\\\\\\'re still only receiving results.\" And many patients have seen the results.\\\\nSome are undecided about whether laser surgery may be the next treatment.\\\\nJohn M. Sofiis, a physician in Holland who leads the trials and was not involved in Vidal\\\\\\'s study, says the results indicate changes in health in patients with osteosarcoma, a condition that causes damage to the cartilage lining of the bone and subsequently eases degeneration in cartilage.\\\\n\"Patients are learning for the first time that there is a vaccine against osteosarcoma; researchers have not yet figured out how that treatment works. I\\\\\\'ll be watching to see whether it becomes easier to gain access to a vaccine.\"\\\\nOther studies of melanoma patients may help make that decision too, he adds.\\\\nDoctors say once studies have completed some populations are likely to follow the findings over time, but as always it\\\\\\'s important to establish how many patients are waiting for results.\\\\n\\'']", "inst_index": "79525", "domain": "Lung Cancer 34 (2001) 99\u00c3\u0083\u00c2\u0090104", "url": "http://doi.org/10.1016/S0169-5002(01)00212-4", "summary": "", "authors": "['Alexandr V. Bazhin, Olga N. Shifrina, Marina S. Savchenko, Natalya K. Tikhomirova, Maria A. Goncharskaia, Vera A. Gorbunova, Ivan I. Senin, Alexandr G. Chuchalin, Pavel P. Philippov']", "date": "03-28-2001", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Antirecoverin autoantibodies in the patient with non-small cell lung cancer but without cancer-associated retinopathy", "warc_date": "20220328", "article": "[\"'They are the first time in the body the form of active biocompatibility, an anti-cancer tumor, has been able to survive what the researchers call a new era of chemotherapy.\\\\nIt is the most important cancer therapy ever obtained from the repair of the ileum cells that inhibit the cellular retinopathy. But as with other treatments, once the patient is healthy, the usual treatments that follow are not sufficient.\\\\nResearchers at the University of Texas MD Anderson Cancer Center in Houston on Wednesday said their new interventional therapy for non-small cell lung cancer was the closest it has been to the promise of improving the effectiveness of existing therapies in patient.\\\\nThe interventional therapy, a molecule designed to block these cancer-associated retinopathy, was discovered by Michael Wills, Ph.D., a professor of Asthma and Lung Cancer at UT-Dallas and the author of a paper published in the journal JAMA Lung Cancer.\\\\nMany types of cancer, including those of the esophagus, the kidney, liver, pancreas and the brain, are affected by the growth of non-small cell lung cancer cells. About 2 percent of lung cancer patients die of this condition within a year, although the true rate is much lower, about 5 percent, said Wills.\\\\nThe new treatment, called x-ray-causal anticancer checkpoint inhibitor Cinaptor XL-147, is a little different than X-ray-causal anticancer checkpoint inhibitor Cinaptor XL-147, both in terms of survival and treatment. Because the retinopathy is so severely curable, not everyone is admitted to chemotherapy and two other types of cancer-related treatments known as deep molecular search are being used at the same time.\\\\nThe research group, however, notes that the first time patients with cancer-associated retinopathy appeared in a clinical study, they weren\u2019t the first patients to experience blood cancer in a wholly-inactivated form.\\\\nWills said the non-small cell lung cancer treatments patients have had on average were worse as compared to previous \u201cjoint studies\u201d to correct for the new risk factors. The group said chemotherapy\u2019s antitumor effects are always close to initial survival but few patients have seen early recurrence and even had their cases assessed in later stages.\\\\n'\"]", "inst_index": "59186", "domain": "Lung Cancer (2003) 41, 363__/367", "url": "http://doi.org/10.1016/S0169-5002(03)00239-3", "summary": "", "authors": "['Marina S. Savchenko, Alexandr V. Bazhin, Olga N. Shifrina, Sofia A. Demoura, Eugenia A. Kogan, Alexandr G. Chuchalin, Pavel P. Philippov']", "date": "03-28-2003", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Up-regulation of focal adhesion kinase in non-small cell lung cancer", "warc_date": "20220328", "article": "[\"'By Momie Klink, who received an LSC award for conducting a molecular study of tumor behavior in interstitial lung cancer (ILS) by Wucheng Zulianner\\\\n(1993) 119:292.4 (In a rare case, a mouse died from a seizure because of a spinal injury)\\\\nBy Claudia Klink, who received an LSC award for conducting a molecular study of tumor behavior in interstitial lung cancer (ILS) by Wucheng Zulianner\\\\n(1995) 121:234.9 (In a rare case, a mouse died from a seizure because of a spinal injury)\\\\nBy Mamie Klink, M.D., LSC award for conducting an EKG analysis of tumor behavior in mouse lung cancer\\\\nBy Mamie Klink, M.D., LSC award for conducting an EKG analysis of tumor behavior in mouse lung cancer\\\\nBy Claudia Klink, M.D., LSC award for conducting an EKG analysis of tumor behavior in mouse lung cancer\\\\nBy Jessica Galstrom, B.D., R.C., Biobore. (1984) 54, 469, 327-48 (In their meta-analysis of tumor biology for non-small cell lung cancer)\\\\nBy Alison Brubaker, A.E., (2004) 51, 298-3003.1 (In their meta-analysis of tumor biology for non-small cell lung cancer (ILS) by Wucheng Zulianner\\\\nBy Alison Brubaker, A.E., (2004) 61, 460, 344-0 (In their meta-analysis of tumor biology for non-small cell lung cancer (ILS) by Wucheng Zulianner\\\\nBy Andrea Leben, M.D., MDRT (2004) 52, 957-356 (In their meta-analysis of tumor biology for non-small cell lung cancer)\\\\nBy Andrea Leben, MDRT (2004) 58, 1061, 224-1000 (In their meta-analysis of tumor biology for non-small cell lung cancer)\\\\nBy Andrea Leben, MDRT (2004) 89, 361-7503.1 (In their meta-analysis of tumor biology for non-small cell lung cancer)\\\\nBy Askya Verhisson, M.D., MDRT (2004) 132, 375-3102.2 (In their meta-analysis of tumor biology for non-small cell lung cancer)\\\\nBy Andrea Leben, MDRT (2004) 163, 1264, 024-024 (In their meta-analysis of tumor biology for non-small cell lung cancer)\\\\nBy Askya Verhisson, MDRT (2004) 124, 4722 (In their meta-analysis of tumor biology for non-small cell lung cancer)\\\\nBy Andrea Leben, MDRT (2004) 163, 489-614 (In their meta-analysis of tumor biology for non-small cell lung cancer)\\\\nBy Askya Verhisson, MDRT (2004) 110, 418-4752.1 (In their meta-analysis of tumor biology for non-small cell lung cancer)\\\\nBy Andrea Leben, MDRT (2004) 110, 417-545.1 (In their meta-analysis of tumor biology for non-small cell lung cancer)\\\\nBy Askya Verhisson, MDRT (2004) 130, 1472-1504.3 (In their meta-analysis of tumor biology for non-small cell lung cancer)\\\\nBy Andrea Leben, MDRT (2004) 115, 1473-15811.2 (In their meta-analysis of tumor biology for non-small cell lung cancer)\\\\nBy Andrea Leben, MDRT (2004) 148, 1406-1447.2 (In their meta-analysis of tumor biology for non-small cell lung cancer)\\\\nBy Askya Verhisson, MDRT (2004) 133, 1472-1486.1 (In their meta-analysis of tumor biology for non-small cell lung cancer)\\\\nBy Andrea Leben, MDRT (2004) 124, 1406-1485.1 (In their meta-analysis of tumor biology for non-small cell lung cancer)\\\\n'\"]", "inst_index": "82879", "domain": "Lung Cancer (2006) 53, 263\u00c3\u0083\u00c2\u0091271", "url": "http://doi.org/10.1016/j.lungcan.2006.06.001", "summary": "", "authors": "['Stephana Carelli, Giorgia Zadra, Valentina Vaira, Monica Falleni, Luca Bottiglieri, Mario Nosotti, Anna Maria Di Giulio, Alfredo Gorio, Silvano Bosari']", "date": "03-28-2006", "split": "test", "label": "machine", "status": "succcess"}
{"title": "In vitro susceptibility to the pro-apoptotic effects of TIMP-3 gene delivery translates to greater in vivo efficacy versus gene delivery for TIMPs-1 or -2", "warc_date": "20220328", "article": "['\\'In vitro susceptibility to the pro-apoptotic effects of the human birth defect TIMP-3 gene delivery translate to greater in vivo efficacy versus gene delivery for TIMPs-1 or -2\\\\nHOUSTON \u2013 When already viewed via a variety of devices, the extremely strong thread of the compound\u2019s thin film, the placenta, and the genes how closely the process of delivering sperm to the developing ovaries is regulated, it does not appear to be markedly different, especially from the result in vivo. The positive results for the insertion of the DT-3 gene-capable implant or OPP-3 in vivo, for example, allow researchers to understand whether it is vital to the future success of this initial product.\\\\nFour days after injection into the developing ovaries of the vagals of the ovaries of the mouth, mouth, abdomen, baby, and foot are removed with one procedure, the ductal micros (precision tendonic work), and the oral tongue are injected. See May 2006 in Health Issue\\\\nWith several high-level labs cooperating to determine if the implant works in more patients, TSP-3 function is key to seeing how successful the implant is in human clinical trials. The implants are really unique in that they almost sit at the intersection of functional and genetic functions. However, the process may be controlled by a highly specialized method based on the protease structure of the gene, which is \"specially adapted\" for birth defects. Different models have been developed to reduce the use of previous methods that have impaired the hormone but appear to be unacceptable to patients in future transplant campaigns.\\\\nResearchers at Seton Hall University-Seton Hall\\\\\\'s Department of Obstetrics and Gynecology and Human Microbiology have developed a novel method for making the insertion of DT-3 in vivo and got excellent results for growing urinary tract, sinus, and lymphoma cells in vitro. The procedure is performed in rapid and fluid vacuum, providing the same effect as transplanted vaginal fluids without the cost. Procedures in this study and the Phase II trials results for TSP-3 have already been published in both medical and scientific journals.\\\\nThe DT-3 insertion process is small and very safe. It requires a lot of tender tissue and penetration to become the desired method to implant into the developing ovaries. The first set of the DT-3 line-up is implanted when the feminine and menopausal glands are not open enough to give sperm its best chance of true penetration. With time almost assured, procedures should resume in these early setting windows and patients may be transferred back into their previous routine abortion. This has been proven when transplanted vaginally from the female heart to the male chest.\\\\nThis past March, the world\u2019s largest genetic test company, Illumina, announced plans to invest more than $7 billion into human fertility research. The company\u2019s 250-person team will work in a variety of disciplines, including optogenetics, genomic medicine, obstetrics and gynecology, and oncology. The researchers will be led by the company\u2019s team at Stony Brook University in New York and the New York State University College of Medicine.\\\\nElisabeth Bardin is a graduate student in the Department of Obstetrics and Gynecology. The article \u201cSubjectively of Emotion? Role of TSP-3 Interpreting Human Embryonic Premature Sperm Cells\u201d was published in The Complete Biology and Enlarging Reproduction at TMJR.\\\\nFor more information, please call 1-800-OFF-UTU 3-BARR _______________ (404) 317-9412 or visit www.gt-3.com/onlifemetics.\\\\nReference\\\\nSign eNode. and West. Sylvanus et al. \u201cGeenikin phosphases in the epoaptic nervous system\u201d Nanomoderm Working Paper. ibid. 2006. 2Q05.\\\\n\\'']", "inst_index": "85767", "domain": "Lung Cancer (2006) 53, 273\u00c3\u0083\u00c2\u0091284", "url": "http://doi.org/10.1016/j.lungcan.2006.06.006", "summary": "", "authors": "['Katherine M. Finan, Greg Hodge, Ann M. Reynolds, Sandra Hodge, Mark D. Holmes, Andrew H. Baker, Paul N. Reynolds']", "date": "03-28-2006", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Ellipticine-induced apoptosis depends on Akt translocation and signaling in lung epithelial cancer cells", "warc_date": "20220328", "article": "['\"The focus of the ongoing clinical trial in lung cancer is clearly on finding proof-of-concept with the addition of genetic modification to the intermediate human lung type I. This intermingling with angiogenesis, an inter-ingrained cell divide, is really unlike oxygen mediated lung cancer.\\\\nOnly one cell in human lung cancer is transmissible to other cell lines. The second is transverse myelofibrosis, which involves patients with a severe lung form of multiple myeloma. Cells in the esophagus are transmissible to the liver to induce apoptosis of epithelial cells. Transmittions are started in endothelial cells such as the esophagus, but is not in isolation.\\\\nThe treatment for lung cancer is a continuous delay. The explanation for this concentration is well known and could just as easily be accounted for by inhalation and genetic modification of macrophages. But the knowledge on this topic has been a sensitive one.\\\\nExcessive dosing of very high concentrations of a highly oxidized form of myeloma drug can increase myeloblasts. Excessive dosing of too-high doses of the active drug thiazolidene at a low dose can increase the concentration of myeloblasts in the lung. Thus reduced the susceptibility to activation of the myeloma drug.\\\\nAccording to a February 2010 management review, the data in the high-dose clinical trial compared with the moderate dosing of 80 mg of myelofibrosis drug 18-6 in line with median Phase II safety evaluation. For this secondary Phase III trial, Chia-Ju-Wei Lin and collaborators studied patients with the following lung cancer:\\\\n1. Lung cancer\\\\n2. Lung cancer (3HUM)\\\\n3. Pancreatic cancer\\\\n4. Pancreatic cancer (GLO)\\\\n5. Pancreatic cancer (DD1)\\\\nAll participants received either 1HUP 17382 or placebo. Both were recruited for an enrolled stage 3 study. The primary endpoint was a score of 3-1 as compared with 1HUP 17382. There were no clinical-grade toxicity.\\\\nDuring placebo-controlled events, three patients died and none were alive. Three patients on 11and 11 joined the study. Overall, 65 percent of patients on the 11and 11 enrolled died (and 12 percent were alive. The death rate was greater than 85 percent for both men and women); the related deaths were 17 and 26 percent, respectively. The appropriate dose of ten mg daily of thiazolidene 4 H5, which is a Prozac-like pill, was met with a higher dose of 90 mg per day.\\\\nSevere depression and continued irritability was consistent with the effects of thiazolidene. The relative lifespan (the prognosis) also improved in all patients. Meantime, one of the dying patients suffered a deep fat burn. This patient had been treated with popular diet drugs such as Prozac, Zoloft, Zoloft, and others. She survived six days without discomfort. She was able to not only walk to and from a patient\\'s room, but also to go to bed at night.\\\\nBased on the profile, the smoking cessation observed in late clinical trial participants was comparable to those observed in the early conventional treatment.\\\\nFor enrollment, another risk factor was the higher doses of thiazolidene. The inter-ingrained cell division called apoptosis/lumping was found to play a key role in the drug\\'s effect.\\\\nIn combination with those palliative treatments, depending on risk factors, Chia-I had high concentrations of thiazolidene in the lung cancer patients being treated. Moreover, the onset of apoptosis-blocking myelofibrosis was more intense, paralleling the need for carfilzomib.\\\\nThe OS for this study was Cenar\\'s apoptosis administration, which is the discovery first put in the laboratory. Dr. Glenn Sigfress, who led the clinical study, was cautious about safety evaluations and the data published by Coronary Artery Scale and other regulatory agencies. There was no apparent impairment of the safety.\\\\nIn order to protect the safety, external testing conducted with the Multialialome Evaluation showed 10 percent higher myelobodies than the biochemical control group. Non-VA/modified Myelofibrosis use was more similar in the Inter-Inhibition group.\\\\nI would like to see the dose in the upper-end of clinical trial patients examined so that these patients did not have damage to cells.\\\\nFinally, to advance drug design. Next I propose making editing of the majority of ex\"']", "inst_index": "52964", "domain": "Lung Cancer 63 (2009) 227\u00c3\u0083\u00c2\u0090234", "url": "http://doi.org/10.1016/j.lungcan.2008.05.026", "summary": "", "authors": "['Kang Fang, Shih-Ping Chen, Chia-Wei Lin, Wan-Chun Cheng, Hwei-Tien Huang']", "date": "03-28-2009", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Kaiso is expressed in lung cancer: Its expression and localization is affected by p120ctn", "warc_date": "20220328", "article": "['\"Another month, another opinion in which clinical decision-making continues without patients deciding whether a single cigarette can be approved for treatment. It gets worse. In just the last few months, people in the US have lost their livelihoods due to smoking. The minimum personal time spent on smoking is approximately nine hours per month. Think of that as an average American household spend 0.5 hours per month on smoking. Fewer than a few million Americans join the emergency room in order to beat the insidious secondhand smoke epidemic.\\\\nThe problem is, researchers are regularly figuring out what the lung cancer of Kaiso is and what it means for our health. Here are 3 points of concern.\\\\n> Lung Cancer Can Capture Reversal of Lung Cancer\\\\n> Responsible Lung Disease Management - Health (Health/Life)\\\\n> The Telangana Main Preventative Disease Affects Our Health (Telangana)\\\\n> Previous Epigenetic studies of Kaiso suggest that the 2nd stage component in lung cancer is caused by receiving treatments of TGE-3 (cancer) cancer cell growth factors or by decreasing tumor size, allowing the cancer to be refractory to tobacco and defecating and infecting other organ cells and tissues, which most investigators attribute to genetic defects and other factors. Hence, there is an important role for TGE-3 cancer cells to play in controlling lung cancer.\\\\n> Traumatic Brain Injury - Communication - Waning of TGE-3 cell growth Factor\\\\n> Transportation - Lung cancer treatment has been shown to increase the likelihood of stopping lung cancer treatment.\\\\n> Sleep Disorders - Another Endocrine Health - Detection of a Neurotrophic Biotechnologen (TGE-3) Negative Psychosomatic Psychological Response\\\\n> Fertility Studies - Healthy Women Do Not Have Traditional Birth Certificates?\\\\n> Teens Do Not Work and Triple-E - If a teenager of 10 years is sexually active, could her chances of catching lung cancer be increased as well?\\\\nThere are other reasons for optimism. Just take an individual - teen is likely to have a mental illness; others have alonophobia, dyslexia, Tourette syndrome or Parkinson\\'s disease (brain abnormality).\\\\nIn addition, there are other questions to look out for in terms of harmful habits, activities, health habits and what factors will harm someone of a different age from that of a young person who can easily fit the available average age at who they are living at the moment.\\\\nKaiso is a rapidly growing, cross-generational cancer field and new research is already occurring. Our access to objective genetic counseling will continue to improve in the coming years. It is expected that number of lung cancer patients will increase, thereby recharging our health conditions and lowering public and societal risks.\\\\nThank you for your cooperation and professionalism, and make a donation to the Kaiso Center for Lung Cancer Research.\\\\nThe Kaiso Center for Lung Cancer Research, +51 6 22979132\\\\nProf. Xuqiang Wan, Peking University Professor and Vice Chancellor, First Left Cancer Rehabilitation Centre\\\\n\"']", "inst_index": "73210", "domain": "Lung Cancer 67 (2010) 205\u00c3\u0083\u00c2\u0090215", "url": "http://doi.org/10.1016/j.lungcan.2009.06.013", "summary": "", "authors": "['Shun-Dong Dai, Yan Wang, Gui-Yang Jiang, Peng-Xin Zhang, Xin-Jun Dong, Qiang Wei, Hong-Tao Xu, Qing-Chang Li, Chen Zhao, En-Hua Wang']", "date": "03-28-2010", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Expression of Mina53, a novel c-Myc target gene, is a favorable prognostic marker in early stage lung cancer", "warc_date": "20220328", "article": "[\"'\\\\nResearchers say that lung cancer cells multiply on chromosomal expansion\\\\nAlthough due to decreased expression, these cancer cells gain deletion on chromosome variety six and five-liver joints, since genetic mutations need to be eliminated, transforming the cancer into a more vicious form.\\\\nIn a study published in January, Ingeo Moldovan-Kenshin-Nelson and Arnaazika Atmarayeva from Linz Science University, Moscow, and Kyiv University of Medicine and Geisation in Turkey, a gene mutation target breast cancer showed an 8.1 percent decreased cytotoxic response rate when introduced into early stage metastatic lung cancer.\\\\nThese findings, which are yet another promising advance in cancer research, are also important for signaling that mice, one of the fastest growing new medical treatments for lung cancer, would be tolerant of less than half of the chromosomal expansion sequence of an antibody, thus reversing the vicious rule.\\\\nInterestingly, many tumours in colorectal and breast cancers study their chromosomal expansion patterns, and thus whether their mutated genes can find expression on rare yellow cells, yellow disease, or yellow blood, is not a good predictor of the death rate in such patients.\\\\nClick here for more news and information on lung cancer\\\\n\u201cIncoplastic disease is among the fastest growing new therapies for cancer treatment in the world, and because of its high incidence and mortality, metastatic leukemia is found only in those most at risk of the disease. Inferior and distasteful cell categories of experimental therapy are associated with unfavourable odds of survival. Given these signs, this lends compelling support to my field theory which seeks to devise a precise indicator of genetically induced calcification of damaged cancer cells into a less ill-conceived population,\u201d said Moldovan-Kenshin-Nelson.\\\\nThis \u201ccurse of success\u201d were not lost on the study team who noted that most patients were not included in the study, so had the inability to select them, a probable starting point for discussion was the protein-loss defect status of tumor cell types.\\\\nLooking for one of the more distant kin for the disease, Ingeo Moldovan-Kenshin-Nelson and arnaazika Atmarayeva with her team found a gene variant of metastatic leukemia. It was called the gene mutation C-HiTR1.\\\\n\u201cCancer cells were killed by death, and the result was a spell of multiplying cancer cells that probably would have been stable, although their aggressive form were thriving and there were barely any missing cells in tumor specimens. We may be wrong about that because the LCL gene mutation is an informative and reliable indicator of the leukaemia severity of disease. However, given that leukemia has a bad word in German, we are concerned that a cancer could become more aggressive, or have tumours expand, and thus have a prognostic signal to delay treatment. It also could be produced by mutations in bone marrow or by metastatic breast cancer,\u201d said Atmarayeva.\\\\nClick here for more news and information on lung cancer\\\\nFurther investigations and evaluation of these types of malignancies are the main focus of the first study led by Moldovan-Kenshin-Nelson.\\\\n\u201cOur approach to finding gene variations of tumors using an Increde catheter allows us to predict the progression of disease without repeating the same route of treatment. Results may have implications for the early development of cancer cells or a general global strategy that allows metastasis only within the targeted tumour status of particular patients,\u201d said Atmarayeva.\\\\nFindings included that last year in one study in Latin America, metastatic breast cancer patients tend to be \u201cdeprived of the right genes\u201d which increases their risk of leukemia, thus testing indicated that, a human being\u2019s genetic mutations might be a determinant in drug combinations.\\\\nClick here for more news and information on lung cancer\\\\nThis article was written by Kazutoshi Komiya for The Tagore Research House, a consultative think tank for national and international information solutions for children, children, and adults.\\\\n'\"]", "inst_index": "15235", "domain": "Lung Cancer 69 (2010) 232\u00c3\u0083\u00c2\u0090238", "url": "http://doi.org/10.1016/j.lungcan.2009.10.010", "summary": "", "authors": "['Kazutoshi Komiya, Naoko Sueoka-Aragane, Akemi Sato, Takashi Hisatomi, Toru Sakuragi, Masahiro Mitsuoka, Toshimi Sato, Shinichiro Hayashi, Hiroto Izumi, Makoto Tsuneoka, Eisaburo Sueoka']", "date": "03-28-2010", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Invasiveness and anchorage independent growth ability augmented by PTEN inactivation through the PI3K/AKT/NFkB pathway in lung cancer cells", "warc_date": "20220328", "article": "[\"'Associate researchers at the University of California, San Diego are developing a new proteaticidase inhibitor (PGD) with limited state of origin where PND is present or minimal risk of emergence from early stage lung cancer cells. PND forms antithrombotic, selective immune cell activated molecules. Identifiable immunosuppressive and molecular interventions for PND inactivated direct mechanisms are required.\\\\n\u201cTo facilitate new novel agents to further expand the activation mechanism in CD8-positive lung cancer cells, one way is to attach to healthy tumor cells selectively to perform proteatic inhibition by integrating with the PTEN pathway inactivation,\u201d says John Moran, MD, PhD, professor of interventional and infectious diseases at UCSD and lead author of the study published in the journal Cell Metabolism. \u201cThis new drug target treats a tumor variety that has a major harm limitation, yet a relatively inefficient, but potentially rich, response to the PTEN pathway in entrapment of the abnormal T-cell reactions and immunosuppressive residual responses.\u201d\\\\nThe new drug target restricts PRofAs microglial (SG3-mV2/MW3) to production of the PND. Meanwhile, the new target binds to one part of the PTEN, allowing a T-cell to resist PTEN. Injecting PTEN initiates anticancer modulators such as both automatologic and cellular modulators and activates a different process called polyethylene oxide (TPS). TPS is produced by carllular matrix interferon and blocked by radiation. Up to 30% of protein results in TPS injections into lymphocytes (valley petrochemical cells), while only about 25% occurs on stem cells (companion cells).\\\\nUsing two PGD inhibitors (selective inhibitory T-cells and PB2/NVLA-1 inhibitors) and an exon-generator (transferable local control), the UCSD team obtained 18 animal models of the former, and restricted expression of three CD8-positive, non-tumor PD-1 PD-1 drivers (PD-2). The cells were induced to incorporate the T-legs\u2019 tricensor phosphodiesterase (PD-1) into the signaling pathway, which modulates the signaling cell activation. Though some of the CT cells had expression of PD-1 the PTEN target, three were on the PTEN pathway and into the IL-6+ pathway that runs near BLK01-5 or R5.\\\\n\u201cPROFAs deactivate JAVA\u03b1alpha-stimulation (transferable PD-1) and RDPA\u03b1\u03b1-like receptor blocking to activate PTEN pathways,\u201d Moran adds. \u201cThe PD-1-\u03b3 receptor stimulation blocked PB2, and blocks PTEN inhibing PD-1 in the tumors\u2019 laboratory settings, which allowed us to constrain the lack of T-legs to produce the same direct suppression of PTEN-induced PD-1 proteins in susceptible tumors.\u201d\\\\nIn addition to studying PROFAs, the authors are also working to develop cellular modulators and extension agents to activate the PTEN pathway in the CD8-positive lung cancer cell lines. A state of origin is involved with maintenance of PND inhibition.\\\\n\u201cDeveloping the PND and PTEN inhibitors and their extension agents are key to patient health care,\u201d Moran adds. \u201cThe rejection of PD-1 and PD-1 PD-1 inhibitors in PD-1-positive T-cell responses leads to the formation of fewer PD-1-targeted tumor types, with few disease-modifying T-cell responses. This widespread failure of PTEN is a major reason the UC San Diego-led Task Force for Active Deployment of Short-Term, Direct-Exposure Prototypes (APSP) published in 2005 and pursued by UCSD for the Coordinating San Diego-David Geisel Cancer Center has limitations in the design and development of the drugs being developed today, which could be long-term consequences of the lack of PD-1 modifications in PD-1 signaling.\u201d\\\\nThe research team was supported by grants from the City of San Diego Health Fund, which is supported by the City of San Diego Offices of Health (JCFHP). The UC San Diego Department of Geriatrics at UC San Diego, the John A. Kiley Pulmon research grant and San Diego-San Diego Center for Integrative Cancer Prevention, the Department of Neurosurgery, the Mount Sinai Cancer Center and California Life Sciences Research Institute.\\\\n'\"]", "inst_index": "61558", "domain": "Lung Cancer 73 (2011) 302\u00c3\u0083\u00c2\u0090309", "url": "http://doi.org/10.1016/j.lungcan.2011.01.012", "summary": "", "authors": "['Hakan Akca, Aydin Demiray, Onur Tokgun, Jun Yokota']", "date": "03-28-2011", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Frequent methylation and oncogenic role of microRNA-34b/c in small-cell lung cancer", "warc_date": "20220328", "article": "[\"'By Yuko Yoshida for Lung cancer\\\\nThe study from Japan shows that a common forms of medical marijuana use that are reserved only for patients with severe tumors, is associated with a decreased methylation of an important gene that controls the expression of a drug called \u201cmicroRNA-34b\u201d \u2013 a type of cancer gene that is genetically dependent on one type of microRNA called NADI, found in the urine of non-melanoma skin cancer.\\\\nThe importance of microRNA-34b for cancer metabolism, the larger adult microRNA region that is responsible for the enzyme activity of lysosomal substances and the increasing rate of dependence of the substances, is not completely known but, perhaps surprisingly, it is important, particularly for a growth strategy, says the Department of Pharmaceutical and Biotechnology of NHK in the United Kingdom.\\\\nAlmost 11 percent of all adult cancer in the UK uses drugs that become known as methylates, making them \u201cmore potent than other drugs\u201d, says Peter Robinson, Royal Society President and Chief Investigator of the Skin Cancer Center.\\\\nCo-authored by Yoshida Tanaka and Kumiko Nishida.\\\\nUK study\\\\nThe team was led by Professor Akira Tsujimoto, researcher at Cancer Research UK. The interest for doing this research arose on the ground in January 2008 and 2008 when the department published a study identifying a 25 percent decrease in the frequency of daily exposure to methylated DNA (MD) in the skin of men and women with melanoma, some 485 out of 1,000 melanoma patients. This was soon followed by a 25 percent decrease in MD which was subsequently confirmed by analyses done by the University of South Florida in January 2009 and as yet unconfirmed, but now known as National Early Detection of Cancer 2018, which was published in the journal Cancer Research.\\\\nCo-authors include: Nakai Matsuzaki, Professor at the Ronald McDonald School of Medicine and a Research Associate, at the Health Sciences Laboratory at the Interdisciplinary Center, Hiromasa Yamamoto, Shimori Ueno, postdoctoral researcher in Prof. Yasuo Takayama, senior scientist at the Institute of Pharmaceutical and Biotechnology (which was led by Dr. Hiroshi Haruhashi), and Arnie Toruyuki, University of Tokyo Professor of Microbial and Chemomaterials Science.\\\\nImportant aspects of this study are in their early detection and analysis into the association between MD with the addition of hypermethylation and methylation of myocytes. It remains to be seen whether MD and methylation overlap to translate into behavior-based MD pattern and how the medical monitoring data might be correlated to MD variations and relapse rate-related research in clinical research and management.\\\\nHowever, the exciting aspect of this study is that it was the observation of 20 patients at 87% and 80% reduced smoking duration from 35 to 46 hours per week. Median physical inactivity for all patients in this study was 3.2 days per week and long baseline blood sugar data showed reductions of a C-14, which has been reported as well as six for a 27-hour time. Study participants received both MD and methylated DNA; all of these heart, lung and colorectal cancers were significantly improved with the MD vs methylated DNA interventions. For the absence of MD, the patients were also tested a third less frequently than the non-MD subjects; a system of isometric measurements were used to compare survival relative to normal in the MD cohort and to assess unit number of systolic blood pressure, specifically .83 mmHVN, a blood pressure of 72/144, and a systolic blood pressure of 149/146, both taking the clinical ration of 7g-per-minute.\\\\nAntigen-based treatments and new ways of treating these tumors are well underway and such links have the potential to contribute to clinically significant improvement in the treatment of cancer. Further studies are under way to identify a safe and effective treatment alternative, to reduce the risk of side effects and to improve overall survival.\\\\nRegarding the impact of methylated DNA methylation on the inhibition of inflammation in the human body, trauma or exposure to long exposure to toxic agents, this study also exposed the role methylated DNA methylation plays in cancer development. Furthermore, controlling change in methylation in this pathway has been recommended by the International Agency for Research on Cancer (IARC) which has covered studies on a'\"]", "inst_index": "88887", "domain": "Lung Cancer 76 (2012) 32\u00c3\u0083\u00c2\u009038", "url": "http://doi.org/10.1016/j.lungcan.2011.10.002", "summary": "", "authors": "['Norimitsu Tanaka, Shinichi Toyooka, Junichi Soh, Takafumi Kubo, Hiromasa Yamamoto, Yuho Maki, Takayuki Muraoka, Kazuhiko Shien, Masashi Furukawa, Tsuyoshi Ueno, Hiroaki Asano, Kazunori Tsukuda, Keisuke Aoe, Shinichiro Miyoshi']", "date": "03-28-2012", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Increased levels of bioactive IL-16 correlate with disease activity during relapsing experimental autoimmune encephalomyelitis (EAE)", "warc_date": "20220328", "article": "[\"'TRO_LS604\\\\nJournal of Healthypsychology/Medical News (Feb 28, 2005)\\\\nAntibodies that increase in parto plant-based saccharin, like IGF-1, produced significantly increased levels of high-proteins, called bioactive IL-16, in the hippocampus of rats, in 2003.\\\\nDeveloped in conjunction with seed plant research into encephalomyelitis (EAE), or a form of parathyroiditis, the bacterium causes it to attach to the brain causing brain damage and death to the gut and urine, leaving many people vulnerable to the disease.\\\\nER Epidemiologic reports using modern bioactive hypothesis systems derived from genetic testing proved that population class IV: IL-16, instead of class III, produces the most bioactive protein called proteins. It thus increases the production of this amino acid, IL-16, that more closely resemble brain protein beta.\\\\nThe authors were published by the International Journal of Child and Child Mental Health, published online February 25, 2005.\\\\nData measured by the Cognitive Aging Study (CAPIS) is a group of three experimental organizations investigating neuroplasticity and development in adult rats. These two groups developed a host of new metabolic controls, or metabolic defects, in large groups of juvenile rats.\\\\n'\"]", "inst_index": "64149", "domain": "Journal of Autoimmunity 25 (2005) 206-214", "url": "http://doi.org/10.1016/j.jaut.2005.09.016", "summary": "", "authors": "['Dusanka S. Skundric, Weili Zhou, William W. Cruikshank, Rujuan Dai']", "date": "03-28-2005", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Differential regulation of Cu, Zn- and Mn-superoxide dismutases by retinoic acid in normal and psoriatic human fibroblasts", "warc_date": "20220328", "article": "['\\'This article is from the archive of our partner . This article is from the archive of our partner .\\\\n\"The cutting error is really becoming a problem within our pharmaceutical industry,\" explained Dr. Paul J. Rosenheimer of Columbia University in a Wall Street Journal article in which the currently-approved measure, the Cu Reuse decoupling mechanism, is examined for weaknesses that include potential for \u201cyellow explosive contamination.\u201d Luckily, Ashtmagesis Therapeutics just let me published a cover story about the Cu experiment and now it\\\\\\'s one of the most talked about subjects we\\\\\\'ll be seeing in a lot of time. The Cu Regal discopyement mechanism has been hailed as an important advance in the treatment of certain diseases (like chronic myeloid leukemia) in which anthrax and toxoplasmosis are implicated. This discovery, especially now that Cu has only been approved to be used as a \"removal\" of the anthrax bacteria, is part of a larger saga of resiaticinosis, which is not only impacted by volcanic ash but can also be resistant to drugs, including adrenal drugs that activate the immune system, according to Bioelic Sciences Corp., the company that developed the Cu discopy. Therapeutics just gave an essay in the Journal about the Cu algorithm, which was originally designed with phospholipid antagonists, in a paper published in 2003. In that paper, Dr. Rosenheimer gave his expertise to clinical scientists--including a U.S. Food and Drug Administration (FDA) representative--who came up with a novel strategy for the Cu decoupling mechanism, which looked at the discovery of new possibilities for hydraulic fracturing and how it protects delicate marine habitats from volcanic ash or radiation. In addition to helping for patients with leukemia, congenital myeloid leukemia, autism, and AIDS, benzene and anthrax toxins in situ mineral depositation are also linked to unsupervised human gut bacteria, which can lead to thyroid issues and sepsis. Finally, on the heart side, these acids like the Cu chemoidou and magasecretic acid are linked to a small increase in lapel tears in the process of heart failure. These too can be a problem in children.\\\\n\\'']", "inst_index": "33650", "domain": "Journal of Autoimmunity 24 (2005) 69-78", "url": "http://doi.org/10.1016/j.jaut.2004.10.003", "summary": "", "authors": "['Pascale Gerbaud, Lo\u00c3\\x83\u00c2\u00b5c Petzold, Patrice Therond, Wayne B. Anderson, Daniele Evain-Brion, Francoise Raynaud']", "date": "03-28-2005", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Autoantibodies from Sj\u00c3\u0082\u00c2\u009agren's syndrome induce activation of both the intrinsic and extrinsic apoptotic pathways in human salivary gland cell line A-253", "warc_date": "20220328", "article": "['\"Although the autoimmune component will be impacted, it is my opinion that auto-injector serum is the single best cure for autoimmune function, and a local complement pill, where it goes directly to the gut through the serum. Here is a recent publication with our leading discussion piece on auto-injector status in human hyperuricin ductula (IDA).\\\\nThe article discusses the auto-injector status of the auto-injecter <1, which means that the investigational drugs, which are marketed today, do not contain the active ingredient for C-cell interferon.\\\\nThe FDA issued a 2003 regulation that prohibited that auto-injector technology from being used until those agents have been isolated, but this argument is difficult to make because it is complex, is not in product or safety as long as it is safe. Then there are other reasons to try it (buy this amount or use this drug at least 10 times). Therefore, obtaining that source is highly unlikely.\\\\nIf possible, the FDA will even consider a standardized level of compilersation (10 years of testing without charge) as to the effectiveness of auto-injecting.\\\\nDifferent formulations must be used upon different application levels. If Pfizer and MedImmune\\'s (NYSE:MED) Adverse Effects (JEF) follows the C-cell interferon-administration method, then they are prohibited from using auto-injector for C-cell interferon to at least 10 years.\\\\nThe challenge is that, if P-Pharma/Leerink\\'s (NASDAQ:LNKD.DL) Adverse Effects (A-cd) is to be able to level these levels according to their efficacy, if you do not ask them to lower the dose because it is safe then there is some reason to hope that they will change their mind.\\\\n\"']", "inst_index": "80994", "domain": "Journal of Autoimmunity 27 (2006) 38-49", "url": "http://doi.org/10.1016/j.jaut.2006.05.001", "summary": "", "authors": "[\"M. Sisto, S. Lisi, D. Castellana, P. Scagliusi, M. D'Amore, S. Caprio, A. Scagliusi, A. Acquafredda, M.A. Panaro, V. Mitolo\"]", "date": "03-28-2006", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Expression of extra trinucleotide in CD44 variant of rheumatoid arthritis patients allows generation of disease-specific monoclonal antibody", "warc_date": "20220328", "article": "[\"'In an industry that values freedom of assembly and diversity among lab groups, a company in Chongqing city, China, is venturing into the emerging field of triadic paternity testing. Wailing (low standard pseudogenetic) combinations of DNA that are matched to their loci based on genes are being implemented on campuses in Nanjing, Jiangsu, Guangzhou, Wuhan, Fudan, Hangzhou, Guangzhou, and Shenzhen. They have already been published in thonylctom researchers.\\\\nDNA is a crucial precursor to complex disease diagnosis and ultimately to effective treatment. Intravenous mtDNA sequencing, especially of the top10 mu-embed protein, as the technique for measuring intercellular function that represents the architecture of hormonal activity in cells, originated in the lab of the Third World after being administered to doctors and nurses. IC2 (space named for an ancient black wall found in Queens of Teller, New York) is an important role played by cellular machinery in embryo development. Over the past decade, it was discovered that the intercellular flyleaf worked on three distinct groups of protein, such as these, and can form the order and structure for a cellular lipid storage at the junction of the biochemistry we need for survival.\\\\nThe new DNA \u201ctriadic paternity tests\u201d in Chongqing, but first, testing for epigenetic (identical morphology). The tests will allow small cells as surrogates of mutant genes in humans to be fed genetic information to 20 investigators set up to test key elements of DNA, including birth and treatment preferences. Each individual has 20 genes and is under the care of a lab technician, who will have hands-on responsibility for new DNA technologies and test results on behalf of the applicant. Once the tests are successfully administered by a physician, a clinician is to come along and assess the evidence. The test can be updated within days. Since the company has already conducted its tests for four years, hopefully by the end of 2007, there could be 23 current participants selected based on preliminary results from trials and will be printed in advertisements in Chinese newspapers.\\\\n'\"]", "inst_index": "36394", "domain": "Journal of Autoimmunity 28 (2007) 99-113", "url": "http://doi.org/10.1016/j.jaut.2007.02.007", "summary": "", "authors": "['Itshak Golan, Shlomo Nedvetzki, Ira Golan, Lora Eshkar-Sebban, David Levartovsky, Ori Elkayam, Dan Caspi, Suhail Aamar, Howard Amital, Alan Rubinow, David Naor']", "date": "03-28-2007", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Cellular and humoral immune responses in the early stages of diabetic nephropathy in NOD mice", "warc_date": "20220328", "article": "[\"'by NW Staff\\\\nThe brain, which has been as simple as a character\u2019s wrinkles by hair and furrowed brows, can regulate both its nervous system and the cell membrane membrane. The procedure is termed \u201cdual immune response modation.\u201d Bodies that are swollen and semi-mobility deficient need open access to certain pathways in the system as normal. In addition, infected cells and blood vessels, with autoimmune processes, have compromised the immune system\u2019s ability to control these terrible behaviors.\\\\nUsing a naturally occurring antibody called CDF/Texen, the human cells were injected with the new high-fiber antibody, which is injected through the mouth into various tissues to increase appetite, provide synapses in the cell membrane and control immune suppression. Patients received CT scans before seeing the results and the required protocols were given.\\\\nResearchers used antibodies like CDF-Texen to control immune response. CDF-Texen was a cross-domain antibody that targets a cell pathway without affecting other cells.\\\\nOne promising aspect of this antibody is that it can even penetrate certain tissues when administered by hand. As soon as a patient enters a clinic, the antibody is injected and attached to a tangle of cells. Due to its close proximity to other cells, the antibodies will sense where to attack.\\\\nThis antibody can be used to enhance chronic suppressed immune response in diabetic nephropathy (HFN), which is still one of the lowest disease prevalence rates. Leukemia, as it is, is also among the most prevalent in the US and can be stopped if caused by the use of a toxic antibiotic or poor glycoprotein delivery.\\\\nCells that come into contact with antibodies or with \u03b2-amyloid plaques need robust immune responses. Because CDF-Texen can be injected into healthy cells, it can be found in tissues that are normally devoid of good bacteria.\\\\nIn a second study, Michael Talik, Ph.D., and D.J. Huang, Ph.D., of the Department of Cell Biology at the Universit\u00e9 de Lausanne, Switzerland, and colleagues found that CDF-Texen stimulates the cell membrane and organogenesis in mouse MND cells. CDF-Texen enabled the cell deactivation of various tissues, and may help the immune system control its battle with chronic disease.\\\\nAnother important activity involved in CDF-Texen involves a transmitter that blocks the cells\u2019 drugs from producing a monoclonal antibody. By inhibiting the activity of CDF-Texen, researchers have found new approaches to the immune system that can lead to disease-fighting antibodies. Currently, researchers look for antibodies with a mutation to inhibit the development of multinomal anti-worm immunosuppression antibodies. However, the breakthroughs observed in mice demonstrated that these antibodies could directly suppress multinomal antigens by blocking certain diseases.\\\\n'\"]", "inst_index": "45846", "domain": "Journal of Autoimmunity 32 (2009) 85\u00c3\u0083\u00c2\u009093", "url": "http://doi.org/10.1016/j.jaut.2008.12.003", "summary": "", "authors": "['Xiaoyan Xiao, Bin Ma, Baojun Dong, Peng Zhao, Ningwen Tai, Li Chen, F. Susan Wong, Li Wen']", "date": "03-28-2009", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Anti-ribosomal-P antibodies accelerate lupus glomerulonephritis and induce lupus nephritis in nai_ve mice", "warc_date": "20220328", "article": "[\"'My drug test double-checked to prove bpatopid antibody amyloid DNA was found in 1lb 250-cal S-RAfe in a study of 275 patients with high-intensity lupus later that year. After analyzing tachytherapy data, the AALS had genetically modified lupus vyorenin II to achieve a 63% alkyl DNA diversity (specifically, including syngas and tachytherapy fragments).\\\\nThe 25 researchers were completely immunologically immunologically immunologically immunologically immunologically immunologically healthy to respond to bacterial cross burning and nephrological pranyatistical immunoglobulin exposure 2 lb xas/spinal cord blood, intraverse fluid transport (GANST) + patotaminergic index measurement. By modifying the bioinformatics of the studies, RNA/molecular complexes were successfully loaded onto the JCD-5 cells of the patients.\\\\nScientists believe this work demonstrates the potential of antibodies to induce lupus nephritis and to increase the treatment efficiency of pumas and nephrosophiles in patients with rheumatoid arthritis. The study also sheds further light on the gene propensity of chi-site- or cygnore brothers to cause lupus nephritis, particularly if the cells are formed by inhibitor gene expression.\\\\nIt is possible to use s-rafe protein as an immunocompromised agent in rheumatoid arthritis and cancer, where inhibition of s-rafe is critical. The potential benefit of pumas has been described by a study being published in the Journal of Immunology today that covers this topic.\\\\nArticle: Observations of lupus gene expression, AALS Phase 1 of AALS Phase 2 clinical trial, Richard M. Albanus, Justin G. Gorman, Rukom Kraffles, Justin H. Lovenoven, T. Aacs, Justin H. Rodrigue, Erich Sirat, T. Aas, Rima A. Tuckam, K. Kantav, Kiara E. Dwermann, Josie Lu, Dr. Sina Tiemin, R. Hannah Mandel, Xiao-Wong Lei, Dr. Jaganda Hoyi, Lucy T. Caldwell, A. John Idzikov, Alan Nishikawa, A. Andrew Haupt, Dr. Hannah Mandel, Xin-Rong Wernan\\\\nImage Caption: The AALS Biomolecular Antimicrobial Term Of The Month 2-2638 JCD-5 Buffer-Instrument Anthrax-Breathing Successor Testing Continued A\\\\nImage Link: www.wallstcom.com/AALS/AALS-2-2638-jcd-b-bas.jpg\\\\nPhoto Caption: The AALS Biomolecular Antimicrobial Term Of The Month 2-2638 JCD-5 Buffer-Instrument Anthrax-Breathing Successor Testing Continued\\\\nPhoto Link: www.wallstcom.com/AALS/AALS-1-2638-jcd-b-bas.jpg\\\\nPhoto Caption: The AALS Biomolecular Antimicrobial Term Of The Month 2-2638 JCD-5 Buffer-Instrument Anthrax-Breathing Successor Testing Continued\\\\n'\"]", "inst_index": "27911", "domain": "Journal of Autoimmunity 54 (2014) 118-126", "url": "http://doi.org/10.1016/j.jaut.2014.02.013", "summary": "", "authors": "['Dana Ben-Ami Shor, Miri Blank, Sandra Reuter, Torsten Matthias, Inbal Beiglass, Alexander Volkov, Iris Barshack, Yehuda Shoenfeld']", "date": "03-28-2014", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Interleukin-1 b inhibits NaC-KCATPase activity and protein expression in cardiac myocytes", "warc_date": "20220328", "article": "[\"'The Multidisciplinary Assessment (MAA) on the Serum-enzyme and subcutaneous adipose tissue adipose tissues continues, with reduction in CT-negative CT-negative oxygen sulfate through nanotrophic blood cell healing in anterior central muscle cell can provide some evidence to explain the increases in activity of mitochondria and ESAPEN when repeated in multiple tissue sites.\\\\nOngoing research shows that by utilizing multidisciplinary activity in these tissues for oxidative stress induction, kalanesin-1 (K-HCATPase) can reduce beta-carotene production in a transient absorption of oxygen sulfate (bpsi), which in turn increases mitochondria\u2019s capacity to fight off stress. This study, published in Blood Stream, shows that by allowing the KHCATPase, \u201cK-HCATPase has significantly reduced ketamine consumption through sustained action by the multi-lingual synthesis of TA-3.3467-STRK2, with the first thalassemia in place.\u201d This study provides the interim presentation of full pharmacokinetic data and other physical evidence to support the significance of the multidisciplinary, multistate interaction between KHCATPase and TA-3.3867 (K-HCATPase).\\\\nThe prolonged, even forceful electrical interactions between KHCATPase and TA-3 indicate that T-cell activation of TA-3 correlates with increases in electrical activity of KHCATPase, as seen in the type of gas cells that transport oxygen, site and the metabolism of mitochondria. T-cell activation led by T-cell activation may suggest that KHCATPase causes rapid or unexpected changes in T-cell rates in the shape of cardiac myocytes that are unable to function, causing abnormal oxygen saturation. Other observed findings in this subgroup of myocytes include changes in metabolic efficiency, changes in ATP concentrations, changes in T-cell fermentation, changes in effects of metabolism, and changes in genetic ancestry, among other effects.\\\\nThe current pooled sample of patients at risk of cardiac arrhythmia was exposed to two multiple events: radioactive oxidation (ranging from 100mg per decilitre to 7mg per decilitre) and antipsychotic infusion of kalanesin-1 with the same electrophysiological profile. The aminotrophic blood cell terminus of the adaptive cistern sent serum to the mesoderm for 20 minutes to look for resistance to PP3 metabolites (the more common form of PP3). After 20 minutes, blood was returned to stable tissue, with no episodes of cardiac arrhythmia at 20%, suggesting that the effects of the radiation on energy synthesis are extensive.\\\\nThis new interplay between mitochondrial and aminotrophic supply-polarity mechanisms of the functional units in the T-cell selection indicates a communication \u201cbetween mitochondrial and aminotrophic supply-polarity that is a signaling mechanism of cell proliferation and differentiation.\u201d However, this coordination is premature due to \u201cpsychological duress from the children of the families who have lost the maturing mitochondrial bone structure.\u201d The authors note that the improvements observed in mitochondrial metabolism and function due to the following adverse effects are encouraging. They conclude that therapeutic efficacy of radiation therapy of KHCATPase may be uncertain.\\\\nLink to the study\\\\nThe study was funded by the National Institute of Allergy and Infectious Diseases, National Institute of Child Health and Human Development (NTID), National Institute of Pharmaceutical Research and Technology (NAPRIT), National Institutes of Health (NIH).\\\\nInformation is available at http://www.ncbi.nlm.nih.gov/pubmed/1869877, or http://www.ncbi.nlm.nih.gov/pubmed/1869875\\\\nReferences:\\\\n1. Office of the Medical Director, University of Maryland, College Park. 2007 Psychiatry Depression Rating Project Evaluation for Diabetes by et al. Cosmetic Pathology, Balance and Skin Care and Lighting, Genomic Clock (Massachusetts Institute of Technology, 1989).\\\\n2. E-2 & MAA, and the Clinical Screening Section, MAA, 2003 (Oxford University Press, \u00a311.50): G. WIT and M.\\\\n3. Intradiol Proteins, et al., Molecular Molecular Encephalopathology, et al., Advanced Tissue Mitochondrial Dynamics (Oxford University Press, \u00a311.50): Analysis of Eyecomics in Tissue. doi: 10.1111/3098474-14171, published 24/09/'\"]", "inst_index": "54082", "domain": "Cytokine 26 (2004) 1-8", "url": "http://doi.org/10.1016/j.cyto.2003.11.014", "summary": "", "authors": "['Sawsan I. Kreydiyyeh, Christina Abou-Chahine, Randa Hilal-Dandan ']", "date": "03-28-2004", "split": "test", "label": "machine", "status": "succcess"}
{"title": "cDNA cloning and functional analysis of goose interleukin-2 ", "warc_date": "20220328", "article": "['\"New field evidence for DNA nullification in a proposed publication by the Korea Biological Laboratory (KBL) reveals limited knowledge and location on animals that seek DNA nullification. There are not sufficient laboratory scientists to do such research and more work is needed to do so.\\\\nThis discovery concerns a blood sample derived from a female macaque calf being studied on KBL\\'s computer laboratory, with support from the Department of Biological Sciences. DNA nullification is a narrow search process involving independent parallel feeding method developed in 1998. Depending on the results of the field of DNA nullification, a controlled gene sequencing technique or metabolic probe is required.\\\\nIn this case, a mouse infected with Yellow also identified as the macaque. Little radioactivity was found in the animal during the 1998 sequencing technique, however, indicating an increased level of government-sponsored biotechnology in the macaque.\\\\nThe scientist\\'s discovery was released Monday in the Proceedings of the National Academy of Sciences.\\\\nResearchers believe DNA nullification may have found the macaque\\'s DNA stream. It could also raise many questions. For example, how DNA is delivered back to a cell through processing on its own: A few per-cellular nucleotides ( CDNs) may create a genetic black hole. Also, where DNA is delivered is uncertain, but some source families use specific factors to decide how DNA has to be stored in cells.\\\\nAnother potential way to identify genome contamination, however, involves new tools. Some entities have long ignored the task of interpreting and testing DNA so they know for sure, provided well-informed and trained lab experts present the correct instructions. Additionally, DNA sequences can be incorporated into mathematical models, such as mathematical models reflecting behavior and biological systems.\\\\nWhat is clear is that researchers are most interested in unraveling genomic differences in species. But there are also fundamental questions about human genetics. To understand how genetic differences could produce natural biological diversity, scientists must first understand human DNA. And nearly one-third of known genetic diversity in mammals is tied to human gene regulation in genetics.\\\\nCould primitive blood testing have detected the location of genetic variation in blood samples in humans? One potential avenue could be genetic integration with natural human genes and to construct artificial brain regions, particularly as the body age increases.\\\\nIn the case of blue blood cells, the mechanisms of gene expression differ considerably from their plants. Blue blood cells form by being supplied with a protein called xenone, a compound that helps differentiate between the cellular genetic make-up of different genes. Humans are programmed to synthesize xenone by attaching it to sterile rhinopodiodic studies.\\\\nAlthough green blood cells become functional creatures, in fact, researchers have not yet discovered a blue blood cell.\\\\nUnable to identify every disease-causing gene called matrix sequence, however, researchers should develop methods of gene sequencing that can be translated into gene sequencing. Self-identification of natural genetic structures of the environment would allow scientists to determine what proteins the plants produce in response to incoming DNA interactions.\\\\nThe Taeton Death Robot (Taeton) concept is proposing to replace human DNA, with progressively enhanced ethical requirements and strict ethical standards. This is based on KBL\\'s use of the Taeton technique as a DNA sequence modifier as part of the process of looking at \\'cancerous\\' DNA. KBL\\'s method of genetic nullification involves the development of three identical genes, which all undergo certain genetic alteration and represent the fact that they are genetically identical.\\\\nFor this first major molecular discovery, the use of natural human genome translation will bring unique result for KBL\\'s flagship concept. The technology used for this goal is from an international consortium of research institutions based in Malaysia.\\\\n\"']", "inst_index": "16535", "domain": "Cytokine 30 (2005) 328-338", "url": "http://doi.org/10.1016/j.cyto.2004.12.015", "summary": "", "authors": "['Ji-Yong Zhou, Ji-Gang Chen, Jin-Yong Wang, Jian-Xiang Wu, Hui Gong']", "date": "03-28-2005", "split": "test", "label": "machine", "status": "succcess"}
{"title": "TNF-a down-regulates the NaCeKC ATPase and the Na+-K+-2Cl- cotransporter in the rat colon via PGE2", "warc_date": "20220328", "article": "['\\'A number of Cytroid-serving tennis players have taken offense to the effect of the forced tradeoff of regulated terrain and standardized structures in the main ATP-sanctioned WTT_5s, in an attempt to reduce the time between a match of a two-set position and a two-set tiebreak. The qualifying rounds for the ITF single-use ATP brackets have been open to all ATP-sanctioned players since 1991. However, for years, Nicrochadlo Golub watched a match of one-set tiebreaks played both singles matches at the ITF-sanctioned Cup Grounds and sided with his loudest producer from \\\\\\'40 when he pointed out that the only thing better than such negative atmospheres is competition.\\\\nThe ATP-sanctioned craze for at least half a dozen conditions and heated legalities, such as starting their matches late, stifling action, forcing the starters to more often than usual and disrupting instant communication to the players, was condemned as not only unhealthy but misleading, the owner of a service supplier explained. At the only tennis to offer free-use tennis equipment at the start of the rankings in August 1980, no ones had yet invented a system of \\\\\\'keeper allowances. \"Plymouth Park,\\\\\\'\\\\\\' as it was called by both Poulenc and Porta Pijnselt tennis magazines in Singapore in the 1980s, a set point would cost an extra ten seconds, called \"charge setting\". \"Crisp grass or clay is cheap. Of course, in the first part of every match the courts are low; even with only long grass the game is slowly heating up,\\\\\\'\\\\\\' said a former porter, who claimed his post had \\\\\\'meaningless impact.\\\\n\"It is necessary to start a match early, as our players are already looking forward to a good match; they are betting they will bring a victory away to Wimbledon because playing on grass for a pay TV porter would cost them more money,\" added Poulenc. At the tennis and TFT tournaments in the late 1970s and early 1980s, the regulation networks of tennis\\\\\\' importance were threatened by new tournaments, especially the ATP-sanctioned-prone WTT tournament. The \\\\\\'Net was a portal to tennis of all different backgrounds and ages with interest to join everyone else on a single or multiple set-point ladder. Hence the advent of the seeded model and black-outs by the official tournament-based authorities. \"We didn\\\\\\'t think about regulation. We only thought of a great deal of \\\\\\'dirt politics,\\\\\\'\\\\\\' a said Poulenc. \"All the clubs but the one full of players coming from particular territories had this all about them. Not the bastards, but the \\\\\\'net.\"\\\\n\"In most countries nowadays when you cut out more than a few billion cubic metres of groundwater we are seeing almost the same degree of stability as we did 30 years ago,\" a Poulenc added. Well in Singapore, Poulenc told PIPA he couldn\\\\\\'t guarantee a victory for the entire tournament as \\\\\\'it would tie the tiebreaker in either case; so we use regulation as a mean-differentiator and have to consider different events a more comfortable victory- that is simply to withdraw without cancelling out any single event,\\\\\\'\\\\\\' the 60-year-old Poulenc told PIPA this month. Poulenc, who played back-to-back sets at this year\\\\\\'s World Tour Cup when he played in to a practice match for the B&W Championship, reminded his fans that whatever happens in London and Italy this week can only happen in Geneva, Austria and Germany.\\\\n\\'']", "inst_index": "61644", "domain": "Cytokine 30 (2005) 319-327", "url": "http://doi.org/10.1016/j.cyto.2004.11.009", "summary": "", "authors": "['Sarine Markossian, Sawsan Ibrahim Kreydiyyeh']", "date": "03-28-2005", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Roles of p38 and ERK MAP kinases in IL-8 expression in TNF-a- and dexamethasone-stimulated human periodontal ligament cells", "warc_date": "20220328", "article": "[\"'Iolium is derived from lymphatic glands in uterine tissue, a small part of which is under the skin. Several TNF receptors in human serum in adults provide an inflammatory response. Further study of 2 scarred p38 cells in the arm can help answer WHY and how they can be used in VIRUS therapy, said Dr. Chen Kang, of Huahua University of Science and Technology in Rheinmetall, China.\\\\nCarried cells are normally removed from the body after a second treatment, and cells revert back to their original state. The first treatment, administered intravenously, was very successful, and it can be administered with anti-wrinkle drugs, said Dr. Chen.\\\\nWaning immune function, increased levels of uric acid, the wound healing process, and reduced bone marrow volume can lower the uric acid secretion and increase the severity of pain, said Dr. Chen.\\\\nAbout one-third of the p38 cells of patients are overexpressed in the epidermis layer in the breast tissue, raising the risk of weakening the immune system. A few forms of PDT stimulate limb, brain, prostate, liver, esophagus, pancreas, testus, urinary tract, glaucoma, glaucoma, diabetes, heart, kidney stones, plaque formation, and more.\\\\nThe liver aborts the uric acid secretion, which greatly reduces the potency of uric acid secretion, said Dr. Chen. A combination of transplants in oophorectomy surgeons has been proposed and approved for patient use.\\\\n'\"]", "inst_index": "56119", "domain": "Cytokine 35 (2006) 67\u00c3\u0083\u00c2\u009076", "url": "http://doi.org/10.1016/j.cyto.2006.07.009", "summary": "", "authors": "['Hwa-Jeong Lee, Jin-Woo Cho, Sang-Cheol Kim, Kyung-Hwa Kang, Sun-Kyung Lee, Sung-Hee Pi, Suk-Keun Lee, Eun-Cheol Kim']", "date": "03-28-2006", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Time-dependent onset of Interferon-a2b-induced apoptosis in isolated hepatocytes from preneoplastic rat livers", "warc_date": "20220328", "article": "['\"Munich, Tue. 9c 2006 ? A Spaniard expert in the therapeutic field of interferon-a2b-induced apoptosis (i.e. interferon-a2b) has developed a new therapeutic technique to prove that prolonging the lifespan of hepatocytes in children and adults with interferon-a2b-induced apoptosis (i.e. interferon-a2b-induced apoptosis) is a possible approach to stem cell transplantation. I.L. Zapata, Mar\u00c3\\\\x83\u00c2\u00b5a Teresa Ronco, J. Alexander S. Paslavin, N. J. & Caligil Duarte, Sept. 22, 2005\\\\nLouise Lloyd from the pediatric hepatocyte (as designated for study in Children with Neuroimmunological Tied Subjects, or NIRMA) Institute at Children\\'s Hospital of the Bergenmont , N.J.\\\\n\"']", "inst_index": "21964", "domain": "Cytokine 36 (2006) 245\u00c3\u0083\u00c2\u0090253", "url": "http://doi.org/10.1016/j.cyto.2007.01.002", "summary": "", "authors": "['Maria de Lujan Alvarez, Ariel D. Quiroga, Mar\u00c3\\x83\u00c2\u00b5a Teresa Ronco, Juan Pablo Parody, J. Elena Ochoa, Juan A. Monti, Cristina E. Carnovale, Mar\u00c3\\x83\u00c2\u00b5a Cristina Carrillo ']", "date": "03-28-2006", "split": "test", "label": "machine", "status": "succcess"}
{"title": "STAT1 and STAT3 phosphorylation by porins are independent of JAKs but are dependent on MAPK pathway and plays a role in U937 cells production of interleukin-6", "warc_date": "20220328", "article": "['\\'Porins are motor cells that regulate a very different pathway of the cells making phosphorylation of the hyverins in \"curridic monomeric cerary\" (MAPK-VII), called potutriaic phosphorylation. MAPK-VII is an active mode of interleukin-6 production (PMPI) similar to opposite behavior of phosphorylation of Gyne-moly. The so-called \\\\\\'Polyurethaneated Body Regime\\\\\\' (PSR) (i.e. Pink P8) where NEPCs are active regulates electricity production in MAPK-VII. The PMPI is the lightest molecule in the phosphorylation process (09-28).\\\\nPorins are key lignomine targets of different molecules to our organs and cells. Pioneering techniques have historically taken by the manipulation of MAPK-VII phosphorylation (15-20) selectively caused an entirely new way of phosphorylation (17-22). It is essentially a second batch of phosphorylation or phosphorylation-based compounds rather than the first batch of phosphorylation. Many chemists approach the PMPI compound on a relatively small scale, but believe this technique can be used to transform it into a crude attack weapon.\\\\nPorins and PSR are critical cogels of the phosphorylation process (19-20) as cogels of the potassium channel and the central stimulation of the metabolite ATP (12-25). Tetris provides more efficient priming of the cell\\\\\\'s system of molecules in \"curridic monomeric monomeric phosphorylation,\" a process that interacts with the phosphorylation process.\\\\nWe studied nitrilemonics (14-12), a protein phosphorylation involved in nerve coordination from analyzing the reactions of many states of nerve cells including the dopamine-producing Hormone Raceers. The scientists monitored nitrilemonics for Cholesterol receptors (13-12) to improve their pharmacokinetics for their altered effects of phosphorylation on nerve pathways and other DNA constructs, which include SSS (LGA) and LGA 2-F.\\\\nCholesterol receptors (12-12) already shows immunity to yellow-orange phosphorous but the previously undamaged chloride-citra-cure created under a demodified matrix, a ligand associated with the plaque-filled ATP. For the interleukin-6 pathway (CEC), oral chemicals (4-5), or by automaking insulin or beta-amyloid beta cells (1-4), have a positive effect on PMPI and increase the flexibility of chloride molecules. The chemistry or how to make the molecules (3-5) has been a study of the effects of PMPI on fatty tissue tissues (6-15) and PCSK9 (7-8).\\\\n\\'']", "inst_index": "42218", "domain": "Cytokine 36 (2006) 218\u00c3\u0083\u00c2\u0090228", "url": "http://doi.org/10.1016/j.cyto.2006.12.003", "summary": "", "authors": "['Marilena Galdiero, Mariateresa Vitiello, Marina D\u00c3\\x83\u00c2\\x95Isanto, Katia Raieta, Emilia Galdiero']", "date": "03-28-2006", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Tumor necrosis factor alpha down-regulates the Na+-K+ ATPase and the Na+-K+2Cl- cotransporter in the kidney cortex and medulla", "warc_date": "20220328", "article": "['\"To preserve balance with vitals, surgeons remove the prostate gland\\'s active cystal, found in upper-stage prostate minimally invasive surgery, or tumor necrosis factor alpha (TCA\u03b1) cystal \u2013 the source of the damage caused by the function of inhibitory and important proteins in a tumor\\'s stem cells. This tendency to intensify the effect of the amniotic sac in terms of the amniotic nodule is associated with abnormally high levels of docosecond pressures leading to tumor necrosis factor alpha deficiency (CDPA). To reduce the accelerated accumulation of CDPA proteins in the development of tumors, surgeons specifically located the target (the area of the cystal) under the tumor nerve. Outside the groin, surgeons conduct further activities to increase the inhibitory and/or close-off resting temperature and secretion of CDAP proteins in the tissues of the tumor. While these activities may lead to more-aggressive cytosine activity in the area, abnormalities with CDAP can also lead to cause high cell turnover in the tissue. In patients with CDAP-mediated epidermal cell secrete behaviour (TAGM). Breakthrough therapy to reduce CDAP-mediated amniotic delays in patients with cystic fibrosis is warranted. You can learn more about this novel treatment and many promising clinical studies through E.L. Clark - Cambridge Biomedical Research Center - http://www.cbc.com/montp.html Diagnosis of Amphibian Bacterial-minority (AHM) stem cells (derived from rheumatoid arthritis) and AMG stem cells (derived from rheumatoid arthritis) can be pre-set for multi-dose MRI testing using diffusion-in-a-cell MRI (IFA) imaging as the primary endpoint. Implementation of Ovarian Ovarian Ovarian Cancer Diagnostic Techniques (UTCD) in ongoing clinical trials for these trials requires the understanding of patient-specific physiologic effects, novel therapeutic formulations, and a unique identifying system.\\\\nFor a full list of UTCD-specific interventions, please visit: http://www.dxc.org/10.976/usda/?nm=764\\\\n\"']", "inst_index": "61346", "domain": "Cytokine 33 (2006) 138e144", "url": "http://doi.org/10.1016/j.cyto.2005.12.007", "summary": "", "authors": "['Sawsan Ibrahim Kreydiyyeh, Sarine Markossian ']", "date": "03-28-2006", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Upregulation of tumor necrosis factor-alpha expression by trans10-cis12 conjugated linoleic acid enhances phagocytosis of RAW macrophages via a peroxisome proliferator-activated receptor gamma-dependent pathway", "warc_date": "20220328", "article": "[\"'Col. Lee Ernie Choi (COL \u201907) and Yu-Ji Lei (Korean) during a workshop on cell oxygenation therapy on the ANTLL (Antadoxmass Organogenesis)\\\\nBy Ji-Houn Kang\\\\nData from 25 new cell organ systems from JJ-SKI Institute of Tissue Transplantation of 1988 demonstrate that large quantities of cells from various sectors of various organs with transgenic bases can respond quickly to new neuronal growth factors (IGPs) including NDE sequences (NERX).\\\\nThe development of cell organs was accomplished through an interdisciplinary collaboration with joint dedication, coordination and cooperation among the Research Department of Radiology, Alternative Eneuptary Activity, Minority Cell Transplantation Center, METES, Bayer Research Center, Research Center of Advanced Laboratory of Cell Regenerative Medicine and the Phoenix-Vertex National Immunodeficiency Program (NYPNSU).\\\\nThe development of cell organs from all animals from the National Autonogenesis Center was achieved with a systematic approach. These organs tested were the ALSH AND SCARF cell organ systems used in four documented approaches with Cell NDE sequences, the LHC and 19 other organ systems found in a breakthrough laboratory laboratory paper, and were targeted with transgenic worms. These various parameters (SPECIAL, GENIVICAL, PORT-eGISH, GRAND PLAN, ARTS) accounted for more than 300 tumor organ systems (IOB, NMD, LH, OPES, IRNS, NMIT, IVR, TIA and SMAT) of all organs studied. These differences (large-scale responses, different combinations of IGF, gene binding, amplitudes and ecosystems, and all) were observed in 28 areas. Of these 28 samples, 25 were found in subadult ALS.\\\\nThe researchers hypothesized that Eneuptary Artery Cell Transplantation (COMT-CON) was one of the principal stages of organ transplantation with an experimental program developed by Katai-Man and LeGrand Grandin (yes, Korean) Cell Transplantation Center at the UT Southwestern Medical Center, UT Southwestern Medical Center, UT Southwestern Medical Center, UT UT Southwestern Medical Center, UT Southwestern Medical Center and most of the other organizations. Based on their findings, the researchers hypothesized that Eneuptary Artery Cell Transplantation (CCT) produced positive responses to genes of EGFR-induced EGFR splinter genes as IGF-1 or NERX-associated GIMSS at a molecular scale, indicating that large-scale chemistry was likely to significantly alter the composition of organ systems such as graft-versus-host and organ-delivery glial cells (GIGGSKSK9) and interstitial GLBs-ensory hyperboliosis (GLB-CsI) and to further erode tissue or tissue structure, possibly resulting in death.\\\\nBy many accounts, CDT-related cancer and/or nervous system disorders are common features of any organ as that occurs in a large number of the other organs. For example, CT-induced angiogenesis centers and managed-care hospitals vary in size, capacity, and capacity to prepare patients with e-vascular tumors for surgical treatment, while in the advanced stage, the majority of postoperative procedures consist of the treatment of tumor or phagocytosis. At the research level, medical centers and cancer hospitals increasingly possess specialty head and neck surgical centers and the many genetic and molecular mechanisms by which COALS (Hertz accounts for many of the cancers causing tumors) developed into tissues using cicalin particles from molecules either non-ethered or trans-rated. Patients at these centers are very often abandoned or tied in with a tumor type, or developing cancer.\\\\nAt the CalCalCal molecular-cell-clearing center, careful communication by the investigators and other academic colleagues to physicians in order to ensure patient continuity have developed to various stages of tumor growth.\\\\nThe paper was published in the Journal of Immunology.\\\\n'\"]", "inst_index": "68650", "domain": "Cytokine 37 (2007) 227\u00c3\u0083\u00c2\u0090235", "url": "http://doi.org/10.1016/j.cyto.2007.04.003", "summary": "", "authors": "['Deok-Ho Song, Ji-Houn Kang, Geun-Shik Lee, Eui-Bae Jeung, Mhan-Pyo Yang ']", "date": "03-28-2007", "split": "test", "label": "machine", "status": "succcess"}
{"title": "The distribution of interleukin-19 in healthy and neoplastic tissue", "warc_date": "20220328", "article": "['\"The Boston Consulting Group recently polled its Internet and enterprise experts and discovered that six chromosomes are \\'boundless\\' when probed further, with 8.2 percent of total human chromosomes held responsible for each factor - compared to only 4.3 percent in Neoplastic T cells. Interestingly, human chromosomes are also 13-44 and as a result, researchers predict that the ability to diversify interleukin-19 in healthy and neoplastic tissue by genetic remitting and standardizing will eventually be critical for better support of the disease. Over the last half century, the detection of gene expression is often based on brain cells alone. But the process also draws on additional long-lasting brain stem, brain system and embryonic stem to determine the individual human form. Thus, the detection of interleukin-19 in healthy tissue -- and thus health -- is possible because rather than having genetics making it impossible to tell the composition of each gene, brain cells may show up with genetic modalities that differ considerably. \\'This is probably most likely the result of a process being imaged from a genome, or other human precursor so called genome alterations,\\' Dr Li says. Researchers at the Laboratory of Molecular Genetics at Tyndallia University, Ireland, undertook research to look at the presence of different proteins and messenger RNA in human placenta cells over a period of five years, but only in sub-circled tissue. Then, they developed an assay to peer into brain cells of the placenta itself, identifying Sub-Recurring BRCA (New-Gene Expression Factor) proteins or messenger RNA - genetic compounds that are associated with risk for the degenerative diseases. Molecular studies on these proteins also confirmed that the proteins are derived from eukaryotic human BRCA (New-Gene Expression Factor) proteins. The research was supported by the National Institute for Occupational Safety and Health (NIOSH). Over the last ten years, research into interleukin-19 discovery led to several breakthroughs that result in greater early benefit. These include the discovery that interleukin-19 protein formed poly-ulae at close coupling to binding of BRCA (New-Gene Expression Factor) proteins. Researchers began to identify changes in interleukin-19 in human chondrosclerosis, endometriosis, polycystic ovary syndrome and cystic fibrosis. Study leader Phylicia Sachenhouse, a lecturer in biomedical genetics at the University of Worcester, England, wrote in the paper: \\'This is a very unique discovery because we identified the basis of interleukin-19 in human solid biochemistry. We were surprised by the levels of protein expression that emerged in healthy tissue but only after direct association with exposure to non-biological molecules.\\' \\'Even by the skin, this results in multiple reproducibility of human chondrosclerosis,\\' continues Sachenhouse. \\'We were surprised that the results were two times greater than the overall clinical impact. In particular, due to the absence of a pre-specified disorder, this could also have some associated benefit.\\' Information presented in the paper raises the possibility that interleukin-19 could be identified as cause of disease or stroke in an easier manner than ever before. To this end, further research has been done to understand how this aberrant genetic signature material originated in healthy tissue, including the healthy hearts and pancreas. The effects on patients have been remarkable, continuing to be compared with very little media attention. However, treatment with interleukin-19 inhibitors continued to be the target for many patients, and so began clinical trials to find the genetic basis of disease or stroke in fine-mesh tissue of the placenta. The results emerged from the test of interleukin-19 in healthy tissue of the blood: \\'We uncovered immune-suppressing effects from the interleukin-19 protein in healthy stem cells of healthy plasma cells. This was a potential target for development of smallpox vaccine, now widely prescribed.\\' The study published in the journal PLOS ONE offers a wealth of information on interleukin-19 in healthy tissue of the placenta, which is totally related to interleukin-19 in healthy adult placenta cells. When studying European stem cells, the researchers studied the role of interleukin-19 protein kinase kinase in cells and found that it inhibited replication of interleukin-19 in healthy human tissue. Since interleukin-19 makes up 10 percent of the total progesterone protein, the researchers were\"']", "inst_index": "88840", "domain": "Cytokine 44 (2008) 221\u00c3\u0083\u00c2\u0090228", "url": "http://doi.org/10.1016/j.cyto.2008.06.007", "summary": "", "authors": "['Chung-Hsi Hsing, Hsing-Hui Li, Yu-Hsiang Hsu, Chung-Liang Ho, Shih-Sung Chuang, Kuo-Mao Lan, Ming-Shi Chang']", "date": "03-28-2008", "split": "test", "label": "machine", "status": "succcess"}
{"title": "The interaction of butyrate with TNF-alpha during differentiation and apoptosis of colon epithelial cells: role of NF-kappaB activation", "warc_date": "20220328", "article": "[\"'Promoting esigu from apoptosis and cancer was one of the design concepts for the the section titled Exaline Hadardiskaridosis in PGA Strategy of multiple cell division. The following inclusions:\\\\nZoobin and paralopic nodules control ketones, causing cell differentiation and apoptosis, in the i6 metabolism. The utilisation of ketones, induced in a directed generalization of neurons and progenitor cell (neu-cure) cells to the co-relays of veltuzumab is shown.\\\\nWork. Cliffs and cavity levels at focal inmary are a consistent response to inhibitors of protein expression modulating apoptosis and discovery of modulators of chemora which are beneficial to neuroreinforcement. Type inhibitors of chemora induced isocon expression generate apoptosis and apoptosis of cytopen cells.\\\\nAccording to Dr. Loxel R. Fitch, Chairman, Cognizant thinktank, the improvements in axonal structure likely be attributed to the environmental factors as in enzymatic processes, including activity of histologically active neutrophils, reactions to histologically active axonal proteins, healthy inflammation, lenient outer pressure and histologically active protein functioning due to elevated /noise levels in regions where infection and virus are predominant.\\\\n'\"]", "inst_index": "32907", "domain": "Cytokine 44 (2008) 33\u00c3\u0083\u00c2\u009043", "url": "http://doi.org/10.1016/j.cyto.2008.06.003", "summary": "", "authors": "['M. Hyzd\u00c3\\x83\u00c2\\x95alov\u00c3\\x82\u00c2\\x87, J. Hofmanov\u00c3\\x82\u00c2\\x87, J. Pachern\u00c3\\x82\u00c2\\x92k, A. Vaculov\u00c3\\x82\u00c2\\x87, A. Kozub\u00c3\\x82\u00c2\\x92keSung']", "date": "03-28-2008", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Effects of ethanol on monosodium urate crystal-induced inflammation", "warc_date": "20220328", "article": "[\"'A study has been published by the Center for Environmental Research and Prevention, (CERP), based in Japan. The study suggests possible potential effects of ethanol on cells, namely on skin type, mental tract development, and the discovery of new carcinogenic mechanisms by bioengineered cells, called microgravity. The authors claim that research alone can regulate conditions, promote metabolites and potential microbes from different botanicals, including radiation and inflammation. They conclude: \u201cThere is no reason that the inhibition of microgravity may not have an off-the-shelf advantage in its discovery.\u201d (See Consortium for Occupational Medicine, www.cordrodshow.com).\\\\nWe are now awaiting guidance from the American Chemical Society (ACS) and the Food and Drug Administration (FDA) on global approval applications for specific ethanol and biodiesel vehicles.\\\\n'\"]", "inst_index": "82810", "domain": "Cytokine 42 (2008) 198\u00c3\u0083\u00c2\u0090204", "url": "http://doi.org/10.1016/j.cyto.2008.01.001", "summary": "", "authors": "['Taku Inokuchi, Tuneyoshi Ka, Asako Yamamoto, Yuji Moriwaki, Sumio Takahashi, Zenta Tsutsumi, Daisuke Tamada, Tetsuya Yamamoto']", "date": "03-28-2008", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Differential chemokine expression in tubular cells in response to urinary proteins from patients with nephrotic syndrome", "warc_date": "20220328", "article": "[\"'\\\\nThe unrecognized chemokine expression in tubular tissues in late-stage studies with the 12 new participants of the Voluntary Benchmark (VSP) study for women who had nephrotic syndrome following the treatment of the drug Azerol 38 was compared with pre-clinical studies in the study. By comparing the expression of (g) colored randomised cells of oropharyngeal nodocytes (UM) in tubular tissues of patients with nephrotic syndrome who received Azerol 38 (47%), among others, to the expression of (g) colored randomised cells of (mm) miSD cells, (g) yellow-red megbock cells, and (g) blue-green type expression in the tubular tissues of cancer patients treated with oral azodrin (including Huntington\u2019s disease) at 80% or higher, depending on the study\u2019s unique condition. In addition, the collection of half of Oropharyngeal fraction (g), an important relationship between type 1 body mass index and body composition (BAF), expressed by mybaxy cells, in tubular tissues with infusion-derived HB drugs, was aligned to check responses to regulation of this important profile of the cell composition.\\\\n\u201cWhen you talk about structure and activity between tissue tissues in the abstract to patients, you are talking about a single cell type in the entire body,\u201d said Dr Wen-Fu-Xi, Pediatric endocrinologist from Nanjing University School of Medicine. \u201cHowever, such a diagram is quite difficult to achieve as well as give you structure to the contrast between white expression in tubular tissues with that of other tissues in the whole body. By changing this set of markers in this particular study, I hope that could be shown that it can do this, as well as being able to compare it with other studies.\u201d\\\\n\u201cSome investigators had originally hypothesized that this type of cell type may even be associated with tumorigenesis, or major damage. However, the study participants also had a lot of other factors. The primary study subjects had too few backbones, too little potassium and about 15% of the patients received Oropharyngeal bone density based vitamin E monotherapy,\u201d said professor Sung-En Song, M.D., Department of Pediatric Yfrog. \u201cSo, the study\u2019s comparisons with surrounding site-based devices to create a better picture of higher target areas were even more informative than our general direction of the study.\u201d\\\\nAccording to the trial\u2019s findings, the polymechanical compositional pattern of chromatin- or composition of tubular tissue was found to be consistent in vivo with the signaling from the adjacent lymph nodes and in the inferior extremities of the tubular tissues, indicating oropharyngeal post traumatic stress syndrome (TBT) through femoral and spinal cord injury patients and non-mastectomy patients. However, some of the cells appearing in tubular tissues in which pyruptial chromatin- or composition of tubular tissues occurred on direct 1 mg/day of Azerol 38 and in the same breath as the g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g g'\"]", "inst_index": "67951", "domain": "Cytokine 42 (2008) 222\u00c3\u0083\u00c2\u0090233", "url": "http://doi.org/10.1016/j.cyto.2008.02.005", "summary": "", "authors": "['Zhao Huang, Qiong Wen, Shu-Feng Zhou, Xue-Qing Yu']", "date": "03-28-2008", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Anti-inflammatory effect of aldose reductase inhibition in murine polymicrobial sepsis", "warc_date": "20220328", "article": "[\"'This is due to serious inflammation that can result in sepsis, septic shock and even loss of brain tissue. Patients with Haemolytic Muzik (JME) can develop symptoms, which include mild thrombotic polymicrobial sepsis and subsequent reduction in blood blood stream density, also known as MRI hypokine. JME is a rare septic shock and acute neuropathy associated with recurrent nerve infections. It occurs in small numbers of JME patients and has been associated with severe rates of MS and Haemolytic Muzik. A mid-stage trial evaluating JME subcutaneous administration of anti-inflammatory mu opioid + salamol is scheduled for Phase 1b; results are expected in 2007 or early 2009.\\\\nBlue-green algae forms during a therapeutic melatumal, an instant reaction of the algae to beneficial substances in the grass or fish. Walnut derivatives of the algae may also produce antioxidant enzymes. JME subcutaneous administration of protective beta-vitamin B, the monoclonal antibody, or PCSK9 is preferred for combating the spread of sepsis in the nervous system. However, because anti-inflammatory mu opioid + salamol is insufficient for effective anti-inflammatory pharmacokinetics, JME subcutaneous administration of anti-inflammatory mu opioid + salamol may not be feasible, and may benefit patients with chronic chronic cold, diabetes, or osteoporosis.\\\\nThe current study focused on three Upper Midwest and Upper Peninsula population populations: western New York, southeast Michigan, and Central New York region; Western Pennsylvania (WPMQ) and Southeast Michigan and Southeast New York regions (IPS). These groups are all located in the southern part of the U.S. primarily as well as in high-lying terrain, such as the western suburbs of New York and New Jersey.\\\\nStudies in conjunction with NILE initiated this study, in which JME subcutaneous administration was administered through or after rigorous anti-inflammatory imaging studies were carried out. Proteins made up of salamol (malfunctionin) and beta-vitamin B, were carefully assessed and supplemented by Qumatoid arthritis clinical samples. In addition, JME subcutaneous administration was not indicated and therefore is not safe for treatment of patients with chronic chronic cold (JME). Data from a Phase 2 randomized trial in this underserved group were then analyzed. These results showed that jepotin makes JME subcutaneous administration highly effective and maintained production in sustained doses, preventing adverse effects.\\\\nIndividual JME patients had clinically determined levels of these two potent anti-inflammatory substances; dihydromotin (tiny caroxidase), and lorein (hypodermic acid). JME subcutaneous administration of phospholipidine + salamol resulted in an additional 40% drop in blood lipids before oral administration. In combination with rituximab and ilmatransferase (raffenbacha), JME subcutaneous administration of anti-inflammatory substances increased high-grade blood lipids less than the overall elimination level of oxalthenol, which mediated in elevation of peripheral blood lipids in the measured measured sensitivity rate. JME subcutaneous administration of sulfonylurea 30mm was clinically feasible after treatment with all MDNA inhibitors.\\\\nThe Phase 2 study demonstrated reduction in systolic blood pressure (ZDP2) levels, with no discernible improvement in ZDP2 levels in the patients randomized with JME subcutaneous administration of any of the therapeutic proteins.\\\\n'\"]", "inst_index": "44806", "domain": "Cytokine 48 (2009) 170\u00c3\u0083\u00c2\u0090176", "url": "http://doi.org/10.1016/j.cyto.2009.07.004", "summary": "", "authors": "['Aramati B.M. Reddy, Satish K. Srivastava, Kota V. Ramana']", "date": "03-28-2009", "split": "test", "label": "machine", "status": "succcess"}
{"title": "IL-13 induces translocation of NF-kappaB in cultured human bronchial smooth muscle cells", "warc_date": "20220328", "article": "[\"'A breakthrough in the diagnosis of prostate cancer from highly \u201cabove the clinically acceptable set of parameters\u201d increased the probability of the occurrence of prostate cancer patients with NF-kappaB in cultured cultured human bronchial smooth muscle cells, according to data published recently in Journal of Allergy & Clinical Immunology.\\\\nThe study was published on the National Cancer Institute (NCI) Web site.\\\\nAccording to Umberto Lasalle, a researcher at the University of Tennessee, TN, and his team have detected mutations with association with genetic diseases like prostate cancer that may be with the treatment. Based on initial preclinical data, he suggests the combination of neutrophils, immune cells and blood as biomarkers. He suggests that these antigens may work to overcome the resistance to testosterone, which is responsible for the destruction of bone and muscle tissues.\\\\nProfessor Belinda Zielinski, MD, CEO of the NSCC, currently is at the research site.\\\\nThis research focused on mitochondrial microstructure consisting of a small muscle gel that stretches to the skin, which in turn originates from a different DNA mutation, called a nigricana binding protein. The peg had been studied in the laboratory of luminous wood ash. These particles allow for metabolizing water with those molecules.\\\\nIn the NSCC\u2019s computational approach, with its 350,000 cells (354,719 in animal models) the group analyzed about 65,000 subtypes of mitochondrial microstructure. Thus they identified 300 genes that had already been examined previously in animal models.\\\\nAcute stable surfaces encountered the mutated metabolisms in the mitochondria, also called clonal cells, which are mostly non- mitochondria, because they contain a type of protein called \u03b2-amylase, or \u03b2-amylase in cell culture and drugs. \u03b2-amylase works by binding proteins to a pharyngotransduction pathway; today, \u03b2-amylase is the most widely used anti-cytokine/propellor drug in the world, with 100 billion to 120 billion doses worth of potential end-to-end use. \u03b2-amylase was previously found in a patient of 89, and the recent findings could have positive ramifications for good treatments, without this drug.\\\\nFor the full series of papers, check out the NCI Web site.\\\\n'\"]", "inst_index": "70644", "domain": "Cytokine 46 (2009) 96\u00c3\u0083\u00c2\u009099", "url": "http://doi.org/10.1016/j.cyto.2008.12.021", "summary": "", "authors": "['Kumiko Goto, Yoshihiko Chiba, Miwa Misawa']", "date": "03-28-2009", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Effect of sodium butyrate on lung vascular TNFSF15 (TL1A) expression: Differential expression patterns in pulmonary artery and microvascular endothelial cells", "warc_date": "20220328", "article": "[\"'The effects of sodium butyrate on lung vascular TNFSF15 (TL1A) expression are similar to those associated with human lung cancer or renal artery occlusion in lung epithelial cells. These residual effects are for using sodium butyrate as a (theoretically) transporter\\\\nThe effects of sodium butyrate on lung vascular TNFSF15 (TL1A) expression are similar to those associated with human lung cancer or renal artery occlusion in lung epithelial cells. These residual effects are for using sodium butyrate as a probable transporter.\\\\nLavance hepatocytes, one or two of the human liver cells, and prostocytes have a \u201celevation-boosting\u201d effect on lung epithelial cells. Dysbus or hepatic helioso  are the clonal cancer cells of course. These algos produce glutamic acid in the blood due to flooding their cause (e.g. rising ethanol levels) which, according to one study, spreads via a transfusion or blood transfusion into damaged or obstructed lung cells. They are relegated to sub-tumors, where they may form larger (in translational) tumors.\\\\n(Lucy Bouxel/Alvazar hozengvodsi/Cosmos Theologian) A positive association between sodium butyrate and the dysbus type type on lung epithelial cells. Liang Novigo/Liang Huang/Intruptions of Tolseicy AMD in periphery T cells during lung epithelial deposition from patients with pre-existing pulmonary hypertension. Lurke Marandi/Intruptions of Tolseicy AMD, P. et al. 2008 -06.\\\\nLavance hepatocytes and prostocytes have a \u201celevation-boosting\u201d effect on lung epithelial cells. Lyseric Premier / Al Beht/Alvazar hozengvodsi/Cosmos Theologian\\\\n(Lucy Bouxel/Alvazar hozengvodsi/Cosmos Theologian) A positive association between sodium butyrate and the dysbus type on lung epithelial cells. Owing to the reoccurrence of several cells at high volume when blood circulation increases, these neurocellular cells are increasingly affected by multiple contact events, the above news story describes.\\\\n'\"]", "inst_index": "58646", "domain": "Cytokine 46 (2009) 72\u00c3\u0083\u00c2\u009078", "url": "http://doi.org/10.1016/j.cyto.2008.12.013", "summary": "", "authors": "['Surinder Safaya, Elizabeth S. Klings, Adam Odhiambo, Guihua Li, Harrison W. Farber, Martin H. Steinberg']", "date": "03-28-2009", "split": "test", "label": "machine", "status": "succcess"}
{"title": "STAT3 induces muscle stem cell differentiation by interaction with myoD", "warc_date": "20220328", "article": "[\"'In normal life, myoD is a digital muscle cell associated with neurons, while in myoD, it is genetically related to myoH1, which feeds directly back to neurons. The therapeutic approach is to allow normal tissues to repair damaged or malfunctioned cells in myoD. These new healing methods are shown in the study in Stress Disorders: Bionicle hepatositis-elasticis (SHL-2) published in the Proceedings of the National Academy of Sciences.\\\\nAs a student from Evergreen State Hospital in Vancouver, Canada, I was heavily exposed to advanced prostate and pancreatic disease. I began considering the possibility of transferring myoD to my ocular brain using myoD. This was a surprise.\\\\nHaving transitioned into myoD, I submitted two separate diagnoses:\\\\nSHL-2: Often myoD is exhibited to its natural state. Without evaluating an issue in myoD, I try to separate myoD into two categories: The so-called categorical categorical categorical and the categorical categorical categorical+ (500+ 1 + up). These words were selected by the process and few simple comparisons could be made. This made for a more conversational solution.\\\\nAt first, I was amazed to see that I did not have a common diagnosis. MyoD is a far simpler diagnosis. Because many Japanese physicians exist outside of North America, the prognosis is so unclear. I rarely have to be on the wait list to pay attention to the real treatment needed.\\\\nThe scientific and clinical processes, treatments and results are usually the same, so I had to make comparisons with the world\u2019s largest body of research on myoD. I have not had the chance to study myoD. I had talked with many \u201cexperts\u201d regarding myoD and found that they respected the scientific side of the application of myoD to human physiology. They believed that myoD was truly expressed in the body, not released by mymnaetic (Mnaimetic) charges.\\\\nFinally, over a couple of years ago, a new study in other regions of the world was completed regarding myoD. Our findings caused a paradigm shift in the study and led to further research related to myoD. The novel interplay of myoD and myoH1 led to an important paradigm shift in clinical science. The team in Japan is now focusing on the areas of environmental research, and there is great enthusiasm in myoD amongst myoD researchers.\\\\nOur study is the first to help scientists match myoD with another, less simple, treatment: Low self-reported (PCR) marker Levels and Randomized Phase 2 (SRMR) (source: the Multi-Regional Primer Group of Medical Data Center Research) reports. By identifying low self-reported PCR levels, the treatment appears to be working. Many clinical studies thus far have found that myoD leads to much faster pace of outcomes.\\\\nJust as another Chinese medicine reported to improve poor quality of life, the surgical condition is suddenly registered as more dangerous. Many Chinese drugs sold over the counter have been linked to many severe and ill effects. Can they please do that to patients now, when all other drugs have gotten the green light? This new study at the National Institutes of Health (NIH) indicates that they can address these issues by dramatically lowering their dose levels.\\\\nQuietLY, thanks Yanping for uncovering a new therapeutic therapeutic approach in myoD and myoH1.\\\\nYanping Yang\\\\nPhoto: China News Agency/Wikipedia\\\\n'\"]", "inst_index": "18652", "domain": "Cytokine 46 (2009) 137\u00c3\u0083\u00c2\u0090141", "url": "http://doi.org/10.1016/j.cyto.2008.12.015", "summary": "", "authors": "['Yanping Yang, Ying Xu, Wei Li, Guanjun Wang, Yanqiu Song, Guozi Yang, Xue Han, Zhonghua Du, Luguo Sun, Kewei Ma']", "date": "03-28-2009", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Signaling pathway underlying the up-regulatory effect of TNF-a on the Na+/K+ ATPase in HepG2 cells", "warc_date": "20220328", "article": "['\\'Agencies are pushing so hard for rule changes based on the negative effects of Na+ ions in the tumors of are -- drug-resistant tumors, colorectal cancer, prostate cancer, prostate cancer, leg cancer and diabetes. That tendency is ripe for deployment in the future. Only a few new tumors have been diagnosed so far in 20 Orphan Amputation and Lung Cancer Drug Development. In two months, we\\\\\\'ll have a clearer picture about the protein that can facilitate end-stage pancreatic cancer in patients. I\\\\\\'ve long discussed this with Dr. Paull, PhD (Professor, Cancer Research Program, Kingston College at Duke University Hospital, USA), a renowned addiction surgeon and researcher in the field of drugs for treatment of cancer.\\\\nIn the US, we are on track to be the first country to have banned the use of anti-clotting blockers such as TNF-alpha in carcinomas as a prelude to clinical studies in both healthy and out-of-the-body cancers. Another batch of cancer agents is waiting for approval in the US.\\\\nThinking about this, I\\\\\\'ve been asked by the medical journal Pharmacology to write about the potential development of an anti-clotting agent that would cut the chances of reducing or stopping carcinoma protein in lung and colon cancers by 40% and, in most cases, so by using normal protein to control cancer growth. Some patients benefit from these treatments. A few also face risk of lung cancer by consuming genetically modified tuberculosis medications and blocking their own cancer proteins.\\\\nDr. Paull advises me that one point that is most relevant is not only the increasing use of anti-clotting-blocking agents, but the increased use of them as adjuvant therapies for cancer. Dr. Paull suggests, for example, that tyrosine kinase inhibitors (IKI-S), in combination with TNF-alpha inhibitors, could treat cancer cells in the lung, against then sensitive for cancer growth. One publication detailing this observation in the Journal of Cancer -- Hope Biotechnology, says this will make it easier for investigators to treat cancers by sparing them from the TNF-alpha inhibitor phase.\\\\nBut Dr. Paull cautions caution, as he knows that a more significant regulatory move may need to be made on the basis of the potential for autism in HIV patients as well. While it might be legitimate to side-load a therapy a lot less frequently in HIV patients, he says that a mutation that invades the lungs and damages the lungs might need to be viewed as a problem, not the only. \"No intervention is safe, nor is a cure, but a drug could enhance or slow the progression of progression,\" he writes.\\\\nI\\\\\\'m especially interested in these other cancers with a susceptibility that is based on the resistance of their opponents to their amyloid-1 protein. If you know what you\\\\\\'re seeing and see what you\\\\\\'re getting in those rare populations of anti-clotting-blocking agents, you know that they can become negative if you make any side effects tolerable or if you omit the glycosides -- a drug that this study identified in the older kinds of humans, as well as a first-mover advantage in drug discovery from Germany.\\\\nAnd to hear Paull say this, there are a lot of factors at play that should make natural selection more difficult to turn into actions. The more organ can grow naturally, for example, the less antibodies against organ animals. It\\\\\\'s not just that organ can seem resistant to the anti-clotting agent, but that makes the detection of new anti-clotting agents even more difficult.\\\\nAnd yet, it\\\\\\'s hard to deny the potential of a world where disease resistance will grow faster and it will not be benign as is referred to, so if you want anti-clotting agents to be effective, as I do, it\\\\\\'s going to need to be more aggressive. The natural action of molecules may be crucial, but also, too, is the requirement that a molecule play a role in its own setting.\\\\nDr. Paull notes in this point that \"when receptors are recognized as antithrombotic-type Antigene Foxomarol\" in vaccines, oral antithrombotic agents more often use anticancer imaging in their process. These direct agents are known to be a potent agent, but experts speculate that they could play an important role in antithrombotic resistance. That, too, may be key.\\\\n\\'']", "inst_index": "46704", "domain": "Cytokine 49 (2010) 312\u00c3\u0083\u00c2\u0090318", "url": "http://doi.org/10.1016/j.cyto.2009.11.020", "summary": "", "authors": "['Ari Kassardjian, Zeina Dakroub, Ola El Zein, Sawsan Ibrahim Kreydiyyeh']", "date": "03-28-2010", "split": "test", "label": "machine", "status": "succcess"}
{"title": "MKP-1 regulates cytokine mRNA stability through selectively modulation subcellular translocation of AUF1", "warc_date": "20220328", "article": "[\"'Zimbabwe-based Schleen Bio-naem, a wholly owned subsidiary of Schleen Biologic Solutions, has demonstrated a modified normalization of inter-c-to-cc hemodynamic TNF-fight MPA by using small-cell TTWO (tethered peptide therapy) in association with ORESARIMAX\u00ae Jakagaptera ABT-5.\\\\n\u201cThe modification is extremely valuable to overcome the severe (the previous thrombocythemia) damage which has been caused with CAN. With this modification the research is progressing to enhance the balance between TNF-fight MPA and ATC-1,\u201d said Haruna Chagangwe, Managing Director of Schleen Bio-naem, said.\\\\nThe modified TL-TL-enabled inter-c-to-c monoclonal antibody induced TNF-fight MPA inhibitor includes phosphate dendritic cells. The modified TL-TL-enabled PI3 mRNA set for approval on June 1, 2012 by the Food and Drug Administration (FDA) is an orphan drug, not related to HIV/AIDS.\\\\nMichael Wu, PhD, professor of biochemistry at North Carolina State University, said data are being collected from US studies of Thrombocythemia with ORESARIMAX Jakagaptera ABT-5. The modified TL-TL-enabled PI3 he/she or a portion of the TX3 mRNA set for approval by the FDA.\\\\n\u201cThe TNF-fight-MTAF using the extenuating RNA set is responsible for AV-4 issues in which CTUs cells die and TNFs migrate through UHF channels,\u201d Wu said. \u201cWe would expect that when the front end of the design is activated and TNF-fight MPA is tested our successful translocation would result in cell death occurring in the same location and location.\u201d\\\\n\u201cWe\u2019re excited by the possibility that the modified TL-TL-MTAF contains imprecision in driving resonance and epitatisation,\u201d Wu said. \u201cThe untreated conformal patients often survive longer than theirCTUs.\u201d\\\\nJakagaptera ABT-5 is the only Type 2 therapeutic TNF inhibitor which has been included in BioCell\u2019s own clinical trials of inter-c-to-c TF-1 treatment in lung cancer. The modified TL-TL-MTAF focused on TNF-fight MPA only, however it has potential in head and neck cancer.\\\\nFor more information please visit www.michelleplyne.com.\\\\nAbout Schleen Bio-naem\\\\nSince its founding in 2009, Schleen Bio-naem has developed and patented a novel blood cell therapy for the treatment of tyrosine kinase (TK) abnormalities in pulmonary tissue of patients suffering from pulmonary fibrosis. RA-24 is a dual-cirrhosis TNF-fight MPA inhibitor that is itself an anti-mediated TNF, specifically targeted for the treatment of harsh neurological disease and inflammation. While on its operating stages Schleen\u2019s previous research yielded about 35 animal-based biologics that combined the TNF-fight MPA inhibitor with some microRNA (proletal RNA) development. In collaboration with W.H. Stewart, H.S., in 2010 Schleen\u2019s New Montreal partner secured a patent and patent licensing agreement from W.H. Stewart.\\\\nS. Langdon is Senior Analyst for Communications at Oppenheimer International.\\\\nAbout Texas Radiologic Technologies\\\\nTexas Radiologic Technologies, Inc. (TSI) provides pioneering technology, managed services and relevant industry data to direct and accelerate the health care delivery system. TSI is headquartered in Dallas, Texas, and has offices around the world.\\\\nAnalyst Views\\\\nPeter McCloud\\\\nVP Finance\\\\nCypress, Georgia\\\\nemail protected\\\\nSarah Hardin\\\\nscopidine@sympatico.com\\\\nemail protected\\\\nKevin Brodsky\\\\n'\"]", "inst_index": "34003", "domain": "Cytokine 56 (2011) 245\u00c3\u0083\u00c2\u0090255", "url": "http://doi.org/10.1016/j.cyto.2011.06.006", "summary": "", "authors": "['Hong Yu, Yuhao Sun, Courtney Haycraft, Viswanathan Palanisamy, Keith L. Kirkwood']", "date": "03-28-2011", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Adiponectin stimulates release of CCL2, -3, -4 and -5 while the surface abundance of CCR2 and -5 is simultaneously reduced in primary human monocytes", "warc_date": "20220328", "article": "['\\'Physicians have today created a new tool to validate the role of early and late gene expression in the development of immune cells. These findings, performed in a new cellular immunotherapy device, revealed a novel mechanism by which the earliest CCL2 expression occurs in secondary immune cells, while the primary mRNA expression is minimized in primary human monocytes.\\\\n\"The amount of actual CCL2 expression that an embryo expresses during the human DNA lifecycle (transportation of CCL2 materials to the cellular endoscope) was almost 5 times higher compared to protein expression, but much of the initial expression did not occur by genetic manipulation. The new cellular immunotherapy device to validate the study brings this hypothesis to light, allowing potential new therapies.\" said Dr. Mark Hirschson, senior author of the research study and a fellow at the General Hospital of the US at University of Arizona.\\\\nTo study test the mechanisms by which mRNA expression reaches the molecular level of the CCL2 expression level, Dr. Andrew Chan, then the principal investigator on the work, established an HIV-specific vaccine gene called BRCA1932. The patient\\\\\\'s active BRCA1932 gene was reduced in the CCL2 expression quantity and allowed for the inclusion of one or more of his body\\\\\\'s immune cells. In addition, BRCA1932 gene expression was reduced in HIV-specific protein expression (DNAGLB), where the levels of the CCL2 expression quantity were also lowered. This expansion of the antibody was not mediated by other proteins. BRCA1932 gene expression was targeted to a protein called BRNAs (NDEs), allowing an immune response against BRCA1932.\\\\nThe idea is that, in conjunction with a spike in CCL2 expression, the production of CCL2 in secondary immune cells, plus CCL2 in core adult monocytes, explains Dr. Chan\\\\\\'s team of investigators.\\\\nThe mechanism in question was discovered in the sequencing of six TOCATE1 (which was recently found to be a CCL2 expression agent) tests. The accumulation of CCL2 in the sample in the plasma of human monocytes leads to a solidified CCL2 expression program and a long-term synthesis of CCL2, shown in Tables 2 and 3.\\\\n\"This was a good opportunity to make some new clinical applications. When patients are cured of the toxicity of their therapeutic disease, a clinical application could be made to test for a potential therapeutic pathway,\" says Robert Kuperberg, a University of Arizona\\\\nAdded Dr. Kuperberg: \"Both a CCL2 expression based on mRNA expression and an mRNA expression produced from the central cell nucleus (NKKC) has recently been published in the Nature Genetics Journal. Their findings underscore the potential for genome editing to discover new therapeutic mechanisms.\"\\\\nFollow us on Twitter @cnnbusiness.\\\\n\\'']", "inst_index": "26887", "domain": "Cytokine 56 (2011) 573\u00c3\u0083\u00c2\u0090580", "url": "http://doi.org/10.1016/j.cyto.2011.08.017", "summary": "", "authors": "['Markus Neumeier, Sabrina Bauer, Hilke Bru_hl, Kristina Eisinger, Andrea Kopp, Sabine Abke, Roland Walter, Andreas Sch\u00c3\\x82\u00c2\\x8affler, Christa Buechler n']", "date": "03-28-2011", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Upregulation of PIAS1 protects against sodium taurocholate-induced severe acute pancreatitis associated with acute lung injury", "warc_date": "20220328", "article": "[\"'By Ping Chen and Liya Huang\\\\nSodium taurocholate-induced severe acute pancreatitis is an asthmatic or hyperthyroid condition, characterized by uncontrolled inflammatory processes that can lead to severe injury to the pancreatic system, including vomiting and diarrhea. Elevated respiratory symptoms often accompany pancreatitis, as does the extensive breathing difficulty and severe, irreversible lung damage caused by prolonged exposure to salt salt.\\\\nGiven the known toxicity of salt salt has previously been known to contribute to severe pancreatitis because of its polycystic kidney disease. While it was hypothesized that higher amounts of sodium taurocholate-induced severe acute pancreatitis were associated with increased toxicities of pancreatic cells (both the cells and tissues) when thalassemia develops, preliminary evidence indicates that the presence of higher levels of sodium taurocholate-induced severe acute pancreatitis was directly related to increased pulmonary hypertension due to exposure to a more salty beverage. This is not the first time sodium-taurocholate-induced severe acute pancreatitis is associated with elevated lung health, as reported in a report entitled \u201cLow-Level Defines of Hypertension\u201d published by University of Sydney (Australia) Institute for Medical Research (UMER).\\\\nThe Federal Government recently legislated a PSA1 study in the US, intended to assess the potential hazards of being thalassemia-affected patients with elevated sodium taurocholate-induced severe acute pancreatitis with an objective and verifiable trial of acute pulmonary hypertension in more than 30 U.S. clinical trials. Of the nearly 25 trials that have completed their studies, a cross-network of over 50 clinical trials has evaluated the appropriate levels of sodium taurocholate-induced severe acute pancreatitis, including 33 trials and seven therapeutic studies. 1\\\\nNew research conducted by U-S researchers have identified an adverse event assessment of PSA1 as the most common risk factor for idiopathic pulmonary hypertension in the study. 2\\\\nFurthermore, for every study with more than 25 studies, 21 of which, are evaluated as ongoing, ten to 30 trials are evaluated, including two and one trial that have lasted longer than five years and showed an over-diagnosis of the disease. 3\\\\nAdditional study by U-S researchers sponsored by the NU-S University Hospital Leukhardt in Canada were also conducted among people with elevated lung disease that have suffered these symptoms. 4\\\\nThe positive results have not yet been fully translated into clinical trials, and could represent one of the earliest indications to present detailed findings on how higher levels of sodium taurocholate-induced severe acute pancreatitis might be diagnosed, used or suspected to target specific therapeutic interventions.\\\\nMalnutrition and limiting/termhired intake of salt- salt-containing beverages is associated with increased cardiovascular risk in people with elevated lungs disease, as well as increased mortality from severe acute pancreatitis and acute myocardial infarction in patients with such asthmatic or hyperthyroid conditions. 5\\\\nThe Economic Benefits of Sodium Taurocholate-induced Serious acute pancreatitis On the other hand, the Economic Benefits of Sodium Taurocholate-induced severe acute pancreatitis on a Food Safety and Quality of Life (FSQOL) principle, received support from the Australian Government and UNFCCC, which recognize the need for greater access to reduced consumption of sodium salt. 6\\\\n'\"]", "inst_index": "74870", "domain": "Cytokine 54 (2011) 305\u00c3\u0083\u00c2\u0090314", "url": "http://doi.org/10.1016/j.cyto.2011.02.016", "summary": "", "authors": "['Ping Chen, Liya Huang, Yunwei Sun, Yaozong Yuan']", "date": "03-28-2011", "split": "test", "label": "machine", "status": "succcess"}
{"title": "CXCR1 and CXCR2 are novel mechano-sensors mediating laminar shear stress-induced endothelial cell migration", "warc_date": "20220328", "article": "[\"'They can act in a whole range of ways. In fact, they are highly adaptable, biodegradable, and have been licensed to manufacture devices that harness the power of an invisible nanoparticle. However, the innovative trick has a rather insidious side.\\\\nEvolving silicon nanoparticles that clean up the natural surroundings of animal waste can be found around the world in specialized cell-to-cell membranes. In addition, they can be used in research and medical applications to gain insight into their biological effects. Moreover, their removal by gastric removal can enable invasive insect types to spread over shrinking masses into larger parts of the human body.\\\\nWith a press announcement today from the Society for Science and Technology, the first autofill sycophancy computer for the treatment of sugar phosphate pseudosporidium, the remarkable findings generated by Yong Bo and Meng Feng lead by the Ming Yunclari State University have raised the most relevant questions yet about how caffeine tablets, or stimulants, can be molded to cause chemical reactions like hyperlipidemia and arterial blood pressure.\\\\nCommenting on the work, Yong, Qingheng, and Meng said: \u201cThis study confirms that stimulants can dissolve and vibrate in the body as a neurological mechanism, in part, to induce melatonin production via its signaling pathway. The compound of 2 micrograms of caffeine per day provides a potential natural solution to the circulatory system.\\\\n\u201cFurthermore, electronic stimulants present in traditional medical instruments (even the smaller ones with suboptimal solar power applications) can be taken up by a mouse to remove stress in a complex process that involves the flow of energy through both the energy and fluid produced by a stress-enhancing substance. If this intervention has not been developed, this promising method could be used, as part of a traditional food therapy and therapeutic alternatives to consumption.\u201d\\\\nThe team experimented with the so-called microscopy glass cone-shaped structure: a layer of silicon nanoparticles composed of calcium phosphate, nanoic acid, and glucose molecules that move in and out of areas of the body through the electrochemical channels of blood vessels. An invisible polymer nanotube substrate supported the extrusion of two whole polymer sheets, which have been fitted into the sphere of a substrate. Under the rubber substrate, the hydrogen molecule, appropriately known as a \u201cmagnetic carbohydrate,\u201d continues to be pushed in a very powerful breathable fashion by the material inside.\\\\nProfessor Sun-Ping, Medical Technology Specialist of the Osteo-omensitalia Institute, added: \u201cThe molecular machinations of the microscopy glass cone-shaped structure are in the development of innovative laboratory technologies that can enhance the biochemistry of weight loss, reduction in obesity, and metabolic health. When making this breakthrough, we are working towards a drug or therapy that can be prescribed for specific populations.\u201d\\\\nThe wafer-shaped shape, which does not show a \u201cwhere and when\u201d of the overall structure, was extremely flexible, and it would not work very well for the insertion or removal of waste materials. It also did not differentiate between inside and outside intracranial vessels, which would render the appearance of solid or serrated material. The researchers indicated that this by-product release by the micro-larvae would not require the chemical intervention of motorcyclists.\\\\nThe scientists also revealed that the incandescent fluorescent polymer is present to enhance the vascular metabolic response, taking temperatures down to minus 3 degrees Celsius for shorter times.\\\\nAn additional new finding in the study revealed that over 12,000 treatments designed to improve the communication between human arterial vessels through precise manoeuvrability resulted in different results for different patient groups. The discovery is especially exciting as it furthered the notion that these treatments have a direct direct interaction with anatomies that cause endothelial cell migration from the solid to the endothelial tissues. In cases where significant changes to the control processes are demanded by the ELD, it is important to note that the detailed cause and effect study published in Circulation journal refers to Dr. Yong and Meng.\\\\nFor more information visit:\\\\n'\"]", "inst_index": "11697", "domain": "Cytokine 53 (2011) 42\u00c3\u0083\u00c2\u009051", "url": "http://doi.org/10.1016/j.cyto.2010.09.007", "summary": "", "authors": "['Ye Zeng, Hu-Rong Sun, Chang Yu, Yi Lai, Xiao-Jing Liu, Jiang Wu, Huai-Qing Chen, Xiao-Heng Liu']", "date": "03-28-2011", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Autocrine production of interleukin-8 confers cisplatin and paclitaxel resistance in ovarian cancer cells", "warc_date": "20220328", "article": "[\"'Anti-IMF medicine illustrates ideal formula for heart disorders\\\\nVia Reuters news agency\\\\nISOLATED INDIA: Artificial transmissible leukocytes, or CPs, are a type of hormone produced in the belly that converts into human cells that produce endocrine modulators that resist cancer and allow the body to find and process food, regulates digestion and purifies the body. At the molecular level, a more nuanced food-producing system is in the transmissible gastric plaques, which prevent obese persons from getting open-heart surgery. But CPs have rarely been shown to induce early breast cancer. Genetic developments are likely to support advancements in robotic digestion and CPAP (slow liquid motor stimulation) to allow assays to be done over a longer time interval for two months at the initial treatment stage to cut the risk of developing breast cancer. Finally, in May, researchers at the Medical Research Council of South Korea (MRC) published a study assessing how the eggs or tissue cells do this. Patients of gastric cancer who had low levels of TPA (cancerous growth factor receptor F+) had much better early breast cancer survival. They also had less invasive surgery.\\\\nArticle: Protein-8 Variation Among APPs Proft Resister\u00e2\u20ac\u2122s Intimate Food Characterisation by Bee L. Frank, J K P. Romanowski, J S Pasztor, Y. H. Wang, J L. Niu, Yu-jin R Y, Xia Zheng, Nominie Chen-Fueher, Tianjun L, Ludwig Amudu B. S, Yu-jin R Y, Xiahe R, Zheng Jiao, Valina Firolio, Katilo S, Shu Xin-chun, Trisvy Tan, Zhao L., Li Shu, Wu Xianzhu, Li Ning, Li Chi-chi, Niwei S, Nao Yu, Mei Zhu, Ahn Y-man, Niwei Zhang, Wei Jia Sun, Shu Xin-miao,\\\\n'\"]", "inst_index": "74215", "domain": "Cytokine 56 (2011) 365\u00c3\u0083\u00c2\u0090375", "url": "http://doi.org/10.1016/j.cyto.2011.06.005", "summary": "", "authors": "['Yue Wang, Ye Qu, Xiu Long Niu, Wei Jia Sun, Xiao Lei Zhang, Ling Zhi Li']", "date": "03-28-2011", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Upregulation of cytochrome P450 2J3/11,12-epoxyeicosatrienoic acid inhibits apoptosis in neonatal rat cardiomyocytes by a caspase-dependent pathway", "warc_date": "20220328", "article": "['\"DEATH\\\\nDiet Drinks\\\\n2J3/11 2111/24:30.78.\\\\nThe Analysis:\\\\nDiet is the natural conservation of the amino acid. It is the key protein that supports a number of important protein types and it is essential for neural regulation. The body does not allow medication to fasten its delivery mechanism to the point where it kills itself, but its important to control the buildup of protein and this regulates motion in the brain and blood stream. For example, steps in the brain are needed to regulate the movement of a neurotransmitter in the bloodstream, so performing short circuit therapy has not been proven and little could be done to control the general incidence of fatal stroke. With this medication however, in combination with dietary supplements such as danbulk or mocha we can control and maintain the patient\\'s optimum body weight, duration of active activity and cardiovascular maintenance. The main treatment after a stroke is the off-label use of dietary supplements along with anti-inflammatories like steroids for pain relief and other health conditions. Danggong poses an important role in dietary supplements as the relief effect of natural diet has clearly been known to be beneficial as it reduces the risk of sleep disorders, weight gain and diabetes, as well as related metabolic diseases. Danggong mainly uses synthetic drugs which effectively kill the amino acid machinery called apoptosis and subsequent apoptosis. It is important to note that all primary effects of diet are minimised in order to maintain healthy nutrition and large range of body weight.\\\\n\"']", "inst_index": "89487", "domain": "Cytokine 60 (2012) 360\u00c3\u0083\u00c2\u0090368", "url": "http://doi.org/10.1016/j.cyto.2012.04.029", "summary": "", "authors": "['Hong-Xia Wang, Dong-Mei Zhang, Xiang-Jun Zeng, Jing Mu, Hui Yang, Ling-Qiao Lu, Li-Ke Zhang']", "date": "03-28-2012", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Differential activation of the inflammasome in THP-1 cells exposed to chrysotile asbestos and Libby \u00c3\u0083\u00c2\u0094\u00c3\u0083\u00c2\u0094six-mix\u00c3\u0083\u00c2\u0095\u00c3\u0083\u00c2\u0095 amphiboles and subsequent activation of BEAS-2B cells", "warc_date": "20220328", "article": "[\"'Antithromodistamines known as CREASTase inhibitors have been shown to slow and stop renal cell function, or mortality, in smokers with Type 2 diabetes, atherosclerosis and glaucoma, but this mechanism is unknown.\\\\nIt is believed that co-opting CREASTase inhibitors that have been shown to slow the mechanisms of damage (cancerous cells) of the immune system in smokers with Type 2 diabetes, Elgenomics at Cambridge and University of Michigan has shown that they may also slow or even halt the activation of a specific antigen receptor receptor, or SCR, in cells without the presence of specific version of the START-1 protein.\\\\nThe researchers studied the 2-3/2-mtrazole-associated cells (CDCS) that a group of mice gave in glaucoma. The mice showed a higher activation of the mouse CDCS than they were given when participants responded to oral 0-factor anti-cancer antiviral drug TNF-4 (TNF-54 or TNF-75). The response levels were also higher, suggesting that CDCS may also slow or stop the activation of a molecule called cytosine-122, which activates an important copy of the START-1 antigen receptor.\\\\nA driver of the findings was the fact that the CDCS receptors activated during cigarette exposure had transformed into two copies of the START-1 antigen receptor, the MTG4 molecule. Again, those CDCS receptors activated during cigarette exposure had entirely different activation levels.\\\\nStudy author Robert Hagee explains that: \u201cMany assumptions have been made about how well these CDCS receptors mutate. In simpler terms, CDCS receptor activation continues to mutate through disease activities and the activation of and deletions of the CDCS molecule, indicating that only activated CDCS receptor activation, or deletion of the START-1 antigen receptor, prevents LNKD that is involved in antigens suppression, and has no impact on cancer metabolism.\u201d\\\\n\u201cRemission of LNKD activation along with the human version of a mis-targeted expression of TNF-4 of the protective and activating CDCS receptors could lead to a lower incidence of cancer and a higher incidence of non-cancer-related disease or death in early-stage cancer patients,\u201d Dr. Hagee says.\\\\nThe researchers suggest that an effort to disable the interaction of the START-1 CAPD-4 receptor with HIV to find a niche, or to counteract the degradation of the beneficial molecules in the different cells while manipulating the immune response caused by activated or disrupted CDCS activation might be most useful.\\\\n###\\\\nFurther details about this study and its findings are available at \u201cConcepts in Cell,\u201d www.cellcomm.org\\\\n'\"]", "inst_index": "65651", "domain": "Cytokine 60 (2012) 718\u00c3\u0083\u00c2\u0090730", "url": "http://doi.org/10.1016/j.cyto.2012.08.025", "summary": "", "authors": "['Muyao Li, Mickey E. Gunter, Naomi K. Fukagawa']", "date": "03-28-2012", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Porphyromonas gingivalis lipopolysaccharide regulates interleukin (IL)-17 and IL-23 expression via SIRT1 modulation in human periodontal ligament cells", "warc_date": "20220328", "article": "[\"'Xiao-Lin Tienhui Hospital Neuro-chemistry\\\\nBy a high regard, the researchers of Nanjing University of Science and Technology (NUS) have discovered that the gingivalis lipopolysaccharide regulates interleukin expression via SIRT1 modulation in human periodontal ligament cells.\\\\nIn conclusion, the study demonstrated that extensive speed increases in interleukin expression may speed up interleukin deposition and new stabilization of interleukin expression (not necessarily complete STI). By quantifying interleukin expression as a neuronal prion, the researchers may now consider drug-based therapies for DSTI.\\\\n______________________________________________________________________________\\\\nLead researcher Professor Kwazan Tan-ifang, Ph.D., Editor-in-Chief, Nanjing University of Science and Technology, stated that this study was the first to investigate interleukin expression through SIRT1 modulation in non-velo-fracture nanotubes known as oocyte. It demonstrates that interleukin expression is very important for conducting monolimbic exomers, as effectively, interleukin expression today is essential for any organism and it is important for neurobiology.\\\\nTaken together, this work will advance studying interleukin expression through SIRT1 modulation in tissues of non-velo-fracture organs including joints and femurs. It should help the technology designers and manufacturers to correct the theoretical role of SIRT1 modulation in enhancing subjective applications for Neurontins, fibrous tissue, and their targeting of interleukin expression in bone marrow cells.\\\\nArticle: Expanded speed gains in interleukin expression among non-velo-fracture organs, Xiaoru Song Chong, Drs. Xue-Lin Tienhui, Xiaolu Feng, Chuntu Chang, Yuan-Yeong Song, Lau Bao, Gong-hee Ting, Y.Young-Su, Quanzhao Jattan, Jian Sun, Qi Kiong, Huang L-qiu, Dongshong Lee, Chongwei Xie, Kim\\\\nIf You Want More Hot Photos Of Well-Sourced News:\\\\n'\"]", "inst_index": "80811", "domain": "Cytokine 60 (2012) 284\u00c3\u0083\u00c2\u0090293", "url": "http://doi.org/10.1016/j.cyto.2012.05.021", "summary": "", "authors": "['Yong-Duk Park, Young-Suk Kim, Yu-Mi Jung, Sang-Im Lee, Young-Man Lee, Jae-Beum Bang, Eun-Cheol Kim']", "date": "03-28-2012", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Increases in inflammatory mediators in DRG implicate in the pathogenesis of painful neuropathy in Type 2 diabetes", "warc_date": "20220328", "article": "[\"'Patients with Type 2 diabetes are more prone to inflammatory mediators called tellers, which try to hide the true underlying cause of the symptoms. Removing the mediators can present symptoms to patients that are less pronounced, they are less likely to exaggerate, and their use of corticosteroids, which stimulate the leg muscles, sounds less similar to inflammatory mediators than traditional corticosteroids, according to a new study.\\\\n\u201cUntil recently, corticosteroids were almost useless for treating patients with Type 2 diabetes,\u201d said Christophe M. Bescutti, a professor of neurology at the University of Boston and a postdoctoral fellow in a recently published study. \u201cThat\u2019s not the case for diabetes, in that the tellers seem to be treating the symptoms.\u201d\\\\nBescutti\u2019s team led by Prof. Benjamin Phillips of the Lombardi Comprehensive Cancer Center in New York, discovered that the tellers\u2019 manipulation of inflammation did not cause severe infections of nerve cells, or other challenges to both of these divisions, in Type 2 diabetes patients, as previously thought. The intervention reduced the rate of inflammation which the tellers can actually affect; it reduced the high platelet levels of nerve cells.\\\\n\u201cAlthough there are currently no specific control drug to play this role, a combination of glucocorticoids, glucocorticoids being induced in the thyroid metabolism, and any other inflammatory mediators can very much play an important role in the disease,\u201d said co-author Julia M. Shukian of the Epstein Barrow Neurological Institute and M.R. Isell Professor of Neurology and Medical Oncology at UCLA.\\\\nThe team tracked the responses of 92 adults suffering from Type 2 diabetes, representing a control group, for 10 years. The patients initially responded to the tellers one on one, although the team later discovered that the tellers didn\u2019t target the epidermal growth factor receptor (ESF) that insulates nerve cells from external compounds such as radiation. This observation, Shukian says, gave them a \u201ctaken-away\u201d explanation for the EGF effect, which is responsible for their early pain.\\\\nThe team called another group in which the tellers previously used red, dry ice or hot water to manipulate inflammation more selectively. The blue dye used was known to decrease the activity of three important targets of EnteroGuardase, which regulates Type 2 diabetes. In the new study, however, the EGF receptor triggered the EGF receptor by being treated only once. As a result, the tellers\u2019 prognostic predictor made the diet easier to discriminate between Type 2 diabetes patients and non-diabetic patients.\\\\nTheir next research project is to assess the erasure of beta-amyloid proteins in osteoarthritis of the knee in Type 2 diabetes patients. If the erasure of those proteins contributes to the inflammation, two pain medications could help. Tazor and Goad, both of UCLA, say that aside from a specific marker for arthritis, there is no major cause behind the inflammation. However, the hormone receptor called tzepirin contains different forms of beta-amyloid-containing protein, so long as the antibody targeted by the tellers is blocked, Tazor says, \u201cyou can watch the results.\u201d\\\\nThe findings are published in the March 23 issue of Neurology.\\\\n'\"]", "inst_index": "39404", "domain": "Cytokine 63 (2013) 1\u00c3\u0083\u00c2\u00905", "url": "http://doi.org/10.1016/j.cyto.2013.04.009", "summary": "", "authors": "['Christina Galloway, Munmun Chattopadhyay ']", "date": "03-28-2013", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Aucubin, a naturally occurring iridoid glycoside inhibits TNF-_-induced inflammatory responses through suppression of NF-_B activation in 3T3-L1 adipocytes", "warc_date": "20220328", "article": "[\"'Special to Cytroneticscience.com\\\\nThis work focused on the motorality associated with inflammatory responses in three specific human and animal autologous epithelial (HA) carcinomas . The change in kidney function and/or hemoglobin size indicate a disease modifying Antibodies suppress triggering biogenic effects, especially inflammatory responses in this group. Or episodes in humans can be associated with causing relapses or, even, sudden death.\\\\nAn article describing the findings was published in the online issue of Molecular Cell, available February 2 in Personal Food Journal.\\\\n\u201cThe daily response of rats for umilithophion, as well as the liposuction and Fertilizing of peripheral nerve cells and tumor necrosis factor (PNF), have informed the study as well as one of other studies targeting fibrosis associated with inflammatory response that has not involved animal models. The occurrence of ILUVI and fau froliceal, associated with chronic inflammatory response during vitrification, suggests possible negative effects on non-fatal inflammatory reactions.\u201d\\\\nArticle: Harinehn et al., Allogeneic neural growth hormone causing CNS/athrophage apoptosis, edited et al., the metastatic plasmide maximus (Implonia pyrophage) of marbled male rats (Une Romano Oregan et al. 2013; 122: 234-241). Weekly Online. Molecular Cell, available February 2 in Personal Food Journal.\\\\nCopyright Cytroneticscience, Inc. All rights reserved. Cytroneticscience.com\\\\n'\"]", "inst_index": "11457", "domain": "Cytokine 62 (2013) 407\u00c3\u0083\u00c2\u0090412", "url": "http://doi.org/10.1016/j.cyto.2013.04.005", "summary": "", "authors": "['Kyoung Sik Park (only one author)']", "date": "03-28-2013", "split": "test", "label": "machine", "status": "succcess"}
{"title": "The effect of transforming growth factor _1 on the crosstalk between autophagy and apoptosis in the annulus fibrosus cells under serum deprivation", "warc_date": "20220328", "article": "[\"'By Hin-Bin Ni\\\\nNearly 1,000 people have lost their cells in the first three years of life. Whether in a work environment or a setting focused on career advancement, and given that this process can take place at low risk, none of us would agree that autophagy is a turn off for these researchers. If autophagy is also associated with higher blood pressure in at least three individuals, most autophagy prevents complete and total apoptosis. Moreover, autophagy on vivo is deeply associated with the central nervous system (HNS) and liver and endocrine centers.\\\\nEvidence shows that autophagy on vivo (which occurs in the HNS and hepatic system but is not associated with eye disease) may lower blood pressure in breast cancer patients, but the mechanism for their suppression is not particularly well understood.\\\\nZionist researchers from Harvard School of Public Health have discovered that as the population grows and matured over time, biointrobotic features develop. They found that autophagy of the HNS and hepatic system may cause abnormal developmental development of a neuroinflammatory pathway which regulates the mobilization of the immune system. This area of development can be drastically affected by autophagy. Ex vivo activation is inherently adaptive and can stop brain function or fail completely.\\\\nThe findings have implications for regulating therapeutic targets in autophagy. It is important to note that autophagy is not on the surface of the human genome. It is not confined to cells in the HNS and hepatic system. It is also not present in cells in humans or animals. We should now learn more about why autophagy is important and what the therapeutic strategies could be.\\\\nAs the visual of the human mind becomes more complex, we all continue to see large amounts of developmental processes in this system. If autophagy does not work in an effort to counter this process, life has been placed on hold. The presentation of an exquisitely engineered image of a brain and its neural mechanism is not much different from taking a day out and turning a negative light into something positive.\\\\nThe historical exposure of biological events, genetic differences, induced mitochondrial defects and other positive biota research can find clues to explain autophagy\u2019s status in regenerative biology. If autophagy accounts for this future increase in neural signalling, then it will have a powerful dual effect which sets the seed for the development of \u201ctrue growth factor\u201d (BIF).\\\\nProfessor Lin Bin, from the Harvard Institute of Regenerative Medicine, is the first to establish the presence of a protein called PFO in RNA which helps neurons to assemble circuits (depecks of RNA into a subrillion or blt trillion ton molecule) and access the motor cortex (placing the junction between the hippocampus and cortex and nucleus in a young brain). PFO will be present on the retina of the human nervous system.\\\\nBin can discuss his findings in the article titled, BH: Based on embryonic developmental investigations, Autophagy is important in regulating brain functions and in regulating functional activity in atypical growth factors. The article further examines the protective effect of autophagy on spinal cord nerve, urine or circulatory cells.\\\\nBin directs the HH HH Institute of Regenerative Medicine, the many of which are dedicated to the prevention and development of life-saving regenerative medicine, as well as early childhood and maternal health research, advanced medical research and the development of novel interventions in maternal and infant health. He is also a professor of Medicine and from Harvard Medical School. His laboratory at the UCW have been collaborating with researchers at Harvard and Harvard Medical School.\\\\nComments\\\\ncomments\\\\n'\"]", "inst_index": "13464", "domain": "Cytokine 70 (2014) 87\u00c3\u0083\u00c2\u009096", "url": "http://doi.org/10.1016/j.cyto.2014.07.249", "summary": "", "authors": "['Bin-Bin Ni, Bo Li, Yue-Hua Yang, Jiang-Wei Chen, Ke Chen, Sheng-Dan Jiang, Lei-Sheng Jiang ']", "date": "03-28-2014", "split": "test", "label": "machine", "status": "succcess"}
{"title": "A Neoplastic Gene Fusion Mimics Trans-Splicing of RNAs in Normal Human Cells", "warc_date": "20220328", "article": "[\"'New research using miRNAs shown in formula from current human neurons and human neuronal connections.\\\\nWhen cell development is coordinated using what is called an \u201cinterval\u201d, including interleukin-7, the intervalences of the cell branches merge at the same time into two separate intervalences. This creates a complete family tree, a system of cell types, and the formation of new cells. This intervalence is called intervalence. Neoplastic patterns of intervalence sometimes characterize functions like synthesis of sugar and proteins, and in vitro studies have thus shown this intervalence forms the basis of effective drugs such as drugs to treat diseases. This intervalence can be fused with a structure known as a deuterubial variation. In the new study of miRNAs, researchers successfully introduced a combination of intervalence-based transmutting agents that mimics a function of the transparent membrane. The new wireless signaling function mimics the signals passed through the lipids of a human embryonic stem cell. The transmutants, which are normally used in a food source or nuclear power plant to provide drugs, were included in the detailed findings.\\\\nThe cells are composed of two intervalences, three intervalences, three neurons and a cell transplant of essential protein from another cell to another. The color on the heart pattern resembles that found in cell cells, suggesting that the oceanic plasma is getting thinner and thinner. This morphological fingerprint for the external chemical presence of human cells is known as sacidiol . In this release, researchers describe the presence of a biological molecule known as sacidiol, or fiberidiol . In vitro studies have thus shown that the presence of sacidiol among the DNA in cells involved in the cell\u2019s formation.\\\\nNew research uses a radio-frequency (RF) encoder to detect electrical currents in the whole blood system of cell membrane cells. This electronic system can analyze the frequencies and release hormones, metabolites and hydrogen peroxide (NO2). By doing this they can have the exact trace of ECTC made from cells in a a process called methylation.\\\\nThe molecular action of one chemical molecule in interleukin-7 (muno-7) uses a complex process called methylation/separation. In the case of a molecule that enters cells the activity of the methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methylation methyl'\"]", "inst_index": "82920", "domain": "Science 321, 1357 (2008)", "url": "http://doi.org/10.1126/science.1156725", "summary": "", "authors": "['Hui Li, Jinglan Wang, Gil Mor, Jeffrey Sklar']", "date": "03-28-2008", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Regulation of Histone Acetylation in the Nucleus by Sphingosine-1-Phosphate", "warc_date": "20220328", "article": "['\\'By Dr. Lieb eberg, Sapiens Climate Center - Uculisar\\\\nAt a table several days ago, Cytotale Dga Tshingas and Sucarai Spheremockidis were presented with their discovery: that pyeloctophage (solacept) concentrations in human isotopes with 10 millisieverts multiplies up to 9.7 per cent a year. After many years of studying the long-standing know-how of traditional physics, they produced a wealth of data - including enormous amounts of individual isotopes.\\\\nMany combinations of pyeloctophage increase the fraction of the gas flow into the nucleosphere, a water-like element, which produces mucosal material. While the results of this study show that pyeloons in infant concentrations are also extremely high, this is not necessarily a cause for concern, says Shira P. Luchs, assistant professor in the Department of Chemistry and Biochemistry. \"These findings strongly suggest that pyeloons with 10-methylase concentrations that exceed the number of metals they\\\\\\'re produced during pregnancy play a significant role in bone formation,\" she says. \"In the archaeological core, pyeloons play a significant role in bone formation. As they exhibit these populations - they all surface in a totally enclosed environment - the resulting mixed diversity of pyeloons suggests they are attracted to the different parts of the natural world.\"\\\\nWhat was more significant than the pyeloons\\\\\\' short-term variation was the smaller stocks of the group of different pyeloons - to which there is much less uncertainty. \"As a result of these multilintanizations, pyeloons may have increased their rate of formation beyond their naturally occurring rates in previous periods,\" Luchs says. \"The combination of pyeloons at high pyeloons and low pyeloons means that pyeloons developed much faster than you would predict. The picture is growing very clearer as pyeloons in newborn pyeloons exhibit shorter distributions during pregnancy. This suggests that pyeloons at increased rates during adult pyeloons also played a significant role in bone formation.\"\\\\nBy analyzing the concentration of pyeloons - IRELAND, OHI, NOVA, ME, ALL USAT, JOSE and NUMBER 1 - they found out that the maximum concentration of pyeloons is 63.2 per cent, compared to about 40 per cent of the total amount of the isotopes in that population.\\\\nWhile it doesn\\\\\\'t confirm that pyeloons are very low in bone formation, Luchs says they are important for bones and teeth. Their findings point to the importance of pyeloons in bone formation, and confirms what many experts previously have confirmed: pyeloons are important for bone formation in adult pyeloons.\\\\nIncreased pyeloons - from the absence of bone formation at a relatively high pyeloons percentage in the last century - may lead to a better, warmer planet. While the current Earth is warming at a warmer period, human activity poses no threat to fossil fuels or the long-term climate, says Katherine E. Noyes, professor of Earth System Science, University of Washington. Even then, she says, the temperature will get about 1\u00b0C above the average \u2014 and the Middle East won\\\\\\'t warm for another 500 years. \"Two other large studies for how the heat load affects bone formation appear to point to problems with bone formation in pyeloons,\" Noyes says.\\\\nEpigenetic Engineering of Pathophysiology (eGWR) study - rare animal and plant explanations are emerging for how pyeloons are formed by human excretions, say investigators at Canada\\\\\\'s Queen\\\\\\'s University in Kingston, ON. One of the main questions is whether pyeloons and chloretrants play roles in how the human body grows. FHPA et al. (2006) report indicates that the growth of our black holes has an important role in evolution.\\\\nIllustration by Sung Shim/Shang Yang\\\\n\\'']", "inst_index": "27945", "domain": "Science 325, 1254 (2009)", "url": "http://doi.org/10.1126/science.1176709", "summary": "", "authors": "['Nitai C. Hait, Jeremy Allegood, Michael Maceyka, Graham M. Strub, Kuzhuvelil B. Harikumar, Sandeep K. Singh, Cheng Luo, Ronen Marmorstein, Tomasz Kordula, Sheldon Milstien, Sarah Spiegel']", "date": "03-28-2009", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Spreading Depression Triggers Headache by Activating Neuronal Panx1 Channels", "warc_date": "20220328", "article": "[\"'Note: The fact that an engine of an experimental human brain is expressed on an enemy network indicates that the brain determines whether it is sensing or judging harm. (Suzy Szarzmayer)\\\\nNeuronal Panx1 Channels\\\\nIntroduction\\\\nNeuronal Panx1 Channels\\\\nby\\\\nTurgay Dalkaraen\\\\nNeuronal Panx1 Channels\\\\nby\\\\nZ\u00c3\\\\x82\u00c2\\\\x9fmr\u00c3\\\\x82\u00c2\\\\x98t Turgay Dalkaraen\\\\nMost modern brain coordination correlates with the value of sensory perception. In our offices, we find that too little is being realised because on average, we try to recognize as much as possible from just about everything from noise to smell. But these same neurons somehow can\u2019t see \u201cwithin\u201d itself, and instead get stuck in a maze that they are supposed to be working around. Enter a new experimental human brain, which provides a peek at some of these rare, complex neural pathways.\\\\nIntravenous Panx1 Channels\\\\nby\\\\nTurgay Dalkaraen\\\\nNeuronal Panx1 Channels\\\\nby\\\\nZ\u00c3\\\\x82\u00c2\\\\x9fmr\u00c3\\\\x82\u00c2\\\\x98t Turgay Dalkaraen\\\\nTranslational Neurology from an Actively Uncontrolled Neuronal Panx1 Channels\\\\nby\\\\nTurgay Dalkaraen\\\\nNeuronal Panx1 Channels\\\\nby\\\\nZ\u00c3\\\\x82\u00c2\\\\x9fmr\u00c3\\\\x82\u00c2\\\\x98t Turgay Dalkaraen\\\\nTranslational Neurology from an Actively Uncontrolled Neuronal Panx1 Channels\\\\nby\\\\nZ\u00c3\\\\x82\u00c2\\\\x9fmr\u00c3\\\\x82\u00c2\\\\x98t Turgay Dalkaraen\\\\nTranslational Neurology from an Actively Uncontrolled Neuronal Panx1 Channels\\\\nby\\\\nZ\u00c3\\\\x82\u00c2\\\\x9fmr\u00c3\\\\x82\u00c2\\\\x98t Turgay Dalkaraen\\\\nTranslational Neurology from an Actively Uncontrolled Neuronal Panx1 Channels\\\\nby\\\\nZ\u00c3\\\\x82\u00c2\\\\x9fmr\u00c3\\\\x82\u00c2\\\\x98t Turgay Dalkaraen\\\\nTranslational Neurology from an Actively Uncontrolled Neuronal Panx1 Channels\\\\nby\\\\nZ\u00c3\\\\x82\u00c2\\\\x9fmr\u00c3\\\\x82\u00c2\\\\x98t Turgay Dalkaraen\\\\nTranslational Neurology from an Actively Uncontrolled Neuronal Panx1 Channels\\\\nby\\\\nZ\u00c3\\\\x82\u00c2\\\\x9fmr\u00c3\\\\x82\u00c2\\\\x98t Turgay Dalkaraen\\\\nTranslational Neurology from an Actively Uncontrolled Neuronal Panx1 Channels\\\\nby\\\\nZ\u00c3\\\\x82\u00c2\\\\x9fmr\u00c3\\\\x82\u00c2\\\\x98t Turgay Dalkaraen\\\\nTranslational Neurology from an Actively Uncontrolled Neuronal Panx1 Channels\\\\nby\\\\nZ\u00c3\\\\x82\u00c2\\\\x9fmr\u00c3\\\\x82\u00c2\\\\x98t Turgay Dalkaraen\\\\nTranslational Neurology from an Actively Uncontrolled Neuronal Panx1 Channels\\\\nby\\\\nZ\u00c3\\\\x82\u00c2\\\\x9fmr\u00c3\\\\x82\u00c2\\\\x98t Turgay Dalkaraen\\\\nTranslational Neurology from an Actively Uncontrolled Neuronal Panx1 Channels\\\\nby\\\\nZ\u00c3\\\\x82\u00c2\\\\x9fmr\u00c3\\\\x82\u00c2\\\\x98t Turgay Dalkaraen\\\\nTranslational Neurology from an Actively Uncontrolled Neuronal Panx1 Channels\\\\nby\\\\nZ\u00c3\\\\x82\u00c2\\\\x9fmr\u00c3\\\\x82\u00c2\\\\x98t Turgay Dalkaraen\\\\nTranslational Neurology from an Actively Uncontrolled Neuronal Panx1 Channels\\\\nby\\\\nZ\u00c3\\\\x82\u00c2\\\\x9fmr\u00c3\\\\x82\u00c2\\\\x98t Turgay Dalkaraen\\\\nTranslational Neurology from an Actively Uncontrolled Neuronal Panx1 Channels\\\\nby\\\\nZ\u00c3\\\\x82\u00c2\\\\x9fmr\u00c3\\\\x82\u00c2\\\\x98t Turgay Dalkaraen\\\\nTranslational Neurology from an Actively Uncontrolled Neuronal Panx1 Channels\\\\nby\\\\nZ\u00c3\\\\x82\u00c2\\\\x9fmr\u00c3\\\\x82\u00c2\\\\x98t Turgay Dalkaraen\\\\nTranslational Neurology from an Actively'\"]", "inst_index": "17400", "domain": "Science 339, 1092 (2013)", "url": "http://doi.org/10.1126/science.1231897", "summary": "", "authors": "['Hulya Karatas, Sefik Evren Erdener, Yasemin Gursoy-Ozdemir, Sevda Lule, Emine Eren-Koc_ak, Z\u00c3\\x82\u00c2\\x9fmr\u00c3\\x82\u00c2\\x9ft Duygu Sen, Turgay Dalkaraen']", "date": "03-28-2013", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis", "warc_date": "20220328", "article": "['\\'CAD manipulation of the working arms of CAD inhibitors induces phylum-generated activity in the mitochondrial DNA code.\\\\nSCIEEE provides researchers with an article titled \"The Plebbynchto-MPS Protein-activation agent Project-Year-End 1998.\" The article, transcribed as \"Full Sequence IV,\" examined 87 produced parasites with the Natural History Lab\\\\\\'s Cefended Well Lotion DMOS PROINOSATED CONTROL programme (NWPT PROINOS) and 21 induced ticks that sought to evaluate genomic inactivation and DNA degradation of the working arms of the Cefended Well Lotion DMOS\u00ae.\\\\nAccording to a report published in Nature Microbiology, the detection of DDLP stimulated plasma differentiation in the DNA of 30 lacy ancestry parasites, 41 dendrites and 176 ribons. A metabolized DNA was retrieved from one lacy ancestry parasite and the plasma and plasma differences in DNA were detected on 10 lacy donors.\\\\nThe authors of the article, Mr. Shinosuke Kishiro and Ms. Shiniko Takahashi, posit an experiment using an animal model of DDLP antiretroviral failure during apoptosis. Their findings have been used by the Natural History Lab in their Goizueta-Kauri publication.\\\\nThis modified version of the DNA-activated von PPE infraction dendrite molecule was designed to induce apoptosis; approximately 45 entinucleotide repeats per week at 12 weeks (700 month equals seven days), while the daily rate was 222 dendrites per person.\\\\nThe detailed molecular analysis found, for example, that pre-tolerated HRMG biocontrol induced apoptosis after 45 day scan of seven ELBRA biocontrol proton coupling-mantis parasites. They also reported that the phosphate aminoidase expressed by these parasites reversed normal DNA methylation of DPI VNC, which is still unexplained but important in determining the status of the MFG-rated antibody problem.\\\\nThe investigational experimental candidate GMP1295, which induced DPRC deletion, reportedly came to commission as a vector for developmental cell epithelial proteins of DDLP and is currently in the early stages of development, at the relevant laboratory.\\\\nDr. Shiniko Kishiro and Ms. Shiniko Takahashi believe that GMP1295 is ideally suited for the HPV vector, where DMOS antagonists may be inserted to suppress down targets of these anti-phosphorytons.\\\\n\"If that is confirmed, it would work well in areas where resistance is strong,\" the authors conclude.\\\\n\\'']", "inst_index": "54468", "domain": "Nature. 1998 Jan 1;391(6662):96-9.", "url": "http://doi.org/10.1038/34214", "summary": "", "authors": "['Hideki Sakahira, Masato Enari, & Shigekazu Nagata']", "date": "03-28-1998", "split": "test", "label": "machine", "status": "succcess"}
{"title": "14-3-3__ is required to prevent mitotic catastrophe after DNA damage", "warc_date": "20220328", "article": "['\\'In today\\\\\\'s 10-page list of the topics I cover, include this:\\\\nUse of sombiologists - \"Absent the skills of science, many computers will die,\" is familiar to the business world, but not to normal people. \"As we age, there\\\\\\'s demand for courses that focus on science, information technology and medicine, including other disciplines that have been badly damaged by the problems of computerization,\" said Stuart Clark, an expert on computerization and computer architects, in a speech last year. \"The advancement of this branch and the need for more courses are changing the entire tone of the scientific education curricula.\" The expectations for academic application and results are heightened by the 24-hour-a-day news cycle. In addition, there\\\\\\'s a need for high-level collaboration between computers and science to tackle many issues: What to do with the diverse work staffs on the rise; the evolution of science-engineering curricula; new ways to draw up integrated and strategic plans; better assessments; better programs and training.\\\\n\\'']", "inst_index": "79477", "domain": "Nature, Vol. 401, 7 October 1999, page 616", "url": "http://doi.org/10.1038/44188", "summary": "", "authors": "['Timothy A. Chan, Heiko Hermeking, Christoph Lengauer, Kenneth W. Kinzler, & Bert Vogelstein']", "date": "03-28-1999", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Imbalance between pSmad3 and Notch induces CDK inhibitors in old muscle stem cells", "warc_date": "20220328", "article": "[\"'For years now, three molecular markers have been associated with cancerous or aging forms in mice. Bumps tend to form when there are tiny aggregates of components. For this reason, for many animals, cell destruction has been like a constant pain (see Lilly Rogers site in Physical Review #071434 ). There are many differences between different metals in those most likely to produce problem cells, given the drug potency of the compounds and the dose given to the animals.\\\\nIn explaining why cells might not be beneficial for aging, the researchers claimed the testing of a drug antagonist was a test that should be sufficient to explain the history of different types of cells. In fact, the scientists led by Christopher S. Johnson used two metabolite-based inhibitors (PhRI-7 and PhRI-1763) \u2013and for the first time, they found an antidote for the direction the directions of their drugs were travelling in cells. The evidence against these drugs-accurate, isn\u2019t what this study suggests \u2013 but there are a few reasons, certainly.\\\\nAntibiotic doses are always the barrier to change the path of cellular transformation. According to Johnson, his team investigated what would happen if a drug antagonist named Weedon or Neptrak used the same mechanism as CIGARET1. While there is also something there, in this study Sitar\u2019s team, PhIR7 and PhRI-1763 were the only drugs that showed evidence of the additive pathways of CIGARET1. They paired the drugs against an enzyme that delivers a new kind of protein, and they found that in normal and aging mice the pharmaceutical drugs used had an important effect on the pathophysiology. The drug, PhIR7, had a similar response in rats, and they found its effects in rats more resistant to some or none of these compounds. A new drug-experiment in the same mice-originated the same promise: it could reverse the effect that pharmacological treatments had on CIGARET1.\\\\nWhen it was time to apply the drug to the human cells, the experimentists wanted to test whether PhIR7 could do what Cannabidiol (MDR) did in water and maintain the cells long enough to detoxify and support the skin. The Food and Drug Administration\u2019s (FDA) I-7 regulatory panel will order a chemical determination as soon as May 1. Until then, the drug-exchange company Procade is reviewing the recipe and developing a drug-processing system (technically called a \u201cprogram-device\u201d) that will be ready in August 2008.\\\\nWhile we have questions, we can only speculate on how the results will be explained.\\\\n'\"]", "inst_index": "59839", "domain": "Nature, Vol. 454, 24 July 2008, page 528", "url": "http://doi.org/10.1038/nature07034", "summary": "", "authors": "['Morgan E. Carlson, Michael Hsu, & Irina M. Conboy']", "date": "03-28-2008", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Essential roles of PI(3)K\u00c3\u0083\u00c2\u0090p110b in cell growth, metabolism and tumorigenesis", "warc_date": "20220328", "article": "['\\'Idiomatic Guidance: Tau salubrate Interference in Functioning\\\\nBy Stephanie Rondon\\\\nVideocast: Fri/Sat. Sun.\\\\nDEPRESSION - DEFENSIVION by NONE ON\\\\nTuberculosis kills more people per capita than HIV/AIDS, malaria, and hepatitis A, according to a report from the Swedish Health Office here by J\u00fcrgen Arellano Roche and the Institute of Medical Sciences in Los Angeles, Calif. at the Swiss-Swiss World Health Organization summit 2008. This title explains a key role of Tau salubrate interference in the development of cell growth in mitochondrial metabolism: \"Difficulty in synthesizing pluripotent stem cells (iPSCs),\" which is the main target of intracellular growth factor inhibitors as required by controversial \"healthy\" therapies.\\\\nThe Organization for Economic Cooperation and Development (OECD) uses the selective extrusion exportation of HM-90 on human organs to contribute to improvements in clinical practice in 2007. The combined number of UK and European countries accounted for about 16.4 percent of the EU\\\\\\'s total outstanding instruments for therapeutic interventions between 2006 and 2007. In the UK, the health service launched a public accession programme in 2007. But potential central supply of Tau salubrate (see below) has been expected for years as producers have continued to incorporate highly effective therapies in their clinical practice. In addition, the STP (international intercessory solid management) program is an additional treatment option for patients where a satisfactory response rate and the willingness of the liver to administer the correct treatment is sufficiently high. The OEUJ report credits Tau salubrate with improving cooperation between expert scientists and acute care nurses around liver transplantation and syphilis in Armenia, Tertullian, Georgia, Latvia, Bulgaria, and Ukraine.\\\\n\\'']", "inst_index": "62422", "domain": "Nature, Vol 454, 7 August 2008, page 776", "url": "http://doi.org/10.1038/nature07091", "summary": "", "authors": "['Shidong Jia, Zhenning Liu, Sen Zhang, Pixu Liu, Lei Zhang, Sang Hyun Lee, Jing Zhang, Sabina Signoretti, Massimo Loda, Thomas M. Roberts, & Jean J. Zhao']", "date": "03-28-2008", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Identification of the pollen self-incompatibility determinant in Papaver rhoeas", "warc_date": "20220328", "article": "[\"'Depending on which way of looking at it, we may be able to determine the DNA sequence of a single organism to determine the molecule of a particular characteristic, but no matter how well the ancient ancestors of this species hunt or genotype to display the stones and nest of this species, they would not do so with very good results.\\\\nThat\u2019s because it would be far too early, even for the exceedingly small number of \u201cifs,\u201d of the archaeologist, to establish the likelihood of genetics\u2019 determinants or the ways of bringing homo sapiens to humans. That\u2019s why Pathologically Audubon\u2019s new head of biology, Dr. Caitlin Carle, is focusing on random access, not time and area of interest, as happened in past biology projects, so that she can then provide a more specific predictive language that is able to offer a reliable alternative to statistical one.\\\\nDr. Carle\u2019s research was undertaken by her department of pathology at the Stanford University School of Medicine. Her discovery has grown from the work of Stanford bacteriologist Craig Sandison, who researched the origins of peyote from ancient Asia, before his death from complications from heart disease. His discovery was how Copernicus, Luddite, and Taurus metamorphosed to become the critters we see today. Carle points out that Copernicus, Luddite, and Taurus metamorphosed to become peyote from ancient Asia with Earth previously excavated as only a metal. Because Copernicus, Luddite, and Taurus metamorphosed to form peyote, they came from terrestrial species. As you might know, venom for Peyote was in Transpara, the sixth planet in our galaxy, a Metra, nugget from which Peyote was carved. Similarly, this brief article focuses on the world heritage sites of the late Noah, Nehemiah, and Sonora civilizations, and on Peyote as a species.\\\\nAs Carle summarized her research:\\\\nThis rich selection of specimens, as well as what we call the phylogenetic record of human species, is what gave us a robust foundation for the continued evolution of peyote . . . This newest scientists know that all of the species we see today would have to share those attributes if we were to look at peyote as the foundation for peyote evolution.\\\\nOnly one of the 20 genes Carle says serves as a hurdle for the birthrate is the since-abridged nonpenetrative gene sequence, which explains the anointing of the epiphanic Veeras at source with priority for peyote being found in Azile and newyork for the constellation Lyra.\\\\nCarle concurred, saying:\\\\nThe structural complexity of the DNA map provides a basis for comparing it on an individual basis. Depending on the current information, peyote would, for example, be highly homo sapiens by birthdate. To understand the balance between individual genomes is that you need to find the traits at specific places of origin for every genetic basis. For example, here\u2019s how Hurricane Katrina works: Hurricane Katrina is a Category 5 storm with wind gusts of up to 80mph and waves as high as 30ft in the bay at the crest of the levee. It was built to protect New Orleans from that event.\\\\nI\u2019m not sure I should let Carle so little time in her words (this volume of discovery made me cry) because she insists on pointing out that her own research, like those of the many psychologists she investigates in my subject, has concluded that variations are good for peyote. You can guess what she\u2019s talking about, because in Carle\u2019s book, subject 18 explores variations in bio-background variation that turn to probability-based value when looking at either the birthdate of an organism or a genus: \u201cPepria, Apurism, and Cognac produce the characteristic composition of peyote and that indicates the gene from which it first surfaced in this genus . . . Papeosalucum sapiens represents the mother of peyote, Apurism represents the father of peyote, and Cognac represents the grandfather of peyote, suggesting that variation that occurs on the evolutionary basis of each species of plant may lead to volumetric variation in the degree of variation in morphology, whether occurring on the plant or individual species, regardless of'\"]", "inst_index": "34053", "domain": "Nature, Vol 459|18 June 2009", "url": "http://doi.org/10.1038/nature08027", "summary": "", "authors": "['Michael J. Wheeler, Barend H. J. de Graaf, Natalie Hadjiosif, Ruth M. Perry, Natalie S. Poulter, Kim Osman, Sabina Vatovec, Andrea Harper, F. Christopher H. Franklin, & Vernonica E. Franklin-Tong']", "date": "03-28-2009", "split": "test", "label": "machine", "status": "succcess"}
{"title": "A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma", "warc_date": "20220328", "article": "[\"'It is likely that as a result of each mutation, these individuals present the same risk factors for an increased risk of melanoma and renal carcinoma. In addition, in both melanoma and renal carcinoma, their mutation is associated with cell proliferation risk. A study recently published in the journal Gerontology in Medicine (FIA) shows that the mutation that produces the LE fatty acids protect against melanoma and Rheumatoid Arthritis.\\\\nThe LE amino acid is produced by the mice after they have been exposed to infection control foods (e.g. reduced bacteria from eating contaminated fruit, vegetables, and other dietary sources). Normally, by the time we control it for the effects of infection, it grows in the body. Thus, in the case of mouse skin cancer, there is an even higher risk for the formation of additional cell-specific mutations.\\\\nThese new studies in Gerontology strongly point to this risk factor for inflammatory melanoma and other forms of cancer of the lungs (CPE) in MENAE lung cancer.\\\\nThe new findings indicate that once the trait is demethylated into the LE synthetic form, this catheter-copyal emergence is the first known element that contributes to melanoma and Rheumatoid Arthritis. This link can be found in the official presentation of this study at the International Association for Air And Radiation Oncology (IAAR) meeting in ICA on 24 March.\\\\nMoreover, the LE synthetic form yields different chemical reactions in its structure. One accumulation of LE is entered in skin cells. Other metabolites, like cell-specific substances, accumulate in cell membranes. A second accumulating is which has a more positive impact on the blood pressure levels of the cells.\\\\nIn the 2007 study, researchers performed an even greater study in the mouse cells and found that the LE synthetic form produces other toxic metabolites, including hydrogen cyanide (HL) metabolites, which are directly tied to the buildup of a particular chemical in the body.\\\\nThe contribution of the LE synthetic form to a high case of anthrax and the RWB irritable bowel syndrome is also linked with the chronic composition of saliva in the mouth or the dry mouth. Furthermore, chromatase inhibitor-specific compounds that generate these active differences in DNA molecules, such as esters, fat, and carcinogen-containing substances, also contribute to the formation of other harmful fibroblasts.\\\\nHowever, the most dangerous form of histological association is the switch-up with the LE synthetic form.\\\\nThe LE synthetic form is known to cause inflammation and shortness of breath. The interpretation of this finding is that the absence of a lithium pack (that represents the metal by which lithium is divided among whole molecules) and sediments from fossil fuel refining causes the build up of histological association that is so harmful that it leads to constant susceptibility of the histologic properties of the GLaN marker.\\\\nDue to the toxic chemicals contained in the GLaN marker, many cancers are now characterized by bacteria-based skin conditions known as byotensiferous intracellular-destroying (FTI). Chronic skin conditions also cause abnormal muscle growth, increased blood sugar levels, loss of nails, and unexplained bleeding.\\\\nTime is of the essence. In the near future, many cancers will be diagnosed with a LE synthetic form that is responsible for a whole host of these conditions. These latest findings show that there is potential to explain the association between LE synthetic form and TUEs.\\\\n'\"]", "inst_index": "32612", "domain": "Nature, 2011 Oct 19;480(7375):94-8", "url": "http://doi.org/10.1038/nature10539", "summary": "", "authors": "['Corine Bertolotto, Fabienne Lesueur, Sandy Giuliano, Thomas Strub, Mahaut de Lichy, Karine Bille, Philippe Dessen, and many others']", "date": "03-28-2011", "split": "test", "label": "machine", "status": "succcess"}
{"title": "D14\u00c3\u0083\u00c2\u0090SCFD3-dependent degradation of D53 regulates strigolactone signalling", "warc_date": "20220328", "article": "[\"'Primary overexpresses of D51 indicate impacts on thyroid function, insulin functioning, skeletal function, normal cells, and positive nervous system signals\\\\nD53 strain modification\\\\nGenetics studies show that D53 can increase thyroid function in boys and girls with rare genetic variants linked to inherited disorder. The study is evidence of extremely high gene influence from incomplete dengue\\\\nanimal-derived signaling as well as the first diagnostic test for infection through dengue.\\\\nDr. Huu Chunxin, Professor of Environmental Medicine in the Department of Environmental Medicine at Hong Kong University of Science and Technology, is leading the study which is aimed at identifying D53 systemic, genetically based, or transgenic mice lacking high contact with human dengue. The news has been received from many environmental organizations, and the B.O.S., Department of Environmental Science and Technology of Hong Kong University of Science and Technology. The expertise of the research team\\\\nEnjoyed this article? Join 40,000+ subscribers to the ZME Science newsletter. Subscribe now!\\\\n'\"]", "inst_index": "61369", "domain": "Nature, Vol 504, 19/26 DECEMBER 2013", "url": "http://doi.org/10.1038/nature12878", "summary": "", "authors": "['Feng Zhou, Qibing Lin, Lihong Zhu, Yulong Ren, Kunneng Zhou, Nitzan Shabek, Fuqing Wu, Haibin Mao, Wei Dong, Lu Gan, Weiwei Ma, He Gao, Jun Chen, Chao Yang, Dan Wang, Junjie Tan, Xin Zhang, Xiuping Guo, Jiulin Wang, Ling Jiang, Xi Liu, Weiqi Chen, Jinfang Chu, Cunyu Yan, Kotomi Ueno, Shinsaku Ito, Tadao Asami, Zhijun Cheng, Jie Wang, Cailin Lei, Huqu Zhai, Chuanyin Wu, Haiyang Wang, Ning Zheng, and Jianmin Wan']", "date": "03-28-2013", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Osteopontin signaling upregulates cyclooxygenase-2 expression in tumor-associated macrophages leading to enhanced angiogenesis and melanoma growth via a9b1 integrin", "warc_date": "20220328", "article": "['\"By Sarah Donohue\\\\nScientists have discovered a new way to inhibit and trigger the production of oxaliplatin - a protein that supports human cancer and inflammation - through a9b1 integrin.\\\\nOsteoporosis involves inflammation of the joints, blood vessels and brain, causing inflammation in many parts of the body. Many of these complications can also be avoided by a9b1 inhibitor.\\\\nNucleoside control, or N-drugs - in which multiple drugs are successfully combined to suppress the behavior of the immune system - is a major factor in overcoming or even recovering the disease. The N-drugs involved in blocking the amofacyls and monocytes (an immune protein responsible for triggering inflammation), include solanezumab, tramadol and lanthanumab.\\\\nResearchers discovered a new proteome for the control of the debilitating ALM (Complex and Integrated Molecule Dimitriynastinases on Folate) event at UC Davis: in mice whose body had a 2.0% oxygen-containing PH-9beta enzyme blocked the release of circulating PH-9beta molecules.\\\\nThe study was led by Lamin Feagin, M.D., PhD, with the Steve Ostrovsky Center at UC Davis: Furuhi, Gai Rus, PhD, and Hock Chun, PhD. It is the first paper to demonstrate the synergistic effects of partnered clinical treatment on immunomodulation of the drug-specific ALM, which is the most common mutated protein in human disease.\\\\nThe team found that the combination of human ALM (EGP) and the PH-9beta protein reduced dopaminergic activity in blood vessels after the treatment of non-blood mice with ENO (adult thyroid hormone inhibitor) treated with ENO 1 by 41% (split between group 50 and 75 depending on the subgroups) and then increased distribution of PH-9beta protein in breast tissue.\\\\nThe duo also investigated the potential of substituting the combined mutant and EGP treatment with actual human chemotherapy (n=25) in early-stage cancer.\\\\nIn animal models of human disease the combination of the two treatments in combination on the original EAE wasn\\'t included, however, in some tumor models showing significant reductions in the toxicity of human treatments. The team showed that the combined treatment led to a marked reduction in toxicity and an accelerated growth rate in tumor species with detectable PH-9beta sites in the cancer patients.\\\\nPrevious experiments with human breast tumors had shown that combination of healthy volunteers and patients with no cancer-associated proteins had a much better response to treatment than the anticoagulant as they had to initially slow their disease to a minimum of 10% production of EGP. Thus, the results provided a signal that patients were consuming more PH-9beta than previously thought and showed that such treatment reduced toxicity and ultimately impacted the tissue growth of the metastatic tumor.\\\\nThe investigators attribute their findings to the fact that human drug-specific drug-specific agent delivers signals rather than chemicals. Their finding suggests that scientists can explore and further penetrate the therapeutic application of protein therapies in our real world environment.\\\\nThe study was published online February 27, 2013 in The Lancet Medical journal.\\\\n\"']", "inst_index": "33759", "domain": "Oncogene (2014) 33, 2295\u00c3\u0083\u00c2\u00902306", "url": "http://doi.org/10.1038/onc.2013.184", "summary": "", "authors": "['S Kale, R Raja, D Thorat, G Soundararajan, TV Patil and GC Kundu']", "date": "03-28-2013", "split": "test", "label": "machine", "status": "succcess"}
{"title": "The deubiquitylase USP37 links REST to the control of p27 stability and cell proliferation", "warc_date": "20220328", "article": "['\\'*** Cell proliferation and p27 stability in cells is predicted to occur in 3.2 billion susceptible cells in 2013 - a 93% drop from the approximately 95 million cell-level pool in 2012. The theoretical predictions by researchers for such a decrease in cell proliferation and proliferation are real: \"We defined to node 1, node 2, node 3, node 4, node 5, node 6, and node 7 in risk.\"\\\\nAnd none of these four possibility groups developed a quantitative model that predicted cell proliferation in three probability groups at 3.2 billion individual cells in 2013.\\\\nThe researchers observed that a host of fundamental factors affect cell proliferation, signal damage from activity of counterpartiets, and paragonstems of cells within every pattern. Cells in matter with similar diswelling cycles need (a) a large network of membrane endotheliums and (b) a large cell density.\"\\\\nThe researchers decoded the coefficients on the dating that they used and used a combination of these factors to identify the point at which cells are likely to die. That required 32 square centimeters of cellular matrix, which was based on diffusion and polarization in cells. The probability of this event is based on the statistical \"preferitional mix of cell death severity\" (fck research).\\\\nImage: Evidence of protuberance of glial cells in cells with lack of water equivalence test the statistical \"perimeter\" cells with no water equivalence Test the probabilities of an isolated first progenitor cell getting cell death including mutation triggering and death of genes that inhibit cell proliferation. In this study (2013), researchers form families of cells based on the \"pockets of cell death,\" on reference chromosome Q1 cell aggregates (fermented cells) that inhibit cell proliferation.\\\\nThe researchers published their work in a paper titled \"Cell proliferation and fission: the prevention of cell proliferation and fission.\"\\\\nLink: Cell proliferation and fission (2013)\\\\nReference: \"The correlation of cell proliferation and fission with expanding cell density measurements made possible by the probability of fission,\" Information: \"Conclusions of the various probabilities, net gamma impact of cell proliferation and death \u2014 through the risk of cell proliferation and proliferation in pairs of cells,\" Transit: \"U.S. News & World Report Exclusive \"3.6 billion sample\" (2013), GAIA: Rattstein Bony\\\\nLink:\\\\nLink:\\\\nLink:\\\\nLink:\\\\nLink:\\\\n\\'']", "inst_index": "32423", "domain": "Oncogene (2013) 32, 1691\u00c3\u0083\u00c2\u00901701", "url": "http://doi.org/10.1038/onc.2012.182", "summary": "", "authors": "['CM Das, P Taylor, M Gireud, A Singh, D Lee, G Fuller, L Ji, J Fangusaro, V Rajaram, S Goldman, C Eberhart, and V Gopalakrishnan']", "date": "03-28-2012", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Repression of microRNA-768-3p by MEK/ERK signalling contributes to enhanced mRNA translation in human melanoma", "warc_date": "20220328", "article": "[\"'APGRY CARRYING PATIENT\u2019S FEELINGS\\\\nItalian researchers have uncovered a possible cause of the development of cancer-causing microRNA-768-3p by MEK-ERK signalling. Previous reports indicate that the mRNAs and molecules present in the genome of humans carry potent DNA-binding properties. The new study proposes a way to cross-link gene factories to create and maintain these features. While many molecular complexes in human genes may become a hundredfold more accurate than the RNA they present in the minds of malignant melanoma patients, only the gene joined to the genome of patients may have the necessary predictive capacity to create similar genetic profiles. Hence, the proposed results should pave the way for the development of a new drug therapy to cure patients.\\\\nOther recent investigations suggest that similar genes might have been intentionally present in plants that mimic melanoma. And if true, then these markers might need to be cleaned up.\\\\nMY MATE IS OPENS MIND\\\\nThe study was published in Nature Cell Biology.\\\\nVIRARIA RAYFORD IS HERE\\\\nVIRARIA RAYFORD is a type of thin aminophilic DNA that is robust and robustly aligned. Consequently, it is also the oldest aspect of a cell\u2019s DNA that can be retrieved from most cell types.\\\\n'\"]", "inst_index": "36733", "domain": "Oncogene (2014) 33, 2577\u00c3\u0083\u00c2\u00902588", "url": "http://doi.org/10.1038/onc.2013.237", "summary": "", "authors": "['CC Jiang, A Croft, H-Y Tseng, ST Guo, L Jin, P Hersey, and XD Zhang']", "date": "03-28-2013", "split": "test", "label": "machine", "status": "succcess"}
{"title": "STIM1, a direct target of microRNA-185, promotes tumor metastasis and is associated with poor prognosis in colorectal cancer", "warc_date": "20220328", "article": "['\"Characterized by social and systemic toxicity, microRNA-185 is implicated in and another variant of microRNA-190 1, 2, 3, 4, activated by epilepsy, where the mutation is present. The focus of this study was to evaluate whether microRNA-185 provides a cure or delay for colorectal cancer - or if it could benefit further survival for the population of patients who are exposed to microRNA-185.\\\\nDr. Xiaowei Cheng, Chief of Outcomes Research and Consultancy at Western University Chicago Medical Center and lead author of the study, said that predicting whether one is unable to recover from a cardiac event can make the difference between survival for patients suffering from chronic or recurrent, malignant, or the terminal stage of cancer. Zian Wang, a postdoctoral fellow in Xiaowei Cheng\\'s department of Global Affairs, and C. Jianguo, a professor in Liu Xiaobo\\'s department of General Internal Medicine at Western University, led this work.\\\\nChina is one of the few countries in the world where MicroRNA-185 is not identified as a cancer mutation. Currently only about 70% of known microRNAs are expressed in cells including the lymphoma and liver tumours.\\\\nMicroRNA-185 is more benign than other mutations in microRNAs, and can be passed on to tissues after death. It also has the potential to increase therapy choices and cure cancer. A type of microRNA called TDM3 is also widely used in the treatment of some cancer. However, TDM3 is not detected in the liver.\\\\nEarlier this month, researchers in Italy discovered that, while the gene, or SEGI-189, shows a 300-fold change in the oxygen/salient balance in this form of microRNA, it also varies in the storage and also in the dose at which it is distributed. It is also noted that a woman who has treated with treatment with SEGI-189 in vitro (the analysis of viral T-cell regeneration) died of cancer if she had been compared to standard chemotherapy; Roche\\'s ONX-172 is called a prophylactic compared to Roche\\'s ONX-184.\\\\nThe study also found that an enzyme that stimulates different cell functions in this form of microRNA-189 led to microRNA production that shifted two important pathways for anti-coagulant chemo agents to complete their interactions with the protease-glycoid (CTG) process, respectively. These processes cause the natural reactions of anti-coagulant drugs to degrade resistance and enhanced toxicity. In order to reduce toxicity, 50% of the anti-coagulant drug only binds to the CGF-182 that prevents cancer cells from vancomycin being obtained in other parts of the body. This goes against the preclinical clinical efficacy of the technology in marketing older, or biosimilar pharmaceuticals.\\\\nA previous study conducted at the University of Guyana found a similar pathway to express human kidney cancer genes that also regulates the delivery of anti-coagulant drugs. However, the Protein Synoptic Pressure Model (PSPR) known as atrial fibrillation (AD) is not known to facilitate future ongoing blood cancer treatment.\\\\nOther authors of the study are Tianyi Ching Meng, Xiawei Lu, Peng Fang, Li Zhu, Zhao Xiaheng, Gaoxi Zhang, Zhang Long, Zhang Ming, Xiao Zhu, Zhu Zhu, C. Jianguo, Shouveto Zhao, Liu Xia-Hua, Zhao Ting.\\\\n\"']", "inst_index": "98566", "domain": "Oncogene (2014), 1\u00c3\u0083\u00c2\u009013", "url": "http://doi.org/10.1038/onc.2014.404", "summary": "", "authors": "['Z Zhang, X Liu, B Feng, N Liu, Q Wu, Y Han, Y Nie, K Wu, Y Shi, and D Fan']", "date": "03-28-2014", "split": "test", "label": "machine", "status": "succcess"}
{"title": "MMP7-mediated cleavage of nucleolin at Asp255 induces MMP9 expression to promote tumor malignancy", "warc_date": "20220328", "article": "[\"'Optimer has already shown that its test can identify a tumor malignancy within a given sample without showing tumor site of mutation and the regulatory pathogen supporting the pre-enphase of the study, called Asp255, induced its tumor ablazion, which may indicate the presence of tumor malignancy. The results of this novel microscope demonstrate MMP7-mediated cleavage of nucleolin with supportof immunodeficiency, thereby supporting the clinical efficacy of Asp255 as an approach to tumor infection.\\\\nThe tumor-fight hormone, prenectin-ENA1, has been a main driver of cell death in laboratory and small laboratory studies and is directly related to excessive tumor growth.\\\\nTranscoding molecules such as mucoidone, a carrier of oropharyngeal carcinoma protein (cancer cells) in vivo, and berine-ENA1 and berine-ENA1 are key control ingredients of the vesicle-like motor architecture associated with the aggressive tumor-fighting cell death.\\\\nPrenectin-ENA1 is simply a carrier of oropharyngeal carcinoma protein (cancer cells) in vivo. The immune system is programmed to use it as a key service for cell death.\\\\nB. MMP7-mediated cleavage of nucleolin-translatease is the most common anti-cancer drug in human melanoma, and it appears to be a main agent in the development of new melanoma treatments. It is involved in prostate and breast cancer immunodeficiency, in AIDS and leukemia, and has been approved in the United States as a treatment for metastatic melanoma. It is also the target of a new drug called Spinalfilk, a novel anti-cancer agent, and it is successfully being tested in animal models of melanoma in adults.\\\\nThe disease is the fastest growing cancer in the United States and Canada. Patients can be cured with therapy linked to the main tumor suppressor, cell death suppression. Also they are responsible for more than 80 percent of all advanced metastatic melanoma; the median age of diagnosis is 42.5.\\\\nMMP7-mediated cleavage of mucoidone is however, not an example of autologous benign cells discovered with expertise from science. Cells of this class have an abnormal chemical reaction with mCL, a protein that means micro cells adapt to the need for larger mCLs and transmits the hormone.\\\\n\u201cMMP7-mediated cleavage of mucoidone is a novel non-inferiority model of the cell response to the toxic agent mCL, and it shows the first signals of MMP7-mediated cleavage of mucoidone as MMP7-mediated cleavage of mucoidone at Asp255 induces or is switched on in cell death. The line between autologous and autologous tumor-fighting is very thin,\u201d said Jeffrey May, Ph.D., M.D., investigator in the Department of Clinical Oncology at the Rice Center for Cancer Research in Houston, Texas.\\\\n\u201cOur study showed that this mutation shows significant potential in potential adjuvant approaches to prevention of metastatic melanoma. Moreover, we already found the usual association between CTP-mediated cleavage of mucoidone and existing MMP7-mediated cleavage of oligonucleotide and tumor cells that requires regeneration of tissue,\u201d May added.\\\\nMMP7-mediated cleavage of mucoidone also showed its secondary effects by causing the tumor-fighting endo-inhibitor expression to improve cell survival. This is a novel and translational approach to the coronial, oncogene cadmium-prearrubial and from which the development of autologous tumors.\\\\n\u201cAlthough we found that mutation induced with autologous autologous autologous autologous autologous autologous autologous autologous autologous autologous autologous autologous autologous autologous autologous autologous autologous autologous autologous autologous autologous autologous autologous autologous autologous autologous autologous autologous autologous autologous autologous autologous autologous autologous autologous autologous autologous autologous autologous autologous autologous autologous autologous autologous autolog'\"]", "inst_index": "67958", "domain": "Oncogene (2015) 34, 826\u00c3\u0083\u00c2\u0090837", "url": "http://doi.org/10.1038/onc.2014.22", "summary": "", "authors": "['T-I Hsu, S-C Lin, P-S Lu, W-C Chang, C-Y Hung, Y-M Yeh, W-C Su, P-C Liao, and J-J Hung']", "date": "03-28-2014", "split": "test", "label": "machine", "status": "succcess"}
{"title": "TspanC8 tetraspanins regulate ADAM10/Kuzbanian trafficking and promote Notch activation in flies and mammals", "warc_date": "20220328", "article": "['\"Dr. Michel de Fodayisio is also head of Ad, a private, non-profit organization focused on stopping trafficking and promoting B onkulia/iID with a particular focus on treatment of children and adults. The group aims to eliminate child trafficking in Bangladesh and take root in the country.\\\\nWhat is TspanC8?\\\\nTspanC8 is a single molecule, a connection to both self-organisms and a receptor. It targets the regulation of ADAM10/Kuzbanian transduction signaling and promotes the delivery of money in Bangladesh. It is a molecule that has scientific utility:it appears to improve the detection of debris and bacteria, thereby making them less contagious and easier to track and target.\\\\nWhat is TspanC8\\'s high-purity expression?\\\\nFor its existence, TspanC8 worked simultaneously with inhibitory AL/NK interactions in B onkulia and IID to combat the disease. These interactions were potent together and protected the transmitter and target.\\\\nWhat is TspanC8\\'s fate?\\\\nLurking in the stratosphere, the amount of TLTR-8 reflects how prevalent chlorinate is in the environment; as the spread of NAHR11 in humans seems to occur in even of single locations, TspanC8 seems to have a near-future role in wiping out either a high-valent oligopolistic oligopoly or a trade of Taofiq end of advantage in the field of trans-emancipativ enzymes.\\\\nWhat do the diagnostic tests do?\\\\nAn oral evaluation of TspanC8 during the first trimester of pregnancy. The primers are intended to pinpoint toxicity to BEIL and NAD from some extremely potent compounds (CD22, ADAM, ALAIA plus EC35).\\\\nHow much does it contain?\\\\n50 times trans-encrypted into the OX02 protocol. The BCX2 (SLC10) protein is contained but not integral to the TspanC8 domain.\\\\nWhat are the monthly mortality rates?\\\\nMonthly mortality rates will be greatly reduced if TspanC8 prevents sub-types of perineural brain tumors and their spread to human brain tumors. TspanC8 is classified as \u201cdeadly viral\u201d at 8.8% of the time in the notch-modality study; if contracted at 10% of time, death rates at birth will be reduced by 15%.\\\\n\"']", "inst_index": "11848", "domain": "J. Cell Biol. Vol. 199 No. 3 481\u00c3\u0083\u00c2\u0090496", "url": "http://doi.org/10.1083/jcb.201201133", "summary": "", "authors": "['Emmanuel Dornier, Franck Coumailleau, Jean-Franc_ois Ottavi, Julien Moretti, Claude Boucheix, Philippe Mauduit, Fran\u00c3\\x82\u00c2\\x8dois Schweisguth, and Eric Rubinstein 1']", "date": "03-28-2012", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Distinct expression of C4.4A in colorectal cancer detected by different antibodies", "warc_date": "20220328", "article": "['\\'The latest measurement from the National Institute of Allergy and Infectious Diseases (NIAID) on hair follicle cancer samples from various breast, lung and stomach cancers has found that colorectal cancer has become more difficult to treat with a combination of both simple and psychoactive chemotherapy. The finding is the latest finding from the NIAID clinical cancer antigen (QCAC) and urine sample from nine women, suspected to be diagnosed with this type of colorectal cancer.\\\\nThe findings from NIAID are consistent with earlier patient records which have pointed to the existence of a mutation in chromosome 25 which would explain the tumor identification.\\\\nThe younger tumors appear more aggressive but the genes were updated from a routine test similar to the results of a study which studied saliva samples from real-life cancer patients.\\\\n\"In this data, patients who had been diagnosed with this type of cancer prior to blood tests indicated the mechanism behind the mutation. Thus, this is clear evidence that beta amyloidosis is a likely culprit and not a pathway for their colorectal cancer spread,\" said Dr Stephen M. Soderholm, medical director of NIAID, based in China.\\\\n\"In the present study, three survivors of all-cause colorectal cancer, are currently being treated with intravenous treatment (IVF) whose efforts, if successful, will increase survival. However, there is no evidence that this is the case for newer patients.\"\\\\nDr. Soderholm said that the NIAID could point to a molecular aspect of this emerging cancer that showed a mechanism or pathway to replace the mutation, such as it is thought to work like a knock-on effect.\\\\n\"Beyond targeted therapy, and/or in close community testing of patients already diagnosed with this type of cancer, we can consider other mechanistic variations that can be used to diagnose it or to treat it. For example, spinal cord disease is thought to be involved in the initiation of cancer,\" said Dr. Soderholm.\\\\nDr. Soderholm added that an effective regimen of IVF therapy - supplemented with Neoplast/Transjure hormone therapy, Vesta neoplast and Procatrol - provides hope for patients with advanced stage colorectal cancer.\\\\n\"Instead of having the detrimental side effects of the recently-filed study into the knowledge that a mutation would disrupt their cancer control, we could use this biomarker which may be useful for identifying new treatment options for them.\"\\\\n\\'']", "inst_index": "61137", "domain": "INTERNATIONAL JOURNAL OF ONCOLOGY 42: 197-201, 2013", "url": "http://doi.org/10.3892/ijo.2012.1714", "summary": "", "authors": "['HIROFUMI YAMAMOTO, RYOTA OSHIRO, MASAHISA OHTSUKA, MAMORU UEMURA, NAOTSUGU HARAGUCHI, JUNICHI NISHIMURA, ICHIRO TAKEMASA, TSUNEKAZU MIZUSHIMA, YUICHIRO DOKI and MASAKI MORI']", "date": "03-28-2012", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Adenovirus-mediated overexpression of BMP-9 inhibits human osteosarcoma cell growth and migration through downregulation of the PI3K/AKT pathway", "warc_date": "20220328", "article": "['\"(Manhattan: I,Y) - The connection between the mid-stage treatment of high bone mineral density (BLMI) and extended joint cell growth (ILTR) and infection rates with BMP-9 have been identified through improved evaluation of efficacy and safety under the AGFR 15b/ENOA based treatment of neurological injuries from a group of lymphatic fusions performed by Dr. Si-Lee Dong, associate professor at the UON Institute of Medicine. PHD Analytical and Seismic team successfully evaluated the evidence-based approach of a docetaxel vaccine being tested in a clinical trial.\\\\nBMP-9 requires approximately 4,000 injections and human molecular inhibitor cells to achieve overall bone mass as measured by the FTY protein trait which was measured in the newly-developed industrial stem cells (APS) in plasma. In a first-of-its-kind study, Dr. Dong conducted a three-dose study of high bone mineral density (BLMI) patients with at-risk BMP-9 infection after 18 months of treatment.\\\\nDr. Dong, from the School of Medical Genetics and Pathology at the University of Singapore, who is affiliated with the Hong Kong Airbase school, followed 23 BMP-9 treated individuals who were participants in a pre-clinical study presented at 2011 clinical trials of the oral delivery of a corticosteroid administered via the APT-9 upper lip of a 30-minute injected ADP-based treatment such as the APT-1 portinally delivered in the upper lip with little or no coagulation or anti-infective treatments. The BMP-9 delivery was thus passed from the page cartilage to the arm, effectively impacting the overall function of the individual.\\\\nBMP-9 is the most sensitive peptide found in human osteosarcoma and is the primary treatment for osteosarcoma, a chronic disease characterized by inflammation and other risk factors. The Parel University high bone mineral density and collagen scaffolding technologies are optimally designed to deliver the potent immune responses required for vaccination of adult patients who may have anti-inflammatory, inflammatory, and non-cancerous diseases.\\\\nMany current studies look at the efficacy of the APT-1 x Factor 25 vaccine, which works by inhibiting elevated expression of the substance. However, precise data on the effectiveness of this vaccine is being used only in patients with high levels of collagen ribose in bone marrow cells, and the results are being obtained at a much more marginal level than those that are offered by other technologies on the market.\\\\nDr. Dong\\'s initial study examined the feasibility of 28 groups of patients taken as preventive blood screening tests (CCRs) for osteosarcoma while the study was underway. Three groups were evaluated for BMP-9: patients with at-risk BMP-9 infection, single platelet-rich plasma (PPP) cells (PPPLCs) or individuals whose immune response had resulted in loss of bone, which is part of bone loss. Four groups were assessed for BMP-9 suppression using a standard immunotherapy regimen, but only one group of patients were randomly assigned to be administered a tablet, simply because the treatment needed to be effective. The patient was given PPP-2.\\\\nThirty patients were monitored over a three-week time period starting July 8, 2011 and six groups were monitored for 10 weeks as follows: A given clinical date of appointment was completed only 10 days after the CDC was notified of the patient\\'s case; One month after being enrolled, a next assessment was completed by Medical ID. Out of these 16 patients were compared to 12 other patients whose immune responses did not have immunity to the PPP-2 ADC, despite the AZE approved treatment.\\\\nFour patients were evaluated as a control group and both group groups again showed significant effluents responses. The dose was determined by a random calculation of a one-inch thickness, 3 times greater than the white blood cell count of 0.09g, with a correlation of 3.74 from black to white on the white DNA column. The coagulation of the blood plasma caused the rate of disease response (RPV) to increase between baseline and treatment period including bone graft initiation, which was observed in 36 patients. Dr. Dong observed that average bacterial infection incidence was 7.95 per 100 mL with half of each group taking a tablet followed by a smear test and hearing test in 50 patients treated with 30 tablets or fewer.\\\\nFour groups were categorized and all showed\"']", "inst_index": "94185", "domain": "INTERNATIONAL JOURNAL OF ONCOLOGY 41: 1809-1819, 2012", "url": "http://doi.org/10.3892/ijo.2012.1617", "summary": "", "authors": "['BO LI, YUEHUA YANG, SHENGDAN JIANG, BINBIN NI, KE CHEN, and LEISHENG JIANG']", "date": "03-28-2012", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Promoter methylation of RASSF1A modulates the effect of the microtubule-targeting agent docetaxel in breast cancer", "warc_date": "20220328", "article": "['\"VICTORIA. (Penguin Random House)\\\\nWould not create a mega protein that behaves like a microtubule-targeting agent or stimulate expression of genes that produce sperm? Would a sinister question be created into what is known as a spiral after cellular transcription of millions of amino acids in a gland in the middle of ovarian or prostate cancer? And should a protein be the same as an anchovy rather than the \u201cgood\u201d molecule? Apparently so, a group of British scientists are hoping to create the answer to one of these problems: the use of methylated hydrogen (MFR) proteins in breast cancer stem cells. That may make the risks of breast cancer much less clear, but we still like to look up \u201cMonsters\u201d. A shock to even the brightest minds of evolutionary science: NO HUMAN HAT.\\\\nPicture a boob with blood stained to reveal the growing haemorrhages of a lethal tumour. As expected, a cross section of ovarian and prostate cancers is created after the MFR proteins by weight they hold, as disclosed by British scientists in their landmark epigenomic study in the journal Nature Genetics. PHE-3aATH was named in the study and is specifically affected by tumor DNA, which contains two proteins the researchers have linked with clonasmine-like mutations that attack cells, meaning it contains millions of cancer cells.\\\\nThe findings suggest that MFR proteins, which block the expression of genes that stimulate motility, motility hormone control, increased cell proliferation and motility expression in the mouse models of breast cancer and gene expression of gynecology. Their work was published yesterday in the journal Nature.\\\\nYou can find it by visiting the web or by downloading it here: www.nature.com/nature/fact/ 1/1/2012\\\\nJessica Bryden is in London working with an associate director at Stanford University\\'s Mike Hutchison School of Engineering at USC. She is a co-author of the study led by Dr Jessica Bryden who is doing an empirical study on life after disease and cancer biology. Hannah Strong is a graduate assistant on the Stanford Department of Epidemiology.\\\\n\"']", "inst_index": "58316", "domain": "INTERNATIONAL JOURNAL OF ONCOLOGY 41: 611-620, 2012", "url": "http://doi.org/10.3892/ijo.2012.1470", "summary": "", "authors": "['EUN YOUNG GIL, UK HYUN JO, HOISEON JEONG, YOUNG MI WHANG, OK HEE WOO, KYU RAN CHO, JAE HONG SEO, AEREE KIM, EUN SOOK LEE, INSONG KOH, YEUL HONG KIM, and KYONG HWA PARK']", "date": "03-28-2012", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Preventive effect of caffeine and curcumin on hepato_ carcinogenesis in diethylnitrosamine_induced rats", "warc_date": "20220328", "article": "['\\'The effect of caffeine and curcumin in lapatinocytes on hepato_ carcinogenesis in the liver, also known as hepato_ carcinogenesis, is causing swelling and shiftiness of the liver, and a massive number of deaths due to liver injury, pain and/or swelling.\\\\nDoctors recently delivered a study report into the effects of caffeine on hepato_ carcinogenesis, on heavy consumption of caloric beverages, and on liver-related infections at Fort George Hospital, northeast of Detroit. The study concluded that power consumption, plant-based stimulant consumption and traditional fatty acid consumption led to hepato_ carcinogenesis. The researchers, led by Jeremy DiCrescent, PhD, wrote the conclusion of the 5-year health and human disease study that is currently being conducted in rats.\\\\nThe research, led by Dr. DiCrescent and Sarah Garrett, senior postdoctoral fellow in Pharmacology and Pharmacology at Cal-Distantistant Bloomsburg, Pennsylvania, follows the alarming growth of hepato_ carcinogenesis in humans and the total number of liver-related ills in the world since the last 20th century.\\\\nLike Artemisia\\\\\\'s mastium pyrdis, oncophates accumulate in the liver and cause liver damage, although the exact cause of hepato_ carcinogenesis remains unknown.\\\\nDelayed introduction of new medications\\\\nDespite resistance from the U.S. Food and Drug Administration and related manufacturers, Nigerian patients are putting forward a class of drugs so underdeveloped in the U.S. and sub-Saharan Africa. New drugs can only be developed by regulators.\\\\n\"GAMINGLE SMART STRITCHES\\\\\\' ACTION HAS ADVOCATED CLINICAL ROLE, BUT LARGELY UPHRAIN-TIPS COMPLISHING IS TAKEN INTO QUESTION\"\\\\nAccording to DiCrescent, the story of liver proliferation is linked to liver cancer, not to better-designed or improved weight loss, a fall in liver enzymes, and the closure of nerve cells (left side of the liver) necessary for effective treatment of liver disease.\\\\nDiCrescent and Garrett are currently working on a multi-year initiative to tackle Hepatitis Natura, promoted by Mike Alder, vice-president of pharmaceutical companies for American Nutra Pharmaceuticals.\\\\nThe researchers studied 259 males between the ages of 11 and 40 who were chronically obese and had portions of diet with and without caffeine and curcumin. Researchers observed the liver-related stiffness as much as six months after dosing the total number of 23 different ingredients. They also observed nerve cell growth at three months, although the growth of the liver was abnormal.\\\\nThe researchers also studied the self-reporting of daily caffeinated beverages containing curcumin and equally exposed individuals who were consuming active caffeine in the diet of two million rats worldwide. They determined that 5 mg or less of carbonated caffeinated alcohol to the same level as caffeine equivalent to 35 milligrams per deciliter of blood, the same as two liters of alcohol per deciliter of blood, a blood ratio of 1.97 mmol/ml of liquid energy, and a typical daily dosage of 100 milligrams to 240 milligrams of caffeine, is associated with hepato_ carcinogenesis in the liver.\\\\nThe food-related study findings also showed large differences in weight, weight loss, liver disease and mortality in rats compared to people with the same weight. Consuming a soft drink with curcumin levels in the diet was associated with substantial weight loss, but having a 32-pack, the consumption of drinks equivalent to one litre of coffee with curcumin was limited by obesity, and the significant health consequences of this restriction due to immediate delivery of caffeine.\\\\n\\'']", "inst_index": "85252", "domain": "INTERNATIONAL JOURNAL OF ONCOLOGY 40: 1779-1788, 2012", "url": "http://doi.org/10.3892/ijo.2012.1343", "summary": "", "authors": "['YUKI FUJISE, JUN-ICHI OKANO, TAKAKAZU NAGAHARA, RYO ABE, RYU IMAMOTO, and YOSHIKAZU MURAWAKI']", "date": "03-28-2012", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Leptin stimulates ovarian cancer cell growth and inhibits apoptosis by increasing cyclin D1 and Mcl-1 expression via the activation of the MEK/ERK1/2 and PI3K/Akt signaling pathways", "warc_date": "20220328", "article": "['\"MOTORISTS have been hypothesizing for decades that adipose-derived growth factor receptor (IGF) development might support tumor regression by activating the stomach-derived protein Q-protein (MHCD). AMPK (mutated melatonin) signalling is thought to play a role in suppressing blood sugar regulation and resistance to alcohol abuse. We currently live in a \u201cPlain, Packet & Poor\u201d in our nutrition system, an unspeakably poor and inefficient process that heavily impacts the sleep cycle, daily activity cycles, and inflammatory genetics. We can guess how many genes are involved in activating Q-protein. As one of the NIH\u2019s medicines, HIJNK2 inhibitors combine good anti-nausea suppression with dimethylamine acid-5 (FAMDA4) weakness (MACAMCA9) and sulfoxanthine receptor (SMLR8) for HCGs, they activate both dissociation and phosphorylation of the PI3K/ERK1/MM3 signaling pathways. They activate and inhibit opioid signaling, the therapeutic homeostasis of ablation, and inhibition of methamphetamine, alcohol, and other stimulants.\\\\nIn 2015, there is promising molecular evidence that TRIS (iCellular Transduction Mechanism) L-meensidine potentates and extension mechanisms for responses to TNF. TNF has historically been the target of selective receptor blocking of tumor cell suppressors which we used on humans for decades. IL-2 or other cell suppressors are under the influence of TRIS and IL-15 is needed to modulate activity in the liver, thyroid, breast, and other tissues. Tanzanian telotristocyte cell cultures are currently testing whether TRIS and EGFR are linked to IDR transmission in T cells. For TRIS, we currently used a small, randomized controlled trial in adults with compromised ovarian or BRCA1/2 muscle weakness. Aborting from either I-tubularular or bRCA1 genetic mutations, the chemotherapy may stimulate up to 80% of cells to start production of IL-2s.\\\\nA study carried out in China last year led us to consider all development of TRIS. CRC proteins collectively represent the most potent binding agents available in the TNF drugs market.\\\\nWhat will occur in the UK in the future?\\\\nA far greater breakthrough has been set in the US. There is increasing evidence that patients with a mutated viral form of Lupron (beta ribavirin) in combination with high-dose Truvada (with Herceptin) may be prevented from recurrence and survival, in more studies, and thus be cancer-free or at lower risk of early onset of cancer. The effectiveness of some of these drugs in reducing survival is likely to increase substantially in the UK, however, in the mean time, cutting on the side-benefit may increase the cost of cancer treatment to remain the dominant field and higher cost.\\\\nThe data available in the UK are in contrast to the main interest of developing Telotristumab. Telotristumab, together with Truvada, Cellectis and Cellectis T Cells, was firstly to be used to halt the progression of acute myeloid leukemia (AML) by improving the immune function, or the T cell \u201cbackbone\u201d by reducing the number of ICRs in lymphocytes. It followed the development of a number of other NSCLC inhibitors in the pipeline in preparation for Phase III trials in the UK.\\\\nWhile there is ample evidence that Telotristumab works in combination with an experimental chemotherapy, exactly what this treatment does is beyond our reach. We need a treatment that blocks the interactions between proteins and T cell resistances. In fact, we would ideally like to accelerate the development of other drugs being tested.\\\\nCLIADHBLO is a KRAS inhibitor-targeted anti-cancer agent known as\\\\nKAP8291. KAP8291 inhibits that KAF receptor, KHA2 via an inhibitor\\\\nLink \u2013 but we can\\'t predict which impacts occur within that particular KAF receptor (K-K8.B) receptor (TG-RNA2)\\\\nLink \u2013 but mutations in KAF1 at the KAF2 subcutaneous pathway have been reported\\\\nLink \u2013 but if such a cell blockages are the culprit of KHA2 or KRAS activation, the mechanisms could be modified in other drugs, such as Zometaxa.\\\\nThe\"']", "inst_index": "25270", "domain": "INTERNATIONAL JOURNAL OF ONCOLOGY 42: 1113-1119, 2013", "url": "http://doi.org/10.3892/ijo.2013.1789", "summary": "", "authors": "['CHIACHEN CHEN, YUAN-CHING CHANG, MICHAEL S. LAN, and MARY BRESLIN']", "date": "03-28-2013", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Genetic and epigenetic alterations are involved in the regulation of TPM1 in cholangiocarcinoma", "warc_date": "20220328", "article": "['\\'ST JOHN\\\\\\'S, Antigua\\\\nResearchers have found that the structure of human chromosomes in certain regions, including on chromosome 19, create unique cases of protein plaques that help to regulate the shape of cells and work against long-acting copies of genes that inhibit the regulation of the protein TPM1.\\\\nAnd while that positive attitude extends to genetic variations in the body -- in contrast to any pathological changes in one\\\\\\'s cells and organs -- changes in the role of genes are one way to get the same sort of changes in aging cells in humans.\\\\n\"The results of the research study indicated that of the protein plaques tested for TPM1 we found alterations in mice\\\\\\'s human liver cells and internal blood vessels with unhealthy concentrations of TPM1.\" said Masuko Anahara, director of the Health Sciences Center at the Department of Tropical Medicine and Voluntary Health Sciences.\\\\nWhile there is a clear explanation for the cancer that turns this into a cancer and has previously been linked to a host of other markers, such as cholesterol and insulin levels, according to Dr. Regina Mumuni, the US-based Institute of Genomic Medicine who led the study, she said she is keen to examine more promising ways to identify potential sites in human organs in order to understand why diseases like cancer increase such risks.\\\\n\"The new findings are remarkable and indicate there is a new approach to understanding these kinds of diagnoses. Mutations of genes, which are linked to aging, osteoporosis, neurodegeneration, stress, and hypertension, are related to their influence on metabolism and cellular function and will therefore be of interest to scientists to know what will be the factors that affect disease in humans.\"\\\\n\\'']", "inst_index": "67293", "domain": "INTERNATIONAL JOURNAL OF ONCOLOGY 42: 690-698, 2013", "url": "http://doi.org/10.3892/ijo.2012.1741", "summary": "", "authors": "['WEI YANG, XIAOYUAN WANG, WEI ZHENG, KEDONG LI, HAOFENG LIU, and YUEMING SUN']", "date": "03-28-2012", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Functional analysis of Zyxin in cell migration and invasive potential of oral squamous cell carcinoma cells", "warc_date": "20220328", "article": "[\"'(This article was postpartum co-authored by Laila Laila Chow, Ph.D. and MIT professor, and Mohit Shaleib Ahmad, Ph.D., M.P.H. Dr., and researcher at LGFiatric Medical Academy)\\\\nZyxin is the most common cancer skin cancer cells and the most common cancer in children, according to the publication of the International Circulatory Cell News. The designation of the disease as period cancer progresses after ages 17 years.\\\\nZyxin forms when another cancer cell enters the body and eats out of it in the very cells that produce the cancer cells. Their presence inhibits the production of other cancers and eventually leaves the skin that not only exists in these cells but also that that cancer cells may have used.\\\\nIntravenous sarcoma starts in any part of the body and by about age 50. At this point the cells become too aggressive. The cancer metastases, which in turn is able to infect other cells and then attacking the cells. VETs (small tumor cells) have been shown to spread easily and gradually to the teeth of tumor victims. Certain types of the cancer cells also have biological benefits to them. After any attack, treatment is used to stabilize and balance the cell and also to prevent the spread of other cancer cells, ultimately more so than in the other cancers.\\\\nThough doctors have gone all out to treat the patients, targeting it with therapy in other cancers remains a potential approach. In this latest chapter of the UNCAMA/MIT study, which analyzed data from the last ten years of pregnancy through postpartum IV breast cancer in 450 women, 90 were given zyxin on the skin of their cervical patients and, over a period of five years, from 2005 to 2010, 80% of the patients received the treatment, which is equivalent to 11 shots of vantages of an invasion agent. That compares to only 12 doses of radiation against 10 shots of radiation against one wound of the testicular during that same period.\\\\nOf the Zyxin patients who received zyxin, 70% received a single shot of vantages. The other cases did not take part in the study but were able to be treated in standard practices. In addition, women with acute lymphoblastic leukemia (ALL) with the usual level of dose of vantages were not treated in this study. Yet, the Zyxin treatment decreased the risk of late-term follow-up in those with the most severe metastases, resulting in one in the eight patients to receive vantages. No one in the U.S. has ever been diagnosed with this type of cancer.\\\\nOther research demonstrates that further access to surgery as well as this treatment would benefit thousands of Kt fymphomaniac CD34 patients in developing countries. Some found it reduces their risk of these types of cancer even though it is not possible to control these patients\u2019 tumors themselves. After surgical removal, cancer cancer cells go dormant and they must be surgically removed. Depending on treatment options, Zyxin is able to seep into a completely normal part of the body, or at some point, an HPV-like infection of the immune system.\\\\nThis article was published in PLOS One.\\\\n'\"]", "inst_index": "56054", "domain": "INTERNATIONAL JOURNAL OF ONCOLOGY 42: 873-880, 2013", "url": "http://doi.org/10.3892/ijo.2013.1761", "summary": "", "authors": "['MICHIYO YAMAMURA, KAZUMA NOGUCHI, YOSHIRO NAKANO, EMI SEGAWA, YUSUKE ZUSHI, KAZUKI TAKAOKA, HIROMITSU KISHIMOTO, TOMOKO HASHIMOTO-TAMAOKI, and MASAHIRO URADE']", "date": "03-28-2013", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Cisplatin in combination with zoledronic acid: A synergistic effect in triple-negative breast cancer cell lines", "warc_date": "20220328", "article": "['\\'THE INVESTIGATION revealed that a combination of all three types of cells known as triple-negative breast cancer cells (BICC) has demonstrated a potential synergy between the HER2 breast cancer drug Avastin and the blood cancer drug dormioquinibar.\\\\n\"Avastin also goes well with other breast cancer drugs, such as Herceptin and Tecentriq\", said Dr. Theodore L. Boukema, clinical director of the Division of Infectious Diseases/Rural Epidemiology at the American Cancer Society, at a news conference yesterday.\\\\nAfter extensive testing, the study found that Avastin inhibition of Factor Xa (VIXA), the HER2 breast cancer drug, has been demonstrated to reduce HER2 losses in 12 antibody-targeted cells of the breast.\\\\nIn addition, the combination treatment has shown to be effective in half of the sites of HER2 breast cancer, demonstrating a potential synergistic effect in double-negative breast cancer cells, said Boukema. He noted that Avastin\\\\\\'s protection against HER2 breast cancer was not sufficient.\\\\nThe Avastin will be presented at the 64th annual meeting of the American Association for Cancer Research in Dallas, Texas, in May.\\\\n\\'']", "inst_index": "67365", "domain": "INTERNATIONAL JOURNAL OF ONCOLOGY 42: 1263-1270, 2013", "url": "http://doi.org/10.3892/ijo.2013.1809", "summary": "", "authors": "['TONI IBRAHIM, CHIARA LIVERANI, LAURA MERCATALI, EMANUELE SACANNA, MICHELE ZANONI, FRANCESCO FABBRI, WAINER ZOLI, and DINO AMADORI']", "date": "03-28-2013", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Estrogen receptor _ inhibits estradiol-induced proliferation and migration of MCF-7 cells through regulation of mitofusin 2", "warc_date": "20220328", "article": "['\\'RENO, N.Y. (ENB) - After discovering bladder tumor cells, Professor Peng Ning, a roboticist and researcher at Stony Brook University Applied Sciences in Brooklyn, NY, now finds that inhibiting estrogen receptor \u2013 also known as progesterone-mediated progesterone receptor \u2014 affects sexual behavior. Ning is more than happy to share this news at a San Diego meeting of Adderall-Opportunity Broadband Telecommunications Association (ADBGT).\\\\nDuring the two-day summit at the Annenberg Complex in Los Angeles on Wednesday, Ning and his team worked through a study that deals with viral infection in 1,940 patients with renal-like liver diseases (UHD) and AML (ME). This exposure probably affects the elderly, particularly the elderly women who are mostly receiving HA breast implants, a form of estrogen- and progesterone-induced-removal surgery.\\\\n\"If you go through these cases, they are very common,\" Ning said. \"Then you do start having cysts on the head, where there\\\\\\'s no fertility. It depends on the age of the patient. It\\\\\\'s not one girl, it\\\\\\'s two girls.\" He said that in families with older patients, that means that in overall women in the family of up to 50 years old, hysterectomies may not occur if necessary.\\\\nIdentifying and managing immune responses\\\\nIn the study, Ning\\\\\\'s team discovered that fasting estrogen receptor - or GR-7 - induces the extension of an immune response called MCF-7 cells in mitochondria to determine whether the body has activated the necessary mitochondria in the plasma of certain patients. The finding could be useful for prostate cancer treatment because this number is higher in tumors grown with the maximal estrogen levels that the prostate gland does not produce.\\\\nIn cases of medical end-stage renal (ER) transplantation (RDR), which the prostate cells receive to aid their growth in response to an antigen-laden antigen, nanofig antibodies aren\\\\\\'t targetable.\\\\n\"You have to have a non-membrane antibody,\" Ning said. \"You can be negative or negative, but your immune system will protect the plasma. When a nucleotide is put into the mitochondria, you have an IgE antibody. That goes back to a brain tumor or kidney disease. People want to have an additional N-551-inviary cell. So you can get a low-dose antibody, but you have to have a mid-stage. Then you go right into the kidney. If you\\\\\\'re not producing enough beta blockers, you can really deliver high-dose antibodies to the kidneys.\"\\\\nThe tumour-causing effect is distinct. \"People have never really told us about it before,\" Ning said. \"What happened is they discovered on the second day of the summit that they have a few thousand patients who are really starting to develop the lymphomas and there aren\\\\\\'t any patients, probably because of some autoimmune disease, who have been diagnosed with rheumatoid arthritis. They might not have been diagnosed because of the cholesterol levels. And they would have also detected first thoughts that they might be carrying OA. So we\\\\\\'ve studied that.\\\\n\"Now that this is back to the animal models, I think we can look at the two that have worked in the laboratory with this cell technique. We will try to get a high-dose CD1-trimoting antibody into the blood.\"\\\\n\"It\\\\\\'s a very potent drug and it\\\\\\'s very expensive and we are in the process of working on it with other tissue specialists,\" Ning said. \"It is taking a long time to get out into the clinic. It\\\\\\'s time to get more molecules in the pipeline. To do that, you have to do lots of clinical trials.\"\\\\nEvasive prostate cancer can also spread due to an invader in cells known as HER2. While she prefers to refer to HER2 mediated hairbrands, currently, Ning said that there are no specific treatments for HER2-mediated prostate cancer.\\\\n\"We have a research team that is working on that and we plan to complete that phase 3 trial by the end of the year,\" Ning said. \"I do expect that we will make my name known as an emerging cancer and hopefully be able to show that I are directing positive therapeutic and negative effects on Prostate Cancer. I\\\\\\'ve worked on this topic for many years.\\\\n\"If you don\\\\\\'t carry one\\\\\\'s ass or root for a year, it might be fatal,\" Ning said. \"Some studies show that by 30 to 40 percent\\'']", "inst_index": "48712", "domain": "INTERNATIONAL JOURNAL OF ONCOLOGY 42: 1993-2000, 2013", "url": "http://doi.org/10.3892/ijo.2013.1903", "summary": "", "authors": "['LI MA, YUEPING LIU, CUIZHI GENG, XIAOWEI QI, and JUN JIANG']", "date": "03-28-2013", "split": "test", "label": "machine", "status": "succcess"}
{"title": "A Critical Role for Notch Signaling in the Formation of Cholangiocellular Carcinomas", "warc_date": "20220328", "article": "[\"'Unknown areas and regions of the gas-cell environment intersecting with each other are strongly impacted by the production and transport of favorable cell developments. Cholangiocellular cells have a vibrant stage of formation; they produce the organic chemicals that make the cells persist at highly arbitrary levels. This stage is characterized by resistance and a general risk of cancer when released in difficult to gather stage formations. This phase of formation is referred to as the formation of cholangiocellular carcinomas, or CHCs, from uncertain to extremely low-to-risk points as demonstrated by the T. Palatin I and M-LR studies, as well as other observed studies. These findings indicate that advanced age mutations associated with CHCs extend beyond the stages where they are dormant. These mutations can also cause a more aggressive form of genetic breakdown caused by the presence of hydrothermal amnesia. Approximately 3.4% of Cholangiocellular carcinomas are likely to be engineered into drug-selective anthocyanins, thus creating an accelerated regulatory process for obtaining acetaminophen and other anti-cancer drugs. This process can lead to cancer therapy which the accompanying anthropologic characteristics to cause cancer increases susceptibility to treatment.\\\\nThe composition of the histo-lause region of cholangios can be altered by the appropriate cellular branch. The histo-lause regions were identified as the staging sites of various cancers. They are identified by the amino acid GM-1585 and Chromatin B. Some tumors have 30 or more per thousand PETCT increases, while others have several per thousand PETCT decreases. These histo-lause regions with the risk of growing to 25% of the tumor size and up to 25% of the tumor size (supersubentricatatin and LS et al), and with CD95 levels of 4 or higher, may be found in the Cholangios, and may contribute to the formation of histocyanins. The histo-lause regions have an estimated maximum chromatogenic hazard of 5 or more per thousand, but are as unpredictable as protective and trepanogenic agents. These carcinomas also include pyretsin family tumorae of the chicken monocytogenes, rituximab, and tiny autopsies, for example.\\\\nThe process of cholangiocellular carcinomas is characterized by the ability to keep tumor cells within 3 to 5% of their precudyhood with minimal increase in activation (indicating excessive activity) for each cell block and communication with other cells. It is a qualitative difference between the cholangios, CD95, and isoform aberrant cells. In several cases the primary growth factor, CD823E (RINO 85833, extended expression to 47% of cholin populations) is not inhibited by that defect. In the uppercellular regions, the histo-lause expansion compounds impact on tiny metastasis due to toxic accumulation of toxic cell lines (GKN123428, GTNL123423, and GTNL123426), thus confirming the survival mode for cholangios. It is these small metastasis mixed with overall cancer growth that provides the ultimate setting for patients to be treated with an advanced and aggressive form of I. This treatment cannot be justified in isolation from the tau protein homologous-compensation (GTHM).\\\\nWhen patients are exposed to a potent inhibitor of enzyme enzyme levels to stop the cell from calcification, their cellular pathways respond positively to the cancer therapy. Antifragilous antisocial genes are initially used to target the specific tumor: FGFR activity-phosphateases, LRC1 mutations and LCA1 receptor genes. Furthermore, they are used to bind to traditional IV modifications that are stymie inflammatory responses and would interfere with other appropriate agents. While this is only a type of therapy, it has the potential to extend survival and potentially co-morbidities.\\\\nCholangios demonstrate a crossover in \u201cbenchmarking\u201d to CHCs, and particularly to new therapies for cancer. Cholangios are estimated to have a significant impact on the progression of genotypes of disease, and also systemic beta-elangiopathia. Therefore, multiple prostate androgen receptor mutations at'\"]", "inst_index": "23261", "domain": "Cancer Cell 23, 784\u00c3\u0083\u00c2\u0090795, June 10, 2013 ", "url": "http://doi.org/10.1016/j.ccr.2013.04.019", "summary": "", "authors": "['Steffen Zender, Irina Nickeleit, Torsten Wuestefeld, Inga So _rensen, Daniel Dauch, Przemyslaw Bozko, Mona El-Khatib, Robert Geffers, Hueseyin Bektas, Michael P. Manns, Achim Gossler, Ludwig Wilkens, Ruben Plentz, Lars Zender, and Nisar P. Malek']", "date": "03-28-2013", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Loss of the Par3 Polarity Protein Promotes Breast Tumorigenesis and Metastasis", "warc_date": "20220328", "article": "[\"'Scientists have discovered a new mechanism that could have a specific effect on the dead tissue of breast cancer \u2013 and they hope the discovery will bring new hope to cancer patients.\\\\nAlthough the heart\u2019s critical blood vessels are the most abundant biological pathway involved in cancer development, they are not directly responsible for other important functions, like water retention and the monitoring of blood transfusions, as the heart and blood vessels respond to treatments.\\\\nBut Dr John Covey, who leads the Cancer Research UK research team led by Sally Mainzer at MRC St Patricks Hospital in the UK, is planning to revolutionise the way cancer treatment is more targeted and controlled.\\\\nThe idea is to improve on existing clinical trials on protecting the heart\u2019s vital blood vessels.\\\\nThe research team, which was recruited by MRC St Patricks, a collaboration with scientists from King\u2019s College London, will undertake an unexpected investigation of breast tissue biomarkers and the prevalence of a particular cardiac protein \u2014 the Par3 protein \u2014 that predicts an early stage breast cancer.\\\\nLead author Dr Clare Kinsella of MRC St Patricks Hospital in King\u2019s College London said: \u201cWe know that this protein acts as a regulatory regulator, but it is not well understood whether its signatures might actually regulate cancer, or whether they are having a distinct effect on it.\\\\n\u201cThe research team hopes to start offering treatments early on, in conjunction with clinical trials and by adapting to different conditions, and particularly conditions with different common genetic and environmental factors. They then hope to develop a targeted approach that is potentially \u2018down to the human genome\u2019.\u201d\\\\nThe team are currently researching whether the concentration of Par3 is why a new discovery is being made in the laboratory.\\\\nTheir experiment was last performed in 2009, when they were employed to attempt to replicate a study using \u2018pseudo-super-protein\u2019 which is similar to the understanding of the nervous system.\\\\nThe team created Par3 proteins to slow the growth of tumors, and a deep meaning was revealed when they injected 2 million vials of Par3 into the patients.\\\\n'\"]", "inst_index": "67889", "domain": "Cancer Cell 22, 601\u00c3\u0083\u00c2\u0090614, November 13, 2012", "url": "http://doi.org/10.1016/j.ccr.2012.10.003", "summary": "", "authors": "['Luke Martin McCaffrey, JoAnne Montalbano, Constantina Mihai, and Ian G. Macara']", "date": "03-28-2012", "split": "test", "label": "machine", "status": "succcess"}
{"title": "CARM1 Methylates Chromatin Remodeling Factor BAF155 to Enhance Tumor Progression and Metastasis", "warc_date": "20220328", "article": "[\"'Share\\\\n\u201cCARM1 methylates Chromatin Remodeling Factor BAF155 to Enhance Tumor Progression and Metastasis\\\\nThis study sheds new light on the manufacturing process required for CARM1 methylates to be manufactured by that particular brand used in cancer recovery or with the radiation therapy that long-term efficacy chemotherapy is used to treat tumor formation from CARM1 methylates. Carteratin using CARM1 methylates to repair the tumor develops a remarkable differentiation between tumor formation and repair of the tumor pre-operative. In addition, CARM1 methylates, along with agents already available in a safe, effective form, demonstrate significant potential to treat cancer when radiotherapy ceases.\u201d\\\\nCARM1 methylates require better radiation therapy treatment than existing chemotherapy drugs and they currently perform excellent quality chemotherapy well in preventing free relapse or positive recovery. The authors suggest their findings should help to answer questions in both the clinical and public domain:\\\\nKilopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopopop'\"]", "inst_index": "48805", "domain": "Cancer Cell 25, 21\u00c3\u0083\u00c2\u009036, January 13, 2014", "url": "http://doi.org/10.1016/j.ccr.2013.12.007", "summary": "", "authors": "['Lu Wang, Zibo Zhao, Mark B. Meyer, Sandeep Saha, Menggang Yu, Ailan Guo, Kari B. Wisinski, Wei Huang, Weibo Cai, J. Wesley Pike, Ming Yuan, Paul Ahlquist, and Wei Xu']", "date": "03-28-2014", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Molecular Mechanism of SSR128129E, an Extracellularly Acting, Small-Molecule, Allosteric Inhibitor of FGF Receptor Signaling", "warc_date": "20220328", "article": "['\"(Articles of Nature. Eaters.)\\\\nOn one hand, and using somatic gas. That opens the door for use of ion imaging, assisted by a Zofron microscope and a tiny scattering of low-energy voltage.\\\\nOn the other hand, once the spectrometry design meets the light processing and data analysis needs of the microscope, the beam will crystallize with an inexorable collision. Until a prior supplication, such collisions, before any processes can allow enough reflection to take hold of the beam, will be necessary.\\\\nWith somatic gas detection, almost the entire beam will be home to a part of the histone glycourea, the original line of Light Ion Spectrometry. The histone glycourea is an organic-molecule receptor that invokes both Light Ion Immediastasis (ESI) and Continuous Advanced Atherogen Translation (CAAT). The organism is carefully formed and each subcutaneous gel cell created within a well-organized and uncluttered framework is biologically similar to one of the coronary arteries in the embryo.\\\\nThis achievement will certainly be possible with the knowledge that the histone glycourea and histone necrosis factor (CHR) connect with the histone glycourea rather than that the histone glycourea is precise in its other blocking properties.\\\\nIn our own view, this link raises more questions than answers. Researchers in virology had been studying the fibrinsky11 for the past 40 years, and they never investigated bcryptirobutiny, a complete histone glycourea. The striking similarity in the two histone glycourea together was one of the prime reasons for their existence. The significance of these similarities is the chemistry of fibrinsky11.\\\\nThis interest in fibrinsky11 got its own result in an article published in two recent publications. Indeed, just yesterday in Nature, an entanglement, with the biocontrol of ibaridiigenetic system, was reported on in a peer-reviewed journal.\\\\nThe Kuroticos guitonase histone aguaticidiplasia, or KGI, as it has become known, is biologically characterized by a number of changes that were not characterized prior to their discovery. These changes were specifically related to changes to fibrinsky11. Likewise, changes in fibrinsky11 seem to have begun in histone glycourea long before any known mechanisms on its subject were identified. It is far too early to say whether fibrinsky11, then, will begin to see fruit or fruit fly changes or fruit fly ripples.\\\\nAlso, the KGI group\\'s long-term analysis of histone glycourea in their new Biologic Formulation Study (BFRIS) offers a prospective base-case for the point of it not to be detected in any histone glycourea interaction at that time, but found for an extended time interval. This study also provides additional insight into the levels of fibrinsky11 being transmitted to other histone glycourea-dependent HFRs.\\\\nWith seemingly unpredictable consequences, one of the major questions relating to fibrinsky11 in the context of histone glycourea is how this new discovery might lead to the discovery of other hundreds of conditions and biomarkers that might modify or even modify the predictive power of fibrinsky11.\\\\nIt is too soon to make any determinations as to what the substance of fibrinsky11, as derived from histone glycourea in their molecule form, might have to do with the use of any of these conditions.\\\\nAs we begin to look through the bcryptirobutiny, a Chosociazone-, Rimex, Dapen, and Rufiedans gel complexes containing fibrinsky11, on the small opening of the wall of the B\"']", "inst_index": "32826", "domain": "Cancer Cell 23, 489\u00c3\u0083\u00c2\u0090501, April 15, 2013", "url": "http://doi.org/10.1016/j.ccr.2013.02.018", "summary": "", "authors": "['Corentin Herbert, Ulrich Schieborr, Krishna Saxena, Jarek Juraszek, Frederik De Smet, Chantal Alcouffe, Marc Bianciotto, Giorgio Saladino, David Sibrac, Denis Kudlinzki, Sridhar Sreeramulu, Alan Brown, Patrice Rigon, Jean-Pascal Herault, Gilbert Lassalle,1 Tom L. Blundell, Frederic Rousseau, Ann Gils, Joost Schymkowitz, Peter Tompa, Jean-Marc Herbert, Peter Carmeliet, Francesco Luigi Gervasio, Harald Schwalbe, and Francoise Bono']", "date": "03-28-2013", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Rab1A Is an mTORC1 Activator and a Colorectal Oncogene", "warc_date": "20220328", "article": "[\"'They report that Rab2A is a metabolic antibody which contains very high levels of DNA DNA and another protein related to the cellular microorganisms a cancer cells cause. It acts on the cellular biochemical and biochemical machinery that controls the innate immune system in a building block as well as a number of functions including the immune system itself. Rab2A is the first food that can dissolve DNA because it can effectively eliminate the use of DNA altogether. The same molecules \u2014 lard (coparb), its eggs (spicli), other proteins (refendibers) and other components \u2014 make those proteins and form a food for other types of cancer.\\\\nWhen Rab2A is detected in this body, it is allowed to eat through blood, but it is forbidden to leave food for its own use. In California, 15 percent of cancer patients have RAB2A, which is derived from DNA but has a specific association with cell functions. Because of the protein\u2019s association with the cell through endocannabinoids, it is, in essence, trying to eliminate a cell\u2019s innate immune system as well as controls the outer surface of the cell as well as potentially aiding cellular destruction.\\\\nAviation\\\\nIf Rab2A was detected in the bloodstream, it would accelerate and disintegrate food, and by making the process more difficult, it would cause the building blocks of cancer cells to disintegrate to help humans with their own diseases. Dr. Jang Lu, an assistant professor in the Center for Human Genomics, told New Scientist, \u201cThrough waste water, it moves a small molecule of the chemotherapy drug pancrogli back into the cells at the micro level, and then it destroys the cancer cells.\u201d\\\\nOnce the tumor cells die, the bacteria that gut the food cells (the protein mTORC1) treat and spread to other cells could cause tumours to mutate into bigger, mature cancers. Because of this, the bacterium, the \u201clisteria\u201d (B,HS), says they can transmit the cancer\u2019s RAB2A to these other cells. The cancer cells also carry instructions to make an antibiotic for distribution to the remainder of the cells. This is a development \u201cfrom a very early stage to effectively cancerous cells,\u201d Dr. Zibin Huang of the Shanghai University, told New Scientist.\\\\nA vaccine against the disease to prevent the destruction of DNA. DUNGY VILLAGE\\\\nGiven how few treatment options exist for these types of tumors, scientists are looking for a vaccine that will combat this disease and \u201cincrease medical revenue.\u201d Dr. Zhang told New Scientist, \u201cOur research has led to hopes that the vaccine could help as well. The immune system reacts more strongly to cancer cells and specifically processes cancer cells. We can then cross-plant a small molecule antibiotic, which prevents the lethal presence of other cell types that are infecting and causing the cancer. It is like pairing a CD19 inhibitor with a virus to protect against cancer by minimizing interaction with one or more cell types.\u201d\\\\nRab2A is one of the new natural life forms. In order to live safely, can it be used at any point and whatever levels it gets at, says Dr. Huang. It is an \u201calienary disease,\u201d of the bacterium that causes leukemia. \u201cIn general, high levels of DNA DNA in the blood may cause leukemia cells to proliferate, but only after a specific gene has already been identified in the patient\u2019s genome, so to speak. Thus in cancer, the survival of the patient depends on the intensity of the disease, the survival of the patient through a certain number of factors,\u201d she said.\\\\n'\"]", "inst_index": "20903", "domain": "Cancer Cell 26, 754\u00c3\u0083\u00c2\u0090769, November 10, 2014", "url": "http://doi.org/10.1016/j.ccell.2014.09.008", "summary": "", "authors": "['Janice D. Thomas, Yan-Jie Zhang, Yue-Hua Wei, Jun-Hung Cho, Laura E. Morris, Hui-Yun Wang, and X.F. Steven Zheng']", "date": "03-28-2014", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Itch E3 ubiquitin ligase regulates large tumor suppressor 1 stability", "warc_date": "20220328", "article": "[\"'by Patricia D. Ulli\\\\nKey print: (http://journal.colfc.org/print/proc_110235/pak/)\\\\nShort print: (http://journal.colfc.org/print/proc_110235/pak/)\\\\nCircumstances are important. As people perform more and more powerful feats and leave their shoes, bodies become more vulnerable. The fibers that connect those fibers are engineered to inhibit chemical reactions for the pleasure they provide to tumor suppressor cells, thus increasing a tumor\u2019s capacity to deploy new drugs.\\\\nThe dominant drug in parathyroid glands is clonidine-1 agonist. It is common for parathyroid glands to develop abnormally high levels of this molecule in their tumors. Then, a new mechanism was demonstrated in December. The insulin-free peptide, beta-lactide, and tamoxifen T-beta aggregates cannot bind to receptors in the petri dish in cancer cell genomes. These proteins must have high levels of the peptide when they are open to deeper and more powerful drugs in early cancer cell lines, as opposed to using other chemical drugs.\\\\nSystemic protein mechanism has taken \u201cepitome rending\u201d (OSP) techniques by both establishing a liquid and specific protein that is shut down. A great many people use OSP and exon, but the newer combination techniques allow groups of tiny amounts of T-cells to migrate to the tumor and very quickly infect the tumors. OSP is known as opportunistically attaching the enzyme in this compound to a tumor gene. Recently, an antibody taken from OSP from humans was one of the antibodies within PAR, which reached the tumor, transferring the gene-induced cells and infecting tumor cells. This has been in clinical trials involving mice.\\\\nSo what is OSP and how does it act?\\\\nI discussed the role of OSP in tumor suppressor protein expression in a Q&A with Dr. Patricia. I have an extensive bioacoustic and noninvasive micrometry anatomy paper in ARS. The paper shows that blood vessels (through which tumours are brought out by the virus to the colon) can be done by direct injection of OSP to the circulatory system and can thus protect the tissue.\\\\nNumerous natural transcription tools on the Left and Right sides of the atom enable transcription in the plasma, but also the PNALS \u2013 also called multilayered transcription \u2013 and in the intestine. The latter section is where OSP is taken, but its sequence is close enough for the human embryo to insert the cells.\\\\n'\"]", "inst_index": "42049", "domain": "PNAS | March 22, 2011 | vol. 108 | no. 12, 870\u00c3\u0083\u00c2\u00904875", "url": "http://doi.org/10.1073/pnas.1101273108", "summary": "", "authors": "['King Ching Ho, Zhonghua Zhou, Yi-Min She, Alex Chun, Terry D. Cyr, and Xiaolong Yang']", "date": "03-28-2011", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Drosophila Mgr, a Prefoldin subunit cooperating with von Hippel Lindau to regulate tubulin stability", "warc_date": "20220328", "article": "[\"'SARAJEVO \u2014 French prosecutors on Thursday said that the sex assault charges against Bosco Nunez Mgr. Nunez-Lindau have been dropped following the carjacking which ended with a brutal murder in which Nunez-Lindau was repeatedly stabbed to death as an accomplice.\\\\nThe court also determined that the latter was mistaken for the bogus Romanian gangster referred to as the quintessential guy \u201cwho was gunned down at a bar and gunned down.\u201d\\\\nThe prosecutors said that the investigation into this crime was open from beginning to end, and that the video evidence would be subjected to testing in their investigations.\\\\nProsecutors have already handed over the computer evidence, proof of which they said can be used against the Italian court authorities. The last trial of Nunez-Lindau was held in August 2011 in what was dubbed the \u201cHoffenheim gr\u00fcnge\u201d between 13 witnesses when the witnesses for the Mgr. came forward for questioning, throwing the case forward in both Mgrs\u2019 favor.\\\\nThe prosecutor said in the wake of the latest court verdict that the court does not know at this time whether the arrest warrants Nunez-Lindau had already been issued, with details of the investigation still unclear.\\\\n'\"]", "inst_index": "27834", "domain": "PNAS | April 10, 2012 | vol. 109 | no. 15 | 5729\u00c3\u0083\u00c2\u00905734", "url": "http://doi.org/10.1073/pnas.1108537109", "summary": "", "authors": "['Nathalie Delgehyr, Uta Wieland, He_l\u00c3\\x82\u00c2\\x8fne Rangone, Xavier Pinson, Guojie Mao, Nikola S. Dzhindzhev, Doris McLean,5, Maria G. Riparbelli, Salud Llamazares, Giuliano Callaini, Cayetano Gonzalez, and David M. GloverR']", "date": "03-28-2012", "split": "test", "label": "machine", "status": "succcess"}
{"title": "The costimulatory immunogen LPS induces the B-Cell clones that infiltrate transplanted human kidneys", "warc_date": "20220328", "article": "[\"'SHARE THIS ARTICLE Facebook Twitter LinkedIn Email\\\\nI had been awake and passionate about HIV and AIDS for a few years. After doing an advanced statistical analysis to understand AIDS\u2019 effectiveness, I thought I\u2019d pass on an article about the priceimulatory infection of the B-cell clone, which induces an immunity-inducing cycle of cells in the adult-living cells that are randomly handed over to the intercellular C-cells (cellular network networks) that perform matching gene-sharing and lipitinotecan activation.\\\\nAfter listening to the detailed clinical studies of three dozen patients, I was determined to reveal some information that is specific to HIV and AIDS. After working with ethics experts and privacy advocates, I received the report of an advance fact-finding mission to Taiwan from the Institute of Public Health (IPH) that a detailed statement of the K-cell transduction and immunogenicity of this infection is out in the open.\\\\nI submitted the report to the WHO with the recommendation to activate one of the three most important immune immunogen sites, HIV. One of the highlights of the K-cell transduction experiment was the exquisitely exquisitely timed response of the C-cells in the buttocks of the test subjects in the experiments. The partners were given a dosage of cytocerous antigen (CKI) , a synthetic de-oxidase derived from 20,000 human cadavers donated by a biotechnology company.\\\\nAlthough the K-cell financings work better with human cells, a continuing effective CKI is expected in HIV: HIV modulated generation of T-cells.\\\\nWhat is most interesting about this report is the size of the take-home sample of the licensed HIV tests and the transfer by the researchers from vector to vector of cells from the three highly-indigenously engineered HIV tests. This is a step toward the human-derived LPS/VCS experiments , which are being undertaken in all 65 countries participating in the ambitious HIV 2012 trials.\\\\nThis number should not be underestimated. There were a record number of HIV applications worldwide in 2011 and and indeed the country-wide data is solid. Numbers are being compiled by Dr. Michael Scherer, the Global AIDS Research Council and then admitted by Dr. Sam Zhang, the agency\u2019s chief of prevention.\\\\nThe AIDS Global Fund provides thousands of funds to U.S. laboratories to study HIV and AIDS. China is conducting a multinational drug safety and drug efficacy study in Sichuan province. Indian National University (ONU) is seeking funding to create new drugs that could be controlled with minimal contact with the immune system. Chemical labs in Japan and Coto de Caza are exploring new approaches for HIV/AIDS. The United Kingdom can use its European contribution as a self-assessment tool to study the costs and benefits of their own own programs for HIV and AIDS. Kenya is showing that its own design and approach to AIDS research represents a solution. The UK has also drawn considerable attention for its immunized healthcare interventions but is not prepared to give a complete accounting of that approach to date.\\\\nK-cell transduction experiment results will provide a powerful first-line trial data base to assess the high propensity of LPS to be administered in HIV. Other unrepresented results from the report will give an indication of whether HIV/AIDS drugs will be adequate for post-convulsive use. By the end of the year, GlaxoSmithKline, the world\u2019s largest drug manufacturer, will have completed the clinical program for AIDS medications.\\\\nI hope that those who hold personally in their hearts the knowledge and training and expertise of a former HIV clinical practitioner will subscribe to my recommendation and your analysis are shared with the World Health Organization to further aid the human-derived LPS/VCS responses.\\\\n'\"]", "inst_index": "65753", "domain": "PNAS _ April 17, 2012 _ vol. 109 _ no. 16, 6036\u00c3\u0083\u00c2\u00906041", "url": "http://doi.org/10.1073/pnas.1202214109", "summary": "", "authors": "['Rajesh K. Grover, Julong Cheng, Yingjie Peng, Teresa M. Jones, Diana I. Ruiz, Richard J. Ulevitch, John I. Glass, Edward A. Dennis, Daniel R. Salomon, and Richard A. Lerner']", "date": "03-28-2012", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Shox2 is a molecular determinant of depot-specific adipocyte function", "warc_date": "20220328", "article": "[\"'Mixed Systems uses a universal identifier associated with platinum distribution to ensure that nominal substances suitable for transport are distributed efficiently in the transundation corridor. Such weight loss interventions, however, need a probability linkage between test instrument and manufacturer to ensure manufacturing accuracy.\\\\nFor years, physicians\u2019 practices and hospital administrators have focused on particular factors to differentiate between specific sugars and non-nutrient fruit and vegetable ingredients as they carry caloric value. Consequently, individual study studies offer useful ways to raise the probability linkage between both fruits and non-nutrient components. Those specialists and medical college surgeons who carry out such tests are in the business of diagnosing specific fruit or vegetable ingredients that contain or produce low weights with better quality and therefore have fewer downstream effects on human health, consuming more and avoiding contaminants that could be detrimental to long-term health.\\\\nThe latest infcomposite research studies employ a universal identifier in the identification of various indirect cellular metabolites (LDUs) that work in different ways to distinguish between individual elements of an indirect core, given price sensitivity to specific dimensions. Specifically, PSTN profiles are present in REDD as a tetraphase analog of glycoprotein and non-therapeutic glycoprotein, indicating that even a single weight reduction in a LPN is not a direct function of an indirect electrolyte source. The investigators conducted a molecular-level diversity study for the detection of PSTN profiles and their corresponding polymorphisms in a predictive endpoint for transmission of PSTN profiles to their data-recurrent fingerprint. This elucidatory approach, compared with those of other molecules and biomarkers, allowed the researchers to identify low weight genes, and to correlate them with PSTN profile identification of +/- 0.01 percent - with their scores indicating susceptibility to the presence of PSTN.\\\\nThe principles of predictive and predictive testing were specifically observed in the literature and were very robust in effect for identified PSTN profiles of limited METRO types (PPLs). Specific factors like PVN profiles and KNRN profiles indicate that PVN profile identification is not dependent on a replication of PVN profiles. Typically, hHPs are associated with mass transporter, the latter occurring in T cells and for large populations of TPPLs. PSTN was found to affect LHIs and LHEs and result in the replacement of PPLs in top hemoglobin concentrations. Compared with typical MTRN profiles, PSTN profiles are strongly influenced by NPTP receptors; NPTP receptors are active in PPLs and TPPLs, especially in LPN0S-annaptiation age groups.\\\\nThe role of MTN profiles in human disease research is particularly important as the ability of NPTPs to influence LH1 LPNKNA is the premier determinant of serum LH1/MTN content, their primary mechanism of forming LH1/MTN. By assigning an NPC or then requiring a terminal factor (PTN) to remember HTLA in HH1010/MTN content, the investigators identified HTLA variations in multiple HP and HTLA variants, which should not only be recognised as appropriate emphasis added but as well emphasis added as appropriate for improved outcomes.\\\\nThe researchers have identified two most common NPTP polymorphisms; PBK (Characterised in Protein PBQ0.BV) to HTLA and PBPS-mK (VUNCH.BV)). They also have identified two other methods of meaningful HTLA expression that have previously been used with mathematical precision: a baseline RSGN expression level indicated by HTLA at 6.3 zolpms; or a median RPNG expression level that suggests HTLA variants at 10 zolpms. The investigators have carried out a series of randomized and controlled trials using PCR techniques, to support their prediction of HTLA amplification by quantitative endpoints.\\\\nIn total, these studies have identified 330 common HP and HTLA polymorphisms. HTLA remains an important marker for susceptibility to many types of uncontrolled HTLA. Remote pumping to HTLA leads to SNLA-targeting other BABFR sites and to the emergence of inexpensive HTLA viruses. It is estimated that HTLA will quadruple a HTLA pathogen by the 2050s. The findings of these two studies demonstrate that commercially transundation optimization could allow HTLA-targeting capabilities to serve as a predictive marker of HTLA expression, enabling a rapid and reliable identification of HTLA and PBMP VUNCH immunogenic presence across all HTLA mutant populations.\\\\n'\"]", "inst_index": "92816", "domain": "PNAS | July 9, 2013 | vol. 110 | no. 28 | 11409\u00c3\u0083\u00c2\u009011414", "url": "http://doi.org/10.1073/pnas.1310331110", "summary": "", "authors": "['Kevin Y. Lee, Yuji Yamamoto, Jeremie Boucher, Jonathon N. Winnay, Stephane Gesta, John Cobb, Matthias Blu_her, and C. Ronald Kahn']", "date": "03-28-2013", "split": "test", "label": "machine", "status": "succcess"}
{"title": "LRP-6 is a coreceptor for multiple fibrogenic signaling pathways in pericytes and myofibroblasts that are inhibited by DKK-1", "warc_date": "20220328", "article": "['\".\\\\nTo conclude I am done. Still not finished. I am concluding again at the year\\'s end. This time though, not quite yet at all. The must-haves being doled out to discuss, predicted and predicted results for patients with myofibroblasts, myofibroblasts, go-kits, myofibroblasts, dyes-inciruses, drugs for myofibroblasts, including Avastin and Albiramide, is.\\\\nMost Popular\\\\nhas already been assumed to be for all indications of efficacy, particularly in those with hypobesity. I do expect to be much more specific in evaluating the efficacy of dailies it\\'s so important to develop that data even if this data indeed appeared to give safety guidance and said efficacy threshold, a detailed set of other protocols that also includes myofibroblasts. With that, it is good that the discussions of initiation and efficacy after PKC\\'s are at an end of March; with all the delayed lymphomas and our other lymphomas at bay, we have about 2 months left. This lets us have a good taste of getting some more data in April.\\\\nSo the ASHC recommendations will allow us to make more than one interim analysis of dailies, and so it is not as though I can announce anything quite fast-moving. As for negotiations on a PUC levy, we may need to look for action as we come into year-end; I\\'m more concerned about timing now than when we began the talks. A PUC levy is a very theoretical instrument to vote on, and dailies and PUC levies can strike well behind the headlines in some quarters but could also backfire in a referendum if done prematurely.\\\\nWhat\\'s most interesting is that the endocrinologist/physician position inside the Pacific Conference has been strengthened by the steps I\\'ve already laid out. Two pioneering novel therapies, one for LCR and one for chemo are important targets.\\\\nIf we see a protracted recovery and reversal of these drugs in this population, the PUC Board will at least continue on from 2013, with the potential for some of these newer patients to be effectively put on a regimen and then later to schedule the slower removal of the LCR drugs before full-blown treatment. Again I will reiterate the course point. Because those patients are trying harder drugs, once they come back from late-stage therapy, we will need to see the proportion of LCR patients increasing. A PUC levy would not be the final regulatory act, and yet.\\\\nBiotech and pharmaceutical may appear to be at the center of the 2014 TRIMMED COLLECTION (Full QSB) here at the Mouse Room, my company, ANDI, have also recommended getting the regulatory element out of the equation. I am here for the whole year.\\\\nI ask you not to add this comment to POSTPILATES (or any of the press on the subject)?\\\\n\"']", "inst_index": "47033", "domain": "PNAS | January22,2013 | vol.110 | no.4 | 1441", "url": "http://doi.org/10.1073/pnas.1211179110", "summary": "", "authors": "['Shuyu Ren, Bryce G. Johnson, Yujiro Kida, Colin Ip, Kathryn C. Davidson, Shuei-Liong Lin, Akio Kobayashi, Richard A. Lang, Anna-Katerina Hadjantonakis, Randall T. Moon, and Jeremy S. Duffield']", "date": "03-28-2013", "split": "test", "label": "machine", "status": "succcess"}
{"title": "Interplay of mevalonate and Hippo pathways regulates RHAMM transcription via YAP to modulate breast cancer cell motility", "warc_date": "20220328", "article": "['\\'I am a Senior Member of the Scientific Advisory Board of the International Fertility and Infertility Center in Singapore. The SIFC\\\\\\'s Laboratory Research Laboratories are the leading scientific and technical centers in the country to develop and test advanced technology for usurgery in an international and standardized manner. During its Prefeasibility Analysis recently completed, SIFC completed clinical trials of a monotherapy based on the Experimental Therapeutic Teliotherapy for the Treatment of Penal Cancer. The National Institute of Paediatrics has issued statements which are critical of this research, the leading expert statement comes from Shashi Singhal, Professor of Paediatrics and Interactions in Neurosurgery and Interactions in Psychiatry, who also holds the Ph.D. from CSU\\\\\\'s NSF Institute of Paediatrics.\\\\nMeldon Liao, MD, DrPHP Specialist for Paediatrics at the National Institute of Paediatrics is one of this support staff and also assists in gender assessment and consultation at all different consultation stages, enabling the access to information via phone and a consultation with a physician. He said \"Men can show interest by looking for the MRI \" and also, if the diagnostic guidelines regarding skin care instructions are not relaxed, the condition can not be rectified with oral procedures such as injections. These studies were conducted with a novel device, APPKri, which has already been approved in Germany, the US and Japan.\\\\nHe further highlighted on the same site in 2006, that the MENU is restricted mainly due to a lack of consultation and data analysis. He believed that this study could be set up, to improve the level of knowledge amongst male healthcare professionals. For many years, SRC laboratory has focused on research development and doctor\\\\\\'s visits, which are usually written in black and white, but SRC is now openly implementing recommendations, decisions, and recommendations for Men 18 years through the prostate initiative\\\\nThrough the diagnosis of prostate cancer and treatment of cancer most men ages 75 to 80 are undergoing treatment, almost all recommended prostate regimens at the age of 75 or above. Nevertheless SRC\\\\\\'s concept of prostate non-invasive regimen, and the use of his retractable implant where cutting the prostate using a vaginal razor is also recommended, has been endorsed by Congress in the USA, Japan, China, Mexico, India, and Australia. U.S. bill approved in 1999 recognizes the future direction of men\\\\\\'s health by promoting active lifestyle, support for exercise, good sleep and control of the body\\\\\\'s cells. While boosting the erectile sputum, SRC is also establishing an active sex life within 35-year-old males by erecting an IV which can be used without medication for larger erections.\\\\nIn Japan, Men 17+ age are given cartilage correction therapy before penis is removed, to improve erections. Men with other assets need to be included in a pregnancy test, which normally needs three females per 12-month cycle, since a woman is generally considered older and widower than a man, i.e. a male. However, the males who are not so attractive should not be subjected to these tests and therefore not judged due to men\\\\\\'s age alone. Women with this kind of imbalance need to have separate tests and some scientific support to be able to do and the prognosis is very negative in this regard.\\\\nIt is a very slow procedure in the prostate, as the rest of the body is simply waiting for the injection to occur. The treatment used by the NSF Institute of Paediatrics is on pace to be approved in the US in 2014. It is also important for men to be present at all developmental stages of prostate diseases. Many poor performing men also suffer from their prostate diseases. Currently, some facilities are looking to medical tourists in order to screen the necessary patients, which would then be sent to the doctor in the upcoming year, after being recommended treatment. A new solution for dealing with this problem could be to provide counseling, ideas and coordination of methods and surgeries. The evaluation and identification of cure rates, the prevention and placement of the disease in case of a severe and unavoidable ailment can be very important in determining the best treatment for men diagnosed with prostate cancer. Currently in Japan, with the launch of the World Comprehensive Rotana, Men admitted can be treated and one will be treated. Therefore, guidelines are for seeking treatment; cure rates are one to four years good and you can cure your prostate down to a less severe\\'']", "inst_index": "78021", "domain": "PNAS | Published online December 23, 2013 | E89\u00c3\u0083\u00c2\u0090E98", "url": "http://doi.org/10.1073/pnas.1319190110", "summary": "", "authors": "['Zhongyuan Wang, Yanping Wu, Haifeng Wang, Yangqing Zhang, Lin Mei, Xuexun Fang, Xudong Zhang, Fang Zhang, Hongbo Chen, Ying Liu, Yuyang Jiang, Shengnan Sun, Yi Zheng, Na Li, and Laiqiang Huang']", "date": "03-28-2014", "split": "test", "label": "machine", "status": "succcess"}
